data_1egx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1egx _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.9 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.778 0.323 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.483 HG13 ' NE2' ' A' ' 37' ' ' GLN . 71.5 t -61.08 156.19 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.618 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.441 HD12 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -104.8 -62.04 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.714 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.96 -177.55 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.428 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.454 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 24.4 p -154.0 121.2 5.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.495 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 9.0 p -128.46 154.7 45.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.021 0.439 . . . . 0.0 111.743 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -94.26 120.99 35.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.582 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 93' ' ' PHE . . . -174.1 156.15 2.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.983 0.421 . . . . 0.0 111.929 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.89 92.06 5.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.112 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.58 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 62.1 t -46.13 141.22 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.543 . . . . 0.0 112.065 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.596 ' CB ' ' O ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -134.32 140.92 46.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.06 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD22 ' CE2' ' A' ' 89' ' ' TRP . 11.8 mt -111.55 127.0 55.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.565 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.633 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.6 t80 -80.4 146.94 31.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.18 0.514 . . . . 0.0 111.705 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -120.4 77.21 1.24 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.934 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.51 -29.6 1.84 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.283 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.24 -28.97 62.28 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.881 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -121.16 -6.89 9.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.509 0.195 . . . . 0.0 111.214 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HG3' ' OH ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 64.33 76.75 0.34 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.737 0.303 . . . . 0.0 110.852 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.14 174.63 0.32 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.327 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.633 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 48.1 m95 -91.92 169.39 10.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 15' ' ' LEU . 5.2 mt -165.62 126.8 1.36 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.803 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -40.7 110.73 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.734 2.289 . . . . 0.0 112.738 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.14 -67.21 0.29 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.528 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.25 -112.26 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.688 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.39 -160.4 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.634 0.254 . . . . 0.0 110.732 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.59 -66.25 2.05 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.114 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.08 159.84 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.656 2.237 . . . . 0.0 112.317 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -145.15 163.03 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.161 0.505 . . . . 0.0 111.295 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 171.28 46.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.836 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 61.86 178.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.264 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.6 m -166.42 150.75 7.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.036 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -93.92 95.74 9.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.916 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.45 ' CG1' ' CG2' ' A' ' 49' ' ' VAL . 28.8 t -93.88 129.87 43.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.251 0.548 . . . . 0.0 111.74 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.483 ' NE2' HG13 ' A' ' 5' ' ' VAL . 53.6 mt-30 -126.08 148.79 49.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.062 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.424 ' CD1' ' CA ' ' A' ' 106' ' ' MET . 55.7 mt -97.61 150.11 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.346 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.467 ' HB2' ' HG2' ' A' ' 48' ' ' ARG . 6.4 m-85 -111.46 124.0 51.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.921 0.391 . . . . 0.0 111.42 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.477 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 15.3 t-160 -101.09 89.38 3.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.243 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -101.43 87.57 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.435 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 64.2 Cg_endo -72.5 -17.89 26.38 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.448 2.098 . . . . 0.0 112.598 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 t -52.82 -26.14 13.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.966 0.412 . . . . 0.0 110.498 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.97 5.52 5.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.288 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.11 50.33 13.83 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.184 0.516 . . . . 0.0 110.126 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.9 m -141.42 159.56 41.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.998 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.507 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 75.9 m-85 -130.31 163.34 27.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.467 ' HG2' ' HB2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -162.45 143.8 10.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.71 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.45 ' CG2' ' CG1' ' A' ' 36' ' ' VAL . 3.5 p -94.63 148.33 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.277 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG21 ' CD1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -149.9 116.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.541 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -139.59 147.52 19.24 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.916 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.41 162.67 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.8 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.53 172.65 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.5 mmm -111.94 45.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -133.4 162.92 54.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.865 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.29 -26.15 10.99 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.694 2.263 . . . . 0.0 112.562 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.77 -48.32 79.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.21 85.83 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.028 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -128.37 134.34 48.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.622 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.1 m -73.52 122.0 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 0.0 111.0 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.453 ' CG2' ' HB ' ' A' ' 13' ' ' VAL . 3.5 m -93.8 -20.38 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.278 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.452 HG13 ' CZ3' ' A' ' 89' ' ' TRP . 6.9 tt -139.06 138.16 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.615 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -162.92 66.12 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.52 166.64 14.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.836 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.47 140.2 46.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.981 0.419 . . . . 0.0 111.608 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.73 123.12 68.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.769 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 68' ' ' ARG . 28.2 m -138.3 110.61 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 111.669 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER 26.92 46.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.207 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.79 -22.57 0.1 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.512 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' CD1' ' A' ' 82' ' ' TRP . 2.5 t -105.64 137.86 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 117.201 0.5 . . . . 0.0 110.889 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.81 114.05 16.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.619 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.565 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.7 m-30 -50.53 127.98 19.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -93.86 -40.55 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.07 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 59.04 79.39 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.91 -50.59 72.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.203 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -135.53 173.35 5.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.638 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.72 -24.33 22.99 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.453 2.102 . . . . 0.0 112.303 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -126.16 58.44 1.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -169.74 143.06 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.972 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.503 ' CD2' ' CD2' ' A' ' 72' ' ' TYR . 1.4 m170 -139.62 106.71 5.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.358 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.418 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 1.3 tm0? -117.32 121.11 40.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.413 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.639 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 43.7 p90 -125.42 147.14 49.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.04 0.448 . . . . 0.0 111.346 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -108.46 113.98 27.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.665 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HA ' HG22 ' A' ' 70' ' ' VAL . 2.4 t70 -93.59 -87.55 0.24 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.255 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.73 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.966 0.412 . . . . 0.0 110.942 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.1 ttp85 -139.94 -4.4 1.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.382 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.94 177.99 4.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.03 0.443 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -140.6 124.75 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.317 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.639 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 90.3 m95 -101.33 85.48 2.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.062 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.602 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -97.57 96.74 1.86 Allowed Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.192 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.58 ' CB ' ' HA ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER -93.79 133.36 37.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.177 0.513 . . . . 0.0 111.659 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.46 129.02 39.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.367 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.533 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 7.3 m-85 -96.53 165.51 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.563 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.27 -37.15 2.72 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.978 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 m -120.45 160.73 22.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.198 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -62.16 -44.7 96.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.803 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -58.42 -35.39 72.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -59.06 -66.46 0.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.988 0.423 . . . . 0.0 110.539 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.453 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.86 -30.34 63.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.265 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.09 -43.22 54.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.877 0.37 . . . . 0.0 110.951 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.491 ' NE2' ' HA ' ' A' ' 101' ' ' GLN . 4.4 tp60 -68.11 -43.68 77.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.184 0.516 . . . . 0.0 110.812 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.495 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 4.5 t80 -51.98 -54.93 23.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.331 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.419 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . . . -60.15 -29.17 68.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.747 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.21 -64.28 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.122 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.21 -51.53 49.1 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.072 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 12.6 tpt -47.21 -61.63 1.8 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.933 0.396 . . . . 0.0 110.705 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.11 -37.05 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.402 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 t -65.86 -40.22 91.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.141 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -62.92 -56.29 18.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.745 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.434 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 6.3 mt -59.85 -16.95 32.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.616 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.09 -29.57 15.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.844 0.354 . . . . 0.0 111.916 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.42 1.11 54.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.592 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -111.06 -36.82 5.53 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.319 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -85.67 -32.11 22.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.576 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.407 -1.218 . . . . 0.0 112.475 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.1 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.865 0.364 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 45.1 t -87.35 159.44 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.599 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.457 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -112.39 -69.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.25 -178.4 4.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.761 0.315 . . . . 0.0 111.601 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.472 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -155.44 121.82 5.23 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.307 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.515 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 20.0 t -134.51 156.78 48.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.584 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -98.06 129.41 44.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.122 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.49 ' HB1' ' CD1' ' A' ' 93' ' ' PHE . . . -173.21 179.33 2.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.399 . . . . 0.0 111.192 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 m -114.13 91.59 3.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.294 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.473 ' HA ' HD22 ' A' ' 91' ' ' LEU . 96.1 t -47.23 143.28 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.249 0.547 . . . . 0.0 111.136 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.507 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -139.71 159.98 40.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.735 -179.114 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.43 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 3.8 mt -130.61 112.43 13.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.691 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.1 t80 -75.47 145.67 41.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.122 0.487 . . . . 0.0 111.712 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.82 79.98 1.63 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.962 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.83 -26.28 3.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.286 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.53 -30.94 51.54 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.104 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -129.61 5.08 5.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.637 0.256 . . . . 0.0 111.208 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.56 83.78 0.09 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.831 0.348 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 173.85 157.03 0.13 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.952 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.548 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.4 m95 -74.81 175.23 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.455 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 15' ' ' LEU . 1.4 mt -167.93 124.89 0.89 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.508 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -44.06 97.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.544 2.162 . . . . 0.0 113.056 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.43 ' CB ' ' HG ' ' A' ' 15' ' ' LEU . . . -46.49 -59.28 3.08 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.008 0.432 . . . . 0.0 111.445 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.8 -97.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.927 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.7 p -136.86 -76.26 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.273 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.4 -73.17 0.08 OUTLIER Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.616 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -45.03 164.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.959 2.44 . . . . 0.0 112.284 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -149.69 57.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.032 0.444 . . . . 0.0 111.173 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.22 49.23 1.38 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 61.77 -176.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.481 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -172.95 149.02 1.84 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.555 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.83 98.95 11.42 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.472 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 21.2 t -94.51 135.03 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.234 0.54 . . . . 0.0 112.02 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.472 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 47.4 mt-30 -130.95 152.02 50.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.025 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 53.7 mt -99.39 157.69 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.395 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -122.72 120.22 33.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.458 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 t-160 -93.59 98.18 10.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.682 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -101.26 94.92 4.36 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.864 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 87.1 Cg_endo -80.83 -20.34 7.78 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.281 1.987 . . . . 0.0 112.52 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 m -48.67 -31.51 6.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.154 0.502 . . . . 0.0 110.524 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.36 6.75 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.168 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.95 48.87 4.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.21 0.529 . . . . 0.0 109.969 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.5 t -133.04 155.77 48.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.081 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.531 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 50.9 m-85 -120.09 174.72 6.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.691 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 ttt180 -164.39 152.81 12.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.429 . . . . 0.0 111.733 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -112.88 138.98 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.138 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.0 120.24 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.848 0.356 . . . . 0.0 110.82 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.472 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -140.79 146.25 17.44 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.792 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.91 156.94 29.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.815 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.22 161.51 22.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.624 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -94.55 45.59 1.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.023 0.44 . . . . 0.0 110.588 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -94.52 163.94 21.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.946 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.23 -16.93 43.39 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.334 2.023 . . . . 0.0 111.535 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.75 -31.71 9.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.016 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.74 118.16 0.02 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.736 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -143.48 142.61 31.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 m -71.05 120.55 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.926 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.46 HG23 HG23 ' A' ' 13' ' ' VAL . 3.8 m -93.85 -18.58 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.457 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 7.0 tt -140.04 137.56 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.367 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -163.14 70.02 0.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.1 t -134.8 134.18 40.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.055 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -76.66 135.25 39.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.402 HD12 ' CB ' ' A' ' 47' ' ' PHE . 1.5 pt -108.03 166.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 0.0 111.071 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.8 m -158.43 -173.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.554 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.424 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -61.19 87.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.203 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.65 -33.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.356 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -84.43 130.51 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 117.179 0.489 . . . . 0.0 111.173 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.44 101.77 8.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.421 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -47.56 106.3 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.326 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.71 97.34 8.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.85 88.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.47 80.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 p -136.0 162.81 54.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.744 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.52 -22.9 13.43 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.591 2.194 . . . . 0.0 112.458 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.92 47.73 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.097 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 5.3 t80 -162.96 123.86 2.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.36 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.566 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.3 m170 -98.2 172.84 7.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.609 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.422 ' HG3' ' CH2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER 177.15 118.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.658 0.266 . . . . 0.0 111.185 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.547 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 43.4 p90 -133.85 137.57 45.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 111.921 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -101.09 108.86 20.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.38 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.435 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 28.6 t70 -93.65 -102.24 0.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.664 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -72.91 0.1 Allowed 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.006 0.432 . . . . 0.0 111.075 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.6 ttm105 -140.81 -13.01 0.97 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.358 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -106.74 -176.89 3.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.897 0.38 . . . . 0.0 110.242 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.421 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 1.3 t -136.97 122.91 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.45 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.5 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 71.3 m95 -94.0 91.61 6.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.468 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -72.19 164.61 54.39 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.268 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER -150.44 108.8 3.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.631 0.253 . . . . 0.0 111.17 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.447 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.55 102.44 14.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.26 0.553 . . . . 0.0 109.722 178.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.534 ' CE1' ' HA ' ' A' ' 99' ' ' ALA . 81.3 m-85 -70.16 163.72 25.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.198 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.57 -28.32 6.39 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.282 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.3 p -139.07 167.12 22.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -65.32 -40.6 93.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -43.74 97.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -52.09 -66.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 110.57 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.534 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -47.3 -32.81 5.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.517 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.33 -30.91 60.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 111.151 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -78.36 -48.54 15.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.515 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 4.7 t80 -51.4 -48.43 62.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.961 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.59 -33.82 76.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.986 0.422 . . . . 0.0 110.938 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.89 -67.66 0.27 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.7 -49.32 74.2 Favored Glycine 0 CA--C 1.508 -0.377 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.327 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 12.2 tpt -49.34 -60.27 2.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.865 0.364 . . . . 0.0 110.572 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.4 -36.34 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.224 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -40.93 82.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.023 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -58.34 -56.77 17.8 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.898 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.443 HD21 ' HE2' ' A' ' 106' ' ' MET . 6.3 mt -58.8 -26.23 63.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.181 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -88.65 -22.43 23.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.922 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.88 -3.41 45.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.027 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -109.44 -22.81 11.84 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.222 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.424 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 6.7 mt-10 -89.63 -38.97 13.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.335 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.463 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.714 0.292 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 39.4 t -67.15 153.48 8.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.584 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.427 HG13 ' HB ' ' A' ' 38' ' ' ILE . 0.7 OUTLIER -101.36 -71.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.069 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.76 -173.89 3.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.589 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.517 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 10.2 p -154.71 122.88 5.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.374 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.468 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 40.3 t -131.52 155.99 46.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 111.36 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.76 128.89 44.14 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.584 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.531 ' HB3' ' CD1' ' A' ' 93' ' ' PHE . . . -170.66 -178.61 2.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.965 0.412 . . . . 0.0 111.167 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 m -116.41 89.4 3.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.138 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.538 ' HA ' HD23 ' A' ' 91' ' ' LEU . 89.0 t -45.74 143.43 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.213 0.53 . . . . 0.0 111.504 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.497 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -140.2 150.43 44.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.461 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.41 HD23 ' CE2' ' A' ' 89' ' ' TRP . 2.8 mt -122.8 114.58 20.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.489 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.532 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.2 t80 -73.98 151.84 40.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.189 0.518 . . . . 0.0 111.568 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -128.64 82.05 2.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.16 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.07 -26.59 4.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.202 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.2 -28.8 43.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.252 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -132.29 7.81 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.605 0.24 . . . . 0.0 111.234 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt 53.92 82.11 0.09 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.754 0.312 . . . . 0.0 111.191 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.55 172.79 0.42 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.978 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.532 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.5 m95 -89.12 171.86 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.543 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.27 125.27 1.79 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.547 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -44.11 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.488 2.125 . . . . 0.0 112.741 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.441 ' HB1' ' CZ3' ' A' ' 89' ' ' TRP . . . -47.16 -56.8 5.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.625 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.64 -99.07 0.01 OUTLIER Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.943 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.7 -72.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.389 . . . . 0.0 111.219 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -132.16 -77.04 0.13 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.738 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.05 160.96 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.571 2.181 . . . . 0.0 112.413 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -142.03 57.42 1.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.072 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.39 48.9 1.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.493 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 61.62 -174.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.606 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -174.3 148.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.652 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.93 96.2 9.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.91 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.473 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 38.4 t -94.56 124.51 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.347 0.594 . . . . 0.0 112.082 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.517 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 53.1 mt-30 -114.51 164.29 14.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.42 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 30.9 mt -111.76 151.84 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.872 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.419 ' CD1' HG22 ' A' ' 50' ' ' VAL . 6.3 m-85 -111.99 121.0 43.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.402 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.524 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 15.5 t-160 -96.31 87.89 4.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.842 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.41 92.19 3.13 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.947 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 93.5 Cg_endo -78.49 -17.97 12.5 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.368 2.045 . . . . 0.0 112.601 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -47.47 -37.16 11.23 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.954 0.407 . . . . 0.0 110.854 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.89 -7.33 12.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.097 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.06 40.78 0.25 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.035 0.445 . . . . 0.0 110.39 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.75 170.37 16.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.732 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 40' ' ' HIS . 70.4 m-85 -130.95 171.91 12.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.855 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 1.2 ttt180 -151.59 146.24 25.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.087 0.47 . . . . 0.0 111.952 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.7 p -107.28 129.58 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.706 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 39' ' ' TYR . 1.4 t -138.3 119.09 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.192 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.473 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -142.26 149.89 21.62 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.839 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.1 159.59 35.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 0.0 110.59 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 166.8 15.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.4 mtp -107.95 45.71 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 4.5 pt20 -123.19 160.8 48.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.853 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 7.4 Cg_endo -49.55 -25.4 10.78 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.857 2.371 . . . . 0.0 112.435 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.89 -43.42 58.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.838 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.32 102.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.01 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -141.04 138.58 33.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.3 m -68.94 120.51 16.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.834 0.35 . . . . 0.0 110.918 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.462 HG23 HG22 ' A' ' 13' ' ' VAL . 2.9 m -93.81 -21.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.457 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 8.6 tt -138.13 135.72 44.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.542 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -160.81 64.0 0.3 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.025 0.441 . . . . 0.0 110.894 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.86 147.16 50.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -85.14 135.73 33.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.56 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.416 HD11 ' CB ' ' A' ' 47' ' ' PHE . 1.6 pt -108.45 114.54 46.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.409 ' HA ' HD21 ' A' ' 113' ' ' LEU . 1.8 m -102.56 164.9 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.973 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 1.2 ttm180 -46.44 97.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.178 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.29 -19.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.625 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.473 HG13 ' CE ' ' A' ' 106' ' ' MET . 2.4 t -89.97 119.81 37.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 117.54 0.67 . . . . 0.0 111.183 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -110.8 110.3 20.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.552 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.569 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.6 OUTLIER -49.02 105.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.263 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.9 88.91 5.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.842 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.449 ' NE2' ' CD2' ' A' ' 80' ' ' HIS . 2.1 tp60 -58.72 90.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.948 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.06 93.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.9 p -144.13 172.38 5.58 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.508 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 74.4 Cg_exo -50.1 -24.7 11.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.427 2.085 . . . . 0.0 112.398 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.64 57.75 1.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.767 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 1.1 t80 -159.73 113.29 2.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.475 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.449 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 22.1 m170 -107.91 104.79 14.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.317 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.459 ' HG3' ' CH2' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -116.37 127.26 54.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.512 -178.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.569 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 41.8 p90 -133.58 143.83 48.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 111.728 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.9 ttp85 -110.84 112.61 24.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.276 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.444 ' HA ' HG23 ' A' ' 70' ' ' VAL . 26.5 t70 -93.77 -102.38 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.73 -72.08 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 111.2 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.3 ttp-105 -140.97 -14.58 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.407 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -103.36 -177.79 3.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.459 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 1.8 t -136.17 129.04 46.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.553 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.48 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 77.3 m95 -101.25 97.98 8.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.538 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.459 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -78.84 159.63 46.0 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.002 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 13' ' ' VAL . 0.6 OUTLIER -148.41 106.01 3.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.77 0.285 . . . . 0.0 111.361 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.53 105.43 17.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.284 0.564 . . . . 0.0 109.902 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 11' ' ' ALA . 62.1 m-85 -74.11 161.51 29.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.949 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.42 -32.72 7.57 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.467 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.95 157.96 45.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.777 0.322 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -28.56 65.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -68.29 -48.62 64.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -52.69 -61.39 2.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.608 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.516 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -50.0 -30.95 11.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.365 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.73 -35.92 62.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 0.0 111.038 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 101' ' ' GLN . 6.7 tp60 -74.2 -44.18 54.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.039 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.477 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 2.3 t80 -52.84 -50.3 64.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.86 -32.22 73.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 110.695 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.15 -65.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.089 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.26 -45.66 78.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.904 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.534 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 15.2 tpt -49.34 -59.77 3.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.924 0.393 . . . . 0.0 110.39 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.68 -38.89 7.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.867 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 t -63.56 -36.19 82.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.932 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 106' ' ' MET . . . -66.41 -40.74 89.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.292 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.446 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 0.2 OUTLIER -76.31 -26.58 55.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.049 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.15 -22.83 41.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 0.0 111.5 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.13 -4.49 24.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.528 0.68 . . . . 0.0 109.321 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 5.2 mt -88.07 -36.37 16.98 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.249 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -104.64 -31.96 9.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.744 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.53 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.0 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.686 0.279 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 50.2 t -60.31 155.16 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.578 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -105.62 -69.45 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -133.35 -172.17 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.731 0.3 . . . . 0.0 111.352 -179.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.506 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.3 OUTLIER -157.59 127.68 6.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.482 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 29.6 t -135.69 152.95 51.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.39 . . . . 0.0 111.525 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -94.85 126.94 40.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.345 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' A' ' 93' ' ' PHE . . . -168.73 -176.46 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.067 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 92' ' ' ASN . 1.3 m -119.79 95.65 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.105 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 61' ' ' VAL . 40.0 t -44.95 154.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.107 0.48 . . . . 0.0 111.199 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.495 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -154.53 150.8 28.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.39 -179.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -127.24 110.91 13.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.577 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.553 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.3 t80 -71.34 150.24 45.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.147 0.498 . . . . 0.0 111.851 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.81 88.13 2.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.138 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -53.5 -22.05 7.39 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.501 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.38 -44.14 76.5 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.411 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -128.7 16.11 6.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 0.0 111.001 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 3.4 mmtt 50.7 88.25 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.155 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.79 147.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 13.9 m95 -68.57 169.44 11.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.636 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -165.04 111.65 0.83 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.428 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -40.08 95.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.864 2.376 . . . . 0.0 112.974 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.441 ' HB2' ' CZ3' ' A' ' 89' ' ' TRP . . . -50.85 -35.86 34.71 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.378 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.22 -95.32 0.01 OUTLIER Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.806 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -173.79 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.07 -94.7 0.12 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.835 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.76 161.77 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.726 2.284 . . . . 0.0 112.479 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -142.98 55.81 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.047 0.451 . . . . 0.0 111.185 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.39 47.44 1.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.358 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 60.4 176.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.575 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 11' ' ' ALA . 14.9 m -165.57 149.83 8.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.704 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.85 102.92 15.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.824 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 28.2 t -98.42 117.84 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.338 0.59 . . . . 0.0 112.128 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.506 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 47.8 mt-30 -107.7 151.83 25.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.446 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 106' ' ' MET . 54.2 mt -97.64 154.61 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.91 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.424 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.6 m-85 -117.14 121.98 42.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.492 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 3.7 t-160 -99.98 89.37 4.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.024 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -96.54 100.97 7.91 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.439 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 96.4 Cg_endo -81.67 -22.13 5.64 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.264 1.976 . . . . 0.0 112.692 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.7 p -50.37 -27.41 6.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 110.73 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.38 3.7 6.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.477 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 60.02 48.3 8.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.137 0.494 . . . . 0.0 110.123 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 m -136.27 -173.37 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.502 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.492 ' CD2' ' HA ' ' A' ' 40' ' ' HIS . 78.5 m-85 -151.19 165.03 35.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.973 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 12.8 mtt180 -147.42 157.75 43.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.061 0.458 . . . . 0.0 111.658 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 m -113.15 122.95 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.053 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -130.74 121.29 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.203 -179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 36' ' ' VAL . . . -141.56 140.5 10.26 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.734 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 15.7 ptp180 -123.24 147.1 47.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.799 0.333 . . . . 0.0 110.7 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 168.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.034 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtm -111.66 46.0 1.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.694 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -119.57 163.44 27.24 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.854 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.92 -24.67 14.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.603 2.202 . . . . 0.0 112.561 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.71 -43.96 21.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 60.78 105.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.036 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 2.0 pp0? -141.27 148.89 40.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.511 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.8 m -75.93 120.73 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 111.344 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.431 HG23 ' CG2' ' A' ' 13' ' ' VAL . 4.2 m -93.91 -24.45 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.066 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.46 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 12.2 tt -137.71 134.7 45.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -158.96 65.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.92 0.391 . . . . 0.0 111.004 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.91 -170.86 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.757 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -131.44 150.31 52.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.318 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.55 133.73 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.433 ' O ' ' C ' ' A' ' 68' ' ' ARG . 29.5 m -141.07 110.11 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.425 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 67' ' ' VAL . 1.4 ptt180 23.26 48.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.45 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.95 -23.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.841 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -95.82 130.26 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 117.373 0.587 . . . . 0.0 111.249 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -119.29 105.25 11.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.493 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.55 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.1 m-30 -47.59 105.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.405 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.54 95.18 6.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -59.09 97.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.36 92.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.191 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 0.8 OUTLIER -146.8 175.72 2.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 73.1 Cg_exo -51.32 -24.2 15.25 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.379 2.053 . . . . 0.0 112.501 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -140.48 62.72 1.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.02 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 3.1 t80 -162.42 130.4 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.12 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 30.4 m170 -118.64 105.94 12.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.451 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 1.4 tm0? -116.01 128.35 55.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.878 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.55 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 49.0 p90 -134.82 146.11 48.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 111.843 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -107.7 110.75 22.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.33 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.435 ' HA ' HG22 ' A' ' 70' ' ' VAL . 14.3 t0 -93.67 -97.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.817 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.91 -71.29 0.26 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.992 0.425 . . . . 0.0 111.314 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -141.21 -9.26 0.99 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.66 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.17 -170.82 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.432 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.451 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 1.1 t -141.24 123.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.336 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.533 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 69.6 m95 -97.45 91.69 5.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.382 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.484 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -75.17 153.68 45.31 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.203 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.422 ' HG ' ' CE2' ' A' ' 102' ' ' PHE . 1.9 mm? -140.46 106.99 5.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.576 0.227 . . . . 0.0 110.987 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -92.72 108.73 20.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.236 0.541 . . . . 0.0 110.069 179.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.531 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 39.3 m-85 -80.32 159.46 25.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.828 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.18 -30.08 17.99 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.573 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.44 174.72 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -70.91 -32.1 68.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -50.62 66.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -52.53 -61.86 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 110.456 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.479 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -51.58 -33.22 31.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.365 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.1 -31.66 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -76.75 -44.99 30.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.246 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.482 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 2.8 t80 -53.52 -47.62 69.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.42 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -68.68 -31.03 69.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.948 0.404 . . . . 0.0 110.78 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.64 -65.83 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.073 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.59 -44.66 89.34 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.845 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 15.0 tpt -50.43 -59.76 3.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.996 0.427 . . . . 0.0 110.374 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 111' ' ' GLU . . . -43.69 -41.63 4.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.124 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 t -62.02 -40.14 94.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.329 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.459 ' HB1' ' CD2' ' A' ' 47' ' ' PHE . . . -62.35 -51.62 66.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.422 HD22 ' CE ' ' A' ' 106' ' ' MET . 8.9 mt -65.85 -22.37 66.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.337 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 1.5 tt0 -84.68 -24.61 28.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.972 0.415 . . . . 0.0 111.313 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.71 3.64 34.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.754 0.788 . . . . 0.0 108.959 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.427 ' HG ' ' CD1' ' A' ' 47' ' ' PHE . 6.8 mt -95.45 -41.25 9.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.061 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.81 -31.97 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.743 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.34 -1.256 . . . . 0.0 112.529 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.5 m . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.772 0.32 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 25.1 t -66.02 149.05 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.536 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.429 HD13 ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -100.0 -72.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -121.61 179.67 4.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 111.445 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.497 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -154.33 122.95 6.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.948 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 35.7 t -133.1 153.61 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.052 0.453 . . . . 0.0 111.828 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.42 ' HD3' ' CG ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -95.37 128.77 42.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.961 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.573 ' CB ' ' HA ' ' A' ' 93' ' ' PHE . . . -177.8 156.97 1.14 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.957 0.408 . . . . 0.0 111.761 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.5 m -93.94 90.66 6.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.134 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.409 ' CG1' ' N ' ' A' ' 14' ' ' MET . 77.4 t -42.21 157.48 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.453 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.542 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -156.45 143.36 18.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.256 -179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.404 HD23 ' CD2' ' A' ' 89' ' ' TRP . 9.0 mt -119.59 123.54 44.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.265 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.568 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.0 t80 -79.7 143.23 34.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.179 0.514 . . . . 0.0 111.816 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.46 77.21 1.06 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.571 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.09 -29.01 1.35 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.429 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.78 -28.32 46.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.959 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -128.93 1.09 5.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.491 0.186 . . . . 0.0 111.329 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 5.5 tptt 58.54 82.14 0.14 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.809 0.338 . . . . 0.0 110.923 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER 175.84 161.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.577 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 35.5 m95 -81.25 172.5 13.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.682 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mt -172.86 116.27 0.38 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.669 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -39.91 117.52 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.9 2.4 . . . . 0.0 112.735 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB1' ' CZ3' ' A' ' 89' ' ' TRP . . . -54.57 -53.47 54.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.697 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.22 -107.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 CA-C-N 115.866 -0.607 . . . . 0.0 113.224 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.4 m -129.11 -81.03 0.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.775 0.322 . . . . 0.0 111.174 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.18 -70.7 0.05 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.726 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.75 154.14 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.657 2.238 . . . . 0.0 112.393 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -147.49 164.43 33.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.385 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 170.4 44.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.878 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.42 ' CG ' ' HD3' ' A' ' 10' ' ' ARG . 7.8 m-85 63.26 131.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.33 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 t -119.19 146.4 45.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.982 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.91 94.1 8.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.631 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.439 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 23.4 t -94.01 120.54 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.368 0.604 . . . . 0.0 112.027 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.497 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 9.2 mt-30 -113.58 169.07 9.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.599 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 38.0 mt -111.21 156.23 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.416 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.6 m-85 -114.5 116.88 29.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.37 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.469 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.2 t-160 -94.09 88.45 5.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -101.86 92.2 2.82 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.997 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 84.5 Cg_endo -79.76 -20.2 9.3 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.428 2.086 . . . . 0.0 112.544 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 p -48.7 -32.83 9.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.982 0.42 . . . . 0.0 110.638 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.6 2.55 8.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.211 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 62.93 48.53 3.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.212 0.53 . . . . 0.0 109.948 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.35 151.37 47.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.936 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.513 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 59.6 m-85 -118.51 174.18 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.836 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.9 ttt180 -164.19 150.55 11.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.109 0.481 . . . . 0.0 111.552 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.413 ' CG2' ' CG1' ' A' ' 36' ' ' VAL . 3.8 p -107.39 134.82 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.057 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.4 t -141.96 123.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.352 . . . . 0.0 111.033 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -140.87 144.86 15.23 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.738 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -129.13 142.79 50.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 165.87 13.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtt -107.28 46.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.438 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 1.1 pt20 -105.79 162.99 18.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.732 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 55.4 Cg_endo -69.98 52.58 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.481 2.121 . . . . 0.0 112.195 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -160.98 -35.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 66.4 114.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.068 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -151.52 124.32 8.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 m -65.55 125.29 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.9 m -93.82 -21.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.417 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.469 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 12.4 tt -141.42 140.46 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.619 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -164.43 66.7 0.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 110.875 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.8 t -128.72 131.78 47.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.957 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -75.55 136.49 40.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.396 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pt -109.99 165.78 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.969 0.414 . . . . 0.0 111.079 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HA ' HD11 ' A' ' 113' ' ' LEU . 16.0 m -158.54 -176.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.556 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.449 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 0.5 OUTLIER -58.73 89.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.57 -30.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.35 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -86.43 131.88 33.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 117.128 0.464 . . . . 0.0 110.743 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -119.49 114.94 23.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.777 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.609 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.0 OUTLIER -60.73 106.23 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.043 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.79 86.47 4.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.23 91.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.179 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.69 -57.54 12.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.455 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.3 p -129.09 160.47 63.58 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.348 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.455 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 6.0 Cg_endo -48.0 -26.17 7.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.714 2.276 . . . . 0.0 112.352 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -127.89 59.44 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.006 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 92' ' ' ASN . 7.1 t80 -175.87 130.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.501 ' CD2' ' CD2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -119.23 150.67 39.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.592 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -158.56 150.72 21.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.246 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.609 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 19.7 p90 -151.29 165.5 33.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.344 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -121.74 114.15 20.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.728 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.44 -35.84 12.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 110.44 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.74 -67.25 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.285 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -141.78 16.93 2.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.262 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.22 114.19 16.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 16' ' ' TYR . 2.4 t -93.54 108.93 21.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.865 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.495 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 84.6 m95 -93.78 85.91 4.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.91 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.577 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -97.07 132.48 11.01 Favored Glycine 0 C--O 1.223 -0.544 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.84 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.479 ' CD2' ' CZ3' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -124.09 129.99 51.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.944 0.402 . . . . 0.0 111.679 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.417 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -92.64 110.67 22.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.641 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.573 ' HA ' ' CB ' ' A' ' 11' ' ' ALA . 89.0 m-85 -75.61 162.91 27.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.786 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.87 -27.56 28.6 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.378 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.4 m -148.54 179.42 7.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -34.14 67.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.989 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -63.16 -51.05 67.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -52.66 -58.71 5.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.672 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.48 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -52.81 -33.92 51.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.44 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.43 -32.93 62.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.283 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.406 ' NE2' ' HA ' ' A' ' 101' ' ' GLN . 6.8 tp60 -74.49 -46.76 37.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.004 0.431 . . . . 0.0 111.03 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.506 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 21.5 t80 -51.6 -53.7 35.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.052 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.45 ' CB ' ' CE1' ' A' ' 80' ' ' HIS . . . -62.61 -29.89 70.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.024 0.44 . . . . 0.0 110.651 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.41 -65.82 0.5 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.052 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.33 -45.02 96.01 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.3 -0.952 . . . . 0.0 111.753 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.521 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 15.8 tpt -49.74 -59.46 3.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.924 0.392 . . . . 0.0 110.452 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.73 -37.74 2.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.931 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -38.58 89.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.033 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.513 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -62.63 -56.74 15.04 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.729 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.434 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 11.5 mt -59.86 -20.36 56.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.304 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -94.61 -22.44 18.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.669 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.29 -1.82 43.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.103 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -112.58 -28.92 7.65 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.299 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.449 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 3.3 mm-40 -91.09 -33.93 15.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.453 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.382 -1.232 . . . . 0.0 112.513 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.5 m . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.467 HG11 ' NE2' ' A' ' 37' ' ' GLN . 41.1 t -61.33 145.35 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.737 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.424 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -97.53 -70.16 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.78 -176.91 4.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.86 0.362 . . . . 0.0 111.57 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.516 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 12.6 p -156.15 126.43 6.62 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.222 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 16.7 t -135.72 158.34 44.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.984 0.421 . . . . 0.0 111.615 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HD3' ' CD1' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -102.03 124.67 48.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.397 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB3' ' CD1' ' A' ' 93' ' ' PHE . . . -167.03 -172.64 2.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.501 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' ASN . 18.8 m -124.67 91.49 3.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.149 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.516 HG21 HG23 ' A' ' 61' ' ' VAL . 78.9 t -42.32 156.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.476 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.482 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -153.96 134.59 13.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.778 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mt -112.47 110.7 21.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 0.0 110.285 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 16.7 t80 -71.41 141.03 50.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.115 0.483 . . . . 0.0 111.668 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.46 80.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.932 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.38 -26.2 4.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.33 -32.81 22.78 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.87 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -138.68 15.09 2.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.763 0.316 . . . . 0.0 110.633 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 2.4 mmpt? 46.46 90.7 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.244 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.81 133.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.792 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.566 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 12.3 m95 -59.31 146.2 40.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -141.44 112.3 6.54 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.315 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -40.65 99.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.81 2.34 . . . . 0.0 112.96 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.417 ' HB3' ' CZ3' ' A' ' 89' ' ' TRP . . . -46.95 -34.05 5.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.329 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.29 -108.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.642 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 t -146.34 -47.54 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.743 0.306 . . . . 0.0 111.327 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.28 -87.57 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.737 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.03 166.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.736 2.291 . . . . 0.0 112.451 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -141.91 58.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.41 51.66 2.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.414 ' CD1' ' HD3' ' A' ' 10' ' ' ARG . 52.9 m-85 55.69 178.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.682 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -165.56 143.59 5.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.86 96.22 9.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.925 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.457 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 21.6 t -93.83 114.67 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.369 0.604 . . . . 0.0 112.263 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.516 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 45.7 mt-30 -107.91 156.88 18.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.487 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 51.0 mt -102.93 148.12 8.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.423 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.1 m-85 -109.69 117.71 34.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 111.242 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.455 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.3 t-160 -95.41 88.61 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.11 101.84 9.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.53 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 89.5 Cg_endo -83.05 -21.03 4.87 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.342 2.028 . . . . 0.0 112.634 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.8 m -48.31 -29.66 4.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.041 0.448 . . . . 0.0 110.611 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.17 6.88 4.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.288 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.2 49.28 9.34 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.196 0.522 . . . . 0.0 110.028 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -130.87 166.57 20.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.408 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.531 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 53.4 m-85 -131.58 167.92 18.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.841 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -155.54 148.42 24.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.054 0.454 . . . . 0.0 111.832 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.4 m -109.66 123.41 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.673 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -131.9 119.4 41.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.829 0.347 . . . . 0.0 111.224 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 36' ' ' VAL . . . -136.67 144.58 16.28 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.652 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 1.9 ptt85 -131.21 149.77 52.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.659 0.266 . . . . 0.0 110.751 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -62.24 157.03 20.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.009 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mmt -98.7 45.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -121.5 160.93 44.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.795 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.05 -28.11 18.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.609 2.206 . . . . 0.0 112.435 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.52 -44.6 86.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 62.08 89.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.04 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 3.3 pt20 -131.46 150.12 52.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.86 124.0 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.03 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.516 HG23 HG21 ' A' ' 13' ' ' VAL . 3.7 m -93.85 -24.43 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.453 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 15.9 tt -137.93 143.1 34.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.528 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -166.57 59.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.823 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.53 140.37 50.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.726 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -83.51 134.41 34.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 111.475 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.03 127.33 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.84 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' ARG . 27.3 m -141.66 111.29 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.906 0.384 . . . . 0.0 111.52 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER 27.22 48.17 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.0 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.27 -36.84 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.706 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.564 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.5 t -91.08 141.81 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.472 . . . . 0.0 110.78 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.23 107.21 8.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.806 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 2.9 m-30 -53.55 118.3 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.69 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -93.94 -33.34 13.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.404 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 65.36 80.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.366 . . . . 0.0 110.601 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.65 -34.87 62.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.329 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 15.2 p -154.44 162.0 28.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.712 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 4.5 Cg_endo -46.78 -25.77 4.02 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.853 2.369 . . . . 0.0 112.307 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -122.12 35.21 4.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.216 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 4.8 t80 -154.6 118.52 4.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 111.18 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.456 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.7 m80 -110.97 103.92 12.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.393 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.408 ' HG3' ' CG1' ' A' ' 88' ' ' VAL . 24.5 tt0 -113.07 144.63 42.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.362 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.594 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 43.4 p90 -144.88 161.26 39.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.708 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -118.57 114.96 23.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.498 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.486 ' HA ' HG22 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -93.66 -81.67 0.36 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.395 -178.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.85 -67.73 0.88 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.885 0.374 . . . . 0.0 111.287 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.2 ttm-85 -139.82 -0.59 1.69 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.777 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.62 163.37 19.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.908 0.385 . . . . 0.0 110.395 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.408 ' CG1' ' HG3' ' A' ' 81' ' ' GLN . 1.6 t -120.75 127.62 75.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.805 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.594 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 66.5 m95 -101.63 91.24 4.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.194 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.544 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -86.83 122.47 6.14 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.496 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.489 ' HG ' ' CE2' ' A' ' 102' ' ' PHE . 3.0 mm? -103.02 111.07 23.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.615 0.245 . . . . 0.0 111.51 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -92.63 104.85 17.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.289 0.566 . . . . 0.0 109.625 178.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 11' ' ' ALA . 60.5 m-85 -77.69 164.19 25.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.255 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.77 -26.93 30.66 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.191 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.2 t -150.64 161.25 42.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.794 0.33 . . . . 0.0 110.617 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -25.5 61.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.253 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -58.69 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.079 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.53 -56.24 8.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.052 0.453 . . . . 0.0 110.62 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.503 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -49.16 -33.86 13.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.621 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.44 -30.92 65.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.319 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -76.08 -50.45 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.267 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.493 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 12.1 t80 -49.08 -52.63 24.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.456 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -64.01 -31.38 72.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.827 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.45 -65.38 0.55 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.194 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.9 -47.77 79.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.945 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 12.7 tpt -48.77 -60.67 2.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.969 0.414 . . . . 0.0 110.576 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.65 -37.71 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.314 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -37.78 85.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.968 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.3 -53.7 40.03 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.876 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.427 HD23 ' CE ' ' A' ' 106' ' ' MET . 10.1 mt -63.65 -15.63 58.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.244 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -92.42 -27.0 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.547 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.96 1.48 45.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.24 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -113.2 -37.18 4.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.314 -179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -94.61 -28.79 15.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.829 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.503 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.0 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.754 0.311 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.465 HG11 ' NE2' ' A' ' 37' ' ' GLN . 41.9 t -89.78 151.37 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.444 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -103.59 -69.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.959 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 -178.47 4.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.875 0.369 . . . . 0.0 111.634 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.5 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 9.4 p -152.35 126.21 9.02 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.163 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.501 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 39.1 t -135.03 165.77 24.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.007 0.432 . . . . 0.0 111.609 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -106.51 121.38 44.18 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 93' ' ' PHE . . . -166.77 175.6 7.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 111.129 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -114.84 95.43 5.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.32 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 61' ' ' VAL . 70.4 t -46.31 151.13 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.491 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -149.67 146.59 27.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.742 -179.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 4.0 mt -123.18 108.8 13.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.42 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.8 t80 -71.54 153.17 42.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.22 0.533 . . . . 0.0 111.959 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.83 88.58 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.23 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -53.34 -22.38 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.321 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.38 -34.9 69.4 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.621 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -132.77 13.99 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.666 0.27 . . . . 0.0 111.303 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 51.02 83.75 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.819 0.342 . . . . 0.0 111.036 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 179.11 155.31 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.061 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.55 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 28.8 m95 -73.27 172.63 10.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.53 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.8 115.91 0.91 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.377 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -41.01 94.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.802 2.335 . . . . 0.0 113.002 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HB1' ' CZ3' ' A' ' 89' ' ' TRP . . . -44.31 -44.03 7.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.679 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.56 -105.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.629 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.0 p -123.32 -79.38 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 111.022 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.78 -76.86 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.19 -178.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.617 2.211 . . . . 0.0 112.322 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -146.63 152.2 38.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -178.93 44.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.107 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 52.17 -175.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.418 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' ALA . 93.5 p -174.32 150.88 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.007 0.432 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -93.79 95.51 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.461 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.438 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 20.0 t -94.02 117.42 37.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.288 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.5 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 50.3 mt-30 -109.2 155.94 20.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.379 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.444 ' C ' HG13 ' A' ' 6' ' ' ILE . 62.0 mt -101.02 149.01 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.391 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -112.97 119.91 39.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.99 0.424 . . . . 0.0 110.96 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.485 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 10.7 t-160 -93.58 103.2 15.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.583 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -105.14 84.54 1.07 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.672 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 74.5 Cg_endo -74.97 -22.47 14.84 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.349 2.032 . . . . 0.0 112.432 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.5 p -51.66 -30.43 21.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.085 0.469 . . . . 0.0 110.487 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -129.32 7.39 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.139 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 61.35 48.83 5.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.138 0.494 . . . . 0.0 110.178 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.04 155.77 49.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.323 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.523 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 51.8 m-85 -124.42 178.14 5.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.623 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.1 ttm180 -167.38 157.3 10.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.059 0.456 . . . . 0.0 111.592 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.6 m -120.27 125.66 74.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.035 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.18 125.93 52.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.215 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -140.32 146.51 17.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.756 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -127.5 151.82 48.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.895 0.379 . . . . 0.0 111.146 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -55.58 158.88 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.8 mtp -98.81 45.39 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.569 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -130.44 163.24 49.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.706 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.01 -22.09 29.47 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 112.445 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -43.71 76.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.921 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 63.69 84.08 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -120.78 128.48 52.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.557 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 5.8 m -70.96 120.09 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 0.0 110.631 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 13' ' ' VAL . 3.1 m -93.67 -21.94 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.229 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.45 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 10.4 tt -138.67 139.7 40.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.376 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -165.34 69.13 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.025 0.44 . . . . 0.0 110.899 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 24.4 p -135.2 136.96 42.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -80.32 138.62 36.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.405 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.99 167.88 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 110.813 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 69' ' ' GLY . 21.4 m -156.5 -171.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.485 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 9.6 ttt180 -60.3 83.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.287 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 67' ' ' VAL . . . -177.59 -32.7 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.571 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 82' ' ' TRP . 3.2 t -82.43 133.31 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 117.342 0.571 . . . . 0.0 111.215 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.31 105.82 10.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.634 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.587 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.0 OUTLIER -53.88 104.4 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.284 -179.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -93.93 95.4 9.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.614 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.82 87.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.39 81.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.936 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.503 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 4.4 p -152.68 160.84 30.59 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.227 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 1.1 Cg_endo -43.28 -28.07 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.764 2.31 . . . . 0.0 112.377 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -128.74 57.76 1.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.76 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 2.0 t80 -166.47 113.19 0.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.149 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.491 ' CE1' ' CB ' ' A' ' 103' ' ' ALA . 2.7 m80 -111.21 101.99 10.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.043 0.449 . . . . 0.0 110.541 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HG2' ' N ' ' A' ' 82' ' ' TRP . 2.9 tt0 -108.41 156.42 19.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.036 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.592 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 46.7 p90 -156.4 151.82 26.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.347 0.594 . . . . 0.0 112.047 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.19 111.3 20.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.21 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 5.4 t0 -93.53 -90.92 0.19 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.353 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.02 -68.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.131 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -147.11 -4.01 0.55 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.669 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -105.34 179.98 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.342 . . . . 0.0 110.341 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.447 ' HB ' ' CB ' ' A' ' 16' ' ' TYR . 1.6 t -136.72 115.87 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.542 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.592 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 75.4 m95 -93.62 99.35 11.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.019 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.485 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -93.52 119.15 5.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.707 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.516 ' HG ' ' CE2' ' A' ' 102' ' ' PHE . 3.4 mm? -103.74 108.95 20.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.573 0.225 . . . . 0.0 111.506 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.434 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.83 107.68 19.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 110.108 178.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 11' ' ' ALA . 66.9 m-85 -78.09 161.91 27.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.119 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.69 -28.52 9.46 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.383 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.8 m -135.66 163.21 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.321 . . . . 0.0 110.769 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -63.86 -32.93 74.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -64.73 -53.17 51.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -48.58 -62.1 1.68 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.914 0.387 . . . . 0.0 110.469 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.5 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . . . -46.17 -38.92 8.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.49 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.12 -29.45 62.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.488 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -75.9 -49.63 17.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.516 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 6.6 t80 -51.66 -53.45 38.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.491 ' CB ' ' CE1' ' A' ' 80' ' ' HIS . . . -61.94 -31.91 72.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 110.741 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.94 -66.69 0.37 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.061 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.08 -40.39 98.09 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.639 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 16.9 tpt -51.64 -58.54 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.97 0.414 . . . . 0.0 110.422 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.49 -37.92 5.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.905 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 t -64.98 -38.21 90.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.948 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.523 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -64.51 -53.19 51.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.908 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.433 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 11.3 mt -65.46 -18.32 65.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.103 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -96.19 -21.37 17.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.712 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.22 -3.43 44.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.348 0.594 . . . . 0.0 109.716 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -112.37 -27.94 8.09 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.252 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.476 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 41.3 mt-10 -87.94 -34.44 18.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.535 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.337 -1.257 . . . . 0.0 112.523 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.8 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.945 0.402 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 24.4 t -89.28 159.75 2.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.393 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.488 HG13 HG21 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -112.32 -67.53 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 13.4 p -119.93 178.68 4.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.891 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -157.79 112.21 2.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.586 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 8.4 t -128.68 159.39 35.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 112.056 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -103.15 123.83 47.44 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.206 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 93' ' ' PHE . . . -168.17 -173.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 111.24 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.4 m -120.72 93.25 3.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.174 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.466 ' HA ' HD13 ' A' ' 91' ' ' LEU . 54.3 t -43.43 154.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.245 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.476 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -152.06 158.79 43.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.621 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 2.4 mt -137.44 108.08 6.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.53 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 9.4 t80 -68.23 154.1 42.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.319 0.581 . . . . 0.0 111.949 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.24 81.8 2.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.06 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -48.33 -25.81 1.75 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.466 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.6 -28.99 57.16 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.528 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -134.53 10.59 3.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.613 0.244 . . . . 0.0 111.325 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.86 81.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.926 0.393 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.447 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 177.67 159.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.913 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.566 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 25.3 m95 -75.92 171.67 14.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.611 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.19 119.12 1.18 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.541 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -43.18 93.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.682 2.254 . . . . 0.0 112.951 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' HB3' ' CZ3' ' A' ' 89' ' ' TRP . . . -44.92 -51.55 9.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.617 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -46.6 -96.4 0.01 OUTLIER Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.088 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.71 -82.79 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.297 . . . . 0.0 111.185 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.08 -94.3 0.87 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.562 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.3 166.19 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.541 2.16 . . . . 0.0 112.16 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.8 165.56 27.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.203 0.525 . . . . 0.0 111.473 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 173.28 43.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.583 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 62.53 -176.26 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' ALA . 2.0 t -175.04 153.91 1.72 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.741 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.68 96.83 10.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.418 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 21.9 t -97.43 122.7 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.066 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.481 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 15.9 mt-30 -114.02 172.22 7.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.384 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 68.7 mt -116.87 156.37 18.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.165 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.418 ' N ' HG21 ' A' ' 38' ' ' ILE . 7.6 m-85 -114.75 120.12 38.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.0 111.466 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.458 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 12.9 t60 -93.71 86.62 5.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.74 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.81 96.83 7.06 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.843 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 74.3 Cg_endo -84.53 -23.18 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.54 2.16 . . . . 0.0 112.624 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.4 t -47.85 -30.6 4.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.946 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.85 -5.22 9.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.399 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.05 43.01 0.7 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.089 0.471 . . . . 0.0 110.207 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.51 171.91 13.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.817 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 40' ' ' HIS . 65.0 m-85 -134.45 177.99 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.862 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -163.12 149.51 12.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.129 0.49 . . . . 0.0 111.63 -179.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.407 ' CG2' ' CG1' ' A' ' 36' ' ' VAL . 3.9 p -109.09 135.01 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.098 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.413 HG22 ' CE1' ' A' ' 39' ' ' TYR . 2.1 t -140.3 121.52 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.736 0.303 . . . . 0.0 111.306 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -143.62 147.45 18.79 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.85 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.47 150.78 52.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.757 0.313 . . . . 0.0 110.87 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.46 163.44 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 17.1 mtp -106.71 46.76 0.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -126.91 160.88 56.84 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.784 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.55 -26.45 6.38 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.753 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.89 -44.98 68.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.829 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.91 93.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -134.38 136.86 43.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.7 m -70.82 121.8 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.368 . . . . 0.0 110.863 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.425 ' CG2' ' CG2' ' A' ' 13' ' ' VAL . 3.9 m -93.75 -24.39 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.448 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 9.6 tt -138.28 135.28 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.471 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -161.9 71.88 0.37 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.917 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 18.0 t -136.81 144.9 43.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.037 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -83.82 130.91 34.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pt -102.72 117.0 47.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.869 0.366 . . . . 0.0 111.193 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -106.43 165.95 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.521 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.487 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 60.5 ttp85 -44.02 100.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.106 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.15 -23.52 0.21 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.087 -1.054 . . . . 0.0 113.847 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.482 HG12 ' CD1' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -100.09 123.54 53.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 117.617 0.709 . . . . 0.0 111.162 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.05 134.93 55.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.824 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.54 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.9 m-30 -67.6 126.75 30.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -95.09 -33.05 12.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 58.63 78.9 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.804 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.72 75.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.311 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 p -139.61 166.61 22.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.02 -24.41 14.14 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.44 2.093 . . . . 0.0 112.368 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.71 33.09 5.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -148.43 125.22 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.959 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.466 ' CD2' ' CE1' ' A' ' 93' ' ' PHE . 13.3 m-70 -125.22 98.71 5.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.295 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.42 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -112.76 146.59 38.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.768 -178.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.572 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 26.2 p90 -144.07 144.06 31.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.796 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.39 103.11 14.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.712 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.94 130.6 53.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 60.46 -82.57 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.725 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.44 -30.03 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.302 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -93.75 -168.89 1.98 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.884 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.42 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 2.4 t -137.07 129.68 43.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.977 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.572 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 74.2 m95 -97.61 100.89 12.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.182 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 14' ' ' MET . . . -94.44 130.87 10.48 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.566 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.499 ' HG ' ' CE2' ' A' ' 102' ' ' PHE . 3.0 mm? -114.92 111.54 21.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.808 0.337 . . . . 0.0 111.857 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.89 110.75 22.21 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.552 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 36.5 m-85 -86.69 159.79 19.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.331 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.66 -27.7 49.96 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.348 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 p -149.06 178.71 8.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.815 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -29.0 63.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.33 -56.87 12.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.999 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -52.21 -55.81 18.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.482 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.16 -28.15 62.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.276 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.85 63.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -76.39 -42.45 44.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.511 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 5.9 t80 -54.28 -48.42 71.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.57 78.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.871 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.88 -65.5 0.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.53 -50.5 61.54 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.957 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 11.7 tpt -47.72 -60.98 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 110.661 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.57 -33.63 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.343 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -33.88 69.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.079 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 106' ' ' MET . . . -68.56 -42.26 78.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.524 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.447 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -75.51 -29.48 59.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.063 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -75.32 -25.42 57.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.36 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.14 -3.72 27.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.513 0.673 . . . . 0.0 109.481 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 4.2 mt -90.05 -42.56 11.05 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.131 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.76 -33.84 11.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.68 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.403 -1.22 . . . . 0.0 112.492 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.458 -0.035 0 CA-C-O 120.856 0.36 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 29.4 t -76.54 151.15 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 40' ' ' HIS . 0.5 OUTLIER -107.45 -68.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 24.2 p -115.33 176.98 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.55 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.62 113.21 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.87 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 42.2 t -129.67 152.76 48.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.018 0.437 . . . . 0.0 111.879 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -95.13 130.63 41.76 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.031 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 93' ' ' PHE . . . -176.29 161.14 2.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 0.0 111.688 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.2 m -93.76 83.93 4.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.741 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 88.0 t -40.12 140.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.311 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.474 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.1 OUTLIER -129.62 179.08 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.361 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 88' ' ' VAL . 5.8 tp -160.64 113.78 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 0.0 110.225 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 8.7 t80 -73.53 149.3 42.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.392 0.615 . . . . 0.0 112.565 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.62 87.21 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.931 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -49.11 -23.53 1.27 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.618 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.64 -48.67 42.62 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.771 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -123.69 16.3 9.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.65 0.262 . . . . 0.0 111.164 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 1.1 mtmm 52.06 87.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 111.17 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.1 OUTLIER 178.01 161.91 0.59 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.036 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.534 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 20.5 m95 -80.91 171.14 15.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.566 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 15' ' ' LEU . 4.6 mt -167.17 125.59 1.03 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.541 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -43.83 102.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.587 2.191 . . . . 0.0 112.622 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' CB ' HG13 ' A' ' 13' ' ' VAL . . . -50.01 -38.47 37.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.384 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.81 -119.96 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.705 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.58 -68.04 0.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.852 0.358 . . . . 0.0 111.27 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.5 -72.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.769 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -47.95 167.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -145.53 56.62 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.026 0.441 . . . . 0.0 111.279 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.65 50.64 1.61 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.281 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 59.95 -176.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.433 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.92 142.64 2.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.85 94.34 8.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.055 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.463 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 39.2 t -93.85 146.14 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.342 0.591 . . . . 0.0 112.011 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.468 ' NE2' HG13 ' A' ' 5' ' ' VAL . 17.3 mt-30 -138.18 170.19 16.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.56 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 90.9 mt -112.06 153.9 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.301 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.444 ' CD1' HG23 ' A' ' 50' ' ' VAL . 3.5 m-85 -112.12 119.05 37.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.905 0.383 . . . . 0.0 111.785 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.48 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 23.2 t-160 -93.72 92.23 7.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.676 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -101.81 87.03 0.91 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.722 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 73.4 Cg_endo -74.32 -21.51 17.43 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.293 1.995 . . . . 0.0 112.465 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -48.85 -29.28 4.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.041 0.448 . . . . 0.0 110.568 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.87 8.29 4.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.231 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.71 49.2 8.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.207 0.527 . . . . 0.0 109.9 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 t -129.45 163.82 25.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.335 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 51.6 m-85 -133.5 169.14 17.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.656 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 2.0 ttm180 -165.1 148.61 8.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.738 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.405 ' N ' ' HG2' ' A' ' 48' ' ' ARG . 7.0 m -104.79 129.34 57.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.489 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.444 HG23 ' CD1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -135.27 123.66 39.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.463 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -146.46 146.24 16.03 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.862 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -126.49 158.64 35.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 172.92 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.815 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -108.51 47.52 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -128.27 158.13 72.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.12 -27.86 18.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.641 2.227 . . . . 0.0 112.454 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -42.24 85.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 60.19 99.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -135.98 132.71 36.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.761 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.4 m -70.42 120.94 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.045 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.458 ' CG2' ' CG2' ' A' ' 13' ' ' VAL . 5.9 m -93.84 -21.92 5.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.235 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.464 HG13 ' CZ3' ' A' ' 89' ' ' TRP . 9.9 tt -138.04 134.05 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.479 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -160.16 63.67 0.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.943 0.402 . . . . 0.0 110.86 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.1 t -124.62 139.99 53.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.967 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -87.02 150.38 24.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.349 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.46 141.47 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 68' ' ' ARG . 15.2 m -152.35 110.89 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.665 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER 26.62 47.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.33 179.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.12 -27.7 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.177 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.529 HG13 ' CD1' ' A' ' 82' ' ' TRP . 2.6 t -100.14 138.88 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 111.338 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -126.35 110.61 13.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.569 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' A' ' 106' ' ' MET . 1.5 m-30 -51.02 132.67 27.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.412 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.88 97.49 5.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.79 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.09 104.23 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.92 -34.66 64.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.022 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.4 p -150.28 174.36 3.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.524 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 65.3 Cg_exo -51.78 -24.54 18.52 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.382 2.055 . . . . 0.0 112.354 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -140.37 69.95 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.961 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -173.67 128.27 0.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 99' ' ' ALA . 32.1 m170 -117.04 146.89 42.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.413 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -154.91 138.25 15.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.984 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.542 ' NE1' ' HB2' ' A' ' 89' ' ' TRP . 15.5 p90 -145.96 142.05 28.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.145 0.498 . . . . 0.0 111.935 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.32 111.32 23.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.209 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 14.8 t70 -93.78 -93.43 0.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.608 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.18 -70.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.981 0.42 . . . . 0.0 111.402 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.01 -7.18 1.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.63 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 -168.86 1.43 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 110.621 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.464 ' O ' HD13 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -143.04 120.15 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.048 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.542 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 59.1 m95 -92.69 105.76 17.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.249 0.547 . . . . 0.0 110.74 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.529 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -106.95 174.36 19.88 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.664 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 13' ' ' VAL . 1.1 pt? -177.69 139.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.194 0.521 . . . . 0.0 111.54 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.19 121.37 42.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.404 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.481 ' CD2' ' CB ' ' A' ' 99' ' ' ALA . 53.4 m-85 -85.46 160.25 19.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.117 0.484 . . . . 0.0 111.785 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.55 -27.51 63.16 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.31 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.63 169.97 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 110.775 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -26.01 65.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.15 -49.21 62.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.6 -55.58 32.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.072 0.463 . . . . 0.0 110.056 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.481 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . . . -56.31 -29.17 60.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.367 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -31.22 64.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.384 . . . . 0.0 111.174 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -78.47 -43.41 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.144 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.447 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 5.1 t80 -54.41 -45.94 73.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.206 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.22 -29.31 63.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.69 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.28 -64.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.074 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.43 -49.17 58.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.995 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.48 ' HG2' ' CE2' ' A' ' 72' ' ' TYR . 12.3 tpt -49.19 -60.74 2.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.393 . . . . 0.0 110.611 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.95 -37.4 3.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.313 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -36.67 79.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.031 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.61 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.13 -51.95 58.14 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.679 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.454 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 6.8 mt -63.59 -18.07 63.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.873 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -94.85 -25.59 16.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.567 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.46 1.3 51.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.307 0.575 . . . . 0.0 110.083 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -112.42 -33.54 6.15 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.213 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -87.18 -32.77 19.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.322 -1.266 . . . . 0.0 112.434 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.4 m . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.81 0.338 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 44.0 t -60.66 146.66 10.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.658 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.421 HG13 ' HB ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -98.23 -68.98 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.826 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.78 -175.41 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.505 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.494 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 14.9 p -153.36 118.11 5.02 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.199 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.546 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 7.2 p -120.26 159.98 23.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.121 0.486 . . . . 0.0 111.876 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -107.16 118.77 37.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.564 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB1' ' HA ' ' A' ' 93' ' ' PHE . . . -167.69 -171.88 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.09 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m -123.52 90.62 3.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.16 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.46 HG22 HG21 ' A' ' 61' ' ' VAL . 69.5 t -42.26 148.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.065 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.5 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -143.65 163.8 32.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.065 -178.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.46 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 5.1 mt -136.58 112.0 9.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.454 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.6 t80 -75.93 147.39 38.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.244 0.545 . . . . 0.0 111.934 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.8 89.79 3.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.15 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -52.79 -21.65 4.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.85 -50.76 48.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.62 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -125.08 18.23 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.677 0.275 . . . . 0.0 111.141 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 7.9 mtpt 51.49 91.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.155 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 177.89 151.92 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.576 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 20.6 m95 -76.22 167.94 20.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.565 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' LEU . 1.6 mt -160.33 129.7 3.24 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.532 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.73 94.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.554 2.17 . . . . 0.0 112.903 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.46 ' CB ' ' HG ' ' A' ' 15' ' ' LEU . . . -46.07 -42.94 14.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.464 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.32 -110.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.82 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 t -126.85 -52.82 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 111.253 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.44 -82.68 0.04 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.693 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -47.7 168.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.576 2.184 . . . . 0.0 112.364 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -142.11 154.28 44.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.165 0.507 . . . . 0.0 111.322 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 175.57 44.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.954 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 56.71 175.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.618 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 11' ' ' ALA . 27.2 m -166.5 152.35 8.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.636 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -93.79 97.63 10.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.705 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.451 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 24.1 t -93.74 122.11 44.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.294 0.568 . . . . 0.0 112.092 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.494 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 47.1 mt-30 -116.2 154.82 29.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.763 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 41.8 mt -103.36 151.0 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.61 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.413 ' CD1' HG22 ' A' ' 50' ' ' VAL . 6.1 m-85 -110.28 122.48 47.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.047 0.451 . . . . 0.0 111.525 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.454 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 16.6 t-160 -101.13 91.33 4.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.113 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -101.55 88.51 1.19 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.508 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 63.0 Cg_endo -72.43 -19.55 24.99 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.34 2.027 . . . . 0.0 112.554 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.3 m -52.01 -26.66 11.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.664 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.44 8.56 5.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.84 49.32 14.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.042 0.449 . . . . 0.0 110.266 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.4 m -136.22 165.4 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.29 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.489 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 56.9 m-85 -134.32 173.24 11.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.609 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 7.2 ttp180 -165.8 150.78 8.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.421 . . . . 0.0 111.56 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.438 ' CG2' ' CG1' ' A' ' 36' ' ' VAL . 5.8 p -106.71 135.55 44.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.239 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 39' ' ' TYR . 1.4 t -142.91 118.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.974 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.451 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -138.3 143.56 14.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.934 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -126.09 148.91 49.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.749 0.309 . . . . 0.0 110.802 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.57 168.89 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -108.2 45.37 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -128.25 161.67 55.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.61 -31.03 23.49 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.668 2.246 . . . . 0.0 112.642 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -45.85 90.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.04 91.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.876 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -131.3 136.08 47.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.668 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.2 m -72.71 122.01 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.735 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.46 HG21 HG22 ' A' ' 13' ' ' VAL . 3.3 m -93.71 -20.58 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.24 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.454 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 8.8 tt -140.59 138.79 35.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.626 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -163.38 69.44 0.21 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.689 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -131.56 135.03 46.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.889 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -78.02 141.11 39.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.593 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.87 124.76 73.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.781 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 68' ' ' ARG . 16.1 m -138.59 110.06 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.904 0.383 . . . . 0.0 111.579 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.443 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 1.1 ttt180 29.62 73.47 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.997 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.67 -36.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 119.76 -1.21 . . . . 0.0 113.612 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.478 HG11 ' HB2' ' A' ' 82' ' ' TRP . 2.8 t -87.95 139.1 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.032 0.444 . . . . 0.0 111.519 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.16 97.88 5.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.168 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.7 m-30 -43.99 115.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.713 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -111.46 93.0 4.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.878 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.32 92.44 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.035 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.7 90.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.979 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.467 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 2.7 p -134.57 159.23 73.0 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.335 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 1.2 Cg_endo -44.06 -27.48 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.881 2.388 . . . . 0.0 112.561 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -123.8 47.63 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 111.082 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -155.24 141.71 18.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.955 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.523 ' CD2' ' CE1' ' A' ' 93' ' ' PHE . 15.6 m-70 -136.34 93.42 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.448 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 1.2 tm0? -104.19 140.58 37.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.213 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.563 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 48.7 p90 -143.07 147.28 34.79 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.144 0.497 . . . . 0.0 111.684 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -106.99 113.02 26.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.335 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.454 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 4.4 t70 -93.69 -91.05 0.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.78 -67.92 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 111.36 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -141.63 -8.08 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.512 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.54 -175.41 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.617 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.448 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 2.0 t -138.22 130.21 38.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.493 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.539 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 61.1 m95 -105.14 99.48 9.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.537 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -90.78 125.92 8.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.773 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.486 ' HG ' ' CE2' ' A' ' 102' ' ' PHE . 3.4 mm? -107.08 109.8 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.511 0.196 . . . . 0.0 111.43 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.408 ' C ' HD21 ' A' ' 92' ' ' ASN . 0.2 OUTLIER -92.58 109.42 20.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.404 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.534 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 14.7 m-85 -89.66 164.62 14.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.146 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.23 -40.74 5.39 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.555 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 162.33 25.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -31.13 70.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.946 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.37 -46.82 78.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -55.41 -58.86 6.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.961 0.41 . . . . 0.0 110.719 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 93' ' ' PHE . . . -55.93 -34.15 65.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.083 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.41 -39.99 62.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -67.12 -43.24 82.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.684 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.546 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 9.4 t80 -53.25 -51.87 60.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.904 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.22 68.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.685 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.94 -62.92 1.29 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.898 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.57 -50.26 50.3 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.929 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 12.8 tpt -49.71 -60.96 2.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.943 0.401 . . . . 0.0 110.515 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.55 -36.78 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.139 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -41.47 91.0 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.674 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.489 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -61.05 -56.17 24.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.312 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.408 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 8.0 mt -59.87 -20.48 57.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.946 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.54 -22.8 22.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.34 1.32 38.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.99 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -116.43 -32.7 5.17 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.131 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 21.0 mt-10 -105.34 -28.94 10.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.694 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.542 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.2 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.715 0.293 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 22.0 t -57.62 148.08 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.46 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -101.32 -67.66 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.775 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -137.51 -176.76 4.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.778 0.323 . . . . 0.0 111.558 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.439 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -152.45 124.23 7.91 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.186 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.485 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 13.3 t -133.72 149.17 51.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.794 0.33 . . . . 0.0 111.606 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.4 ttm105 -93.88 127.34 39.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.985 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.475 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -169.21 -176.2 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.925 0.393 . . . . 0.0 111.38 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -118.4 92.39 3.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.435 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 61' ' ' VAL . 53.4 t -44.59 154.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 0.0 111.108 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.2 OUTLIER -152.77 143.42 22.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.978 -179.163 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.1 mt -120.67 114.4 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.311 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.509 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.2 t80 -72.43 151.74 42.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 111.738 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.74 86.66 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.305 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -52.1 -23.49 5.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.411 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.06 -42.07 86.57 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.285 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -126.98 15.62 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 110.82 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER 47.19 83.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.092 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.96 150.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.807 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.526 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 14.4 m95 -69.37 169.0 13.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -165.44 114.17 0.82 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.508 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -41.7 100.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.695 2.263 . . . . 0.0 112.789 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -45.14 -43.97 10.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.536 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.99 -85.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.595 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.46 -80.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.744 0.307 . . . . 0.0 111.069 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -129.78 -70.0 0.12 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.543 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.42 170.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.554 2.169 . . . . 0.0 112.366 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -148.72 63.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.022 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.22 48.12 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 56.22 -178.03 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.707 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' ALA . 7.4 t -170.36 146.58 2.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.858 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -93.8 97.54 10.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.415 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.427 ' HB ' ' CE1' ' A' ' 102' ' ' PHE . 36.3 t -98.12 124.32 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.413 0.625 . . . . 0.0 112.022 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.439 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 55.5 mt-30 -115.06 160.59 19.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.419 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.46 ' C ' HG13 ' A' ' 6' ' ' ILE . 51.4 mt -108.51 147.45 13.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.32 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.416 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.7 m-85 -108.43 118.22 36.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.0 0.429 . . . . 0.0 111.081 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.511 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 t-160 -93.78 87.9 5.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.798 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.27 98.34 5.6 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.538 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 68.4 Cg_endo -85.32 -22.43 2.65 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.366 2.044 . . . . 0.0 112.598 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.9 p -48.28 -30.69 5.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.951 0.405 . . . . 0.0 110.61 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.59 4.5 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.244 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.88 48.59 5.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.237 0.541 . . . . 0.0 110.077 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 m -132.9 152.05 51.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.212 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 52.3 m-85 -120.82 163.53 18.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 31.6 mtt180 -147.54 149.61 32.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.152 0.501 . . . . 0.0 111.916 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.0 120.6 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.362 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.5 t -128.82 120.77 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 0.0 111.617 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.92 149.82 21.49 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.596 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 157.56 46.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 0.0 110.944 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -68.85 159.15 33.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.7 mtt -101.88 47.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -119.66 162.11 34.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.867 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.88 -26.02 17.12 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.555 2.17 . . . . 0.0 112.435 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.32 -42.47 59.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 60.55 99.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.808 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -137.92 137.57 38.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.6 m -71.65 121.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.949 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 13' ' ' VAL . 3.2 m -93.69 -21.34 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.005 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.456 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 16.8 tt -140.38 135.57 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.527 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -159.36 60.17 0.39 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.937 0.399 . . . . 0.0 110.907 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.6 167.91 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -111.84 128.97 56.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.235 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.75 143.56 18.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.07 0.462 . . . . 0.0 111.22 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.97 -170.01 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.336 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 4.9 ttt-85 -56.12 92.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.474 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.72 -26.8 0.13 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.928 -1.129 . . . . 0.0 113.758 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.509 HG23 ' HA ' ' A' ' 84' ' ' ASP . 2.2 t -94.84 122.62 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 117.412 0.606 . . . . 0.0 111.255 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -126.07 117.33 22.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.721 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.566 ' OH ' ' CE2' ' A' ' 102' ' ' PHE . 1.8 m-30 -50.46 127.07 16.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.018 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.77 -29.41 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.105 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.67 77.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 110.682 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.5 -39.76 67.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.264 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.433 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.7 p -150.85 173.51 4.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.431 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 78.4 Cg_exo -50.74 -24.85 13.96 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.384 2.056 . . . . 0.0 112.274 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -132.12 52.15 2.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.789 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 2.2 t80 -160.32 104.11 1.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.235 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.489 ' CE1' ' CB ' ' A' ' 103' ' ' ALA . 4.3 m80 -102.58 104.96 15.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.004 0.431 . . . . 0.0 110.824 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.42 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -115.99 144.1 44.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.159 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.605 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 27.4 p90 -143.51 147.48 34.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.115 0.484 . . . . 0.0 111.743 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -109.3 112.64 24.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.987 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.509 ' HA ' HG23 ' A' ' 70' ' ' VAL . 16.8 t70 -93.67 -96.32 0.15 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.807 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.94 -70.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.936 0.398 . . . . 0.0 111.362 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -137.64 -9.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.696 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -110.18 173.2 6.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.065 0.46 . . . . 0.0 110.923 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.42 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 3.4 t -129.04 130.46 68.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.271 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.605 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 71.0 m95 -105.39 97.27 7.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.31 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.526 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -91.16 122.63 6.79 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.383 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.535 ' HG ' ' CE2' ' A' ' 102' ' ' PHE . 2.5 mm? -106.01 111.57 24.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.826 -0.22 . . . . 0.0 111.489 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.436 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.66 103.25 15.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.333 0.587 . . . . 0.0 109.736 178.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.503 ' CD2' ' CB ' ' A' ' 99' ' ' ALA . 76.5 m-85 -72.85 154.17 40.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.95 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.89 -28.05 12.87 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.297 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 m -133.21 164.06 27.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.753 0.311 . . . . 0.0 110.797 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -29.78 70.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.019 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.79 -52.28 31.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.008 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -49.53 -57.25 7.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.421 . . . . 0.0 110.64 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.503 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . . . -52.11 -41.83 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.546 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.29 -31.49 67.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' ' 101' ' ' GLN . 6.8 tp60 -75.28 -47.59 27.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.239 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.566 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 3.3 t80 -51.54 -52.27 48.42 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.489 ' CB ' ' CE1' ' A' ' 80' ' ' HIS . . . -61.4 -32.49 72.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.91 0.386 . . . . 0.0 110.628 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.3 -66.13 0.44 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.189 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.13 -45.59 70.64 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.762 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.539 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 12.6 tpt -47.97 -60.62 2.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.908 0.385 . . . . 0.0 110.413 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.67 -36.43 11.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.004 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 t -64.82 -34.17 77.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.11 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.545 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -70.39 -51.25 31.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.589 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.416 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 0.7 OUTLIER -63.79 -18.14 63.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.183 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -98.52 -20.79 16.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.927 0.394 . . . . 0.0 111.88 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.75 -0.67 44.95 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.017 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -116.37 -32.79 5.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.315 -179.537 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.48 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 5.0 mt-10 -94.45 -28.07 15.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.53 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.813 0.34 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.485 HG13 ' NE2' ' A' ' 37' ' ' GLN . 65.2 t -88.7 158.6 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.477 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.481 HG13 HG22 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -112.82 -60.4 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.831 0.348 . . . . 0.0 111.931 -179.144 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 p -129.34 177.32 7.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.798 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.425 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.5 OUTLIER -157.98 110.55 2.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.638 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.454 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 4.6 m -128.69 163.55 24.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.208 0.528 . . . . 0.0 112.206 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.3 ttt85 -105.67 127.7 53.22 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.81 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HB1' ' CD1' ' A' ' 93' ' ' PHE . . . -169.85 -177.73 2.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 111.049 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -114.89 89.35 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.353 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.493 ' HA ' HD13 ' A' ' 91' ' ' LEU . 97.8 t -45.56 137.19 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.159 0.504 . . . . 0.0 111.077 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.5 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -136.24 161.24 36.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.789 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.475 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 5.0 mt -134.18 110.49 9.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.55 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.502 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.4 t80 -73.51 147.16 44.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.083 0.468 . . . . 0.0 111.672 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.67 88.04 2.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.356 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.45 -23.2 9.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.91 -36.18 72.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.545 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -133.83 13.44 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.664 0.269 . . . . 0.0 111.287 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 51.25 86.74 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.02 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.54 145.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.169 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.502 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.0 m95 -68.71 167.24 15.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.157 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 4.7 mt -161.3 131.55 3.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.689 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -45.85 92.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.643 2.228 . . . . 0.0 112.959 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.475 ' CB ' ' HG ' ' A' ' 15' ' ' LEU . . . -42.55 -66.66 0.34 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.772 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.61 -95.62 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.263 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.6 p -130.82 -85.03 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.657 0.265 . . . . 0.0 111.325 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.29 -88.38 0.35 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.708 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.32 161.95 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.616 2.211 . . . . 0.0 112.287 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.86 168.03 20.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.172 0.51 . . . . 0.0 111.594 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 166.96 44.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.626 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 62.41 -176.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.297 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -173.99 165.15 4.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -107.87 94.31 5.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.962 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.45 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 35.7 t -93.78 125.52 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.309 0.576 . . . . 0.0 111.908 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.485 ' NE2' HG13 ' A' ' 5' ' ' VAL . 48.8 mt-30 -119.02 155.29 31.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.884 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.481 HG22 HG13 ' A' ' 6' ' ' ILE . 72.4 mt -104.81 149.25 8.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.488 ' HB2' ' HG2' ' A' ' 48' ' ' ARG . 16.9 m-85 -115.37 126.01 53.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.061 0.458 . . . . 0.0 111.366 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.447 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 3.5 t-160 -93.76 98.46 11.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.168 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -102.46 89.52 1.77 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 72.2 Cg_endo -74.98 -20.61 16.74 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.22 1.947 . . . . 0.0 112.454 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -48.4 -31.21 5.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.068 0.461 . . . . 0.0 110.587 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.97 6.93 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.224 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.98 48.17 5.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.045 0.45 . . . . 0.0 110.005 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.7 t -129.79 179.66 5.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.642 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 40' ' ' HIS . 81.9 m-85 -149.56 166.52 28.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.525 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -160.38 152.59 20.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.0 0.429 . . . . 0.0 111.539 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.04 128.62 61.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 2.2 t -132.41 118.31 35.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.976 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -138.82 147.13 19.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.072 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -128.66 157.82 40.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.695 0.283 . . . . 0.0 110.52 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.41 ' CD ' HG11 ' A' ' 61' ' ' VAL . 1.5 tptt -73.38 161.9 29.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.946 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.1 mmt -98.33 42.82 1.08 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.519 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -96.99 163.36 20.21 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.983 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.74 -18.42 33.69 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.212 1.941 . . . . 0.0 111.371 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.39 -36.39 8.45 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.671 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 62.66 125.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.051 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -145.39 137.11 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.639 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 m -65.97 119.49 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.414 . . . . 0.0 111.224 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.451 ' CG2' ' CG2' ' A' ' 13' ' ' VAL . 3.8 m -93.88 -27.31 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.43 HD11 ' CE3' ' A' ' 89' ' ' TRP . 15.5 tt -138.19 132.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.559 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -159.51 67.38 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.399 . . . . 0.0 110.807 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.2 t -126.08 161.53 27.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.796 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -104.19 148.3 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.613 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.74 142.92 32.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.832 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.454 ' O ' ' C ' ' A' ' 68' ' ' ARG . 17.6 m -146.96 112.21 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.489 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 67' ' ' VAL . 1.0 OUTLIER 22.22 76.19 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.336 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.74 -33.26 0.06 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 119.643 -1.265 . . . . 0.0 114.12 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.454 ' CG2' ' HA ' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -93.64 125.37 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.386 0.593 . . . . 0.0 111.568 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 147.5 32.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.081 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.578 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.7 OUTLIER -86.14 104.14 15.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 0.0 111.238 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.04 98.06 10.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.629 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.54 83.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.047 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.12 -28.57 40.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 0.0 110.85 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.452 ' OG1' ' HD2' ' A' ' 77' ' ' PRO . 3.8 t -166.01 150.63 7.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.086 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.452 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 56.3 Cg_exo -37.63 -29.25 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.048 2.499 . . . . 0.0 113.589 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -121.49 50.34 1.41 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.769 0.319 . . . . 0.0 111.547 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 7.2 t80 -170.0 127.51 0.87 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 111.424 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.513 ' CD2' ' CD2' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -118.02 111.83 19.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.287 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.412 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 1.5 tm0? -119.15 131.22 55.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.554 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.578 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 43.8 p90 -138.07 142.25 40.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.207 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -88.22 105.81 17.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.454 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 32.0 t70 -105.04 130.02 53.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.734 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 61.93 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.466 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -136.33 -31.29 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.88 -168.86 1.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.961 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.412 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 2.1 t -137.87 124.86 28.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.651 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.469 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 78.5 m95 -93.78 98.83 11.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.522 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.488 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -80.6 161.91 44.88 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.031 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -148.22 106.99 3.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.474 0.178 . . . . 0.0 110.95 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.41 104.76 17.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.225 0.536 . . . . 0.0 110.016 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 80' ' ' HIS . 78.7 m-85 -71.56 162.85 28.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.928 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.33 -26.2 5.51 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.258 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.47 159.8 40.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.879 0.371 . . . . 0.0 110.802 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -60.97 -40.36 93.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.03 -44.24 97.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.104 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -51.76 -68.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.011 0.434 . . . . 0.0 110.474 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.476 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -47.2 -31.47 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.687 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.51 -36.42 57.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.787 0.327 . . . . 0.0 111.38 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.441 ' HB3' ' OG ' ' A' ' 9' ' ' SER . 6.0 tp60 -77.65 -41.25 38.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.203 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.481 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 7.8 t80 -56.31 -50.78 70.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.014 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.424 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -65.46 -32.71 74.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.443 . . . . 0.0 110.867 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.03 -64.74 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.511 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.9 -51.87 49.86 Favored Glycine 0 CA--C 1.508 -0.354 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.159 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.502 ' HG2' ' CE1' ' A' ' 72' ' ' TYR . 12.2 tpt -46.68 -62.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.48 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.57 -33.27 2.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.451 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.38 -35.44 73.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.087 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' MET . . . -70.7 -46.35 63.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.721 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.449 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 5.0 mt -67.68 -34.26 76.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.722 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -75.69 -20.38 58.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.19 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.17 2.68 29.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.601 0.715 . . . . 0.0 109.095 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 6.9 mt -100.21 -38.37 8.53 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.954 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -105.36 -30.68 9.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.66 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.427 -1.207 . . . . 0.0 112.534 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 CA--C 1.527 0.062 0 CA-C-O 120.847 0.356 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 52.4 t -84.56 158.33 3.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.559 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.432 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -103.59 -68.32 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.71 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -137.23 -170.65 2.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.353 -179.344 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.489 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.4 OUTLIER -156.76 122.54 4.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.201 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 1.5 p -128.83 153.56 47.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 111.751 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -97.84 127.43 43.78 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.707 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -171.44 -175.09 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 111.4 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -117.3 95.47 4.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.427 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.484 ' HA ' HD11 ' A' ' 91' ' ' LEU . 86.4 t -45.82 156.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.096 0.474 . . . . 0.0 111.249 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -154.64 161.84 41.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.245 -179.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 24' ' ' LEU . 1.8 mt -139.03 110.87 7.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.753 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 8.8 t80 -70.92 152.43 43.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.25 0.548 . . . . 0.0 112.044 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -123.26 79.67 1.7 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.063 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -47.24 -26.03 1.1 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.491 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.08 -38.31 89.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.356 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.81 2.85 10.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.672 0.272 . . . . 0.0 111.246 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.5 82.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.824 0.345 . . . . 0.0 110.928 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.25 158.36 0.28 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 18.0 m95 -74.76 170.25 16.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 110.599 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -163.84 117.66 1.06 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.424 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -42.93 93.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.662 2.241 . . . . 0.0 112.789 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' HB1' ' CZ3' ' A' ' 89' ' ' TRP . . . -44.8 -54.07 6.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.648 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.39 -94.05 0.01 OUTLIER Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.813 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -142.12 -79.65 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.845 0.355 . . . . 0.0 111.038 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.51 -71.59 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.504 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.41 170.51 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.552 2.168 . . . . 0.0 112.325 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -153.36 59.05 0.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.04 0.447 . . . . 0.0 111.154 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.97 51.39 1.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.543 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 59.62 -175.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.648 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -176.71 147.74 0.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.533 -179.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.67 99.74 12.1 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.45 ' HB ' ' CE1' ' A' ' 102' ' ' PHE . 47.5 t -98.15 125.8 51.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.329 0.585 . . . . 0.0 112.121 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.489 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 49.0 mt-30 -115.36 156.4 25.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.191 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.454 ' CD1' ' N ' ' A' ' 106' ' ' MET . 45.3 mt -105.68 149.02 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.761 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.427 ' CE1' HG23 ' A' ' 50' ' ' VAL . 6.6 m-85 -111.69 122.09 46.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.996 0.427 . . . . 0.0 111.396 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.565 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 15.9 t-160 -98.19 89.15 4.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.202 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.41 99.77 6.89 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.755 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 79.4 Cg_endo -84.05 -21.62 3.81 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.331 2.021 . . . . 0.0 112.595 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.4 p -49.66 -32.66 13.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.945 0.402 . . . . 0.0 110.709 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.14 -2.23 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.327 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 67.53 45.05 1.61 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.19 0.519 . . . . 0.0 110.254 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.04 179.36 6.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.039 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.565 ' CD2' ' HA ' ' A' ' 40' ' ' HIS . 77.3 m-85 -142.07 179.99 6.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 1.1 ttp180 -164.95 150.38 9.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.073 0.463 . . . . 0.0 111.591 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.7 m -109.74 123.64 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.139 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.427 HG23 ' CE1' ' A' ' 39' ' ' TYR . 1.6 t -128.14 118.11 47.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.145 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -141.26 150.07 21.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.986 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -130.47 155.25 46.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.303 . . . . 0.0 110.613 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.38 165.76 7.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 10.4 mtp -107.12 47.13 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.915 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.24 163.5 29.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.29 -26.4 27.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.618 2.212 . . . . 0.0 112.503 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.88 -41.72 59.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.928 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 103.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.886 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -141.99 138.69 32.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 17.2 m -68.73 118.72 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.435 ' CG2' ' CG2' ' A' ' 13' ' ' VAL . 3.2 m -93.77 -22.17 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.455 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 9.2 tt -137.79 131.01 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.51 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -158.99 69.16 0.46 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.878 0.37 . . . . 0.0 110.995 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.28 135.76 41.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -76.29 137.7 40.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.422 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.34 125.14 69.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.963 0.411 . . . . 0.0 111.095 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.412 ' HA ' HD22 ' A' ' 113' ' ' LEU . 2.1 m -110.63 174.97 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 23.4 ttm180 -48.55 94.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.054 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.24 -19.64 0.15 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.912 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.622 HG13 ' HB2' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -95.59 121.4 46.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 117.719 0.76 . . . . 0.0 111.142 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -108.04 175.48 5.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.294 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.55 ' CE1' ' HG2' ' A' ' 106' ' ' MET . 0.4 OUTLIER -114.15 100.4 8.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 111.197 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.72 81.67 3.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.614 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.414 ' HG2' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -48.36 105.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.17 85.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.43 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -151.94 177.22 1.98 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 77.6 Cg_exo -50.53 -25.24 14.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.367 2.045 . . . . 0.0 112.131 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.87 65.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.781 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.6 t80 -168.16 109.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 3.3 m80 -108.66 119.46 39.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.9 0.381 . . . . 0.0 110.496 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.66 148.18 45.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.265 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.622 ' HB2' HG13 ' A' ' 70' ' ' VAL . 32.9 p90 -147.24 133.55 19.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.684 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -80.09 100.3 8.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.385 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -102.08 125.0 48.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.175 0.512 . . . . 0.0 110.676 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 68.24 -79.01 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.544 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -139.38 -34.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -93.86 -168.13 1.82 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.4 t -137.41 136.03 46.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.947 0.403 . . . . 0.0 111.073 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.594 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 68.1 m95 -100.62 99.08 9.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.076 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.504 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -87.04 131.55 10.64 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.386 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.484 HD11 ' HA ' ' A' ' 13' ' ' VAL . 2.0 mm? -115.82 113.72 23.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.277 . . . . 0.0 111.691 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.94 105.47 17.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.206 0.527 . . . . 0.0 109.673 178.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 80' ' ' HIS . 78.1 m-85 -73.53 153.94 40.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.952 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.98 -28.07 7.96 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.274 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 m -129.29 165.19 21.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 0.0 110.808 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.85 -28.52 66.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.064 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -71.57 -49.31 41.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -49.99 -58.71 4.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.992 0.425 . . . . 0.0 110.738 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -51.39 -41.65 60.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.686 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.54 -34.97 65.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.501 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 101' ' ' GLN . 6.4 tp60 -73.99 -45.23 51.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 111.24 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.512 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 2.7 t80 -52.62 -53.87 41.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.97 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.473 ' CB ' ' CE1' ' A' ' 80' ' ' HIS . . . -60.65 -31.71 70.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.423 . . . . 0.0 110.596 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.28 -66.33 0.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.197 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.57 -43.58 76.1 Favored Glycine 0 CA--C 1.507 -0.426 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.931 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.55 ' HG2' ' CE1' ' A' ' 72' ' ' TYR . 13.8 tpt -47.58 -59.55 3.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.908 0.385 . . . . 0.0 110.36 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 111' ' ' GLU . . . -47.5 -41.34 20.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.741 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -34.41 72.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.358 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . . . -70.95 -44.69 65.56 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 121.035 0.445 . . . . 0.0 110.725 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.45 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -72.71 -34.04 66.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.486 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 1.9 tt0 -75.1 -22.63 58.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.964 0.411 . . . . 0.0 111.45 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.39 -3.52 28.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.675 0.75 . . . . 0.0 109.088 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.481 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 5.4 mt -92.21 -41.64 10.32 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.6 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -99.66 -31.23 11.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.852 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.506 179.937 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.0 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.73 0.3 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.495 HG12 ' NE2' ' A' ' 37' ' ' GLN . 34.9 t -73.85 153.81 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.638 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.424 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -103.53 -69.48 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 -176.73 3.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.029 0.443 . . . . 0.0 111.935 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.52 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 6.2 p -155.89 121.91 5.05 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.065 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.471 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 38.7 t -134.23 155.77 49.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.971 0.415 . . . . 0.0 111.71 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.6 ttp85 -97.85 128.79 44.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.454 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -170.92 -175.89 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.217 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 m -119.53 96.85 5.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.415 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.508 ' HA ' HD13 ' A' ' 91' ' ' LEU . 41.1 t -48.88 151.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.116 0.484 . . . . 0.0 111.153 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 89' ' ' TRP . 0.6 OUTLIER -151.64 144.9 24.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.578 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.6 mt -121.8 116.22 24.06 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.7 t80 -81.19 141.35 34.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.145 0.497 . . . . 0.0 112.017 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.1 84.95 2.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.577 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.77 -23.55 4.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.609 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.17 -27.96 7.83 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.263 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -142.73 16.78 1.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.721 0.296 . . . . 0.0 110.947 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 48.19 87.1 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.93 0.395 . . . . 0.0 111.291 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.47 142.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.747 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.56 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 35.2 m95 -61.39 -178.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 3.0 mt -177.01 114.11 0.25 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.218 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -40.92 99.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.816 2.344 . . . . 0.0 112.917 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB3' ' CZ3' ' A' ' 89' ' ' TRP . . . -44.03 -40.33 4.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.68 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.92 -102.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.476 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 t -133.42 -46.23 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.379 . . . . 0.0 110.886 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.75 -66.32 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.062 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.62 163.16 2.92 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.723 2.282 . . . . 0.0 112.099 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -142.07 139.79 32.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.077 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -170.99 45.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 55.31 173.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.784 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' ALA . 24.4 m -167.14 151.35 6.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.645 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.75 98.62 11.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.72 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.425 ' HB ' ' CE1' ' A' ' 102' ' ' PHE . 23.7 t -97.34 119.92 46.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.259 0.552 . . . . 0.0 111.949 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.52 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 47.8 mt-30 -109.76 166.54 10.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.543 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 106' ' ' MET . 55.1 mt -109.9 151.59 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.52 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.411 ' CE1' HG22 ' A' ' 50' ' ' VAL . 5.5 m-85 -112.65 117.13 31.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.991 0.424 . . . . 0.0 111.349 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.463 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 5.0 t-160 -93.88 90.97 6.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.634 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -103.14 86.85 1.13 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 83.1 Cg_endo -76.35 -19.7 14.91 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.339 2.026 . . . . 0.0 112.536 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -50.26 -32.1 15.91 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.991 0.424 . . . . 0.0 110.551 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.29 6.11 6.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.219 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.45 49.16 5.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.248 0.547 . . . . 0.0 110.039 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.5 m -136.64 150.44 48.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.207 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.515 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 59.2 m-85 -120.62 174.01 6.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.563 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.8 ttp180 -164.34 149.34 10.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.093 0.473 . . . . 0.0 111.592 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 m -109.42 126.31 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.798 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.411 HG22 ' CE1' ' A' ' 39' ' ' TYR . 1.8 t -129.69 121.09 51.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.802 0.334 . . . . 0.0 111.429 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 36' ' ' VAL . . . -137.43 148.87 20.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.866 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.29 146.62 52.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 110.972 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm -54.08 157.4 2.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.159 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 5.8 mtt -103.52 46.4 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -129.0 163.31 46.56 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.04 -24.89 15.18 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.605 2.203 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.99 -44.45 69.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.932 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 60.37 99.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -142.05 138.2 31.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.72 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.4 m -70.77 122.22 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.189 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.426 ' CG2' ' CG2' ' A' ' 13' ' ' VAL . 3.8 m -93.84 -29.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.493 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.458 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 17.2 tt -138.55 138.15 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.874 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -165.89 63.18 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 110.539 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.3 t -126.99 135.28 50.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.911 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -75.36 136.48 40.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.678 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.62 168.28 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.592 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.417 ' CB ' HD11 ' A' ' 113' ' ' LEU . 19.0 m -157.06 -173.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.628 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -57.69 87.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.208 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.37 -30.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.686 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.524 HG11 ' HB2' ' A' ' 82' ' ' TRP . 2.6 t -83.14 133.42 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 117.38 0.59 . . . . 0.0 111.093 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.67 115.61 23.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.845 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.57 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -64.56 106.05 1.08 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -99.77 96.98 7.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 91.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.79 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -151.49 176.35 2.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.405 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 74.3 Cg_exo -49.89 -25.71 12.6 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.289 1.993 . . . . 0.0 112.107 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -138.18 65.89 1.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.649 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.0 t80 -165.9 112.25 0.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.356 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.487 ' CE1' ' CB ' ' A' ' 103' ' ' ALA . 2.0 m80 -110.62 101.33 10.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.061 0.458 . . . . 0.0 110.555 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.413 ' OE1' ' CH2' ' A' ' 23' ' ' TRP . 6.1 tt0 -107.68 150.28 27.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.057 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.57 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 46.0 p90 -151.31 148.57 28.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.965 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -112.29 112.54 24.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.223 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.451 ' HA ' HG21 ' A' ' 70' ' ' VAL . 8.0 t0 -93.45 -92.07 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.453 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.82 -69.38 0.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.988 0.423 . . . . 0.0 110.979 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 22.7 ttp180 -144.49 11.02 1.46 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.055 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.57 159.69 28.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.108 0.48 . . . . 0.0 110.571 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 16' ' ' TYR . 1.5 t -120.3 114.35 43.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.471 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.546 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 66.4 m95 -93.51 94.63 8.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.116 0.484 . . . . 0.0 111.301 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.485 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -86.13 118.48 4.87 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.664 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 13' ' ' VAL . 2.7 mm? -104.39 110.59 22.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.599 0.238 . . . . 0.0 111.377 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.49 106.3 18.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.219 0.533 . . . . 0.0 109.936 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 11' ' ' ALA . 80.1 m-85 -73.81 159.27 33.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.135 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.83 -27.71 15.99 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.312 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.98 161.62 38.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 110.729 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -28.82 67.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.078 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.9 -55.4 14.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -48.63 -59.15 3.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.977 0.418 . . . . 0.0 110.42 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.499 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . . . -47.45 -35.72 8.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.685 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.98 -30.02 62.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.366 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -76.79 -49.75 15.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.285 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.494 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 4.1 t80 -51.3 -53.31 36.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.487 ' CB ' ' CE1' ' A' ' 80' ' ' HIS . . . -62.28 -33.17 74.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.832 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.62 -67.64 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.208 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.1 -40.85 98.49 Favored Glycine 0 CA--C 1.506 -0.524 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.54 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.534 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 16.5 tpt -50.94 -58.57 5.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.93 0.395 . . . . 0.0 110.43 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.83 -37.63 6.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.777 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 t -64.37 -37.96 89.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.045 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.69 -53.05 46.31 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.684 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.435 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 10.0 mt -66.43 -15.22 63.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.054 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -98.79 -23.14 15.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.678 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.35 -1.1 45.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.144 0.497 . . . . 0.0 109.91 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -115.93 -33.36 5.12 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.286 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 37.6 mt-10 -93.07 -28.7 16.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.708 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.362 -1.243 . . . . 0.0 112.536 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.883 0.373 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.498 HG12 ' NE2' ' A' ' 37' ' ' GLN . 32.9 t -83.18 151.89 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.524 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -108.34 -66.86 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.243 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 29.3 p -118.61 178.46 4.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.716 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.47 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -157.76 106.63 2.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.453 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.507 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 28.2 t -126.21 151.55 47.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.022 0.439 . . . . 0.0 111.766 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -93.97 132.46 38.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.289 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -174.59 -179.82 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.89 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.408 ' CG2' ' CG ' ' A' ' 31' ' ' GLN . 1.3 m -116.89 89.98 3.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.35 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.464 ' HA ' HD21 ' A' ' 91' ' ' LEU . 93.7 t -46.07 139.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.213 0.53 . . . . 0.0 110.725 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.504 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -137.25 155.33 49.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.383 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.432 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 10.0 mt -128.01 112.42 14.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.352 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 15.9 t80 -76.13 147.5 38.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 111.633 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.14 86.03 2.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.106 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.33 -25.11 5.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.39 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.09 -27.87 23.97 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.407 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -138.33 12.15 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.559 0.219 . . . . 0.0 111.362 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 tttt 51.94 83.71 0.05 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.7 0.286 . . . . 0.0 111.197 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 178.24 168.79 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.981 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.534 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 25.7 m95 -88.15 172.6 9.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.698 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -163.21 126.23 1.73 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -41.95 101.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.784 2.323 . . . . 0.0 112.962 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB3' ' CZ3' ' A' ' 89' ' ' TRP . . . -47.03 -48.77 21.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.534 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.12 -118.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.754 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.0 p -118.68 -81.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 0.0 111.147 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.51 -83.92 0.5 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.665 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.12 156.39 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.605 2.203 . . . . 0.0 112.396 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.408 ' CG ' ' CG2' ' A' ' 12' ' ' THR . 4.6 tt0 -143.26 142.47 31.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.189 0.518 . . . . 0.0 111.228 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.405 ' N ' ' HG2' ' A' ' 31' ' ' GLN . . . -169.67 44.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.897 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 64.79 -175.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.201 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -173.45 159.33 3.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.036 0.446 . . . . 0.0 111.147 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.86 95.35 7.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.417 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.471 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 21.9 t -94.22 122.4 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.45 0.643 . . . . 0.0 112.163 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.498 ' NE2' HG12 ' A' ' 5' ' ' VAL . 19.4 mt-30 -113.73 171.79 7.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.43 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 88.9 mt -117.01 154.22 18.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.402 ' N ' HG22 ' A' ' 38' ' ' ILE . 7.5 m-85 -112.86 119.55 38.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.025 0.44 . . . . 0.0 111.804 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.52 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.7 t-160 -93.82 89.56 6.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.825 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -99.95 93.74 2.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 98.6 Cg_endo -81.54 -23.25 5.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.35 2.033 . . . . 0.0 112.45 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -47.75 -30.26 3.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.98 6.53 4.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.296 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 61.03 49.46 5.69 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.22 0.533 . . . . 0.0 109.916 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.9 m -133.53 154.43 50.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.432 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.471 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 59.6 m-85 -124.54 172.12 9.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.561 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.4 ttt-85 -162.97 150.97 13.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 0.0 111.584 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 36' ' ' VAL . 4.9 p -108.75 131.09 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.242 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.03 121.86 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.033 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.471 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -142.82 142.14 11.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.83 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.1 158.84 35.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.743 0.306 . . . . 0.0 110.86 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -58.34 168.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mtt -107.05 42.88 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.135 0.493 . . . . 0.0 110.79 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -128.27 162.29 51.38 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.802 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.2 -31.24 11.93 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.604 2.202 . . . . 0.0 112.773 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.06 -50.51 61.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.797 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.04 94.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -125.39 125.21 43.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.5 m -62.79 119.09 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 111.272 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.455 ' CG2' ' HB ' ' A' ' 13' ' ' VAL . 3.2 m -93.85 -20.4 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.452 HG13 ' CZ3' ' A' ' 89' ' ' TRP . 10.8 tt -138.81 136.5 43.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.388 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -161.79 68.57 0.29 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.977 0.418 . . . . 0.0 110.819 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -131.31 134.7 46.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.915 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -77.47 142.08 39.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.692 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.4 125.63 74.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.851 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 68' ' ' ARG . 17.8 m -140.14 111.06 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.65 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.443 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 12.2 ttt-85 27.88 74.31 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.871 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.47 -34.82 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.683 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.494 HG12 ' CD1' ' A' ' 82' ' ' TRP . 2.5 t -92.46 140.68 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 111.331 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.84 108.68 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.468 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.557 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.5 m-30 -52.48 124.62 13.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.25 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.26 110.36 16.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.758 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.64 92.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.936 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.24 90.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.03 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.43 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.7 p -146.64 173.62 4.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.471 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 78.2 Cg_exo -50.8 -25.26 15.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.349 2.033 . . . . 0.0 112.292 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -142.43 61.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.731 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 4.5 t80 -163.39 105.72 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.186 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 1.1 m80 -97.73 115.93 28.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 110.459 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.405 ' HG3' ' CG1' ' A' ' 88' ' ' VAL . 27.7 tt0 -121.9 144.69 48.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.922 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.557 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 43.7 p90 -143.23 150.08 38.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.29 0.567 . . . . 0.0 112.098 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -112.86 117.59 32.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.229 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.427 ' HA ' HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -93.61 -81.03 0.38 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.248 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.71 -66.39 0.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.966 0.413 . . . . 0.0 111.09 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 -139.67 -5.56 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.48 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.24 179.58 4.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.985 0.422 . . . . 0.0 110.761 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.439 ' HB ' ' CB ' ' A' ' 16' ' ' TYR . 2.1 t -139.03 116.1 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.378 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.513 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 72.9 m95 -93.67 83.86 4.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.289 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.477 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -70.41 159.28 53.6 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.228 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 13' ' ' VAL . 1.1 mm? -144.24 108.09 4.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.532 0.206 . . . . 0.0 110.984 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.31 102.43 14.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.28 0.562 . . . . 0.0 109.925 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 11' ' ' ALA . 76.7 m-85 -69.17 159.99 31.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.864 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.55 18.84 19.87 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.341 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.43 163.23 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.74 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -69.57 -30.37 68.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.68 -49.28 48.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.966 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -49.97 -62.76 1.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.994 0.426 . . . . 0.0 110.582 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.487 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -49.43 -36.66 22.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.693 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.85 -33.96 64.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.243 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -77.32 -42.68 35.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.388 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.507 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 6.3 t80 -54.88 -50.74 67.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.298 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.439 ' CB ' ' CE1' ' A' ' 80' ' ' HIS . . . -68.11 -30.06 69.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.965 0.412 . . . . 0.0 110.969 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.79 -64.95 0.65 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.268 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.3 -50.34 56.72 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.985 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 12.2 tpt -48.94 -60.82 2.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.9 0.381 . . . . 0.0 110.476 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.72 -36.24 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.08 -39.78 82.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.046 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -61.79 -57.04 13.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.618 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.425 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 8.0 mt -58.54 -20.55 47.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -92.72 -23.41 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.611 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.16 1.21 44.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.216 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -113.71 -29.67 7.03 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.344 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 3.7 mt-10 -99.05 -30.34 12.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.335 -1.259 . . . . 0.0 112.499 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tmm? . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.891 0.377 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.23 107.77 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.428 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 1.6 mp0 51.14 -169.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.063 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.9 m -119.4 105.46 11.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG13 ' NE2' ' A' ' 37' ' ' GLN . 71.5 t -61.08 156.19 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.618 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.441 HD12 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -104.8 -62.04 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.714 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.96 -177.55 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.428 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.454 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 24.4 p -154.0 121.2 5.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.495 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 9.0 p -128.46 154.7 45.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.021 0.439 . . . . 0.0 111.743 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -94.26 120.99 35.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.582 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 93' ' ' PHE . . . -174.1 156.15 2.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.983 0.421 . . . . 0.0 111.929 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.89 92.06 5.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.112 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.58 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 62.1 t -46.13 141.22 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.543 . . . . 0.0 112.065 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.596 ' CB ' ' O ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -134.32 140.92 46.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.06 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD22 ' CE2' ' A' ' 89' ' ' TRP . 11.8 mt -111.55 127.0 55.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.565 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.633 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.6 t80 -80.4 146.94 31.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.18 0.514 . . . . 0.0 111.705 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -120.4 77.21 1.24 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.934 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.51 -29.6 1.84 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.283 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.24 -28.97 62.28 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.881 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -121.16 -6.89 9.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.509 0.195 . . . . 0.0 111.214 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HG3' ' OH ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 64.33 76.75 0.34 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.737 0.303 . . . . 0.0 110.852 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.14 174.63 0.32 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.327 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.633 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 48.1 m95 -91.92 169.39 10.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 15' ' ' LEU . 5.2 mt -165.62 126.8 1.36 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.803 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -40.7 110.73 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.734 2.289 . . . . 0.0 112.738 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.14 -67.21 0.29 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.528 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.25 -112.26 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.688 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.39 -160.4 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.634 0.254 . . . . 0.0 110.732 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.59 -66.25 2.05 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.114 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.08 159.84 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.656 2.237 . . . . 0.0 112.317 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -145.15 163.03 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.161 0.505 . . . . 0.0 111.295 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 171.28 46.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.836 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 61.86 178.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.264 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.6 m -166.42 150.75 7.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.036 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -93.92 95.74 9.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.916 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.45 ' CG1' ' CG2' ' A' ' 49' ' ' VAL . 28.8 t -93.88 129.87 43.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.251 0.548 . . . . 0.0 111.74 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.483 ' NE2' HG13 ' A' ' 5' ' ' VAL . 53.6 mt-30 -126.08 148.79 49.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.062 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.424 ' CD1' ' CA ' ' A' ' 106' ' ' MET . 55.7 mt -97.61 150.11 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.346 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.467 ' HB2' ' HG2' ' A' ' 48' ' ' ARG . 6.4 m-85 -111.46 124.0 51.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.921 0.391 . . . . 0.0 111.42 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.477 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 15.3 t-160 -101.09 89.38 3.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.243 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -101.43 87.57 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.435 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 64.2 Cg_endo -72.5 -17.89 26.38 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.448 2.098 . . . . 0.0 112.598 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 t -52.82 -26.14 13.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.966 0.412 . . . . 0.0 110.498 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.97 5.52 5.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.288 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.11 50.33 13.83 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.184 0.516 . . . . 0.0 110.126 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.9 m -141.42 159.56 41.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.998 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.507 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 75.9 m-85 -130.31 163.34 27.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.467 ' HG2' ' HB2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -162.45 143.8 10.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.71 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.45 ' CG2' ' CG1' ' A' ' 36' ' ' VAL . 3.5 p -94.63 148.33 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.277 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG21 ' CD1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -149.9 116.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.541 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -139.59 147.52 19.24 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.916 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.41 162.67 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.8 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.53 172.65 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.5 mmm -111.94 45.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -133.4 162.92 54.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.865 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.29 -26.15 10.99 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.694 2.263 . . . . 0.0 112.562 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.77 -48.32 79.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.21 85.83 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.028 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -128.37 134.34 48.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.622 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.1 m -73.52 122.0 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 0.0 111.0 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.453 ' CG2' ' HB ' ' A' ' 13' ' ' VAL . 3.5 m -93.8 -20.38 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.278 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.452 HG13 ' CZ3' ' A' ' 89' ' ' TRP . 6.9 tt -139.06 138.16 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.615 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -162.92 66.12 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.52 166.64 14.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.836 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.47 140.2 46.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.981 0.419 . . . . 0.0 111.608 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.73 123.12 68.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.769 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 68' ' ' ARG . 28.2 m -138.3 110.61 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 111.669 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER 26.92 46.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.207 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.79 -22.57 0.1 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.512 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' CD1' ' A' ' 82' ' ' TRP . 2.5 t -105.64 137.86 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 117.201 0.5 . . . . 0.0 110.889 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.81 114.05 16.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.619 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.565 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.7 m-30 -50.53 127.98 19.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -93.86 -40.55 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.07 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 59.04 79.39 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.91 -50.59 72.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.203 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -135.53 173.35 5.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.638 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.72 -24.33 22.99 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.453 2.102 . . . . 0.0 112.303 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -126.16 58.44 1.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -169.74 143.06 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.972 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.503 ' CD2' ' CD2' ' A' ' 72' ' ' TYR . 1.4 m170 -139.62 106.71 5.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.358 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.418 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 1.3 tm0? -117.32 121.11 40.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.413 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.639 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 43.7 p90 -125.42 147.14 49.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.04 0.448 . . . . 0.0 111.346 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -108.46 113.98 27.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.665 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HA ' HG22 ' A' ' 70' ' ' VAL . 2.4 t70 -93.59 -87.55 0.24 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.255 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.73 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.966 0.412 . . . . 0.0 110.942 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.1 ttp85 -139.94 -4.4 1.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.382 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.94 177.99 4.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.03 0.443 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -140.6 124.75 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.317 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.639 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 90.3 m95 -101.33 85.48 2.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.062 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.602 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -97.57 96.74 1.86 Allowed Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.192 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.58 ' CB ' ' HA ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER -93.79 133.36 37.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.177 0.513 . . . . 0.0 111.659 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.46 129.02 39.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.367 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.533 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 7.3 m-85 -96.53 165.51 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.563 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.27 -37.15 2.72 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.978 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 m -120.45 160.73 22.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.198 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -62.16 -44.7 96.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.803 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -58.42 -35.39 72.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -59.06 -66.46 0.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.988 0.423 . . . . 0.0 110.539 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.453 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.86 -30.34 63.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.265 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.09 -43.22 54.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.877 0.37 . . . . 0.0 110.951 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.491 ' NE2' ' HA ' ' A' ' 101' ' ' GLN . 4.4 tp60 -68.11 -43.68 77.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.184 0.516 . . . . 0.0 110.812 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.495 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 4.5 t80 -51.98 -54.93 23.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.331 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.419 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . . . -60.15 -29.17 68.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.747 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.21 -64.28 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.122 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.21 -51.53 49.1 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.072 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 12.6 tpt -47.21 -61.63 1.8 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.933 0.396 . . . . 0.0 110.705 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.11 -37.05 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.402 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 t -65.86 -40.22 91.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.141 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -62.92 -56.29 18.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.745 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.434 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 6.3 mt -59.85 -16.95 32.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.616 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.09 -29.57 15.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.844 0.354 . . . . 0.0 111.916 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.42 1.11 54.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.592 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -111.06 -36.82 5.53 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.319 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -85.67 -32.11 22.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.576 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.407 -1.218 . . . . 0.0 112.475 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.91 139.96 7.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.67 -176.64 3.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.839 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.1 m -94.49 139.19 31.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.171 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 45.1 t -87.35 159.44 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.599 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.457 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -112.39 -69.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.25 -178.4 4.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.761 0.315 . . . . 0.0 111.601 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.472 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -155.44 121.82 5.23 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.307 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.515 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 20.0 t -134.51 156.78 48.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.584 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -98.06 129.41 44.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.122 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.49 ' HB1' ' CD1' ' A' ' 93' ' ' PHE . . . -173.21 179.33 2.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.399 . . . . 0.0 111.192 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 m -114.13 91.59 3.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.294 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.473 ' HA ' HD22 ' A' ' 91' ' ' LEU . 96.1 t -47.23 143.28 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.249 0.547 . . . . 0.0 111.136 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.507 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -139.71 159.98 40.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.735 -179.114 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.43 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 3.8 mt -130.61 112.43 13.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.691 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.1 t80 -75.47 145.67 41.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.122 0.487 . . . . 0.0 111.712 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.82 79.98 1.63 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.962 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.83 -26.28 3.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.286 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.53 -30.94 51.54 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.104 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -129.61 5.08 5.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.637 0.256 . . . . 0.0 111.208 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.56 83.78 0.09 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.831 0.348 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 173.85 157.03 0.13 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.952 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.548 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.4 m95 -74.81 175.23 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.455 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 15' ' ' LEU . 1.4 mt -167.93 124.89 0.89 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.508 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -44.06 97.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.544 2.162 . . . . 0.0 113.056 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.43 ' CB ' ' HG ' ' A' ' 15' ' ' LEU . . . -46.49 -59.28 3.08 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.008 0.432 . . . . 0.0 111.445 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.8 -97.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.927 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.7 p -136.86 -76.26 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.273 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.4 -73.17 0.08 OUTLIER Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.616 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -45.03 164.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.959 2.44 . . . . 0.0 112.284 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -149.69 57.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.032 0.444 . . . . 0.0 111.173 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.22 49.23 1.38 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 61.77 -176.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.481 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -172.95 149.02 1.84 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.555 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.83 98.95 11.42 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.472 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 21.2 t -94.51 135.03 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.234 0.54 . . . . 0.0 112.02 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.472 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 47.4 mt-30 -130.95 152.02 50.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.025 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 53.7 mt -99.39 157.69 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.395 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -122.72 120.22 33.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.458 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 t-160 -93.59 98.18 10.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.682 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -101.26 94.92 4.36 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.864 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 87.1 Cg_endo -80.83 -20.34 7.78 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.281 1.987 . . . . 0.0 112.52 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 m -48.67 -31.51 6.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.154 0.502 . . . . 0.0 110.524 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.36 6.75 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.168 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.95 48.87 4.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.21 0.529 . . . . 0.0 109.969 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.5 t -133.04 155.77 48.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.081 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.531 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 50.9 m-85 -120.09 174.72 6.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.691 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 ttt180 -164.39 152.81 12.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.429 . . . . 0.0 111.733 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -112.88 138.98 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.138 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.0 120.24 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.848 0.356 . . . . 0.0 110.82 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.472 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -140.79 146.25 17.44 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.792 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.91 156.94 29.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.815 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.22 161.51 22.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.624 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -94.55 45.59 1.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.023 0.44 . . . . 0.0 110.588 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -94.52 163.94 21.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.946 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.23 -16.93 43.39 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.334 2.023 . . . . 0.0 111.535 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.75 -31.71 9.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.016 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.74 118.16 0.02 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.736 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -143.48 142.61 31.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 m -71.05 120.55 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.926 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.46 HG23 HG23 ' A' ' 13' ' ' VAL . 3.8 m -93.85 -18.58 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.457 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 7.0 tt -140.04 137.56 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.367 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -163.14 70.02 0.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.1 t -134.8 134.18 40.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.055 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -76.66 135.25 39.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.402 HD12 ' CB ' ' A' ' 47' ' ' PHE . 1.5 pt -108.03 166.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 0.0 111.071 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.8 m -158.43 -173.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.554 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.424 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -61.19 87.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.203 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.65 -33.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.356 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -84.43 130.51 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 117.179 0.489 . . . . 0.0 111.173 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.44 101.77 8.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.421 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -47.56 106.3 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.326 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.71 97.34 8.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.85 88.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.47 80.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 p -136.0 162.81 54.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.744 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.52 -22.9 13.43 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.591 2.194 . . . . 0.0 112.458 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.92 47.73 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.097 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 5.3 t80 -162.96 123.86 2.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.36 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.566 ' CE1' ' CD2' ' A' ' 72' ' ' TYR . 1.3 m170 -98.2 172.84 7.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.609 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.422 ' HG3' ' CH2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER 177.15 118.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.658 0.266 . . . . 0.0 111.185 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.547 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 43.4 p90 -133.85 137.57 45.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 111.921 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -101.09 108.86 20.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.38 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.435 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 28.6 t70 -93.65 -102.24 0.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.664 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -72.91 0.1 Allowed 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.006 0.432 . . . . 0.0 111.075 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.6 ttm105 -140.81 -13.01 0.97 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.358 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -106.74 -176.89 3.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.897 0.38 . . . . 0.0 110.242 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.421 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 1.3 t -136.97 122.91 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.45 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.5 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 71.3 m95 -94.0 91.61 6.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.468 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -72.19 164.61 54.39 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.268 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER -150.44 108.8 3.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.631 0.253 . . . . 0.0 111.17 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.447 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.55 102.44 14.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.26 0.553 . . . . 0.0 109.722 178.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.534 ' CE1' ' HA ' ' A' ' 99' ' ' ALA . 81.3 m-85 -70.16 163.72 25.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.198 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.57 -28.32 6.39 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.282 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.3 p -139.07 167.12 22.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -65.32 -40.6 93.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -43.74 97.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -52.09 -66.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 110.57 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.534 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -47.3 -32.81 5.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.517 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.33 -30.91 60.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 111.151 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -78.36 -48.54 15.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.515 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 4.7 t80 -51.4 -48.43 62.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.961 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.59 -33.82 76.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.986 0.422 . . . . 0.0 110.938 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -44.89 -67.66 0.27 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.7 -49.32 74.2 Favored Glycine 0 CA--C 1.508 -0.377 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.327 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 12.2 tpt -49.34 -60.27 2.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.865 0.364 . . . . 0.0 110.572 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.4 -36.34 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.224 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -40.93 82.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.023 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -58.34 -56.77 17.8 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.898 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.443 HD21 ' HE2' ' A' ' 106' ' ' MET . 6.3 mt -58.8 -26.23 63.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.181 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -88.65 -22.43 23.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.922 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.88 -3.41 45.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.027 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -109.44 -22.81 11.84 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.222 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.424 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 6.7 mt-10 -89.63 -38.97 13.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.335 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.463 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.786 0.327 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.27 -172.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.906 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -117.23 -171.61 2.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -128.57 115.8 18.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.742 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 39.4 t -67.15 153.48 8.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.584 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.427 HG13 ' HB ' ' A' ' 38' ' ' ILE . 0.7 OUTLIER -101.36 -71.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.069 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.76 -173.89 3.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.589 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.517 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 10.2 p -154.71 122.88 5.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.374 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.468 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 40.3 t -131.52 155.99 46.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 111.36 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.76 128.89 44.14 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.584 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.531 ' HB3' ' CD1' ' A' ' 93' ' ' PHE . . . -170.66 -178.61 2.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.965 0.412 . . . . 0.0 111.167 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 m -116.41 89.4 3.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.138 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.538 ' HA ' HD23 ' A' ' 91' ' ' LEU . 89.0 t -45.74 143.43 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.213 0.53 . . . . 0.0 111.504 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.497 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -140.2 150.43 44.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.461 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.41 HD23 ' CE2' ' A' ' 89' ' ' TRP . 2.8 mt -122.8 114.58 20.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.489 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.532 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.2 t80 -73.98 151.84 40.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.189 0.518 . . . . 0.0 111.568 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -128.64 82.05 2.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.16 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.07 -26.59 4.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.202 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.2 -28.8 43.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.252 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -132.29 7.81 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.605 0.24 . . . . 0.0 111.234 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt 53.92 82.11 0.09 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.754 0.312 . . . . 0.0 111.191 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.55 172.79 0.42 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.978 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.532 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.5 m95 -89.12 171.86 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.543 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.27 125.27 1.79 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.547 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -44.11 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.488 2.125 . . . . 0.0 112.741 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.441 ' HB1' ' CZ3' ' A' ' 89' ' ' TRP . . . -47.16 -56.8 5.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.625 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.64 -99.07 0.01 OUTLIER Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.943 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.7 -72.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.389 . . . . 0.0 111.219 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -132.16 -77.04 0.13 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.738 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.05 160.96 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.571 2.181 . . . . 0.0 112.413 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -142.03 57.42 1.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.072 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.39 48.9 1.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.493 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 61.62 -174.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.606 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -174.3 148.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.652 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.93 96.2 9.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.91 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 38.4 t -94.56 124.51 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.347 0.594 . . . . 0.0 112.082 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.517 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 53.1 mt-30 -114.51 164.29 14.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.42 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 30.9 mt -111.76 151.84 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.872 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.419 ' CD1' HG22 ' A' ' 50' ' ' VAL . 6.3 m-85 -111.99 121.0 43.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.402 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.524 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 15.5 t-160 -96.31 87.89 4.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.842 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.41 92.19 3.13 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.947 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 93.5 Cg_endo -78.49 -17.97 12.5 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.368 2.045 . . . . 0.0 112.601 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -47.47 -37.16 11.23 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.954 0.407 . . . . 0.0 110.854 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.89 -7.33 12.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.097 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.06 40.78 0.25 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.035 0.445 . . . . 0.0 110.39 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.75 170.37 16.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.732 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 40' ' ' HIS . 70.4 m-85 -130.95 171.91 12.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.855 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 1.2 ttt180 -151.59 146.24 25.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.087 0.47 . . . . 0.0 111.952 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.7 p -107.28 129.58 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.706 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 39' ' ' TYR . 1.4 t -138.3 119.09 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.192 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.473 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -142.26 149.89 21.62 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.839 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.1 159.59 35.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 0.0 110.59 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 166.8 15.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.4 mtp -107.95 45.71 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 4.5 pt20 -123.19 160.8 48.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.853 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 7.4 Cg_endo -49.55 -25.4 10.78 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.857 2.371 . . . . 0.0 112.435 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.89 -43.42 58.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.838 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.32 102.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.01 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -141.04 138.58 33.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.3 m -68.94 120.51 16.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.834 0.35 . . . . 0.0 110.918 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.462 HG23 HG22 ' A' ' 13' ' ' VAL . 2.9 m -93.81 -21.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.457 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 8.6 tt -138.13 135.72 44.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.542 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -160.81 64.0 0.3 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.025 0.441 . . . . 0.0 110.894 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.86 147.16 50.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -85.14 135.73 33.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.56 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.416 HD11 ' CB ' ' A' ' 47' ' ' PHE . 1.6 pt -108.45 114.54 46.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.409 ' HA ' HD21 ' A' ' 113' ' ' LEU . 1.8 m -102.56 164.9 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.973 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 1.2 ttm180 -46.44 97.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.178 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.29 -19.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.625 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.473 HG13 ' CE ' ' A' ' 106' ' ' MET . 2.4 t -89.97 119.81 37.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 117.54 0.67 . . . . 0.0 111.183 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -110.8 110.3 20.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.552 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.569 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.6 OUTLIER -49.02 105.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.263 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.9 88.91 5.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.842 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.449 ' NE2' ' CD2' ' A' ' 80' ' ' HIS . 2.1 tp60 -58.72 90.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.948 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.06 93.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.9 p -144.13 172.38 5.58 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.508 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 74.4 Cg_exo -50.1 -24.7 11.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.427 2.085 . . . . 0.0 112.398 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.64 57.75 1.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.767 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 1.1 t80 -159.73 113.29 2.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.475 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.449 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 22.1 m170 -107.91 104.79 14.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.317 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.459 ' HG3' ' CH2' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -116.37 127.26 54.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.512 -178.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.569 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 41.8 p90 -133.58 143.83 48.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 111.728 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.9 ttp85 -110.84 112.61 24.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.276 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.444 ' HA ' HG23 ' A' ' 70' ' ' VAL . 26.5 t70 -93.77 -102.38 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.73 -72.08 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 111.2 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.3 ttp-105 -140.97 -14.58 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.407 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -103.36 -177.79 3.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.459 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 1.8 t -136.17 129.04 46.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.553 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.48 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 77.3 m95 -101.25 97.98 8.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.538 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.459 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -78.84 159.63 46.0 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.002 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 13' ' ' VAL . 0.6 OUTLIER -148.41 106.01 3.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.77 0.285 . . . . 0.0 111.361 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.53 105.43 17.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.284 0.564 . . . . 0.0 109.902 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 11' ' ' ALA . 62.1 m-85 -74.11 161.51 29.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.949 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.42 -32.72 7.57 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.467 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.95 157.96 45.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.777 0.322 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -28.56 65.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -68.29 -48.62 64.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -52.69 -61.39 2.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.608 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.516 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -50.0 -30.95 11.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.365 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.73 -35.92 62.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 0.0 111.038 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 101' ' ' GLN . 6.7 tp60 -74.2 -44.18 54.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.039 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.477 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 2.3 t80 -52.84 -50.3 64.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.86 -32.22 73.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 110.695 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.15 -65.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.089 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.26 -45.66 78.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.904 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.534 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 15.2 tpt -49.34 -59.77 3.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.924 0.393 . . . . 0.0 110.39 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.68 -38.89 7.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.867 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 t -63.56 -36.19 82.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.932 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 106' ' ' MET . . . -66.41 -40.74 89.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.292 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.446 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 0.2 OUTLIER -76.31 -26.58 55.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.049 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.15 -22.83 41.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 0.0 111.5 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.13 -4.49 24.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.528 0.68 . . . . 0.0 109.321 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 5.2 mt -88.07 -36.37 16.98 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.249 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -104.64 -31.96 9.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.744 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.53 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mmm . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.857 0.361 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.58 115.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.476 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 1.4 mp0 -91.29 -168.6 2.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.676 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.0 m -113.81 101.77 9.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.98 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 50.2 t -60.31 155.16 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.578 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -105.62 -69.45 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -133.35 -172.17 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.731 0.3 . . . . 0.0 111.352 -179.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.506 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.3 OUTLIER -157.59 127.68 6.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.482 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 29.6 t -135.69 152.95 51.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.39 . . . . 0.0 111.525 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -94.85 126.94 40.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.345 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' A' ' 93' ' ' PHE . . . -168.73 -176.46 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.067 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 92' ' ' ASN . 1.3 m -119.79 95.65 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.105 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 61' ' ' VAL . 40.0 t -44.95 154.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.107 0.48 . . . . 0.0 111.199 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.495 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -154.53 150.8 28.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.39 -179.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -127.24 110.91 13.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.577 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.553 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.3 t80 -71.34 150.24 45.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.147 0.498 . . . . 0.0 111.851 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.81 88.13 2.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.138 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -53.5 -22.05 7.39 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.501 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.38 -44.14 76.5 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.411 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -128.7 16.11 6.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 0.0 111.001 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 3.4 mmtt 50.7 88.25 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.155 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.79 147.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 13.9 m95 -68.57 169.44 11.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.636 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -165.04 111.65 0.83 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.428 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -40.08 95.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.864 2.376 . . . . 0.0 112.974 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.441 ' HB2' ' CZ3' ' A' ' 89' ' ' TRP . . . -50.85 -35.86 34.71 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.378 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.22 -95.32 0.01 OUTLIER Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.806 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -173.79 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.07 -94.7 0.12 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.835 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.76 161.77 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.726 2.284 . . . . 0.0 112.479 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -142.98 55.81 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.047 0.451 . . . . 0.0 111.185 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.39 47.44 1.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.358 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 60.4 176.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.575 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 11' ' ' ALA . 14.9 m -165.57 149.83 8.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.704 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.85 102.92 15.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.824 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 28.2 t -98.42 117.84 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.338 0.59 . . . . 0.0 112.128 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.506 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 47.8 mt-30 -107.7 151.83 25.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.446 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 106' ' ' MET . 54.2 mt -97.64 154.61 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.91 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 3' ' ' GLU . 5.6 m-85 -117.14 121.98 42.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.492 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 3.7 t-160 -99.98 89.37 4.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.024 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -96.54 100.97 7.91 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.439 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 96.4 Cg_endo -81.67 -22.13 5.64 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.264 1.976 . . . . 0.0 112.692 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.7 p -50.37 -27.41 6.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 110.73 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.38 3.7 6.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.477 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 60.02 48.3 8.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.137 0.494 . . . . 0.0 110.123 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 m -136.27 -173.37 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.502 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.492 ' CD2' ' HA ' ' A' ' 40' ' ' HIS . 78.5 m-85 -151.19 165.03 35.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.973 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 12.8 mtt180 -147.42 157.75 43.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.061 0.458 . . . . 0.0 111.658 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 m -113.15 122.95 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.053 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -130.74 121.29 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.203 -179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 36' ' ' VAL . . . -141.56 140.5 10.26 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.734 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 15.7 ptp180 -123.24 147.1 47.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.799 0.333 . . . . 0.0 110.7 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 168.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.034 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtm -111.66 46.0 1.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.694 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -119.57 163.44 27.24 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.854 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.92 -24.67 14.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.603 2.202 . . . . 0.0 112.561 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.71 -43.96 21.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 60.78 105.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.036 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 2.0 pp0? -141.27 148.89 40.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.511 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.8 m -75.93 120.73 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 111.344 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.431 HG23 ' CG2' ' A' ' 13' ' ' VAL . 4.2 m -93.91 -24.45 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.066 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.46 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 12.2 tt -137.71 134.7 45.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -158.96 65.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.92 0.391 . . . . 0.0 111.004 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.91 -170.86 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.757 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -131.44 150.31 52.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.318 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.55 133.73 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.433 ' O ' ' C ' ' A' ' 68' ' ' ARG . 29.5 m -141.07 110.11 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.425 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 67' ' ' VAL . 1.4 ptt180 23.26 48.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.45 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.95 -23.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.841 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -95.82 130.26 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 117.373 0.587 . . . . 0.0 111.249 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -119.29 105.25 11.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.493 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.55 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.1 m-30 -47.59 105.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.405 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.54 95.18 6.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -59.09 97.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.36 92.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.191 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 0.8 OUTLIER -146.8 175.72 2.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 73.1 Cg_exo -51.32 -24.2 15.25 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.379 2.053 . . . . 0.0 112.501 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -140.48 62.72 1.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.02 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 3.1 t80 -162.42 130.4 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.12 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 30.4 m170 -118.64 105.94 12.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.451 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 1.4 tm0? -116.01 128.35 55.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.878 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.55 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 49.0 p90 -134.82 146.11 48.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 111.843 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -107.7 110.75 22.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.33 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.435 ' HA ' HG22 ' A' ' 70' ' ' VAL . 14.3 t0 -93.67 -97.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.817 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.91 -71.29 0.26 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.992 0.425 . . . . 0.0 111.314 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -141.21 -9.26 0.99 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.66 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.17 -170.82 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.432 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.451 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 1.1 t -141.24 123.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.336 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.533 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 69.6 m95 -97.45 91.69 5.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.382 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.484 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -75.17 153.68 45.31 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.203 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.422 ' HG ' ' CE2' ' A' ' 102' ' ' PHE . 1.9 mm? -140.46 106.99 5.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.576 0.227 . . . . 0.0 110.987 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -92.72 108.73 20.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.236 0.541 . . . . 0.0 110.069 179.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.531 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 39.3 m-85 -80.32 159.46 25.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.828 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.18 -30.08 17.99 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.573 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.44 174.72 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -70.91 -32.1 68.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -50.62 66.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -52.53 -61.86 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 110.456 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.479 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -51.58 -33.22 31.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.365 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.1 -31.66 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -76.75 -44.99 30.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.246 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.482 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 2.8 t80 -53.52 -47.62 69.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.42 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -68.68 -31.03 69.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.948 0.404 . . . . 0.0 110.78 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.64 -65.83 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.073 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.59 -44.66 89.34 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.845 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 15.0 tpt -50.43 -59.76 3.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.996 0.427 . . . . 0.0 110.374 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 111' ' ' GLU . . . -43.69 -41.63 4.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.124 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 t -62.02 -40.14 94.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.329 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.459 ' HB1' ' CD2' ' A' ' 47' ' ' PHE . . . -62.35 -51.62 66.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.422 HD22 ' CE ' ' A' ' 106' ' ' MET . 8.9 mt -65.85 -22.37 66.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.337 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 1.5 tt0 -84.68 -24.61 28.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.972 0.415 . . . . 0.0 111.313 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.71 3.64 34.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.754 0.788 . . . . 0.0 108.959 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.427 ' HG ' ' CD1' ' A' ' 47' ' ' PHE . 6.8 mt -95.45 -41.25 9.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.061 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.81 -31.97 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.743 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.34 -1.256 . . . . 0.0 112.529 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.822 0.344 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 t -147.64 69.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.428 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 2.0 mp0 55.08 -170.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.095 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.5 m -119.88 114.4 22.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.017 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 25.1 t -66.02 149.05 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.536 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.429 HD13 ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -100.0 -72.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -121.61 179.67 4.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 111.445 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.497 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -154.33 122.95 6.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.948 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 35.7 t -133.1 153.61 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.052 0.453 . . . . 0.0 111.828 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.42 ' HD3' ' CG ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -95.37 128.77 42.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.961 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' CB ' ' HA ' ' A' ' 93' ' ' PHE . . . -177.8 156.97 1.14 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.957 0.408 . . . . 0.0 111.761 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.5 m -93.94 90.66 6.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.134 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.409 ' CG1' ' N ' ' A' ' 14' ' ' MET . 77.4 t -42.21 157.48 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.453 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.542 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -156.45 143.36 18.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.256 -179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.404 HD23 ' CD2' ' A' ' 89' ' ' TRP . 9.0 mt -119.59 123.54 44.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.265 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.568 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.0 t80 -79.7 143.23 34.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.179 0.514 . . . . 0.0 111.816 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.46 77.21 1.06 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.571 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.09 -29.01 1.35 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.429 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.78 -28.32 46.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.959 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -128.93 1.09 5.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.491 0.186 . . . . 0.0 111.329 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 5.5 tptt 58.54 82.14 0.14 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.809 0.338 . . . . 0.0 110.923 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER 175.84 161.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.577 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 35.5 m95 -81.25 172.5 13.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.682 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mt -172.86 116.27 0.38 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.669 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -39.91 117.52 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.9 2.4 . . . . 0.0 112.735 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB1' ' CZ3' ' A' ' 89' ' ' TRP . . . -54.57 -53.47 54.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.697 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.22 -107.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 CA-C-N 115.866 -0.607 . . . . 0.0 113.224 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.4 m -129.11 -81.03 0.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.775 0.322 . . . . 0.0 111.174 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.18 -70.7 0.05 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.726 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.75 154.14 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.657 2.238 . . . . 0.0 112.393 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -147.49 164.43 33.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.385 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 170.4 44.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.878 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.42 ' CG ' ' HD3' ' A' ' 10' ' ' ARG . 7.8 m-85 63.26 131.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.33 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 t -119.19 146.4 45.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.982 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.91 94.1 8.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.631 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.439 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 23.4 t -94.01 120.54 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.368 0.604 . . . . 0.0 112.027 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.497 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 9.2 mt-30 -113.58 169.07 9.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.599 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 38.0 mt -111.21 156.23 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' A' ' 3' ' ' GLU . 5.6 m-85 -114.5 116.88 29.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.37 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.469 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.2 t-160 -94.09 88.45 5.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -101.86 92.2 2.82 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.997 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 84.5 Cg_endo -79.76 -20.2 9.3 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.428 2.086 . . . . 0.0 112.544 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 p -48.7 -32.83 9.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.982 0.42 . . . . 0.0 110.638 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.6 2.55 8.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.211 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 62.93 48.53 3.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.212 0.53 . . . . 0.0 109.948 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.35 151.37 47.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.936 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.513 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 59.6 m-85 -118.51 174.18 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.836 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.9 ttt180 -164.19 150.55 11.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.109 0.481 . . . . 0.0 111.552 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.413 ' CG2' ' CG1' ' A' ' 36' ' ' VAL . 3.8 p -107.39 134.82 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.057 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.4 t -141.96 123.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.352 . . . . 0.0 111.033 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -140.87 144.86 15.23 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.738 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -129.13 142.79 50.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 165.87 13.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtt -107.28 46.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.438 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 1.1 pt20 -105.79 162.99 18.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.732 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 55.4 Cg_endo -69.98 52.58 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.481 2.121 . . . . 0.0 112.195 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -160.98 -35.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 66.4 114.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.068 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -151.52 124.32 8.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 m -65.55 125.29 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.9 m -93.82 -21.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.417 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.469 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 12.4 tt -141.42 140.46 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.619 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -164.43 66.7 0.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 110.875 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.8 t -128.72 131.78 47.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.957 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -75.55 136.49 40.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.396 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pt -109.99 165.78 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.969 0.414 . . . . 0.0 111.079 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HA ' HD11 ' A' ' 113' ' ' LEU . 16.0 m -158.54 -176.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.556 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.449 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 0.5 OUTLIER -58.73 89.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.57 -30.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.35 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -86.43 131.88 33.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 117.128 0.464 . . . . 0.0 110.743 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -119.49 114.94 23.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.777 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.609 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.0 OUTLIER -60.73 106.23 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.043 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.79 86.47 4.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.23 91.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.179 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.69 -57.54 12.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.455 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.3 p -129.09 160.47 63.58 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.348 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.455 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 6.0 Cg_endo -48.0 -26.17 7.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.714 2.276 . . . . 0.0 112.352 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -127.89 59.44 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.006 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 92' ' ' ASN . 7.1 t80 -175.87 130.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.501 ' CD2' ' CD2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -119.23 150.67 39.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.592 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -158.56 150.72 21.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.246 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.609 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 19.7 p90 -151.29 165.5 33.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.344 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -121.74 114.15 20.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.728 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.44 -35.84 12.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 110.44 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.74 -67.25 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.285 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -141.78 16.93 2.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.262 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.22 114.19 16.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 16' ' ' TYR . 2.4 t -93.54 108.93 21.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.865 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.495 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 84.6 m95 -93.78 85.91 4.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.91 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.577 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -97.07 132.48 11.01 Favored Glycine 0 C--O 1.223 -0.544 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.84 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.479 ' CD2' ' CZ3' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -124.09 129.99 51.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.944 0.402 . . . . 0.0 111.679 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -92.64 110.67 22.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.641 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.573 ' HA ' ' CB ' ' A' ' 11' ' ' ALA . 89.0 m-85 -75.61 162.91 27.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.786 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.87 -27.56 28.6 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.378 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.4 m -148.54 179.42 7.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -34.14 67.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.989 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -63.16 -51.05 67.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -52.66 -58.71 5.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.672 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.48 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -52.81 -33.92 51.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.44 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.43 -32.93 62.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.283 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.406 ' NE2' ' HA ' ' A' ' 101' ' ' GLN . 6.8 tp60 -74.49 -46.76 37.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.004 0.431 . . . . 0.0 111.03 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.506 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 21.5 t80 -51.6 -53.7 35.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.052 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.45 ' CB ' ' CE1' ' A' ' 80' ' ' HIS . . . -62.61 -29.89 70.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.024 0.44 . . . . 0.0 110.651 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.41 -65.82 0.5 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.052 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.33 -45.02 96.01 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.3 -0.952 . . . . 0.0 111.753 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.521 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 15.8 tpt -49.74 -59.46 3.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.924 0.392 . . . . 0.0 110.452 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.73 -37.74 2.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.931 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -38.58 89.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.033 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.513 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -62.63 -56.74 15.04 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.729 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.434 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 11.5 mt -59.86 -20.36 56.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.304 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -94.61 -22.44 18.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.669 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.29 -1.82 43.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.103 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -112.58 -28.92 7.65 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.299 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.449 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 3.3 mm-40 -91.09 -33.93 15.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.453 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.382 -1.232 . . . . 0.0 112.513 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.793 0.33 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.52 150.96 44.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.408 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 4.5 mp0 -105.63 -168.73 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.5 m -126.19 105.39 8.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.917 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.467 HG11 ' NE2' ' A' ' 37' ' ' GLN . 41.1 t -61.33 145.35 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.737 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.424 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -97.53 -70.16 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.78 -176.91 4.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.86 0.362 . . . . 0.0 111.57 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.516 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 12.6 p -156.15 126.43 6.62 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.222 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 16.7 t -135.72 158.34 44.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.984 0.421 . . . . 0.0 111.615 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HD3' ' CD1' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -102.03 124.67 48.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.397 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB3' ' CD1' ' A' ' 93' ' ' PHE . . . -167.03 -172.64 2.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.501 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' ASN . 18.8 m -124.67 91.49 3.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.149 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.516 HG21 HG23 ' A' ' 61' ' ' VAL . 78.9 t -42.32 156.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.476 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.482 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -153.96 134.59 13.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.778 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mt -112.47 110.7 21.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 0.0 110.285 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 16.7 t80 -71.41 141.03 50.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.115 0.483 . . . . 0.0 111.668 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.46 80.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.932 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.38 -26.2 4.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.33 -32.81 22.78 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.87 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -138.68 15.09 2.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.763 0.316 . . . . 0.0 110.633 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 2.4 mmpt? 46.46 90.7 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.244 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.81 133.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.792 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.566 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 12.3 m95 -59.31 146.2 40.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -141.44 112.3 6.54 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.315 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -40.65 99.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.81 2.34 . . . . 0.0 112.96 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.417 ' HB3' ' CZ3' ' A' ' 89' ' ' TRP . . . -46.95 -34.05 5.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.329 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.29 -108.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.642 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 t -146.34 -47.54 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.743 0.306 . . . . 0.0 111.327 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.28 -87.57 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.737 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.03 166.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.736 2.291 . . . . 0.0 112.451 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -141.91 58.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.41 51.66 2.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.414 ' CD1' ' HD3' ' A' ' 10' ' ' ARG . 52.9 m-85 55.69 178.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.682 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -165.56 143.59 5.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.86 96.22 9.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.925 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.457 ' HA ' ' HA2' ' A' ' 51' ' ' GLY . 21.6 t -93.83 114.67 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.369 0.604 . . . . 0.0 112.263 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.516 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 45.7 mt-30 -107.91 156.88 18.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.487 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 51.0 mt -102.93 148.12 8.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.423 ' CD1' HG23 ' A' ' 50' ' ' VAL . 6.1 m-85 -109.69 117.71 34.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 111.242 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.455 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.3 t-160 -95.41 88.61 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.11 101.84 9.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.53 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 89.5 Cg_endo -83.05 -21.03 4.87 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.342 2.028 . . . . 0.0 112.634 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.8 m -48.31 -29.66 4.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.041 0.448 . . . . 0.0 110.611 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.17 6.88 4.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.288 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.2 49.28 9.34 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.196 0.522 . . . . 0.0 110.028 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -130.87 166.57 20.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.408 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.531 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 53.4 m-85 -131.58 167.92 18.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.841 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -155.54 148.42 24.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.054 0.454 . . . . 0.0 111.832 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.4 m -109.66 123.41 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.673 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -131.9 119.4 41.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.829 0.347 . . . . 0.0 111.224 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 36' ' ' VAL . . . -136.67 144.58 16.28 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.652 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 1.9 ptt85 -131.21 149.77 52.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.659 0.266 . . . . 0.0 110.751 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -62.24 157.03 20.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.009 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mmt -98.7 45.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -121.5 160.93 44.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.795 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.05 -28.11 18.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.609 2.206 . . . . 0.0 112.435 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.52 -44.6 86.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 62.08 89.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.04 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 3.3 pt20 -131.46 150.12 52.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.86 124.0 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.03 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.516 HG23 HG21 ' A' ' 13' ' ' VAL . 3.7 m -93.85 -24.43 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.453 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 15.9 tt -137.93 143.1 34.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.528 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -166.57 59.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.823 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.53 140.37 50.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.726 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -83.51 134.41 34.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 111.475 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.03 127.33 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.84 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' ARG . 27.3 m -141.66 111.29 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.906 0.384 . . . . 0.0 111.52 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER 27.22 48.17 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.0 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.27 -36.84 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.706 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.564 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.5 t -91.08 141.81 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.472 . . . . 0.0 110.78 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.23 107.21 8.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.806 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 2.9 m-30 -53.55 118.3 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.69 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -93.94 -33.34 13.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.404 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 65.36 80.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.366 . . . . 0.0 110.601 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.65 -34.87 62.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.329 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 15.2 p -154.44 162.0 28.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.712 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 4.5 Cg_endo -46.78 -25.77 4.02 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.853 2.369 . . . . 0.0 112.307 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -122.12 35.21 4.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.216 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 4.8 t80 -154.6 118.52 4.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 111.18 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.456 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.7 m80 -110.97 103.92 12.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.393 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.408 ' HG3' ' CG1' ' A' ' 88' ' ' VAL . 24.5 tt0 -113.07 144.63 42.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.362 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.594 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 43.4 p90 -144.88 161.26 39.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.708 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -118.57 114.96 23.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.498 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.486 ' HA ' HG22 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -93.66 -81.67 0.36 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.395 -178.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.85 -67.73 0.88 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.885 0.374 . . . . 0.0 111.287 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.2 ttm-85 -139.82 -0.59 1.69 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.777 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.62 163.37 19.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.908 0.385 . . . . 0.0 110.395 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.408 ' CG1' ' HG3' ' A' ' 81' ' ' GLN . 1.6 t -120.75 127.62 75.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.805 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.594 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 66.5 m95 -101.63 91.24 4.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.194 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.544 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -86.83 122.47 6.14 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.496 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.489 ' HG ' ' CE2' ' A' ' 102' ' ' PHE . 3.0 mm? -103.02 111.07 23.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.615 0.245 . . . . 0.0 111.51 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -92.63 104.85 17.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.289 0.566 . . . . 0.0 109.625 178.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 11' ' ' ALA . 60.5 m-85 -77.69 164.19 25.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.255 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.77 -26.93 30.66 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.191 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.2 t -150.64 161.25 42.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.794 0.33 . . . . 0.0 110.617 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -25.5 61.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.253 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -58.69 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.079 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.53 -56.24 8.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.052 0.453 . . . . 0.0 110.62 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.503 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -49.16 -33.86 13.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.621 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.44 -30.92 65.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.319 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -76.08 -50.45 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.267 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.493 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 12.1 t80 -49.08 -52.63 24.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.456 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -64.01 -31.38 72.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.827 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.45 -65.38 0.55 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.194 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.9 -47.77 79.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.945 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 12.7 tpt -48.77 -60.67 2.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.969 0.414 . . . . 0.0 110.576 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.65 -37.71 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.314 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -37.78 85.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.968 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.3 -53.7 40.03 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.876 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.427 HD23 ' CE ' ' A' ' 106' ' ' MET . 10.1 mt -63.65 -15.63 58.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.244 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -92.42 -27.0 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.547 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.96 1.48 45.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.24 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -113.2 -37.18 4.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.314 -179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -94.61 -28.79 15.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.829 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.503 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.833 0.349 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 m 63.58 -170.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.81 -173.85 4.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.949 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.0 m -93.93 139.15 31.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.965 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.465 HG11 ' NE2' ' A' ' 37' ' ' GLN . 41.9 t -89.78 151.37 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.444 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -103.59 -69.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.959 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 -178.47 4.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.875 0.369 . . . . 0.0 111.634 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.5 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 9.4 p -152.35 126.21 9.02 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.163 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.501 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 39.1 t -135.03 165.77 24.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.007 0.432 . . . . 0.0 111.609 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -106.51 121.38 44.18 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 93' ' ' PHE . . . -166.77 175.6 7.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 111.129 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -114.84 95.43 5.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.32 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 61' ' ' VAL . 70.4 t -46.31 151.13 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.491 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -149.67 146.59 27.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.742 -179.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 4.0 mt -123.18 108.8 13.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.42 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.8 t80 -71.54 153.17 42.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.22 0.533 . . . . 0.0 111.959 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.83 88.58 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.23 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -53.34 -22.38 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.321 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.38 -34.9 69.4 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.621 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -132.77 13.99 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.666 0.27 . . . . 0.0 111.303 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 51.02 83.75 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.819 0.342 . . . . 0.0 111.036 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 179.11 155.31 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.061 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.55 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 28.8 m95 -73.27 172.63 10.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.53 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.8 115.91 0.91 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.377 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -41.01 94.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.802 2.335 . . . . 0.0 113.002 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HB1' ' CZ3' ' A' ' 89' ' ' TRP . . . -44.31 -44.03 7.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.679 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.56 -105.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.629 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.0 p -123.32 -79.38 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 111.022 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.78 -76.86 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.19 -178.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.617 2.211 . . . . 0.0 112.322 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -146.63 152.2 38.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -178.93 44.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.107 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 52.17 -175.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.418 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' ALA . 93.5 p -174.32 150.88 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.007 0.432 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -93.79 95.51 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.461 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.438 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 20.0 t -94.02 117.42 37.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.288 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.5 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 50.3 mt-30 -109.2 155.94 20.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.379 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.444 ' C ' HG13 ' A' ' 6' ' ' ILE . 62.0 mt -101.02 149.01 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.391 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -112.97 119.91 39.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.99 0.424 . . . . 0.0 110.96 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.485 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 10.7 t-160 -93.58 103.2 15.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.583 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -105.14 84.54 1.07 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.672 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 74.5 Cg_endo -74.97 -22.47 14.84 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.349 2.032 . . . . 0.0 112.432 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.5 p -51.66 -30.43 21.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.085 0.469 . . . . 0.0 110.487 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -129.32 7.39 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.139 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 61.35 48.83 5.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.138 0.494 . . . . 0.0 110.178 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.04 155.77 49.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.323 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.523 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 51.8 m-85 -124.42 178.14 5.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.623 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.1 ttm180 -167.38 157.3 10.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.059 0.456 . . . . 0.0 111.592 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.6 m -120.27 125.66 74.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.035 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.18 125.93 52.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.215 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -140.32 146.51 17.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.756 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -127.5 151.82 48.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.895 0.379 . . . . 0.0 111.146 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -55.58 158.88 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.8 mtp -98.81 45.39 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.569 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -130.44 163.24 49.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.706 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.01 -22.09 29.47 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 112.445 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -43.71 76.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.921 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 63.69 84.08 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -120.78 128.48 52.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.557 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 5.8 m -70.96 120.09 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 0.0 110.631 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 13' ' ' VAL . 3.1 m -93.67 -21.94 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.229 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.45 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 10.4 tt -138.67 139.7 40.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.376 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -165.34 69.13 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.025 0.44 . . . . 0.0 110.899 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 24.4 p -135.2 136.96 42.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -80.32 138.62 36.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.405 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.99 167.88 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 110.813 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 69' ' ' GLY . 21.4 m -156.5 -171.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.485 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 9.6 ttt180 -60.3 83.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.287 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 67' ' ' VAL . . . -177.59 -32.7 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.571 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 82' ' ' TRP . 3.2 t -82.43 133.31 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 117.342 0.571 . . . . 0.0 111.215 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.31 105.82 10.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.634 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.587 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.0 OUTLIER -53.88 104.4 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.284 -179.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -93.93 95.4 9.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.614 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.82 87.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.39 81.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.936 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.503 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 4.4 p -152.68 160.84 30.59 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.227 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 1.1 Cg_endo -43.28 -28.07 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.764 2.31 . . . . 0.0 112.377 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -128.74 57.76 1.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.76 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 2.0 t80 -166.47 113.19 0.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.149 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.491 ' CE1' ' CB ' ' A' ' 103' ' ' ALA . 2.7 m80 -111.21 101.99 10.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.043 0.449 . . . . 0.0 110.541 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HG2' ' N ' ' A' ' 82' ' ' TRP . 2.9 tt0 -108.41 156.42 19.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.036 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.592 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 46.7 p90 -156.4 151.82 26.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.347 0.594 . . . . 0.0 112.047 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.19 111.3 20.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.21 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 5.4 t0 -93.53 -90.92 0.19 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.353 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.02 -68.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.131 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -147.11 -4.01 0.55 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.669 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -105.34 179.98 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.342 . . . . 0.0 110.341 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.447 ' HB ' ' CB ' ' A' ' 16' ' ' TYR . 1.6 t -136.72 115.87 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.542 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.592 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 75.4 m95 -93.62 99.35 11.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.019 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.485 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -93.52 119.15 5.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.707 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.516 ' HG ' ' CE2' ' A' ' 102' ' ' PHE . 3.4 mm? -103.74 108.95 20.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.573 0.225 . . . . 0.0 111.506 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.434 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.83 107.68 19.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 110.108 178.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 11' ' ' ALA . 66.9 m-85 -78.09 161.91 27.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.119 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.69 -28.52 9.46 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.383 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.8 m -135.66 163.21 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.321 . . . . 0.0 110.769 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -63.86 -32.93 74.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -64.73 -53.17 51.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -48.58 -62.1 1.68 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.914 0.387 . . . . 0.0 110.469 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.5 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . . . -46.17 -38.92 8.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.49 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.12 -29.45 62.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.488 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -75.9 -49.63 17.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.516 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 6.6 t80 -51.66 -53.45 38.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.491 ' CB ' ' CE1' ' A' ' 80' ' ' HIS . . . -61.94 -31.91 72.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 110.741 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.94 -66.69 0.37 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.061 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.08 -40.39 98.09 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.639 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 16.9 tpt -51.64 -58.54 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.97 0.414 . . . . 0.0 110.422 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.49 -37.92 5.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.905 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 t -64.98 -38.21 90.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.948 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.523 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -64.51 -53.19 51.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.908 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.433 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 11.3 mt -65.46 -18.32 65.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.103 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -96.19 -21.37 17.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.712 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.22 -3.43 44.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.348 0.594 . . . . 0.0 109.716 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -112.37 -27.94 8.09 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.252 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.476 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 41.3 mt-10 -87.94 -34.44 18.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.535 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.337 -1.257 . . . . 0.0 112.523 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 mtm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.6 p -66.07 114.03 4.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -72.85 -174.96 1.59 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.8 m -116.06 147.32 41.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.945 0.402 . . . . 0.0 111.405 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 24.4 t -89.28 159.75 2.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.393 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.488 HG13 HG21 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -112.32 -67.53 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 13.4 p -119.93 178.68 4.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.891 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -157.79 112.21 2.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.586 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 8.4 t -128.68 159.39 35.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 112.056 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -103.15 123.83 47.44 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.206 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 93' ' ' PHE . . . -168.17 -173.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 111.24 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.4 m -120.72 93.25 3.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.174 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.466 ' HA ' HD13 ' A' ' 91' ' ' LEU . 54.3 t -43.43 154.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.245 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.476 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -152.06 158.79 43.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.621 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 2.4 mt -137.44 108.08 6.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.53 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 9.4 t80 -68.23 154.1 42.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.319 0.581 . . . . 0.0 111.949 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.24 81.8 2.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.06 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -48.33 -25.81 1.75 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.466 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.6 -28.99 57.16 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.528 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -134.53 10.59 3.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.613 0.244 . . . . 0.0 111.325 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.86 81.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.926 0.393 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.447 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 177.67 159.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.913 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.566 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 25.3 m95 -75.92 171.67 14.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.611 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.19 119.12 1.18 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.541 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -43.18 93.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.682 2.254 . . . . 0.0 112.951 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' HB3' ' CZ3' ' A' ' 89' ' ' TRP . . . -44.92 -51.55 9.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.617 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -46.6 -96.4 0.01 OUTLIER Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.088 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.71 -82.79 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.297 . . . . 0.0 111.185 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.08 -94.3 0.87 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.562 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.3 166.19 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.541 2.16 . . . . 0.0 112.16 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.8 165.56 27.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.203 0.525 . . . . 0.0 111.473 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 173.28 43.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.583 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 62.53 -176.26 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' ALA . 2.0 t -175.04 153.91 1.72 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.741 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.68 96.83 10.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.418 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 21.9 t -97.43 122.7 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.066 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.481 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 15.9 mt-30 -114.02 172.22 7.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.384 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 68.7 mt -116.87 156.37 18.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.165 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.418 ' N ' HG21 ' A' ' 38' ' ' ILE . 7.6 m-85 -114.75 120.12 38.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.0 111.466 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.458 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 12.9 t60 -93.71 86.62 5.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.74 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.81 96.83 7.06 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.843 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 74.3 Cg_endo -84.53 -23.18 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.54 2.16 . . . . 0.0 112.624 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.4 t -47.85 -30.6 4.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.946 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.85 -5.22 9.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.399 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.05 43.01 0.7 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.089 0.471 . . . . 0.0 110.207 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.51 171.91 13.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.817 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 40' ' ' HIS . 65.0 m-85 -134.45 177.99 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.862 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -163.12 149.51 12.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.129 0.49 . . . . 0.0 111.63 -179.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.407 ' CG2' ' CG1' ' A' ' 36' ' ' VAL . 3.9 p -109.09 135.01 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.098 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.413 HG22 ' CE1' ' A' ' 39' ' ' TYR . 2.1 t -140.3 121.52 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.736 0.303 . . . . 0.0 111.306 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -143.62 147.45 18.79 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.85 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.47 150.78 52.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.757 0.313 . . . . 0.0 110.87 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.46 163.44 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 17.1 mtp -106.71 46.76 0.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -126.91 160.88 56.84 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.784 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.55 -26.45 6.38 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.753 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.89 -44.98 68.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.829 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.91 93.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -134.38 136.86 43.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.7 m -70.82 121.8 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.368 . . . . 0.0 110.863 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.425 ' CG2' ' CG2' ' A' ' 13' ' ' VAL . 3.9 m -93.75 -24.39 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.448 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 9.6 tt -138.28 135.28 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.471 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -161.9 71.88 0.37 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.917 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 18.0 t -136.81 144.9 43.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.037 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -83.82 130.91 34.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pt -102.72 117.0 47.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.869 0.366 . . . . 0.0 111.193 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -106.43 165.95 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.521 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.487 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 60.5 ttp85 -44.02 100.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.106 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.15 -23.52 0.21 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.087 -1.054 . . . . 0.0 113.847 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.482 HG12 ' CD1' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -100.09 123.54 53.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 117.617 0.709 . . . . 0.0 111.162 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.05 134.93 55.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.824 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.9 m-30 -67.6 126.75 30.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -95.09 -33.05 12.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 58.63 78.9 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.804 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.72 75.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.311 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 p -139.61 166.61 22.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.02 -24.41 14.14 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.44 2.093 . . . . 0.0 112.368 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.71 33.09 5.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -148.43 125.22 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.959 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.466 ' CD2' ' CE1' ' A' ' 93' ' ' PHE . 13.3 m-70 -125.22 98.71 5.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.295 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.42 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -112.76 146.59 38.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.768 -178.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.572 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 26.2 p90 -144.07 144.06 31.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.796 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.39 103.11 14.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.712 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.94 130.6 53.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 60.46 -82.57 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.725 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.44 -30.03 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.302 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -93.75 -168.89 1.98 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.884 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.42 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 2.4 t -137.07 129.68 43.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.977 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.572 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 74.2 m95 -97.61 100.89 12.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.182 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 14' ' ' MET . . . -94.44 130.87 10.48 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.566 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.499 ' HG ' ' CE2' ' A' ' 102' ' ' PHE . 3.0 mm? -114.92 111.54 21.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.808 0.337 . . . . 0.0 111.857 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.89 110.75 22.21 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.552 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 36.5 m-85 -86.69 159.79 19.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.331 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.66 -27.7 49.96 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.348 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 p -149.06 178.71 8.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.815 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -29.0 63.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.33 -56.87 12.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.999 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -52.21 -55.81 18.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.482 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.16 -28.15 62.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.276 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.85 63.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -76.39 -42.45 44.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.511 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 5.9 t80 -54.28 -48.42 71.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.57 78.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.871 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.88 -65.5 0.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.53 -50.5 61.54 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.957 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 11.7 tpt -47.72 -60.98 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 110.661 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.57 -33.63 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.343 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -33.88 69.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.079 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 106' ' ' MET . . . -68.56 -42.26 78.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.524 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.447 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -75.51 -29.48 59.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.063 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -75.32 -25.42 57.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.36 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.14 -3.72 27.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.513 0.673 . . . . 0.0 109.481 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 4.2 mt -90.05 -42.56 11.05 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.131 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.76 -33.84 11.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.68 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.403 -1.22 . . . . 0.0 112.492 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ttp . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.797 0.332 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.69 126.07 31.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.053 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.51 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 1.3 mp0 -71.02 -169.55 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.1 m -110.85 126.57 54.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 29.4 t -76.54 151.15 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 40' ' ' HIS . 0.5 OUTLIER -107.45 -68.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 24.2 p -115.33 176.98 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.55 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.62 113.21 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.87 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 42.2 t -129.67 152.76 48.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.018 0.437 . . . . 0.0 111.879 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -95.13 130.63 41.76 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.031 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 93' ' ' PHE . . . -176.29 161.14 2.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 0.0 111.688 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.2 m -93.76 83.93 4.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.741 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 88.0 t -40.12 140.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.311 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.474 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.1 OUTLIER -129.62 179.08 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.361 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 88' ' ' VAL . 5.8 tp -160.64 113.78 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 0.0 110.225 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 8.7 t80 -73.53 149.3 42.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.392 0.615 . . . . 0.0 112.565 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.62 87.21 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.931 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -49.11 -23.53 1.27 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.618 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.64 -48.67 42.62 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.771 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -123.69 16.3 9.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.65 0.262 . . . . 0.0 111.164 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 1.1 mtmm 52.06 87.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 111.17 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.1 OUTLIER 178.01 161.91 0.59 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.036 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.534 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 20.5 m95 -80.91 171.14 15.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.566 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 15' ' ' LEU . 4.6 mt -167.17 125.59 1.03 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.541 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -43.83 102.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.587 2.191 . . . . 0.0 112.622 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' CB ' HG13 ' A' ' 13' ' ' VAL . . . -50.01 -38.47 37.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.384 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.81 -119.96 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.705 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.58 -68.04 0.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.852 0.358 . . . . 0.0 111.27 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.5 -72.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.769 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -47.95 167.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -145.53 56.62 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.026 0.441 . . . . 0.0 111.279 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.65 50.64 1.61 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.281 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 59.95 -176.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.433 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.92 142.64 2.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.85 94.34 8.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.055 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.463 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 39.2 t -93.85 146.14 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.342 0.591 . . . . 0.0 112.011 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.468 ' NE2' HG13 ' A' ' 5' ' ' VAL . 17.3 mt-30 -138.18 170.19 16.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.56 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 90.9 mt -112.06 153.9 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.301 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CD2' ' HB2' ' A' ' 3' ' ' GLU . 3.5 m-85 -112.12 119.05 37.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.905 0.383 . . . . 0.0 111.785 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.48 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 23.2 t-160 -93.72 92.23 7.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.676 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -101.81 87.03 0.91 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.722 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 73.4 Cg_endo -74.32 -21.51 17.43 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.293 1.995 . . . . 0.0 112.465 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -48.85 -29.28 4.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.041 0.448 . . . . 0.0 110.568 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.87 8.29 4.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.231 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.71 49.2 8.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.207 0.527 . . . . 0.0 109.9 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 t -129.45 163.82 25.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.335 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 51.6 m-85 -133.5 169.14 17.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.656 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 2.0 ttm180 -165.1 148.61 8.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.738 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.405 ' N ' ' HG2' ' A' ' 48' ' ' ARG . 7.0 m -104.79 129.34 57.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.489 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.444 HG23 ' CD1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -135.27 123.66 39.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.463 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -146.46 146.24 16.03 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.862 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -126.49 158.64 35.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 172.92 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.815 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -108.51 47.52 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -128.27 158.13 72.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.12 -27.86 18.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.641 2.227 . . . . 0.0 112.454 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -42.24 85.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 60.19 99.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -135.98 132.71 36.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.761 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.4 m -70.42 120.94 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.045 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.458 ' CG2' ' CG2' ' A' ' 13' ' ' VAL . 5.9 m -93.84 -21.92 5.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.235 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.464 HG13 ' CZ3' ' A' ' 89' ' ' TRP . 9.9 tt -138.04 134.05 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.479 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -160.16 63.67 0.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.943 0.402 . . . . 0.0 110.86 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.1 t -124.62 139.99 53.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.967 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -87.02 150.38 24.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.349 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.46 141.47 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 68' ' ' ARG . 15.2 m -152.35 110.89 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.665 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER 26.62 47.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.33 179.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.12 -27.7 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.177 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.529 HG13 ' CD1' ' A' ' 82' ' ' TRP . 2.6 t -100.14 138.88 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 111.338 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -126.35 110.61 13.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.569 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' A' ' 106' ' ' MET . 1.5 m-30 -51.02 132.67 27.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.412 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.88 97.49 5.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.79 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.09 104.23 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.92 -34.66 64.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.022 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.4 p -150.28 174.36 3.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.524 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 65.3 Cg_exo -51.78 -24.54 18.52 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.382 2.055 . . . . 0.0 112.354 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -140.37 69.95 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.961 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -173.67 128.27 0.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 99' ' ' ALA . 32.1 m170 -117.04 146.89 42.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.413 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -154.91 138.25 15.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.984 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.542 ' NE1' ' HB2' ' A' ' 89' ' ' TRP . 15.5 p90 -145.96 142.05 28.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.145 0.498 . . . . 0.0 111.935 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.32 111.32 23.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.209 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 14.8 t70 -93.78 -93.43 0.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.608 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.18 -70.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.981 0.42 . . . . 0.0 111.402 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.01 -7.18 1.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.63 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 -168.86 1.43 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 110.621 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.464 ' O ' HD13 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -143.04 120.15 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.048 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.542 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 59.1 m95 -92.69 105.76 17.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.249 0.547 . . . . 0.0 110.74 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.529 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -106.95 174.36 19.88 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.664 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 13' ' ' VAL . 1.1 pt? -177.69 139.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.194 0.521 . . . . 0.0 111.54 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.19 121.37 42.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.404 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.481 ' CD2' ' CB ' ' A' ' 99' ' ' ALA . 53.4 m-85 -85.46 160.25 19.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.117 0.484 . . . . 0.0 111.785 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.55 -27.51 63.16 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.31 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.63 169.97 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 110.775 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -26.01 65.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.15 -49.21 62.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.6 -55.58 32.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.072 0.463 . . . . 0.0 110.056 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.481 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . . . -56.31 -29.17 60.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.367 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -31.22 64.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.384 . . . . 0.0 111.174 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -78.47 -43.41 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.144 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.447 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 5.1 t80 -54.41 -45.94 73.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.206 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.22 -29.31 63.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.69 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.28 -64.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.074 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.43 -49.17 58.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.995 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.48 ' HG2' ' CE2' ' A' ' 72' ' ' TYR . 12.3 tpt -49.19 -60.74 2.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.393 . . . . 0.0 110.611 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.95 -37.4 3.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.313 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -36.67 79.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.031 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.61 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.13 -51.95 58.14 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.679 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.454 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 6.8 mt -63.59 -18.07 63.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.873 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -94.85 -25.59 16.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.567 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.46 1.3 51.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.307 0.575 . . . . 0.0 110.083 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -112.42 -33.54 6.15 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.213 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -87.18 -32.77 19.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.322 -1.266 . . . . 0.0 112.434 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.814 0.34 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.3 p -58.73 -169.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.049 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.06 -169.31 2.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.794 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.4 m -129.34 106.51 8.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.983 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 44.0 t -60.66 146.66 10.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.658 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.421 HG13 ' HB ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -98.23 -68.98 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.826 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.78 -175.41 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.505 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.494 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 14.9 p -153.36 118.11 5.02 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.199 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.546 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 7.2 p -120.26 159.98 23.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.121 0.486 . . . . 0.0 111.876 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -107.16 118.77 37.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.564 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB1' ' HA ' ' A' ' 93' ' ' PHE . . . -167.69 -171.88 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.09 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m -123.52 90.62 3.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.16 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.46 HG22 HG21 ' A' ' 61' ' ' VAL . 69.5 t -42.26 148.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.065 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.5 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -143.65 163.8 32.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.065 -178.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.46 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 5.1 mt -136.58 112.0 9.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.454 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.6 t80 -75.93 147.39 38.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.244 0.545 . . . . 0.0 111.934 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.8 89.79 3.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.15 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -52.79 -21.65 4.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.85 -50.76 48.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.62 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -125.08 18.23 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.677 0.275 . . . . 0.0 111.141 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 7.9 mtpt 51.49 91.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.155 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 177.89 151.92 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.576 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 20.6 m95 -76.22 167.94 20.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.565 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' LEU . 1.6 mt -160.33 129.7 3.24 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.532 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.73 94.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.554 2.17 . . . . 0.0 112.903 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.46 ' CB ' ' HG ' ' A' ' 15' ' ' LEU . . . -46.07 -42.94 14.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.464 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.32 -110.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.82 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 t -126.85 -52.82 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 111.253 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.44 -82.68 0.04 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.693 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -47.7 168.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.576 2.184 . . . . 0.0 112.364 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -142.11 154.28 44.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.165 0.507 . . . . 0.0 111.322 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 175.57 44.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.954 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 56.71 175.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.618 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 11' ' ' ALA . 27.2 m -166.5 152.35 8.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.636 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -93.79 97.63 10.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.705 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.451 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 24.1 t -93.74 122.11 44.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.294 0.568 . . . . 0.0 112.092 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.494 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 47.1 mt-30 -116.2 154.82 29.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.763 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 41.8 mt -103.36 151.0 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.61 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.413 ' CD1' HG22 ' A' ' 50' ' ' VAL . 6.1 m-85 -110.28 122.48 47.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.047 0.451 . . . . 0.0 111.525 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.454 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 16.6 t-160 -101.13 91.33 4.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.113 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -101.55 88.51 1.19 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.508 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 63.0 Cg_endo -72.43 -19.55 24.99 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.34 2.027 . . . . 0.0 112.554 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.3 m -52.01 -26.66 11.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.664 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.44 8.56 5.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.84 49.32 14.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.042 0.449 . . . . 0.0 110.266 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.4 m -136.22 165.4 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.29 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.489 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 56.9 m-85 -134.32 173.24 11.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.609 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 7.2 ttp180 -165.8 150.78 8.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.421 . . . . 0.0 111.56 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.438 ' CG2' ' CG1' ' A' ' 36' ' ' VAL . 5.8 p -106.71 135.55 44.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.239 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 39' ' ' TYR . 1.4 t -142.91 118.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.974 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.451 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -138.3 143.56 14.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.934 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -126.09 148.91 49.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.749 0.309 . . . . 0.0 110.802 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.57 168.89 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -108.2 45.37 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -128.25 161.67 55.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.61 -31.03 23.49 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.668 2.246 . . . . 0.0 112.642 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -45.85 90.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.04 91.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.876 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -131.3 136.08 47.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.668 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.2 m -72.71 122.01 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.735 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.46 HG21 HG22 ' A' ' 13' ' ' VAL . 3.3 m -93.71 -20.58 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.24 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.454 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 8.8 tt -140.59 138.79 35.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.626 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -163.38 69.44 0.21 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.689 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -131.56 135.03 46.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.889 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -78.02 141.11 39.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.593 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.87 124.76 73.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.781 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 68' ' ' ARG . 16.1 m -138.59 110.06 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.904 0.383 . . . . 0.0 111.579 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.443 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 1.1 ttt180 29.62 73.47 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.997 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.67 -36.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 119.76 -1.21 . . . . 0.0 113.612 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.478 HG11 ' HB2' ' A' ' 82' ' ' TRP . 2.8 t -87.95 139.1 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.032 0.444 . . . . 0.0 111.519 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.16 97.88 5.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.168 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.7 m-30 -43.99 115.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.713 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -111.46 93.0 4.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.878 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.32 92.44 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.035 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.7 90.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.979 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.467 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 2.7 p -134.57 159.23 73.0 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.335 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 1.2 Cg_endo -44.06 -27.48 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.881 2.388 . . . . 0.0 112.561 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -123.8 47.63 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 111.082 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -155.24 141.71 18.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.955 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.523 ' CD2' ' CE1' ' A' ' 93' ' ' PHE . 15.6 m-70 -136.34 93.42 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.448 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 1.2 tm0? -104.19 140.58 37.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.213 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.563 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 48.7 p90 -143.07 147.28 34.79 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.144 0.497 . . . . 0.0 111.684 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -106.99 113.02 26.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.335 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.454 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 4.4 t70 -93.69 -91.05 0.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.78 -67.92 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 111.36 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -141.63 -8.08 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.512 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.54 -175.41 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.617 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.448 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 2.0 t -138.22 130.21 38.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.493 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.539 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 61.1 m95 -105.14 99.48 9.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.537 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -90.78 125.92 8.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.773 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.486 ' HG ' ' CE2' ' A' ' 102' ' ' PHE . 3.4 mm? -107.08 109.8 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.511 0.196 . . . . 0.0 111.43 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.408 ' C ' HD21 ' A' ' 92' ' ' ASN . 0.2 OUTLIER -92.58 109.42 20.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.404 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.534 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 14.7 m-85 -89.66 164.62 14.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.146 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.23 -40.74 5.39 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.555 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 162.33 25.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -31.13 70.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.946 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.37 -46.82 78.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -55.41 -58.86 6.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.961 0.41 . . . . 0.0 110.719 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 93' ' ' PHE . . . -55.93 -34.15 65.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.083 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.41 -39.99 62.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -67.12 -43.24 82.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.684 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.546 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 9.4 t80 -53.25 -51.87 60.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.904 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.22 68.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.685 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.94 -62.92 1.29 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.898 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.57 -50.26 50.3 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.929 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 12.8 tpt -49.71 -60.96 2.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.943 0.401 . . . . 0.0 110.515 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.55 -36.78 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.139 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -41.47 91.0 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.674 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.489 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -61.05 -56.17 24.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.312 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.408 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 8.0 mt -59.87 -20.48 57.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.946 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.54 -22.8 22.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.34 1.32 38.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.99 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -116.43 -32.7 5.17 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.131 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 21.0 mt-10 -105.34 -28.94 10.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.694 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.542 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.859 0.361 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -132.26 46.38 2.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.776 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 56.84 -172.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.2 m -143.1 112.45 6.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 22.0 t -57.62 148.08 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.46 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -101.32 -67.66 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.775 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -137.51 -176.76 4.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.778 0.323 . . . . 0.0 111.558 -179.252 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.439 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -152.45 124.23 7.91 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.186 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.485 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 13.3 t -133.72 149.17 51.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.794 0.33 . . . . 0.0 111.606 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.4 ttm105 -93.88 127.34 39.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.985 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.475 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -169.21 -176.2 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.925 0.393 . . . . 0.0 111.38 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -118.4 92.39 3.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.435 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 61' ' ' VAL . 53.4 t -44.59 154.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 0.0 111.108 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.2 OUTLIER -152.77 143.42 22.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.978 -179.163 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.1 mt -120.67 114.4 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.311 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.509 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.2 t80 -72.43 151.74 42.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 111.738 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.74 86.66 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.305 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -52.1 -23.49 5.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.411 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.06 -42.07 86.57 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.285 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -126.98 15.62 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 110.82 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER 47.19 83.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.092 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.96 150.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.807 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.526 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 14.4 m95 -69.37 169.0 13.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -165.44 114.17 0.82 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.508 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -41.7 100.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.695 2.263 . . . . 0.0 112.789 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -45.14 -43.97 10.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.536 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.99 -85.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.595 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.46 -80.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.744 0.307 . . . . 0.0 111.069 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -129.78 -70.0 0.12 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.543 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.42 170.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.554 2.169 . . . . 0.0 112.366 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -148.72 63.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.022 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.22 48.12 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 56.22 -178.03 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.707 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' ALA . 7.4 t -170.36 146.58 2.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.858 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -93.8 97.54 10.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.415 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.427 ' HB ' ' CE1' ' A' ' 102' ' ' PHE . 36.3 t -98.12 124.32 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.413 0.625 . . . . 0.0 112.022 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.439 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 55.5 mt-30 -115.06 160.59 19.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.419 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.46 ' C ' HG13 ' A' ' 6' ' ' ILE . 51.4 mt -108.51 147.45 13.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.32 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.416 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.7 m-85 -108.43 118.22 36.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.0 0.429 . . . . 0.0 111.081 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.511 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 t-160 -93.78 87.9 5.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.798 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.27 98.34 5.6 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.538 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 68.4 Cg_endo -85.32 -22.43 2.65 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.366 2.044 . . . . 0.0 112.598 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.9 p -48.28 -30.69 5.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.951 0.405 . . . . 0.0 110.61 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.59 4.5 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.244 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.88 48.59 5.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.237 0.541 . . . . 0.0 110.077 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 m -132.9 152.05 51.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.212 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 52.3 m-85 -120.82 163.53 18.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 31.6 mtt180 -147.54 149.61 32.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.152 0.501 . . . . 0.0 111.916 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.0 120.6 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.362 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.5 t -128.82 120.77 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 0.0 111.617 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.92 149.82 21.49 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.596 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 157.56 46.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 0.0 110.944 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -68.85 159.15 33.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.7 mtt -101.88 47.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -119.66 162.11 34.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.867 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.88 -26.02 17.12 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.555 2.17 . . . . 0.0 112.435 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.32 -42.47 59.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 60.55 99.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.808 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -137.92 137.57 38.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.6 m -71.65 121.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.949 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 13' ' ' VAL . 3.2 m -93.69 -21.34 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.005 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.456 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 16.8 tt -140.38 135.57 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.527 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -159.36 60.17 0.39 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.937 0.399 . . . . 0.0 110.907 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.6 167.91 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -111.84 128.97 56.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.235 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.75 143.56 18.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.07 0.462 . . . . 0.0 111.22 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.97 -170.01 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.336 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 4.9 ttt-85 -56.12 92.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.474 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.72 -26.8 0.13 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.928 -1.129 . . . . 0.0 113.758 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.509 HG23 ' HA ' ' A' ' 84' ' ' ASP . 2.2 t -94.84 122.62 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 117.412 0.606 . . . . 0.0 111.255 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -126.07 117.33 22.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.721 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.566 ' OH ' ' CE2' ' A' ' 102' ' ' PHE . 1.8 m-30 -50.46 127.07 16.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.018 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.77 -29.41 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.105 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.67 77.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 110.682 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.5 -39.76 67.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.264 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.433 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.7 p -150.85 173.51 4.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.431 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 78.4 Cg_exo -50.74 -24.85 13.96 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.384 2.056 . . . . 0.0 112.274 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -132.12 52.15 2.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.789 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 2.2 t80 -160.32 104.11 1.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.235 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.489 ' CE1' ' CB ' ' A' ' 103' ' ' ALA . 4.3 m80 -102.58 104.96 15.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.004 0.431 . . . . 0.0 110.824 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.42 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -115.99 144.1 44.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.159 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.605 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 27.4 p90 -143.51 147.48 34.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.115 0.484 . . . . 0.0 111.743 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -109.3 112.64 24.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.987 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.509 ' HA ' HG23 ' A' ' 70' ' ' VAL . 16.8 t70 -93.67 -96.32 0.15 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.807 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.94 -70.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.936 0.398 . . . . 0.0 111.362 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -137.64 -9.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.696 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -110.18 173.2 6.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.065 0.46 . . . . 0.0 110.923 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.42 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 3.4 t -129.04 130.46 68.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.271 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.605 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 71.0 m95 -105.39 97.27 7.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.31 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.526 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -91.16 122.63 6.79 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.383 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.535 ' HG ' ' CE2' ' A' ' 102' ' ' PHE . 2.5 mm? -106.01 111.57 24.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.826 -0.22 . . . . 0.0 111.489 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.436 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.66 103.25 15.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.333 0.587 . . . . 0.0 109.736 178.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.503 ' CD2' ' CB ' ' A' ' 99' ' ' ALA . 76.5 m-85 -72.85 154.17 40.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.95 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.89 -28.05 12.87 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.297 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 m -133.21 164.06 27.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.753 0.311 . . . . 0.0 110.797 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -29.78 70.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.019 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.79 -52.28 31.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.008 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -49.53 -57.25 7.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.421 . . . . 0.0 110.64 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.503 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . . . -52.11 -41.83 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.546 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.29 -31.49 67.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' ' 101' ' ' GLN . 6.8 tp60 -75.28 -47.59 27.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.239 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.566 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 3.3 t80 -51.54 -52.27 48.42 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.489 ' CB ' ' CE1' ' A' ' 80' ' ' HIS . . . -61.4 -32.49 72.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.91 0.386 . . . . 0.0 110.628 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.3 -66.13 0.44 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.189 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.13 -45.59 70.64 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.762 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.539 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 12.6 tpt -47.97 -60.62 2.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.908 0.385 . . . . 0.0 110.413 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.67 -36.43 11.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.004 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 t -64.82 -34.17 77.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.11 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.545 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -70.39 -51.25 31.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.589 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.416 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 0.7 OUTLIER -63.79 -18.14 63.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.183 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -98.52 -20.79 16.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.927 0.394 . . . . 0.0 111.88 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.75 -0.67 44.95 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.017 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -116.37 -32.79 5.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.315 -179.537 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.48 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 5.0 mt-10 -94.45 -28.07 15.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.53 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 mtm . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.789 0.328 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t 63.62 133.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.981 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -114.83 -176.88 3.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.3 m -96.34 142.18 28.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.16 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.485 HG13 ' NE2' ' A' ' 37' ' ' GLN . 65.2 t -88.7 158.6 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.477 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.481 HG13 HG22 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -112.82 -60.4 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.831 0.348 . . . . 0.0 111.931 -179.144 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 p -129.34 177.32 7.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.798 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.425 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.5 OUTLIER -157.98 110.55 2.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.638 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.454 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 4.6 m -128.69 163.55 24.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.208 0.528 . . . . 0.0 112.206 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.3 ttt85 -105.67 127.7 53.22 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.81 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HB1' ' CD1' ' A' ' 93' ' ' PHE . . . -169.85 -177.73 2.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 111.049 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -114.89 89.35 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.353 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.493 ' HA ' HD13 ' A' ' 91' ' ' LEU . 97.8 t -45.56 137.19 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.159 0.504 . . . . 0.0 111.077 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.5 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -136.24 161.24 36.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.789 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.475 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 5.0 mt -134.18 110.49 9.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.55 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.502 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.4 t80 -73.51 147.16 44.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.083 0.468 . . . . 0.0 111.672 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.67 88.04 2.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.356 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.45 -23.2 9.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.91 -36.18 72.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.545 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -133.83 13.44 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.664 0.269 . . . . 0.0 111.287 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 51.25 86.74 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.02 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.54 145.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.169 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.502 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.0 m95 -68.71 167.24 15.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.157 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 4.7 mt -161.3 131.55 3.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.689 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -45.85 92.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.643 2.228 . . . . 0.0 112.959 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.475 ' CB ' ' HG ' ' A' ' 15' ' ' LEU . . . -42.55 -66.66 0.34 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.772 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.61 -95.62 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.263 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.6 p -130.82 -85.03 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.657 0.265 . . . . 0.0 111.325 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.29 -88.38 0.35 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.708 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.32 161.95 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.616 2.211 . . . . 0.0 112.287 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.86 168.03 20.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.172 0.51 . . . . 0.0 111.594 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 166.96 44.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.626 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 62.41 -176.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.297 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -173.99 165.15 4.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -107.87 94.31 5.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.962 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.45 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 35.7 t -93.78 125.52 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.309 0.576 . . . . 0.0 111.908 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.485 ' NE2' HG13 ' A' ' 5' ' ' VAL . 48.8 mt-30 -119.02 155.29 31.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.884 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.481 HG22 HG13 ' A' ' 6' ' ' ILE . 72.4 mt -104.81 149.25 8.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.488 ' HB2' ' HG2' ' A' ' 48' ' ' ARG . 16.9 m-85 -115.37 126.01 53.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.061 0.458 . . . . 0.0 111.366 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.447 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 3.5 t-160 -93.76 98.46 11.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.168 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -102.46 89.52 1.77 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 72.2 Cg_endo -74.98 -20.61 16.74 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.22 1.947 . . . . 0.0 112.454 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -48.4 -31.21 5.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.068 0.461 . . . . 0.0 110.587 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.97 6.93 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.224 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.98 48.17 5.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.045 0.45 . . . . 0.0 110.005 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.7 t -129.79 179.66 5.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.642 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 40' ' ' HIS . 81.9 m-85 -149.56 166.52 28.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.525 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -160.38 152.59 20.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.0 0.429 . . . . 0.0 111.539 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.04 128.62 61.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 2.2 t -132.41 118.31 35.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.976 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -138.82 147.13 19.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.072 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -128.66 157.82 40.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.695 0.283 . . . . 0.0 110.52 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.41 ' CD ' HG11 ' A' ' 61' ' ' VAL . 1.5 tptt -73.38 161.9 29.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.946 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.1 mmt -98.33 42.82 1.08 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.519 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -96.99 163.36 20.21 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.983 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.74 -18.42 33.69 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.212 1.941 . . . . 0.0 111.371 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.39 -36.39 8.45 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.671 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 62.66 125.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.051 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -145.39 137.11 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.639 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 m -65.97 119.49 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.414 . . . . 0.0 111.224 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.451 ' CG2' ' CG2' ' A' ' 13' ' ' VAL . 3.8 m -93.88 -27.31 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.43 HD11 ' CE3' ' A' ' 89' ' ' TRP . 15.5 tt -138.19 132.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.559 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -159.51 67.38 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.399 . . . . 0.0 110.807 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.2 t -126.08 161.53 27.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.796 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -104.19 148.3 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.613 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.74 142.92 32.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.832 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.454 ' O ' ' C ' ' A' ' 68' ' ' ARG . 17.6 m -146.96 112.21 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.489 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 67' ' ' VAL . 1.0 OUTLIER 22.22 76.19 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.336 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.74 -33.26 0.06 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 119.643 -1.265 . . . . 0.0 114.12 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.454 ' CG2' ' HA ' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -93.64 125.37 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.386 0.593 . . . . 0.0 111.568 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 147.5 32.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.081 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.578 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.7 OUTLIER -86.14 104.14 15.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 0.0 111.238 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.04 98.06 10.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.629 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.54 83.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.047 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.12 -28.57 40.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 0.0 110.85 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.452 ' OG1' ' HD2' ' A' ' 77' ' ' PRO . 3.8 t -166.01 150.63 7.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.086 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.452 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 56.3 Cg_exo -37.63 -29.25 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.048 2.499 . . . . 0.0 113.589 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -121.49 50.34 1.41 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.769 0.319 . . . . 0.0 111.547 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 7.2 t80 -170.0 127.51 0.87 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 111.424 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.513 ' CD2' ' CD2' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -118.02 111.83 19.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.287 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.412 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 1.5 tm0? -119.15 131.22 55.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.554 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.578 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 43.8 p90 -138.07 142.25 40.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.207 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -88.22 105.81 17.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.454 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 32.0 t70 -105.04 130.02 53.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.734 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 61.93 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.466 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -136.33 -31.29 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.88 -168.86 1.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.961 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.412 ' CG1' ' HG2' ' A' ' 81' ' ' GLN . 2.1 t -137.87 124.86 28.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.651 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.469 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 78.5 m95 -93.78 98.83 11.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.522 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.488 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -80.6 161.91 44.88 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.031 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -148.22 106.99 3.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.474 0.178 . . . . 0.0 110.95 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.41 104.76 17.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.225 0.536 . . . . 0.0 110.016 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 80' ' ' HIS . 78.7 m-85 -71.56 162.85 28.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.928 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.33 -26.2 5.51 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.258 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.47 159.8 40.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.879 0.371 . . . . 0.0 110.802 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -60.97 -40.36 93.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.03 -44.24 97.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.104 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -51.76 -68.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.011 0.434 . . . . 0.0 110.474 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.476 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -47.2 -31.47 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.687 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.51 -36.42 57.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.787 0.327 . . . . 0.0 111.38 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.441 ' HB3' ' OG ' ' A' ' 9' ' ' SER . 6.0 tp60 -77.65 -41.25 38.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.203 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.481 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 7.8 t80 -56.31 -50.78 70.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.014 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.424 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -65.46 -32.71 74.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.443 . . . . 0.0 110.867 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.03 -64.74 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.511 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.9 -51.87 49.86 Favored Glycine 0 CA--C 1.508 -0.354 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.159 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.502 ' HG2' ' CE1' ' A' ' 72' ' ' TYR . 12.2 tpt -46.68 -62.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.48 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.57 -33.27 2.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.451 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.38 -35.44 73.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.087 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' MET . . . -70.7 -46.35 63.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.721 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.449 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 5.0 mt -67.68 -34.26 76.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.722 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -75.69 -20.38 58.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.19 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.17 2.68 29.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.601 0.715 . . . . 0.0 109.095 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 6.9 mt -100.21 -38.37 8.53 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.954 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -105.36 -30.68 9.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.66 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.427 -1.207 . . . . 0.0 112.534 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.841 0.353 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 t -146.68 175.5 10.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.979 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.458 ' HB3' ' ND2' ' A' ' 41' ' ' ASN . 2.0 mp0 -97.22 -169.62 1.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.6 m -111.65 131.95 54.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.153 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 52.4 t -84.56 158.33 3.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.559 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.432 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -103.59 -68.32 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.71 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -137.23 -170.65 2.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.353 -179.344 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.489 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.4 OUTLIER -156.76 122.54 4.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.201 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 1.5 p -128.83 153.56 47.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 111.751 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -97.84 127.43 43.78 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.707 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -171.44 -175.09 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 111.4 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -117.3 95.47 4.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.427 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.484 ' HA ' HD11 ' A' ' 91' ' ' LEU . 86.4 t -45.82 156.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.096 0.474 . . . . 0.0 111.249 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -154.64 161.84 41.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.245 -179.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 24' ' ' LEU . 1.8 mt -139.03 110.87 7.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.753 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 8.8 t80 -70.92 152.43 43.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.25 0.548 . . . . 0.0 112.044 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -123.26 79.67 1.7 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.063 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -47.24 -26.03 1.1 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.491 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.08 -38.31 89.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.356 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.81 2.85 10.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.672 0.272 . . . . 0.0 111.246 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.5 82.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.824 0.345 . . . . 0.0 110.928 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.25 158.36 0.28 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 18.0 m95 -74.76 170.25 16.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 110.599 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -163.84 117.66 1.06 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.424 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -42.93 93.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.662 2.241 . . . . 0.0 112.789 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' HB1' ' CZ3' ' A' ' 89' ' ' TRP . . . -44.8 -54.07 6.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.648 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.39 -94.05 0.01 OUTLIER Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.813 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -142.12 -79.65 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.845 0.355 . . . . 0.0 111.038 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.51 -71.59 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.504 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.41 170.51 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.552 2.168 . . . . 0.0 112.325 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -153.36 59.05 0.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.04 0.447 . . . . 0.0 111.154 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.97 51.39 1.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.543 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 59.62 -175.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.648 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -176.71 147.74 0.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.533 -179.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.67 99.74 12.1 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.45 ' HB ' ' CE1' ' A' ' 102' ' ' PHE . 47.5 t -98.15 125.8 51.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.329 0.585 . . . . 0.0 112.121 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.489 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 49.0 mt-30 -115.36 156.4 25.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.191 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.454 ' CD1' ' N ' ' A' ' 106' ' ' MET . 45.3 mt -105.68 149.02 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.761 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.427 ' CE1' HG23 ' A' ' 50' ' ' VAL . 6.6 m-85 -111.69 122.09 46.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.996 0.427 . . . . 0.0 111.396 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.565 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 15.9 t-160 -98.19 89.15 4.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.202 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 3' ' ' GLU . 2.4 m120 -97.41 99.77 6.89 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.755 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 79.4 Cg_endo -84.05 -21.62 3.81 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.331 2.021 . . . . 0.0 112.595 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.4 p -49.66 -32.66 13.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.945 0.402 . . . . 0.0 110.709 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.14 -2.23 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.327 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 67.53 45.05 1.61 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.19 0.519 . . . . 0.0 110.254 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.04 179.36 6.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.039 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.565 ' CD2' ' HA ' ' A' ' 40' ' ' HIS . 77.3 m-85 -142.07 179.99 6.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 1.1 ttp180 -164.95 150.38 9.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.073 0.463 . . . . 0.0 111.591 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.7 m -109.74 123.64 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.139 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.427 HG23 ' CE1' ' A' ' 39' ' ' TYR . 1.6 t -128.14 118.11 47.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.145 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -141.26 150.07 21.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.986 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -130.47 155.25 46.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.303 . . . . 0.0 110.613 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.38 165.76 7.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 10.4 mtp -107.12 47.13 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.915 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.24 163.5 29.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.29 -26.4 27.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.618 2.212 . . . . 0.0 112.503 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.88 -41.72 59.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.928 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 103.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.886 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -141.99 138.69 32.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 52' ' ' ARG . 17.2 m -68.73 118.72 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.435 ' CG2' ' CG2' ' A' ' 13' ' ' VAL . 3.2 m -93.77 -22.17 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.455 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 9.2 tt -137.79 131.01 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.51 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -158.99 69.16 0.46 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.878 0.37 . . . . 0.0 110.995 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.28 135.76 41.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -76.29 137.7 40.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.422 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.34 125.14 69.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.963 0.411 . . . . 0.0 111.095 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.412 ' HA ' HD22 ' A' ' 113' ' ' LEU . 2.1 m -110.63 174.97 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 23.4 ttm180 -48.55 94.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.054 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.24 -19.64 0.15 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.912 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.622 HG13 ' HB2' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -95.59 121.4 46.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 117.719 0.76 . . . . 0.0 111.142 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -108.04 175.48 5.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.294 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.55 ' CE1' ' HG2' ' A' ' 106' ' ' MET . 0.4 OUTLIER -114.15 100.4 8.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 111.197 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.72 81.67 3.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.614 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.414 ' HG2' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -48.36 105.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.17 85.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.43 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -151.94 177.22 1.98 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 77.6 Cg_exo -50.53 -25.24 14.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.367 2.045 . . . . 0.0 112.131 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.87 65.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.781 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.6 t80 -168.16 109.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 3.3 m80 -108.66 119.46 39.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.9 0.381 . . . . 0.0 110.496 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.66 148.18 45.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.265 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.622 ' HB2' HG13 ' A' ' 70' ' ' VAL . 32.9 p90 -147.24 133.55 19.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.684 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -80.09 100.3 8.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.385 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -102.08 125.0 48.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.175 0.512 . . . . 0.0 110.676 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 68.24 -79.01 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.544 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -139.38 -34.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -93.86 -168.13 1.82 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.4 t -137.41 136.03 46.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.947 0.403 . . . . 0.0 111.073 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.594 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 68.1 m95 -100.62 99.08 9.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.076 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.504 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -87.04 131.55 10.64 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.386 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.484 HD11 ' HA ' ' A' ' 13' ' ' VAL . 2.0 mm? -115.82 113.72 23.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.277 . . . . 0.0 111.691 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.94 105.47 17.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.206 0.527 . . . . 0.0 109.673 178.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 80' ' ' HIS . 78.1 m-85 -73.53 153.94 40.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.952 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.98 -28.07 7.96 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.274 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 m -129.29 165.19 21.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 0.0 110.808 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.85 -28.52 66.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.064 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -71.57 -49.31 41.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -49.99 -58.71 4.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.992 0.425 . . . . 0.0 110.738 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -51.39 -41.65 60.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.686 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.54 -34.97 65.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.501 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 101' ' ' GLN . 6.4 tp60 -73.99 -45.23 51.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 111.24 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.512 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 2.7 t80 -52.62 -53.87 41.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.97 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.473 ' CB ' ' CE1' ' A' ' 80' ' ' HIS . . . -60.65 -31.71 70.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.423 . . . . 0.0 110.596 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.28 -66.33 0.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.197 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.57 -43.58 76.1 Favored Glycine 0 CA--C 1.507 -0.426 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.931 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.55 ' HG2' ' CE1' ' A' ' 72' ' ' TYR . 13.8 tpt -47.58 -59.55 3.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.908 0.385 . . . . 0.0 110.36 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 111' ' ' GLU . . . -47.5 -41.34 20.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.741 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -34.41 72.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.358 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . . . -70.95 -44.69 65.56 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 121.035 0.445 . . . . 0.0 110.725 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.45 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -72.71 -34.04 66.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.486 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 1.9 tt0 -75.1 -22.63 58.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.964 0.411 . . . . 0.0 111.45 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.39 -3.52 28.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.675 0.75 . . . . 0.0 109.088 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.481 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 5.4 mt -92.21 -41.64 10.32 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.6 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -99.66 -31.23 11.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.852 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.506 179.937 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.797 0.332 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 p -140.5 140.27 35.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -143.82 -170.53 3.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.0 m -121.87 123.78 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG12 ' NE2' ' A' ' 37' ' ' GLN . 34.9 t -73.85 153.81 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.638 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.424 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -103.53 -69.48 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 -176.73 3.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.029 0.443 . . . . 0.0 111.935 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.52 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 6.2 p -155.89 121.91 5.05 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.065 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.471 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 38.7 t -134.23 155.77 49.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.971 0.415 . . . . 0.0 111.71 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.6 ttp85 -97.85 128.79 44.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.454 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -170.92 -175.89 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.217 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 m -119.53 96.85 5.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.415 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.508 ' HA ' HD13 ' A' ' 91' ' ' LEU . 41.1 t -48.88 151.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.116 0.484 . . . . 0.0 111.153 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 89' ' ' TRP . 0.6 OUTLIER -151.64 144.9 24.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.578 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.6 mt -121.8 116.22 24.06 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.7 t80 -81.19 141.35 34.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.145 0.497 . . . . 0.0 112.017 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.1 84.95 2.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.577 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.77 -23.55 4.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.609 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.17 -27.96 7.83 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.263 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -142.73 16.78 1.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.721 0.296 . . . . 0.0 110.947 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 48.19 87.1 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.93 0.395 . . . . 0.0 111.291 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.47 142.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.747 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.56 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 35.2 m95 -61.39 -178.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 15' ' ' LEU . 3.0 mt -177.01 114.11 0.25 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.218 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -40.92 99.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.816 2.344 . . . . 0.0 112.917 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB3' ' CZ3' ' A' ' 89' ' ' TRP . . . -44.03 -40.33 4.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.68 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.92 -102.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.476 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 t -133.42 -46.23 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.379 . . . . 0.0 110.886 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.75 -66.32 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.062 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.62 163.16 2.92 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.723 2.282 . . . . 0.0 112.099 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -142.07 139.79 32.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.077 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -170.99 45.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 55.31 173.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.784 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' ALA . 24.4 m -167.14 151.35 6.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.645 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.75 98.62 11.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.72 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.425 ' HB ' ' CE1' ' A' ' 102' ' ' PHE . 23.7 t -97.34 119.92 46.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.259 0.552 . . . . 0.0 111.949 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.52 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 47.8 mt-30 -109.76 166.54 10.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.543 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 106' ' ' MET . 55.1 mt -109.9 151.59 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.52 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.411 ' CE1' HG22 ' A' ' 50' ' ' VAL . 5.5 m-85 -112.65 117.13 31.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.991 0.424 . . . . 0.0 111.349 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.463 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 5.0 t-160 -93.88 90.97 6.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.634 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -103.14 86.85 1.13 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 83.1 Cg_endo -76.35 -19.7 14.91 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.339 2.026 . . . . 0.0 112.536 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -50.26 -32.1 15.91 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.991 0.424 . . . . 0.0 110.551 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.29 6.11 6.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.219 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.45 49.16 5.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.248 0.547 . . . . 0.0 110.039 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.5 m -136.64 150.44 48.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.207 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.515 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 59.2 m-85 -120.62 174.01 6.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.563 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.8 ttp180 -164.34 149.34 10.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.093 0.473 . . . . 0.0 111.592 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.3 m -109.42 126.31 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.798 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.411 HG22 ' CE1' ' A' ' 39' ' ' TYR . 1.8 t -129.69 121.09 51.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.802 0.334 . . . . 0.0 111.429 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 36' ' ' VAL . . . -137.43 148.87 20.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.866 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.29 146.62 52.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 110.972 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm -54.08 157.4 2.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.159 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 5.8 mtt -103.52 46.4 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -129.0 163.31 46.56 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.04 -24.89 15.18 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.605 2.203 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.99 -44.45 69.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.932 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 60.37 99.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -142.05 138.2 31.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.72 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.4 m -70.77 122.22 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.189 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.426 ' CG2' ' CG2' ' A' ' 13' ' ' VAL . 3.8 m -93.84 -29.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.493 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.458 ' CD1' ' CE3' ' A' ' 89' ' ' TRP . 17.2 tt -138.55 138.15 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.874 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -165.89 63.18 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 110.539 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.3 t -126.99 135.28 50.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.911 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -75.36 136.48 40.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.678 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.62 168.28 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.592 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.417 ' CB ' HD11 ' A' ' 113' ' ' LEU . 19.0 m -157.06 -173.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.628 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -57.69 87.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.208 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.37 -30.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.686 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.524 HG11 ' HB2' ' A' ' 82' ' ' TRP . 2.6 t -83.14 133.42 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 117.38 0.59 . . . . 0.0 111.093 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.67 115.61 23.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.845 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.57 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -64.56 106.05 1.08 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -99.77 96.98 7.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 91.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.79 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -151.49 176.35 2.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.405 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 74.3 Cg_exo -49.89 -25.71 12.6 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.289 1.993 . . . . 0.0 112.107 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -138.18 65.89 1.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.649 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.0 t80 -165.9 112.25 0.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.356 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.487 ' CE1' ' CB ' ' A' ' 103' ' ' ALA . 2.0 m80 -110.62 101.33 10.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.061 0.458 . . . . 0.0 110.555 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.413 ' OE1' ' CH2' ' A' ' 23' ' ' TRP . 6.1 tt0 -107.68 150.28 27.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.057 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.57 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 46.0 p90 -151.31 148.57 28.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.965 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -112.29 112.54 24.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.223 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.451 ' HA ' HG21 ' A' ' 70' ' ' VAL . 8.0 t0 -93.45 -92.07 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.453 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.82 -69.38 0.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.988 0.423 . . . . 0.0 110.979 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 22.7 ttp180 -144.49 11.02 1.46 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.055 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.57 159.69 28.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.108 0.48 . . . . 0.0 110.571 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 16' ' ' TYR . 1.5 t -120.3 114.35 43.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.471 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.546 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 66.4 m95 -93.51 94.63 8.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.116 0.484 . . . . 0.0 111.301 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.485 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -86.13 118.48 4.87 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.664 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 13' ' ' VAL . 2.7 mm? -104.39 110.59 22.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.599 0.238 . . . . 0.0 111.377 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.49 106.3 18.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.219 0.533 . . . . 0.0 109.936 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 11' ' ' ALA . 80.1 m-85 -73.81 159.27 33.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.135 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.83 -27.71 15.99 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.312 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.98 161.62 38.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 110.729 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -28.82 67.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.078 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.9 -55.4 14.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -48.63 -59.15 3.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.977 0.418 . . . . 0.0 110.42 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.499 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . . . -47.45 -35.72 8.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.685 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.98 -30.02 62.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.366 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -76.79 -49.75 15.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.285 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.494 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 4.1 t80 -51.3 -53.31 36.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.487 ' CB ' ' CE1' ' A' ' 80' ' ' HIS . . . -62.28 -33.17 74.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.832 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.62 -67.64 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.208 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.1 -40.85 98.49 Favored Glycine 0 CA--C 1.506 -0.524 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.54 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.534 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 16.5 tpt -50.94 -58.57 5.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.93 0.395 . . . . 0.0 110.43 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.83 -37.63 6.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.777 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 t -64.37 -37.96 89.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.045 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.69 -53.05 46.31 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.684 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.435 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 10.0 mt -66.43 -15.22 63.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.054 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -98.79 -23.14 15.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.678 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.35 -1.1 45.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.144 0.497 . . . . 0.0 109.91 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -115.93 -33.36 5.12 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.286 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 37.6 mt-10 -93.07 -28.7 16.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.708 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.362 -1.243 . . . . 0.0 112.536 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttp . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.844 0.354 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.18 117.35 7.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 61.45 -172.19 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.7 m -135.56 146.57 48.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.091 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG12 ' NE2' ' A' ' 37' ' ' GLN . 32.9 t -83.18 151.89 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.524 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -108.34 -66.86 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.243 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 29.3 p -118.61 178.46 4.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.716 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.47 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -157.76 106.63 2.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.453 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.507 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 28.2 t -126.21 151.55 47.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.022 0.439 . . . . 0.0 111.766 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -93.97 132.46 38.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.289 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -174.59 -179.82 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.89 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.408 ' CG2' ' CG ' ' A' ' 31' ' ' GLN . 1.3 m -116.89 89.98 3.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.35 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.464 ' HA ' HD21 ' A' ' 91' ' ' LEU . 93.7 t -46.07 139.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.213 0.53 . . . . 0.0 110.725 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.504 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -137.25 155.33 49.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.383 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.432 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 10.0 mt -128.01 112.42 14.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.352 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 15.9 t80 -76.13 147.5 38.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 111.633 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.14 86.03 2.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.106 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.33 -25.11 5.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.39 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.09 -27.87 23.97 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.407 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -138.33 12.15 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.559 0.219 . . . . 0.0 111.362 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 tttt 51.94 83.71 0.05 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.7 0.286 . . . . 0.0 111.197 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 178.24 168.79 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.981 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.534 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 25.7 m95 -88.15 172.6 9.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.698 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -163.21 126.23 1.73 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -41.95 101.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.784 2.323 . . . . 0.0 112.962 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB3' ' CZ3' ' A' ' 89' ' ' TRP . . . -47.03 -48.77 21.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.534 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.12 -118.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.754 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.0 p -118.68 -81.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 0.0 111.147 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.51 -83.92 0.5 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.665 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.12 156.39 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.605 2.203 . . . . 0.0 112.396 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.408 ' CG ' ' CG2' ' A' ' 12' ' ' THR . 4.6 tt0 -143.26 142.47 31.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.189 0.518 . . . . 0.0 111.228 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.405 ' N ' ' HG2' ' A' ' 31' ' ' GLN . . . -169.67 44.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.897 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 64.79 -175.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.201 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -173.45 159.33 3.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.036 0.446 . . . . 0.0 111.147 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.86 95.35 7.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.417 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.471 ' HA ' ' CA ' ' A' ' 51' ' ' GLY . 21.9 t -94.22 122.4 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.45 0.643 . . . . 0.0 112.163 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.498 ' NE2' HG12 ' A' ' 5' ' ' VAL . 19.4 mt-30 -113.73 171.79 7.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.43 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 88.9 mt -117.01 154.22 18.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.402 ' N ' HG22 ' A' ' 38' ' ' ILE . 7.5 m-85 -112.86 119.55 38.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.025 0.44 . . . . 0.0 111.804 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.52 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.7 t-160 -93.82 89.56 6.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.825 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -99.95 93.74 2.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 98.6 Cg_endo -81.54 -23.25 5.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.35 2.033 . . . . 0.0 112.45 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -47.75 -30.26 3.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.98 6.53 4.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.296 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 61.03 49.46 5.69 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.22 0.533 . . . . 0.0 109.916 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.9 m -133.53 154.43 50.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.432 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.471 ' CE2' ' HA ' ' A' ' 109' ' ' ALA . 59.6 m-85 -124.54 172.12 9.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.561 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.4 ttt-85 -162.97 150.97 13.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 0.0 111.584 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 36' ' ' VAL . 4.9 p -108.75 131.09 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.242 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.03 121.86 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.033 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.471 ' CA ' ' HA ' ' A' ' 36' ' ' VAL . . . -142.82 142.14 11.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.83 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.1 158.84 35.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.743 0.306 . . . . 0.0 110.86 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -58.34 168.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mtt -107.05 42.88 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.135 0.493 . . . . 0.0 110.79 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -128.27 162.29 51.38 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.802 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.2 -31.24 11.93 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.604 2.202 . . . . 0.0 112.773 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.06 -50.51 61.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.797 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.04 94.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -125.39 125.21 43.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.5 m -62.79 119.09 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 111.272 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.455 ' CG2' ' HB ' ' A' ' 13' ' ' VAL . 3.2 m -93.85 -20.4 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.452 HG13 ' CZ3' ' A' ' 89' ' ' TRP . 10.8 tt -138.81 136.5 43.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.388 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -161.79 68.57 0.29 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.977 0.418 . . . . 0.0 110.819 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -131.31 134.7 46.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.915 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -77.47 142.08 39.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.692 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.4 125.63 74.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.851 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 68' ' ' ARG . 17.8 m -140.14 111.06 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.65 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.443 ' HG3' ' HA ' ' A' ' 114' ' ' GLU . 12.2 ttt-85 27.88 74.31 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.871 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.47 -34.82 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.683 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.494 HG12 ' CD1' ' A' ' 82' ' ' TRP . 2.5 t -92.46 140.68 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 111.331 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.84 108.68 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.468 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.557 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.5 m-30 -52.48 124.62 13.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.25 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.26 110.36 16.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.758 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.64 92.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.936 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.24 90.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.03 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.43 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.7 p -146.64 173.62 4.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.471 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 78.2 Cg_exo -50.8 -25.26 15.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.349 2.033 . . . . 0.0 112.292 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -142.43 61.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.731 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 4.5 t80 -163.39 105.72 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.186 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 1.1 m80 -97.73 115.93 28.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 110.459 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.405 ' HG3' ' CG1' ' A' ' 88' ' ' VAL . 27.7 tt0 -121.9 144.69 48.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.922 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.557 ' CE3' ' CE1' ' A' ' 72' ' ' TYR . 43.7 p90 -143.23 150.08 38.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.29 0.567 . . . . 0.0 112.098 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -112.86 117.59 32.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.229 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.427 ' HA ' HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -93.61 -81.03 0.38 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.248 -178.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.71 -66.39 0.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.966 0.413 . . . . 0.0 111.09 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 -139.67 -5.56 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.48 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.24 179.58 4.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.985 0.422 . . . . 0.0 110.761 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.439 ' HB ' ' CB ' ' A' ' 16' ' ' TYR . 2.1 t -139.03 116.1 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.378 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.513 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 72.9 m95 -93.67 83.86 4.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.289 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.477 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -70.41 159.28 53.6 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.228 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 13' ' ' VAL . 1.1 mm? -144.24 108.09 4.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.532 0.206 . . . . 0.0 110.984 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.31 102.43 14.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.28 0.562 . . . . 0.0 109.925 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 11' ' ' ALA . 76.7 m-85 -69.17 159.99 31.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.864 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.55 18.84 19.87 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.341 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.43 163.23 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.74 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -69.57 -30.37 68.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.68 -49.28 48.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.966 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -49.97 -62.76 1.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.994 0.426 . . . . 0.0 110.582 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.487 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . . . -49.43 -36.66 22.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.693 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.85 -33.96 64.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.243 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -77.32 -42.68 35.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.388 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.507 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 6.3 t80 -54.88 -50.74 67.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.298 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.439 ' CB ' ' CE1' ' A' ' 80' ' ' HIS . . . -68.11 -30.06 69.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.965 0.412 . . . . 0.0 110.969 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.79 -64.95 0.65 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.268 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.3 -50.34 56.72 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.985 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 12.2 tpt -48.94 -60.82 2.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.9 0.381 . . . . 0.0 110.476 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.72 -36.24 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.08 -39.78 82.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.046 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -61.79 -57.04 13.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.618 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.425 ' CD2' ' CE ' ' A' ' 106' ' ' MET . 8.0 mt -58.54 -20.55 47.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -92.72 -23.41 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.611 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.16 1.21 44.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.216 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -113.71 -29.67 7.03 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.344 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 3.7 mt-10 -99.05 -30.34 12.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.335 -1.259 . . . . 0.0 112.499 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.9 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.778 0.323 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.468 HG11 ' OE1' ' A' ' 37' ' ' GLN . 71.5 t -61.08 156.19 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.618 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -104.8 -62.04 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.714 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' HB2' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -139.96 -177.55 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.428 -179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.473 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 24.4 p -154.0 121.2 5.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 9.0 p -128.46 154.7 45.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.021 0.439 . . . . 0.0 111.743 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -94.26 120.99 35.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.582 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.961 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -174.1 156.15 2.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.983 0.421 . . . . 0.0 111.929 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -98.89 92.06 5.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.112 178.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.597 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 62.1 t -46.13 141.22 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.543 . . . . 0.0 112.065 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.596 ' CB ' ' O ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -134.32 140.92 46.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.06 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.719 HD21 ' CD2' ' A' ' 89' ' ' TRP . 11.8 mt -111.55 127.0 55.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.565 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.644 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.6 t80 -80.4 146.94 31.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.18 0.514 . . . . 0.0 111.705 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -120.4 77.21 1.24 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.934 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.51 -29.6 1.84 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.283 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.24 -28.97 62.28 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.881 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -121.16 -6.89 9.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.509 0.195 . . . . 0.0 111.214 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HG3' ' OH ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 64.33 76.75 0.34 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.737 0.303 . . . . 0.0 110.852 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.14 174.63 0.32 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.327 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.644 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 48.1 m95 -91.92 169.39 10.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.494 HD23 ' HD2' ' A' ' 25' ' ' PRO . 5.2 mt -165.62 126.8 1.36 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.803 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 24' ' ' LEU . 96.5 Cg_exo -40.7 110.73 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.734 2.289 . . . . 0.0 112.738 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.14 -67.21 0.29 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.528 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.25 -112.26 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.688 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.39 -160.4 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.634 0.254 . . . . 0.0 110.732 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 31' ' ' GLN . . . -73.59 -66.25 2.05 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.114 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.08 159.84 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.656 2.237 . . . . 0.0 112.317 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 1.6 mt-30 -145.15 163.03 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.161 0.505 . . . . 0.0 111.295 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 171.28 46.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.836 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.407 ' H ' HG23 ' A' ' 12' ' ' THR . 19.1 m-85 61.86 178.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.264 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.42 ' HG ' ' HA ' ' A' ' 53' ' ' LYS . 58.6 m -166.42 150.75 7.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.036 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -93.92 95.74 9.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.916 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.578 HG22 ' HA3' ' A' ' 51' ' ' GLY . 28.8 t -93.88 129.87 43.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.251 0.548 . . . . 0.0 111.74 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.473 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 35.7 mt-30 -126.08 148.79 49.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.062 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 106' ' ' MET . 55.7 mt -97.61 150.11 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.346 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.488 ' HB2' ' HG2' ' A' ' 48' ' ' ARG . 6.4 m-85 -111.46 124.0 51.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.921 0.391 . . . . 0.0 111.42 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.512 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 0.6 OUTLIER -101.09 89.38 3.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.243 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -101.43 87.57 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.435 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 64.2 Cg_endo -72.5 -17.89 26.38 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.448 2.098 . . . . 0.0 112.598 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 t -52.82 -26.14 13.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.966 0.412 . . . . 0.0 110.498 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.97 5.52 5.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.288 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.11 50.33 13.83 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.184 0.516 . . . . 0.0 110.126 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.9 m -141.42 159.56 41.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.998 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.864 ' CE2' HD23 ' A' ' 113' ' ' LEU . 75.9 m-85 -130.31 163.34 27.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -162.45 143.8 10.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.71 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.623 HG13 HG12 ' A' ' 62' ' ' ILE . 3.5 p -94.63 148.33 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.277 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -149.9 116.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.541 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.578 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -139.59 147.52 19.24 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.916 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.41 162.67 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.8 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -65.53 172.65 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.5 mmm -111.94 45.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -133.4 162.92 54.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.865 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.29 -26.15 10.99 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.694 2.263 . . . . 0.0 112.562 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.77 -48.32 79.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.21 85.83 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.028 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -128.37 134.34 48.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.622 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.1 m -73.52 122.0 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 0.0 111.0 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.494 HG23 ' CG2' ' A' ' 13' ' ' VAL . 3.5 m -93.8 -20.38 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.278 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.623 HG12 HG13 ' A' ' 49' ' ' VAL . 6.9 tt -139.06 138.16 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.615 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -162.92 66.12 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.52 166.64 14.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.836 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -111.47 140.2 46.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.981 0.419 . . . . 0.0 111.608 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.422 HD13 ' SD ' ' A' ' 106' ' ' MET . 0.8 OUTLIER -121.73 123.12 68.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.769 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 67' ' ' VAL . 28.2 m -138.3 110.61 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 111.669 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.657 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 26.92 46.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.207 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.79 -22.57 0.1 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.512 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.824 ' O ' HD22 ' A' ' 110' ' ' LEU . 2.5 t -105.64 137.86 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 117.201 0.5 . . . . 0.0 110.889 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.81 114.05 16.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.619 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.565 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.7 m-30 -50.53 127.98 19.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -93.86 -40.55 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.07 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.04 79.39 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.91 -50.59 72.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.203 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -135.53 173.35 5.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.638 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 53.3 Cg_exo -52.72 -24.33 22.99 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.453 2.102 . . . . 0.0 112.303 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -126.16 58.44 1.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -169.74 143.06 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.972 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.889 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.4 m170 -139.62 106.71 5.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.358 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.611 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.3 tm0? -117.32 121.11 40.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.413 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.806 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.7 p90 -125.42 147.14 49.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.04 0.448 . . . . 0.0 111.346 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -108.46 113.98 27.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.665 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.59 -87.55 0.24 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.255 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.73 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.966 0.412 . . . . 0.0 110.942 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.1 ttp85 -139.94 -4.4 1.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.382 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.94 177.99 4.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.03 0.443 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.611 HG12 ' HG2' ' A' ' 81' ' ' GLN . 0.6 OUTLIER -140.6 124.75 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.317 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.719 ' CD2' HD21 ' A' ' 15' ' ' LEU . 90.3 m95 -101.33 85.48 2.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.062 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.612 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -97.57 96.74 1.86 Allowed Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.192 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.961 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -93.79 133.36 37.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.177 0.513 . . . . 0.0 111.659 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.556 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 6.6 t-20 -93.46 129.02 39.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.367 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.459 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 7.3 m-85 -96.53 165.51 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.563 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.27 -37.15 2.72 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.978 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 m -120.45 160.73 22.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.198 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -62.16 -44.7 96.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.803 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -58.42 -35.39 72.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 9' ' ' SER . 17.4 m-20 -59.06 -66.46 0.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.988 0.423 . . . . 0.0 110.539 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.86 -30.34 63.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.265 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.09 -43.22 54.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.877 0.37 . . . . 0.0 110.951 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.667 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 3.5 tp-100 -68.11 -43.68 77.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.184 0.516 . . . . 0.0 110.812 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.487 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 4.5 t80 -51.98 -54.93 23.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.331 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.889 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -60.15 -29.17 68.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.747 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -49.21 -64.28 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.122 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 7' ' ' CYS . . . -65.21 -51.53 49.1 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.072 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' MET . . . . . 1.102 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.6 tpt -47.21 -61.63 1.8 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.933 0.396 . . . . 0.0 110.705 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.11 -37.05 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.402 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 t -65.86 -40.22 91.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.141 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -62.92 -56.29 18.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.745 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.102 HD21 ' HE3' ' A' ' 106' ' ' MET . 6.3 mt -59.85 -16.95 32.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.616 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.09 -29.57 15.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.844 0.354 . . . . 0.0 111.916 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.42 1.11 54.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.592 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.864 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -111.06 -36.82 5.53 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.319 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -85.67 -32.11 22.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.576 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.407 -1.218 . . . . 0.0 112.475 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.1 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.865 0.364 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 45.1 t -87.35 159.44 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.599 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.475 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -112.39 -69.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.25 -178.4 4.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.761 0.315 . . . . 0.0 111.601 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.482 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -155.44 121.82 5.23 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.307 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 20.0 t -134.51 156.78 48.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.584 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HD3' ' HE1' ' A' ' 54' ' ' MET . 31.5 ttp180 -98.06 129.41 44.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.122 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.892 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -173.21 179.33 2.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.399 . . . . 0.0 111.192 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 m -114.13 91.59 3.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.294 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.538 HG21 HG23 ' A' ' 61' ' ' VAL . 96.1 t -47.23 143.28 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.249 0.547 . . . . 0.0 111.136 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.515 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -139.71 159.98 40.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.735 -179.114 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.444 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 3.8 mt -130.61 112.43 13.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.691 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.556 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.1 t80 -75.47 145.67 41.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.122 0.487 . . . . 0.0 111.712 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.82 79.98 1.63 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.962 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.83 -26.28 3.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.286 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.53 -30.94 51.54 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.104 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -129.61 5.08 5.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.637 0.256 . . . . 0.0 111.208 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.56 83.78 0.09 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.831 0.348 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 173.85 157.03 0.13 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.952 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.556 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.4 m95 -74.81 175.23 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.455 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.791 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.4 mt -167.93 124.89 0.89 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.508 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.791 ' HD2' HD23 ' A' ' 24' ' ' LEU . 89.4 Cg_exo -44.06 97.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.544 2.162 . . . . 0.0 113.056 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.473 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -46.49 -59.28 3.08 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.008 0.432 . . . . 0.0 111.445 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.8 -97.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.927 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.7 p -136.86 -76.26 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.273 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.4 -73.17 0.08 OUTLIER Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.616 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -45.03 164.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.959 2.44 . . . . 0.0 112.284 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -149.69 57.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.032 0.444 . . . . 0.0 111.173 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.22 49.23 1.38 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 61.77 -176.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.481 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -172.95 149.02 1.84 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.555 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.83 98.95 11.42 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.529 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.2 t -94.51 135.03 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.234 0.54 . . . . 0.0 112.02 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.482 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 27.1 mt-30 -130.95 152.02 50.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.025 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 106' ' ' MET . 53.7 mt -99.39 157.69 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.395 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.476 ' N ' HG22 ' A' ' 38' ' ' ILE . 16.2 m-85 -122.72 120.22 33.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.485 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 t-160 -93.59 98.18 10.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.682 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -101.26 94.92 4.36 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.864 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 87.1 Cg_endo -80.83 -20.34 7.78 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.281 1.987 . . . . 0.0 112.52 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 m -48.67 -31.51 6.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.154 0.502 . . . . 0.0 110.524 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.36 6.75 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.168 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.95 48.87 4.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.21 0.529 . . . . 0.0 109.969 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.5 t -133.04 155.77 48.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.081 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.74 ' CE2' HD23 ' A' ' 113' ' ' LEU . 50.9 m-85 -120.09 174.72 6.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.691 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 ttt180 -164.39 152.81 12.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.429 . . . . 0.0 111.733 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.645 HG13 HG12 ' A' ' 62' ' ' ILE . 5.6 p -112.88 138.98 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.138 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.0 120.24 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.848 0.356 . . . . 0.0 110.82 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -140.79 146.25 17.44 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.792 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.91 156.94 29.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.815 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.567 ' HD3' HG11 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -82.22 161.51 22.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.624 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.41 ' HE1' ' HD3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -94.55 45.59 1.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.023 0.44 . . . . 0.0 110.588 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -94.52 163.94 21.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.946 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.23 -16.93 43.39 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.334 2.023 . . . . 0.0 111.535 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.75 -31.71 9.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.016 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.74 118.16 0.02 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.736 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -143.48 142.61 31.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.5 m -71.05 120.55 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.926 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.567 HG11 ' HD3' ' A' ' 53' ' ' LYS . 3.8 m -93.85 -18.58 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.645 HG12 HG13 ' A' ' 49' ' ' VAL . 7.0 tt -140.04 137.56 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.367 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -163.14 70.02 0.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.1 t -134.8 134.18 40.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.055 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -76.66 135.25 39.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.5 pt -108.03 166.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 0.0 111.071 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 66' ' ' ILE . 15.8 m -158.43 -173.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.554 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.742 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -61.19 87.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.203 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.65 -33.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.356 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.84 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -84.43 130.51 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 117.179 0.489 . . . . 0.0 111.173 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.44 101.77 8.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.421 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -47.56 106.3 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.326 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.71 97.34 8.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.85 88.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.47 80.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 11.4 p -136.0 162.81 54.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.744 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 75.1 Cg_exo -51.52 -22.9 13.43 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.591 2.194 . . . . 0.0 112.458 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.92 47.73 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.097 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 5.3 t80 -162.96 123.86 2.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.36 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.61 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.3 m170 -98.2 172.84 7.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.609 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.441 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.6 OUTLIER 177.15 118.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.658 0.266 . . . . 0.0 111.185 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.84 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.4 p90 -133.85 137.57 45.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 111.921 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -101.09 108.86 20.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.38 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 28.6 t70 -93.65 -102.24 0.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.664 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -72.91 0.1 Allowed 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.006 0.432 . . . . 0.0 111.075 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.6 ttm105 -140.81 -13.01 0.97 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.358 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -106.74 -176.89 3.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.897 0.38 . . . . 0.0 110.242 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.511 HG13 ' C ' ' A' ' 82' ' ' TRP . 1.3 t -136.97 122.91 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.45 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.57 ' CE3' HD12 ' A' ' 62' ' ' ILE . 71.3 m95 -94.0 91.61 6.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.842 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -72.19 164.61 54.39 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.268 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.892 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -150.44 108.8 3.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.631 0.253 . . . . 0.0 111.17 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 14.0 t-20 -92.55 102.44 14.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.26 0.553 . . . . 0.0 109.722 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.668 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 81.3 m-85 -70.16 163.72 25.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.198 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.57 -28.32 6.39 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.282 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.3 p -139.07 167.12 22.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -65.32 -40.6 93.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -43.74 97.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -52.09 -66.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 110.57 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.668 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -47.3 -32.81 5.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.517 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.33 -30.91 60.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 111.151 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.539 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -78.36 -48.54 15.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.517 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 4.7 t80 -51.4 -48.43 62.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.961 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.61 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -66.59 -33.82 76.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.986 0.422 . . . . 0.0 110.938 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -44.89 -67.66 0.27 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.7 -49.32 74.2 Favored Glycine 0 CA--C 1.508 -0.377 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.327 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.914 ' CE ' HD21 ' A' ' 110' ' ' LEU . 12.2 tpt -49.34 -60.27 2.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.865 0.364 . . . . 0.0 110.572 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.4 -36.34 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.224 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -40.93 82.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.023 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.539 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -58.34 -56.77 17.8 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.898 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.914 HD21 ' CE ' ' A' ' 106' ' ' MET . 6.3 mt -58.8 -26.23 63.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.181 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -88.65 -22.43 23.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.922 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.88 -3.41 45.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.027 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -109.44 -22.81 11.84 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.222 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.439 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 6.7 mt-10 -89.63 -38.97 13.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.335 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.463 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.714 0.292 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 39.4 t -67.15 153.48 8.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.584 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.504 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -101.36 -71.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.069 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.76 -173.89 3.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.589 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.537 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 10.2 p -154.71 122.88 5.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.374 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 40.3 t -131.52 155.99 46.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 111.36 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.76 128.89 44.14 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.584 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.896 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -170.66 -178.61 2.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.965 0.412 . . . . 0.0 111.167 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 m -116.41 89.4 3.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.138 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.506 HG22 HD21 ' A' ' 91' ' ' LEU . 89.0 t -45.74 143.43 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.213 0.53 . . . . 0.0 111.504 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.507 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -140.2 150.43 44.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.461 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.733 HD21 ' CE2' ' A' ' 89' ' ' TRP . 2.8 mt -122.8 114.58 20.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.489 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.2 t80 -73.98 151.84 40.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.189 0.518 . . . . 0.0 111.568 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.579 ' HB2' HD12 ' A' ' 24' ' ' LEU . 1.5 t70 -128.64 82.05 2.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.16 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.07 -26.59 4.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.202 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.2 -28.8 43.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.252 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -132.29 7.81 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.605 0.24 . . . . 0.0 111.234 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt 53.92 82.11 0.09 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.754 0.312 . . . . 0.0 111.191 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.55 172.79 0.42 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.978 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.539 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.5 m95 -89.12 171.86 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.543 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.579 HD12 ' HB2' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -162.27 125.27 1.79 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.547 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD2' HD23 ' A' ' 24' ' ' LEU . 91.1 Cg_exo -44.11 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.488 2.125 . . . . 0.0 112.741 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.476 ' HB1' ' CZ3' ' A' ' 89' ' ' TRP . . . -47.16 -56.8 5.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.625 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.64 -99.07 0.01 OUTLIER Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.943 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.7 -72.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.389 . . . . 0.0 111.219 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -132.16 -77.04 0.13 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.738 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.05 160.96 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.571 2.181 . . . . 0.0 112.413 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -142.03 57.42 1.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.072 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.39 48.9 1.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.493 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 61.62 -174.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.606 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -174.3 148.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.652 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.93 96.2 9.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.91 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.742 HG22 ' HA3' ' A' ' 51' ' ' GLY . 38.4 t -94.56 124.51 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.347 0.594 . . . . 0.0 112.082 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.537 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 34.2 mt-30 -114.51 164.29 14.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.42 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.536 HD13 ' HA ' ' A' ' 106' ' ' MET . 30.9 mt -111.76 151.84 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.872 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.521 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.3 m-85 -111.99 121.0 43.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.402 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -96.31 87.89 4.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.842 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.41 92.19 3.13 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.947 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 93.5 Cg_endo -78.49 -17.97 12.5 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.368 2.045 . . . . 0.0 112.601 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -47.47 -37.16 11.23 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.954 0.407 . . . . 0.0 110.854 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.89 -7.33 12.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.097 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.06 40.78 0.25 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.035 0.445 . . . . 0.0 110.39 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.75 170.37 16.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.732 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 40' ' ' HIS . 70.4 m-85 -130.95 171.91 12.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.855 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 1.2 ttt180 -151.59 146.24 25.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.087 0.47 . . . . 0.0 111.952 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.681 HG13 HG12 ' A' ' 62' ' ' ILE . 5.7 p -107.28 129.58 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.706 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.521 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.4 t -138.3 119.09 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.192 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.742 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -142.26 149.89 21.62 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.839 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -129.1 159.59 35.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 0.0 110.59 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 166.8 15.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.4 mtp -107.95 45.71 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 4.5 pt20 -123.19 160.8 48.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.853 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 7.4 Cg_endo -49.55 -25.4 10.78 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.857 2.371 . . . . 0.0 112.435 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.89 -43.42 58.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.838 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.32 102.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.01 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -141.04 138.58 33.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 60' ' ' VAL . 13.3 m -68.94 120.51 16.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.834 0.35 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.494 HG23 HG21 ' A' ' 13' ' ' VAL . 2.9 m -93.81 -21.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.681 HG12 HG13 ' A' ' 49' ' ' VAL . 8.6 tt -138.13 135.72 44.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.542 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -160.81 64.0 0.3 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.025 0.441 . . . . 0.0 110.894 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.472 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -128.86 147.16 50.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.926 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -85.14 135.73 33.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.56 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.449 ' O ' HD11 ' A' ' 113' ' ' LEU . 1.6 pt -108.45 114.54 46.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.618 ' C ' HD13 ' A' ' 113' ' ' LEU . 1.8 m -102.56 164.9 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.973 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.687 ' H ' HD22 ' A' ' 113' ' ' LEU . 1.2 ttm180 -46.44 97.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.178 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.29 -19.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.625 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.834 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.4 t -89.97 119.81 37.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 117.54 0.67 . . . . 0.0 111.183 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -110.8 110.3 20.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.552 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.569 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.6 OUTLIER -49.02 105.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.263 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.9 88.91 5.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.842 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.72 90.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.948 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.06 93.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.9 p -144.13 172.38 5.58 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.508 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 74.4 Cg_exo -50.1 -24.7 11.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.427 2.085 . . . . 0.0 112.398 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.64 57.75 1.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.767 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 1.1 t80 -159.73 113.29 2.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.475 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.746 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 22.1 m170 -107.91 104.79 14.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.317 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.531 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -116.37 127.26 54.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.512 -178.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.834 ' HB2' HG13 ' A' ' 70' ' ' VAL . 41.8 p90 -133.58 143.83 48.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 111.728 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.9 ttp85 -110.84 112.61 24.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.276 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.482 ' HB2' HG21 ' A' ' 70' ' ' VAL . 26.5 t70 -93.77 -102.38 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.73 -72.08 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 111.2 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.3 ttp-105 -140.97 -14.58 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.407 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -103.36 -177.79 3.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.531 HG12 ' HG2' ' A' ' 81' ' ' GLN . 1.8 t -136.17 129.04 46.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.553 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.733 ' CE2' HD21 ' A' ' 15' ' ' LEU . 77.3 m95 -101.25 97.98 8.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.538 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.823 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -78.84 159.63 46.0 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.002 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.896 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -148.41 106.01 3.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.77 0.285 . . . . 0.0 111.361 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -92.53 105.43 17.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.284 0.564 . . . . 0.0 109.902 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 62.1 m-85 -74.11 161.51 29.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.949 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.42 -32.72 7.57 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.467 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.95 157.96 45.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.777 0.322 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -28.56 65.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -68.29 -48.62 64.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -52.69 -61.39 2.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.608 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -50.0 -30.95 11.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.365 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.73 -35.92 62.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 0.0 111.038 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -74.2 -44.18 54.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.039 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.47 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 2.3 t80 -52.84 -50.3 64.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.746 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -63.86 -32.22 73.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 110.695 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -46.15 -65.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.089 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.26 -45.66 78.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.904 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.818 ' CE ' HD21 ' A' ' 110' ' ' LEU . 15.2 tpt -49.34 -59.77 3.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.924 0.393 . . . . 0.0 110.39 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.68 -38.89 7.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.867 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 t -63.56 -36.19 82.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.932 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . . . -66.41 -40.74 89.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.292 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.818 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.2 OUTLIER -76.31 -26.58 55.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.049 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.15 -22.83 41.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 0.0 111.5 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.13 -4.49 24.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.528 0.68 . . . . 0.0 109.321 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.687 HD22 ' H ' ' A' ' 68' ' ' ARG . 5.2 mt -88.07 -36.37 16.98 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.249 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 68' ' ' ARG . 6.2 mt-10 -104.64 -31.96 9.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.744 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.53 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.0 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.686 0.279 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 50.2 t -60.31 155.16 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.578 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.524 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -105.62 -69.45 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -133.35 -172.17 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.731 0.3 . . . . 0.0 111.352 -179.036 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.529 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.3 OUTLIER -157.59 127.68 6.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 29.6 t -135.69 152.95 51.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.39 . . . . 0.0 111.525 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.543 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 24.2 ttt180 -94.85 126.94 40.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.345 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.692 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -168.73 -176.46 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.067 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 92' ' ' ASN . 1.3 m -119.79 95.65 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.105 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 61' ' ' VAL . 40.0 t -44.95 154.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.107 0.48 . . . . 0.0 111.199 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.501 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -154.53 150.8 28.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.39 -179.176 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.545 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -127.24 110.91 13.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.577 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.564 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.3 t80 -71.34 150.24 45.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.147 0.498 . . . . 0.0 111.851 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.81 88.13 2.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.138 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -53.5 -22.05 7.39 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.501 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.38 -44.14 76.5 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.411 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -128.7 16.11 6.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 0.0 111.001 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 3.4 mmtt 50.7 88.25 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.155 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.79 147.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.564 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 13.9 m95 -68.57 169.44 11.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.636 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.598 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -165.04 111.65 0.83 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.428 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.598 ' HD2' HD23 ' A' ' 24' ' ' LEU . 72.5 Cg_exo -40.08 95.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.864 2.376 . . . . 0.0 112.974 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.613 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -50.85 -35.86 34.71 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.378 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.22 -95.32 0.01 OUTLIER Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.806 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -173.79 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.07 -94.7 0.12 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.835 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.76 161.77 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.726 2.284 . . . . 0.0 112.479 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -142.98 55.81 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.047 0.451 . . . . 0.0 111.185 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.39 47.44 1.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.358 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 60.4 176.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.575 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.479 ' HG ' ' HA ' ' A' ' 53' ' ' LYS . 14.9 m -165.57 149.83 8.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.704 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.85 102.92 15.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.824 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.765 HG22 ' HA3' ' A' ' 51' ' ' GLY . 28.2 t -98.42 117.84 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.338 0.59 . . . . 0.0 112.128 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.529 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 26.0 mt-30 -107.7 151.83 25.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.446 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.534 HD13 ' HA ' ' A' ' 106' ' ' MET . 54.2 mt -97.64 154.61 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.91 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.52 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.6 m-85 -117.14 121.98 42.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.5 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 3.7 t-160 -99.98 89.37 4.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.024 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -96.54 100.97 7.91 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.439 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 96.4 Cg_endo -81.67 -22.13 5.64 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.264 1.976 . . . . 0.0 112.692 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.7 p -50.37 -27.41 6.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 110.73 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.38 3.7 6.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.477 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 60.02 48.3 8.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.137 0.494 . . . . 0.0 110.123 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.557 ' HA ' HD21 ' A' ' 113' ' ' LEU . 14.2 m -136.27 -173.37 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.502 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CD2' HD11 ' A' ' 6' ' ' ILE . 78.5 m-85 -151.19 165.03 35.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.973 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 12.8 mtt180 -147.42 157.75 43.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.061 0.458 . . . . 0.0 111.658 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 62' ' ' ILE . 5.1 m -113.15 122.95 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.053 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.52 HG21 ' CE1' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -130.74 121.29 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.203 -179.211 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.765 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -141.56 140.5 10.26 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.734 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 15.7 ptp180 -123.24 147.1 47.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.799 0.333 . . . . 0.0 110.7 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.479 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -57.45 168.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.034 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.543 ' HE2' ' HG3' ' A' ' 10' ' ' ARG . 15.3 mtm -111.66 46.0 1.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.694 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -119.57 163.44 27.24 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.854 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.92 -24.67 14.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.603 2.202 . . . . 0.0 112.561 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.71 -43.96 21.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 60.78 105.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.036 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.51 ' NE2' HG12 ' A' ' 61' ' ' VAL . 2.0 pp0? -141.27 148.89 40.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.511 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.8 m -75.93 120.73 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 111.344 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 13' ' ' VAL . 4.2 m -93.91 -24.45 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.066 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.653 HD12 ' CE3' ' A' ' 89' ' ' TRP . 12.2 tt -137.71 134.7 45.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -158.96 65.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.92 0.391 . . . . 0.0 111.004 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.91 -170.86 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.757 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.545 ' HB2' ' HD3' ' A' ' 48' ' ' ARG . . . -131.44 150.31 52.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.318 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.468 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -126.55 133.73 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.067 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 67' ' ' VAL . 29.5 m -141.07 110.11 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.425 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.534 ' H ' HD13 ' A' ' 113' ' ' LEU . 1.4 ptt180 23.26 48.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.45 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.95 -23.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.841 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.885 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -95.82 130.26 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 117.373 0.587 . . . . 0.0 111.249 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -119.29 105.25 11.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.493 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.55 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.1 m-30 -47.59 105.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.405 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.54 95.18 6.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.09 97.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.36 92.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.191 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.434 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 0.8 OUTLIER -146.8 175.72 2.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 73.1 Cg_exo -51.32 -24.2 15.25 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.379 2.053 . . . . 0.0 112.501 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -140.48 62.72 1.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.02 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 3.1 t80 -162.42 130.4 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.12 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.597 ' NE2' ' HB2' ' A' ' 103' ' ' ALA . 1.8 m-70 -118.64 105.94 12.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.484 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.4 tm0? -116.01 128.35 55.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.878 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.885 ' HB2' HG13 ' A' ' 70' ' ' VAL . 49.0 p90 -134.82 146.11 48.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 111.843 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -107.7 110.75 22.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.33 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.428 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 14.3 t0 -93.67 -97.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.817 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.91 -71.29 0.26 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.992 0.425 . . . . 0.0 111.314 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -141.21 -9.26 0.99 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.66 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.17 -170.82 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.432 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG12 ' HG2' ' A' ' 81' ' ' GLN . 1.1 t -141.24 123.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.336 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.653 ' CE3' HD12 ' A' ' 62' ' ' ILE . 69.6 m95 -97.45 91.69 5.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.382 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.81 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -75.17 153.68 45.31 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.203 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 90' ' ' GLY . 1.9 mm? -140.46 106.99 5.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.576 0.227 . . . . 0.0 110.987 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 12' ' ' THR . 10.4 t-20 -92.72 108.73 20.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.236 0.541 . . . . 0.0 110.069 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.644 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 39.3 m-85 -80.32 159.46 25.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.828 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.18 -30.08 17.99 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.573 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.44 174.72 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -70.91 -32.1 68.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -50.62 66.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -52.53 -61.86 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 110.456 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.644 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -51.58 -33.22 31.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.365 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.1 -31.66 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.523 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -76.75 -44.99 30.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.246 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.479 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 2.8 t80 -53.52 -47.62 69.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.597 ' HB2' ' NE2' ' A' ' 80' ' ' HIS . . . -68.68 -31.03 69.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.948 0.404 . . . . 0.0 110.78 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -46.64 -65.83 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.073 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.59 -44.66 89.34 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.845 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' MET . . . . . 1.095 ' HE3' HD21 ' A' ' 110' ' ' LEU . 15.0 tpt -50.43 -59.76 3.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.996 0.427 . . . . 0.0 110.374 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 111' ' ' GLU . . . -43.69 -41.63 4.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.124 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 t -62.02 -40.14 94.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.329 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.484 ' HB1' ' CG ' ' A' ' 47' ' ' PHE . . . -62.35 -51.62 66.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.095 HD21 ' HE3' ' A' ' 106' ' ' MET . 8.9 mt -65.85 -22.37 66.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.337 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 1.5 tt0 -84.68 -24.61 28.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.972 0.415 . . . . 0.0 111.313 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.71 3.64 34.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.754 0.788 . . . . 0.0 108.959 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 46' ' ' SER . 6.8 mt -95.45 -41.25 9.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.061 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.81 -31.97 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.743 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.34 -1.256 . . . . 0.0 112.529 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.5 m . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.772 0.32 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 25.1 t -66.02 149.05 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.536 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.438 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -100.0 -72.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -121.61 179.67 4.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 111.445 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.501 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -154.33 122.95 6.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.948 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 35.7 t -133.1 153.61 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.052 0.453 . . . . 0.0 111.828 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.409 ' HD3' ' CG ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -95.37 128.77 42.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.961 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 93' ' ' PHE . . . -177.8 156.97 1.14 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.957 0.408 . . . . 0.0 111.761 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.5 m -93.94 90.66 6.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.134 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.692 HG13 HD12 ' A' ' 91' ' ' LEU . 77.4 t -42.21 157.48 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.453 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.542 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -156.45 143.36 18.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.256 -179.198 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.698 HD21 ' CD2' ' A' ' 89' ' ' TRP . 9.0 mt -119.59 123.54 44.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.265 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.0 t80 -79.7 143.23 34.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.179 0.514 . . . . 0.0 111.816 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.46 77.21 1.06 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.571 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.09 -29.01 1.35 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.429 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.78 -28.32 46.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.959 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -128.93 1.09 5.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.491 0.186 . . . . 0.0 111.329 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 5.5 tptt 58.54 82.14 0.14 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.809 0.338 . . . . 0.0 110.923 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER 175.84 161.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.589 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 35.5 m95 -81.25 172.5 13.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.682 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 24' ' ' LEU . 3.7 mt -172.86 116.27 0.38 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.669 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -39.91 117.52 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.9 2.4 . . . . 0.0 112.735 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.616 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -54.57 -53.47 54.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.697 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.22 -107.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 CA-C-N 115.866 -0.607 . . . . 0.0 113.224 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.4 m -129.11 -81.03 0.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.775 0.322 . . . . 0.0 111.174 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.447 ' O ' ' NE2' ' A' ' 31' ' ' GLN . . . -139.18 -70.7 0.05 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.726 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.75 154.14 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.657 2.238 . . . . 0.0 112.393 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.504 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 2.4 mt-30 -147.49 164.43 33.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.385 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 170.4 44.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.878 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.409 ' CG ' ' HD3' ' A' ' 10' ' ' ARG . 7.8 m-85 63.26 131.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.33 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 t -119.19 146.4 45.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.982 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.91 94.1 8.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.631 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.753 HG22 ' HA3' ' A' ' 51' ' ' GLY . 23.4 t -94.01 120.54 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.368 0.604 . . . . 0.0 112.027 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.501 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 24.3 mt-30 -113.58 169.07 9.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.599 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 38.0 mt -111.21 156.23 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.6 m-85 -114.5 116.88 29.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.37 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.502 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 2.2 t-80 -94.09 88.45 5.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -101.86 92.2 2.82 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.997 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 84.5 Cg_endo -79.76 -20.2 9.3 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.428 2.086 . . . . 0.0 112.544 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 p -48.7 -32.83 9.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.982 0.42 . . . . 0.0 110.638 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.6 2.55 8.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.211 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 62.93 48.53 3.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.212 0.53 . . . . 0.0 109.948 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.35 151.37 47.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.936 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.777 ' CE2' HD23 ' A' ' 113' ' ' LEU . 59.6 m-85 -118.51 174.18 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.836 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.9 ttt180 -164.19 150.55 11.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.109 0.481 . . . . 0.0 111.552 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.611 HG13 HG12 ' A' ' 62' ' ' ILE . 3.8 p -107.39 134.82 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.057 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.502 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.4 t -141.96 123.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.352 . . . . 0.0 111.033 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.753 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -140.87 144.86 15.23 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.738 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -129.13 142.79 50.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HD2' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -66.47 165.87 13.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtt -107.28 46.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.453 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 1.1 pt20 -105.79 162.99 18.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.732 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 55.4 Cg_endo -69.98 52.58 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.481 2.121 . . . . 0.0 112.195 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -160.98 -35.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 66.4 114.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.068 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -151.52 124.32 8.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.457 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 60' ' ' VAL . 17.8 m -65.55 125.29 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.635 HG23 HG21 ' A' ' 13' ' ' VAL . 10.9 m -93.82 -21.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.417 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.66 HD12 ' CE3' ' A' ' 89' ' ' TRP . 12.4 tt -141.42 140.46 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.619 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -164.43 66.7 0.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 110.875 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.8 t -128.72 131.78 47.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.957 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -75.55 136.49 40.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.396 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.5 pt -109.99 165.78 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.969 0.414 . . . . 0.0 111.079 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 66' ' ' ILE . 16.0 m -158.54 -176.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.556 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.74 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -58.73 89.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.57 -30.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.35 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.868 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -86.43 131.88 33.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 117.128 0.464 . . . . 0.0 110.743 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -119.49 114.94 23.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.777 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.609 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.0 OUTLIER -60.73 106.23 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.043 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.79 86.47 4.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.23 91.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.179 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.69 -57.54 12.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.3 p -129.09 160.47 63.58 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.348 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 6.0 Cg_endo -48.0 -26.17 7.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.714 2.276 . . . . 0.0 112.352 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -127.89 59.44 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.006 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' A' ' 92' ' ' ASN . 7.1 t80 -175.87 130.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.939 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -119.23 150.67 39.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.592 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.692 ' HG3' HG12 ' A' ' 88' ' ' VAL . 31.6 tt0 -158.56 150.72 21.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.246 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.944 ' CH2' HD21 ' A' ' 91' ' ' LEU . 19.7 p90 -151.29 165.5 33.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.344 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -121.74 114.15 20.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.728 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.44 -35.84 12.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 110.44 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.74 -67.25 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.285 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -141.78 16.93 2.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.262 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.463 ' HG3' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -128.22 114.19 16.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.692 HG12 ' HG3' ' A' ' 81' ' ' GLN . 2.4 t -93.54 108.93 21.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.865 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.698 ' CD2' HD21 ' A' ' 15' ' ' LEU . 84.6 m95 -93.78 85.91 4.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.91 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.859 ' C ' HD13 ' A' ' 91' ' ' LEU . . . -97.07 132.48 11.01 Favored Glycine 0 C--O 1.223 -0.544 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.84 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.944 HD21 ' CH2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -124.09 129.99 51.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.944 0.402 . . . . 0.0 111.679 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . 10.6 t-20 -92.64 110.67 22.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.641 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.623 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 89.0 m-85 -75.61 162.91 27.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.786 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.87 -27.56 28.6 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.378 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.4 m -148.54 179.42 7.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -34.14 67.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.989 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -63.16 -51.05 67.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -52.66 -58.71 5.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.672 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -52.81 -33.92 51.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.44 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.43 -32.93 62.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.283 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.661 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -74.49 -46.76 37.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.004 0.431 . . . . 0.0 111.03 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.506 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 21.5 t80 -51.6 -53.7 35.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.052 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.939 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -62.61 -29.89 70.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.024 0.44 . . . . 0.0 110.651 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -46.41 -65.82 0.5 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.052 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.33 -45.02 96.01 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.3 -0.952 . . . . 0.0 111.753 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.923 ' CE ' HD21 ' A' ' 110' ' ' LEU . 15.8 tpt -49.74 -59.46 3.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.924 0.392 . . . . 0.0 110.452 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.73 -37.74 2.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.931 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -38.58 89.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.033 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.524 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -62.63 -56.74 15.04 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.729 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.923 HD21 ' CE ' ' A' ' 106' ' ' MET . 11.5 mt -59.86 -20.36 56.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.304 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -94.61 -22.44 18.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.669 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.29 -1.82 43.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.103 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.777 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -112.58 -28.92 7.65 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.299 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.462 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 3.3 mm-40 -91.09 -33.93 15.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.453 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.382 -1.232 . . . . 0.0 112.513 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.5 m . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.634 HG11 ' OE1' ' A' ' 37' ' ' GLN . 41.1 t -61.33 145.35 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.737 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -97.53 -70.16 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.78 -176.91 4.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.86 0.362 . . . . 0.0 111.57 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.535 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 12.6 p -156.15 126.43 6.62 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.222 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.483 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 16.7 t -135.72 158.34 44.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.984 0.421 . . . . 0.0 111.615 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.413 ' HD3' ' CD1' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -102.03 124.67 48.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.397 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.59 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -167.03 -172.64 2.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.501 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' ASN . 18.8 m -124.67 91.49 3.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.149 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.683 HG21 HG23 ' A' ' 61' ' ' VAL . 78.9 t -42.32 156.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.476 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.484 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -153.96 134.59 13.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.778 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 2.9 mt -112.47 110.7 21.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 0.0 110.285 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 16.7 t80 -71.41 141.03 50.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.115 0.483 . . . . 0.0 111.668 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.46 80.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.932 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.38 -26.2 4.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.33 -32.81 22.78 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.87 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -138.68 15.09 2.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.763 0.316 . . . . 0.0 110.633 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 2.4 mmpt? 46.46 90.7 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.244 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.81 133.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.792 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 12.3 m95 -59.31 146.2 40.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -141.44 112.3 6.54 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.315 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -40.65 99.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.81 2.34 . . . . 0.0 112.96 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.538 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -46.95 -34.05 5.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.329 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.29 -108.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.642 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 29' ' ' GLY . 9.9 t -146.34 -47.54 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.743 0.306 . . . . 0.0 111.327 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 28' ' ' THR . . . -152.28 -87.57 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.737 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.03 166.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.736 2.291 . . . . 0.0 112.451 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -141.91 58.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.41 51.66 2.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.413 ' CD1' ' HD3' ' A' ' 10' ' ' ARG . 52.9 m-85 55.69 178.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.682 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -165.56 143.59 5.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.86 96.22 9.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.925 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.829 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.6 t -93.83 114.67 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.369 0.604 . . . . 0.0 112.263 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.634 ' OE1' HG11 ' A' ' 5' ' ' VAL . 36.5 mt-30 -107.91 156.88 18.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.487 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.478 HD11 ' HB2' ' A' ' 106' ' ' MET . 51.0 mt -102.93 148.12 8.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.457 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.1 m-85 -109.69 117.71 34.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 111.242 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.479 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 6.1 t-80 -95.41 88.61 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.11 101.84 9.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.53 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 89.5 Cg_endo -83.05 -21.03 4.87 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.342 2.028 . . . . 0.0 112.634 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.8 m -48.31 -29.66 4.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.041 0.448 . . . . 0.0 110.611 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.17 6.88 4.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.288 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.2 49.28 9.34 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.196 0.522 . . . . 0.0 110.028 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -130.87 166.57 20.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.408 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.809 ' CE2' HD23 ' A' ' 113' ' ' LEU . 53.4 m-85 -131.58 167.92 18.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.841 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -155.54 148.42 24.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.054 0.454 . . . . 0.0 111.832 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 64' ' ' CYS . 3.4 m -109.66 123.41 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.673 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -131.9 119.4 41.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.829 0.347 . . . . 0.0 111.224 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -136.67 144.58 16.28 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.652 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 1.9 ptt85 -131.21 149.77 52.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.659 0.266 . . . . 0.0 110.751 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HB3' ' HG2' ' A' ' 55' ' ' GLN . 10.8 tptt -62.24 157.03 20.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.009 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mmt -98.7 45.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.408 ' HG2' ' HB3' ' A' ' 53' ' ' LYS . 18.2 pt20 -121.5 160.93 44.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.795 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.05 -28.11 18.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.609 2.206 . . . . 0.0 112.435 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.52 -44.6 86.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 62.08 89.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.04 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 3.3 pt20 -131.46 150.12 52.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 60' ' ' VAL . 6.2 m -85.86 124.0 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.03 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.683 HG23 HG21 ' A' ' 13' ' ' VAL . 3.7 m -93.85 -24.43 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.751 HD12 ' CE3' ' A' ' 89' ' ' TRP . 15.9 tt -137.93 143.1 34.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.528 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -166.57 59.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.823 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.434 ' O ' HG22 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -119.53 140.37 50.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.726 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -83.51 134.41 34.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 111.475 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.497 HD13 ' SD ' ' A' ' 106' ' ' MET . 0.9 OUTLIER -113.03 127.33 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.84 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 67' ' ' VAL . 27.3 m -141.66 111.29 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.906 0.384 . . . . 0.0 111.52 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.683 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 27.22 48.17 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.0 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.27 -36.84 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.706 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.832 ' O ' HD22 ' A' ' 110' ' ' LEU . 2.5 t -91.08 141.81 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.472 . . . . 0.0 110.78 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.23 107.21 8.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.806 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 2.9 m-30 -53.55 118.3 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.69 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -93.94 -33.34 13.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.404 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.36 80.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.366 . . . . 0.0 110.601 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.65 -34.87 62.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.329 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.506 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 15.2 p -154.44 162.0 28.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.712 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 4.5 Cg_endo -46.78 -25.77 4.02 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.853 2.369 . . . . 0.0 112.307 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -122.12 35.21 4.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.216 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.421 ' HB2' ' OG1' ' A' ' 76' ' ' THR . 4.8 t80 -154.6 118.52 4.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 111.18 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.784 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.7 m80 -110.97 103.92 12.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.393 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.664 ' HG3' HG12 ' A' ' 88' ' ' VAL . 24.5 tt0 -113.07 144.63 42.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.362 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.761 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.4 p90 -144.88 161.26 39.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.708 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -118.57 114.96 23.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.498 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.431 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -93.66 -81.67 0.36 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.395 -178.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.85 -67.73 0.88 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.885 0.374 . . . . 0.0 111.287 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.2 ttm-85 -139.82 -0.59 1.69 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.777 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.62 163.37 19.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.908 0.385 . . . . 0.0 110.395 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.664 HG12 ' HG3' ' A' ' 81' ' ' GLN . 1.6 t -120.75 127.62 75.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.805 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.751 ' CE3' HD12 ' A' ' 62' ' ' ILE . 66.5 m95 -101.63 91.24 4.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.194 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.555 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -86.83 122.47 6.14 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.496 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.567 HD23 ' CH2' ' A' ' 82' ' ' TRP . 3.0 mm? -103.02 111.07 23.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.615 0.245 . . . . 0.0 111.51 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 12' ' ' THR . 14.1 t-20 -92.63 104.85 17.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.289 0.566 . . . . 0.0 109.625 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.652 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 60.5 m-85 -77.69 164.19 25.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.255 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.77 -26.93 30.66 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.191 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.2 t -150.64 161.25 42.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.794 0.33 . . . . 0.0 110.617 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -25.5 61.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.253 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -58.69 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.079 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.53 -56.24 8.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.052 0.453 . . . . 0.0 110.62 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.652 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -49.16 -33.86 13.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.621 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.44 -30.92 65.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.319 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.633 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -76.08 -50.45 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.267 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.501 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 12.1 t80 -49.08 -52.63 24.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.784 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -64.01 -31.38 72.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.827 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.45 -65.38 0.55 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.194 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.9 -47.77 79.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.945 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' MET . . . . . 1.02 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.7 tpt -48.77 -60.67 2.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.969 0.414 . . . . 0.0 110.576 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.65 -37.71 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.314 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -37.78 85.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.968 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.3 -53.7 40.03 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.876 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.02 HD21 ' HE3' ' A' ' 106' ' ' MET . 10.1 mt -63.65 -15.63 58.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.244 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -92.42 -27.0 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.547 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.96 1.48 45.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.24 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.809 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -113.2 -37.18 4.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.314 -179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -94.61 -28.79 15.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.829 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.503 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.0 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.754 0.311 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.557 HG13 ' HB3' ' A' ' 37' ' ' GLN . 41.9 t -89.78 151.37 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.461 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -103.59 -69.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.959 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 -178.47 4.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.875 0.369 . . . . 0.0 111.634 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.518 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 9.4 p -152.35 126.21 9.02 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.163 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 39.1 t -135.03 165.77 24.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.007 0.432 . . . . 0.0 111.609 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -106.51 121.38 44.18 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.804 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -166.77 175.6 7.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 111.129 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -114.84 95.43 5.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.32 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 26' ' ' ALA . 70.4 t -46.31 151.13 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.496 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -149.67 146.59 27.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.742 -179.168 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 4.0 mt -123.18 108.8 13.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.42 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.8 t80 -71.54 153.17 42.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.22 0.533 . . . . 0.0 111.959 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.83 88.58 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.23 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -53.34 -22.38 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.321 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.38 -34.9 69.4 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.621 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -132.77 13.99 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.666 0.27 . . . . 0.0 111.303 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER 51.02 83.75 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.819 0.342 . . . . 0.0 111.036 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 179.11 155.31 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.061 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.56 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 28.8 m95 -73.27 172.63 10.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.53 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.768 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -164.8 115.91 0.91 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.377 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.768 ' HD2' HD23 ' A' ' 24' ' ' LEU . 83.4 Cg_exo -41.01 94.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.802 2.335 . . . . 0.0 113.002 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.586 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -44.31 -44.03 7.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.679 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.56 -105.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.629 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.0 p -123.32 -79.38 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 111.022 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.78 -76.86 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.19 -178.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.617 2.211 . . . . 0.0 112.322 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.402 ' HA ' ' HE2' ' A' ' 53' ' ' LYS . 1.1 mt-30 -146.63 152.2 38.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.503 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . . . -178.93 44.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.107 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 52.17 -175.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.418 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' ALA . 93.5 p -174.32 150.88 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.007 0.432 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -93.79 95.51 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.461 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.828 HG22 ' HA3' ' A' ' 51' ' ' GLY . 20.0 t -94.02 117.42 37.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.288 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.557 ' HB3' HG13 ' A' ' 5' ' ' VAL . 40.8 mt-30 -109.2 155.94 20.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.379 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 106' ' ' MET . 62.0 mt -101.02 149.01 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.391 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -112.97 119.91 39.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.99 0.424 . . . . 0.0 110.96 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.497 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -93.58 103.2 15.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.583 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -105.14 84.54 1.07 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.672 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 74.5 Cg_endo -74.97 -22.47 14.84 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.349 2.032 . . . . 0.0 112.432 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.5 p -51.66 -30.43 21.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.085 0.469 . . . . 0.0 110.487 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -129.32 7.39 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.139 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 61.35 48.83 5.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.138 0.494 . . . . 0.0 110.178 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.04 155.77 49.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.323 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.812 ' CE2' HD23 ' A' ' 113' ' ' LEU . 51.8 m-85 -124.42 178.14 5.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.623 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.1 ttm180 -167.38 157.3 10.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.059 0.456 . . . . 0.0 111.592 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.424 HG23 HG12 ' A' ' 62' ' ' ILE . 6.6 m -120.27 125.66 74.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.035 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.18 125.93 52.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.215 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.828 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -140.32 146.51 17.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.756 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -127.5 151.82 48.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.895 0.379 . . . . 0.0 111.146 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HD2' ' HB3' ' A' ' 32' ' ' ALA . 21.2 mmtp -55.58 158.88 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.8 mtp -98.81 45.39 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.569 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -130.44 163.24 49.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.706 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.01 -22.09 29.47 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 112.445 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -43.71 76.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.921 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 63.69 84.08 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -120.78 128.48 52.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.557 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 60' ' ' VAL . 5.8 m -70.96 120.09 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 0.0 110.631 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.554 HG23 HG21 ' A' ' 13' ' ' VAL . 3.1 m -93.67 -21.94 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.229 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.719 HD12 ' CE3' ' A' ' 89' ' ' TRP . 10.4 tt -138.67 139.7 40.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.376 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -165.34 69.13 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.025 0.44 . . . . 0.0 110.899 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 24.4 p -135.2 136.96 42.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -80.32 138.62 36.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.405 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -112.99 167.88 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 110.813 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 66' ' ' ILE . 21.4 m -156.5 -171.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.485 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.784 ' H ' HD12 ' A' ' 113' ' ' LEU . 9.6 ttt180 -60.3 83.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.287 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 67' ' ' VAL . . . -177.59 -32.7 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.571 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.859 HG13 ' HB2' ' A' ' 82' ' ' TRP . 3.2 t -82.43 133.31 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 117.342 0.571 . . . . 0.0 111.215 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.31 105.82 10.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.634 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.587 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.0 OUTLIER -53.88 104.4 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.284 -179.712 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -93.93 95.4 9.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.614 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.82 87.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.39 81.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.936 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 4.4 p -152.68 160.84 30.59 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.227 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 1.1 Cg_endo -43.28 -28.07 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.764 2.31 . . . . 0.0 112.377 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -128.74 57.76 1.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.76 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.0 t80 -166.47 113.19 0.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.149 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.887 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 2.7 m80 -111.21 101.99 10.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.043 0.449 . . . . 0.0 110.541 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.654 ' HG3' HG12 ' A' ' 88' ' ' VAL . 2.9 tt0 -108.41 156.42 19.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.036 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.859 ' HB2' HG13 ' A' ' 70' ' ' VAL . 46.7 p90 -156.4 151.82 26.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.347 0.594 . . . . 0.0 112.047 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.19 111.3 20.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.21 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 5.4 t0 -93.53 -90.92 0.19 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.353 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.02 -68.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.131 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -147.11 -4.01 0.55 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.669 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -105.34 179.98 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.342 . . . . 0.0 110.341 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.654 HG12 ' HG3' ' A' ' 81' ' ' GLN . 1.6 t -136.72 115.87 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.542 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.719 ' CE3' HD12 ' A' ' 62' ' ' ILE . 75.4 m95 -93.62 99.35 11.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.019 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.497 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -93.52 119.15 5.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.707 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.584 HD11 HG22 ' A' ' 13' ' ' VAL . 3.4 mm? -103.74 108.95 20.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.573 0.225 . . . . 0.0 111.506 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.42 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 10.5 t-20 -92.83 107.68 19.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 110.108 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.804 ' CD1' ' HB2' ' A' ' 11' ' ' ALA . 66.9 m-85 -78.09 161.91 27.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.119 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.69 -28.52 9.46 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.383 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.8 m -135.66 163.21 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.321 . . . . 0.0 110.769 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -63.86 -32.93 74.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -64.73 -53.17 51.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -48.58 -62.1 1.68 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.914 0.387 . . . . 0.0 110.469 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -46.17 -38.92 8.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.49 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.12 -29.45 62.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.488 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.626 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -75.9 -49.63 17.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.529 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 6.6 t80 -51.66 -53.45 38.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.887 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -61.94 -31.91 72.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 110.741 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.94 -66.69 0.37 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.061 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.08 -40.39 98.09 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.639 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.904 ' CE ' HD21 ' A' ' 110' ' ' LEU . 16.9 tpt -51.64 -58.54 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.97 0.414 . . . . 0.0 110.422 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.49 -37.92 5.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.905 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 t -64.98 -38.21 90.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.948 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -64.51 -53.19 51.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.908 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.904 HD21 ' CE ' ' A' ' 106' ' ' MET . 11.3 mt -65.46 -18.32 65.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.103 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -96.19 -21.37 17.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.712 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . . . -96.22 -3.43 44.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.348 0.594 . . . . 0.0 109.716 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.812 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -112.37 -27.94 8.09 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.252 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.477 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 41.3 mt-10 -87.94 -34.44 18.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.535 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.337 -1.257 . . . . 0.0 112.523 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.8 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.945 0.402 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 24.4 t -89.28 159.75 2.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.393 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.487 HG13 HG22 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -112.32 -67.53 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.585 ' SG ' HD12 ' A' ' 38' ' ' ILE . 13.4 p -119.93 178.68 4.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.891 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -157.79 112.21 2.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.586 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 8.4 t -128.68 159.39 35.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 112.056 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -103.15 123.83 47.44 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.206 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.603 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -168.17 -173.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 111.24 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.4 m -120.72 93.25 3.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.174 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.694 HG21 HG23 ' A' ' 61' ' ' VAL . 54.3 t -43.43 154.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.245 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.485 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -152.06 158.79 43.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.621 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.524 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 2.4 mt -137.44 108.08 6.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.53 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 9.4 t80 -68.23 154.1 42.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.319 0.581 . . . . 0.0 111.949 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.24 81.8 2.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.06 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -48.33 -25.81 1.75 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.466 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.6 -28.99 57.16 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.528 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -134.53 10.59 3.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.613 0.244 . . . . 0.0 111.325 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.86 81.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.926 0.393 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.447 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 177.67 159.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.913 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 25.3 m95 -75.92 171.67 14.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.611 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.677 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -163.19 119.12 1.18 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.541 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.677 ' HD2' HD23 ' A' ' 24' ' ' LEU . 92.8 Cg_exo -43.18 93.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.682 2.254 . . . . 0.0 112.951 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -44.92 -51.55 9.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.617 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -46.6 -96.4 0.01 OUTLIER Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.088 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.71 -82.79 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.297 . . . . 0.0 111.185 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.08 -94.3 0.87 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.562 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.3 166.19 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.541 2.16 . . . . 0.0 112.16 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 0.7 OUTLIER -144.8 165.56 27.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.203 0.525 . . . . 0.0 111.473 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 173.28 43.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.583 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 62.53 -176.26 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' ALA . 2.0 t -175.04 153.91 1.72 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.741 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.68 96.83 10.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.82 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.9 t -97.43 122.7 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.066 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.486 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 31.6 mt-30 -114.02 172.22 7.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.384 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.585 HD12 ' SG ' ' A' ' 7' ' ' CYS . 68.7 mt -116.87 156.37 18.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.165 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.538 ' CE1' HG21 ' A' ' 50' ' ' VAL . 7.6 m-85 -114.75 120.12 38.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.0 111.466 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.481 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 12.9 t60 -93.71 86.62 5.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.74 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.81 96.83 7.06 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.843 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 74.3 Cg_endo -84.53 -23.18 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.54 2.16 . . . . 0.0 112.624 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.4 t -47.85 -30.6 4.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.946 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.85 -5.22 9.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.399 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.05 43.01 0.7 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.089 0.471 . . . . 0.0 110.207 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.51 171.91 13.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.817 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.478 ' CD1' HD11 ' A' ' 6' ' ' ILE . 65.0 m-85 -134.45 177.99 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.862 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -163.12 149.51 12.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.129 0.49 . . . . 0.0 111.63 -179.601 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.653 HG13 HG12 ' A' ' 62' ' ' ILE . 3.9 p -109.09 135.01 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.098 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.538 HG21 ' CE1' ' A' ' 39' ' ' TYR . 2.1 t -140.3 121.52 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.736 0.303 . . . . 0.0 111.306 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.82 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -143.62 147.45 18.79 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.85 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -132.47 150.78 52.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.757 0.313 . . . . 0.0 110.87 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.567 ' NZ ' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -58.46 163.44 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 17.1 mtp -106.71 46.76 0.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.414 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 7.7 pt20 -126.91 160.88 56.84 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.784 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 87.8 Cg_exo -47.55 -26.45 6.38 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.753 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.89 -44.98 68.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.829 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 59.91 93.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -134.38 136.86 43.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 60' ' ' VAL . 16.7 m -70.82 121.8 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.368 . . . . 0.0 110.863 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.694 HG23 HG21 ' A' ' 13' ' ' VAL . 3.9 m -93.75 -24.39 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.653 HG12 HG13 ' A' ' 49' ' ' VAL . 9.6 tt -138.28 135.28 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.471 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -161.9 71.88 0.37 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.917 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 18.0 t -136.81 144.9 43.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.037 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -83.82 130.91 34.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.48 ' O ' HD11 ' A' ' 113' ' ' LEU . 1.5 pt -102.72 117.0 47.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.869 0.366 . . . . 0.0 111.193 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.637 ' C ' HD13 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -106.43 165.95 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.521 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.675 ' H ' HD22 ' A' ' 113' ' ' LEU . 60.5 ttp85 -44.02 100.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.106 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.15 -23.52 0.21 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.087 -1.054 . . . . 0.0 113.847 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.56 HG11 ' CD1' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -100.09 123.54 53.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 117.617 0.709 . . . . 0.0 111.162 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.797 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -121.05 134.93 55.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.824 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.54 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.9 m-30 -67.6 126.75 30.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -95.09 -33.05 12.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.63 78.9 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.804 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.72 75.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.311 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 6.0 p -139.61 166.61 22.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.716 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 76.3 Cg_exo -51.02 -24.41 14.14 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.44 2.093 . . . . 0.0 112.368 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.71 33.09 5.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -148.43 125.22 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.959 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.696 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 6.1 m80 -125.22 98.71 5.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.295 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -112.76 146.59 38.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.768 -178.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.592 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 26.2 p90 -144.07 144.06 31.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.796 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.569 ' HG2' HG22 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -86.39 103.11 14.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.712 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.94 130.6 53.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 60.46 -82.57 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.725 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.44 -30.03 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.302 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -93.75 -168.89 1.98 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.884 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' A' ' 83' ' ' ARG . 2.4 t -137.07 129.68 43.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.977 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.598 ' CE3' HD12 ' A' ' 62' ' ' ILE . 74.2 m95 -97.61 100.89 12.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.182 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.46 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -94.44 130.87 10.48 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.566 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 11' ' ' ALA . 3.0 mm? -114.92 111.54 21.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.808 0.337 . . . . 0.0 111.857 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.481 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 12.8 t-20 -92.89 110.75 22.21 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.647 ' CD1' ' HB2' ' A' ' 99' ' ' ALA . 36.5 m-85 -86.69 159.79 19.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.331 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.66 -27.7 49.96 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.348 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 p -149.06 178.71 8.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.815 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -29.0 63.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.33 -56.87 12.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.999 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -52.21 -55.81 18.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.647 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -57.16 -28.15 62.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.276 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.85 63.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.1 tp-100 -76.39 -42.45 44.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.029 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 5.9 t80 -54.28 -48.42 71.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.696 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -65.47 -34.57 78.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.871 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.88 -65.5 0.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.53 -50.5 61.54 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.957 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.84 ' CE ' HD21 ' A' ' 110' ' ' LEU . 11.7 tpt -47.72 -60.98 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 110.661 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.57 -33.63 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.343 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -33.88 69.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.079 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 106' ' ' MET . . . -68.56 -42.26 78.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.524 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.84 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -75.51 -29.48 59.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.063 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -75.32 -25.42 57.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.36 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.14 -3.72 27.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.513 0.673 . . . . 0.0 109.481 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 68' ' ' ARG . 4.2 mt -90.05 -42.56 11.05 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.131 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.76 -33.84 11.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.68 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.403 -1.22 . . . . 0.0 112.492 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.458 -0.035 0 CA-C-O 120.856 0.36 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.519 HG13 ' HB3' ' A' ' 37' ' ' GLN . 29.4 t -76.54 151.15 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.48 HG13 HG22 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -107.45 -68.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 38' ' ' ILE . 24.2 p -115.33 176.98 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.55 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.62 113.21 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.87 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 42.2 t -129.67 152.76 48.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.018 0.437 . . . . 0.0 111.879 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -95.13 130.63 41.76 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.031 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -176.29 161.14 2.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 0.0 111.688 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.2 m -93.76 83.93 4.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.741 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.677 HG12 ' HB3' ' A' ' 26' ' ' ALA . 88.0 t -40.12 140.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.311 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.544 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -129.62 179.08 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.361 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 88' ' ' VAL . 5.8 tp -160.64 113.78 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 0.0 110.225 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 8.7 t80 -73.53 149.3 42.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.392 0.615 . . . . 0.0 112.565 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.62 87.21 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.931 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -49.11 -23.53 1.27 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.618 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.64 -48.67 42.62 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.771 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -123.69 16.3 9.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.65 0.262 . . . . 0.0 111.164 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 1.1 mtmm 52.06 87.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 111.17 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.1 OUTLIER 178.01 161.91 0.59 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.036 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.546 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 20.5 m95 -80.91 171.14 15.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.566 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.485 HD23 ' HD2' ' A' ' 25' ' ' PRO . 4.6 mt -167.17 125.59 1.03 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.541 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.485 ' HD2' HD23 ' A' ' 24' ' ' LEU . 89.3 Cg_exo -43.83 102.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.587 2.191 . . . . 0.0 112.622 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.677 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -50.01 -38.47 37.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.384 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.81 -119.96 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.705 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.58 -68.04 0.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.852 0.358 . . . . 0.0 111.27 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.5 -72.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.769 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -47.95 167.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -145.53 56.62 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.026 0.441 . . . . 0.0 111.279 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.65 50.64 1.61 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.281 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 59.95 -176.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.433 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.92 142.64 2.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -93.85 94.34 8.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.055 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.779 HG22 ' HA3' ' A' ' 51' ' ' GLY . 39.2 t -93.85 146.14 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.342 0.591 . . . . 0.0 112.011 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.519 ' HB3' HG13 ' A' ' 5' ' ' VAL . 32.5 mt-30 -138.18 170.19 16.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.56 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 106' ' ' MET . 90.9 mt -112.06 153.9 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.301 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.517 ' CE1' HG21 ' A' ' 50' ' ' VAL . 3.5 m-85 -112.12 119.05 37.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.905 0.383 . . . . 0.0 111.785 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.514 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 1.9 t60 -93.72 92.23 7.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.676 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -101.81 87.03 0.91 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.722 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 73.4 Cg_endo -74.32 -21.51 17.43 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.293 1.995 . . . . 0.0 112.465 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -48.85 -29.28 4.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.041 0.448 . . . . 0.0 110.568 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.87 8.29 4.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.231 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.468 ' O ' HD21 ' A' ' 113' ' ' LEU . 0.1 OUTLIER 59.71 49.2 8.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.207 0.527 . . . . 0.0 109.9 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.46 ' HA ' HG12 ' A' ' 67' ' ' VAL . 5.7 t -129.45 163.82 25.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.335 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.727 ' CE2' HD23 ' A' ' 113' ' ' LEU . 51.6 m-85 -133.5 169.14 17.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.656 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 2.0 ttm180 -165.1 148.61 8.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.738 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.606 HG23 HG12 ' A' ' 62' ' ' ILE . 7.0 m -104.79 129.34 57.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.489 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.517 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -135.27 123.66 39.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.779 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -146.46 146.24 16.03 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.862 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -126.49 158.64 35.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 172.92 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.815 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.449 ' HE2' ' HB2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -108.51 47.52 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -128.27 158.13 72.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.12 -27.86 18.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.641 2.227 . . . . 0.0 112.454 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -42.24 85.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 60.19 99.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -135.98 132.71 36.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.761 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.4 m -70.42 120.94 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.045 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.641 ' CG2' HG21 ' A' ' 13' ' ' VAL . 5.9 m -93.84 -21.92 5.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.235 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.606 HG12 HG23 ' A' ' 49' ' ' VAL . 9.9 tt -138.04 134.05 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.479 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -160.16 63.67 0.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.943 0.402 . . . . 0.0 110.86 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.1 t -124.62 139.99 53.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.967 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -87.02 150.38 24.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.349 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.471 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -130.46 141.47 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 46' ' ' SER . 15.2 m -152.35 110.89 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.665 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.581 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 26.62 47.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.33 179.312 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.12 -27.7 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.177 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.843 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.6 t -100.14 138.88 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 111.338 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -126.35 110.61 13.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.569 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CE2' ' HG2' ' A' ' 106' ' ' MET . 1.5 m-30 -51.02 132.67 27.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.412 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.88 97.49 5.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.79 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.09 104.23 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.92 -34.66 64.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.022 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.4 p -150.28 174.36 3.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.524 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 65.3 Cg_exo -51.78 -24.54 18.52 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.382 2.055 . . . . 0.0 112.354 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -140.37 69.95 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.961 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -173.67 128.27 0.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.69 ' HB2' HD21 ' A' ' 91' ' ' LEU . 1.4 m-70 -117.04 146.89 42.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.714 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -154.91 138.25 15.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.984 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.843 ' HB2' HG13 ' A' ' 70' ' ' VAL . 15.5 p90 -145.96 142.05 28.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.145 0.498 . . . . 0.0 111.935 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.406 ' HD3' HG22 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -104.32 111.32 23.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.209 178.392 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.413 ' HB2' HG21 ' A' ' 70' ' ' VAL . 14.8 t70 -93.78 -93.43 0.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.608 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.18 -70.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.981 0.42 . . . . 0.0 111.402 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.01 -7.18 1.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.63 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 -168.86 1.43 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 110.621 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.714 HG12 ' HG2' ' A' ' 81' ' ' GLN . 0.9 OUTLIER -143.04 120.15 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.048 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.605 ' CZ3' ' HB1' ' A' ' 26' ' ' ALA . 59.1 m95 -92.69 105.76 17.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.249 0.547 . . . . 0.0 110.74 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.546 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -106.95 174.36 19.88 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.664 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' ' 80' ' ' HIS . 1.1 pt? -177.69 139.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.194 0.521 . . . . 0.0 111.54 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.406 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 6.6 t-20 -103.19 121.37 42.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.404 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 53.4 m-85 -85.46 160.25 19.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.117 0.484 . . . . 0.0 111.785 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.55 -27.51 63.16 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.31 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.63 169.97 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 110.775 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -26.01 65.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.15 -49.21 62.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.6 -55.58 32.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.072 0.463 . . . . 0.0 110.056 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.694 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -56.31 -29.17 60.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.367 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -31.22 64.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.384 . . . . 0.0 111.174 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.9 tp-100 -78.47 -43.41 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.144 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 5.1 t80 -54.41 -45.94 73.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.206 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.542 ' HB2' ' NE2' ' A' ' 80' ' ' HIS . . . -72.22 -29.31 63.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.69 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -47.28 -64.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.074 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.43 -49.17 58.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.995 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' MET . . . . . 1.059 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.3 tpt -49.19 -60.74 2.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.393 . . . . 0.0 110.611 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.95 -37.4 3.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.313 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -36.67 79.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.031 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.619 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.13 -51.95 58.14 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.679 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.059 HD21 ' HE3' ' A' ' 106' ' ' MET . 6.8 mt -63.59 -18.07 63.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.873 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -94.85 -25.59 16.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.567 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.46 1.3 51.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.307 0.575 . . . . 0.0 110.083 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.727 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -112.42 -33.54 6.15 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.213 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -87.18 -32.77 19.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.322 -1.266 . . . . 0.0 112.434 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.4 m . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.81 0.338 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.564 HG11 ' OE1' ' A' ' 37' ' ' GLN . 44.0 t -60.66 146.66 10.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.658 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.521 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -98.23 -68.98 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.826 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -132.78 -175.41 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.505 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.51 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 14.9 p -153.36 118.11 5.02 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.199 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 7.2 p -120.26 159.98 23.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.121 0.486 . . . . 0.0 111.876 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -107.16 118.77 37.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.564 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -167.69 -171.88 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.09 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 92' ' ' ASN . 3.4 m -123.52 90.62 3.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.16 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.564 HG21 HG23 ' A' ' 61' ' ' VAL . 69.5 t -42.26 148.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.065 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.509 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -143.65 163.8 32.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.065 -178.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.534 HD21 ' CE2' ' A' ' 89' ' ' TRP . 5.1 mt -136.58 112.0 9.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.454 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.6 t80 -75.93 147.39 38.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.244 0.545 . . . . 0.0 111.934 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.8 89.79 3.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.15 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -52.79 -21.65 4.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.85 -50.76 48.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.62 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -125.08 18.23 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.677 0.275 . . . . 0.0 111.141 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 7.9 mtpt 51.49 91.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.155 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 177.89 151.92 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.585 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 20.6 m95 -76.22 167.94 20.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.565 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.7 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.6 mt -160.33 129.7 3.24 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.532 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.7 ' HD2' HD23 ' A' ' 24' ' ' LEU . 87.8 Cg_exo -47.73 94.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.554 2.17 . . . . 0.0 112.903 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.536 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -46.07 -42.94 14.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.464 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.32 -110.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.82 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 t -126.85 -52.82 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 111.253 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.44 -82.68 0.04 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.693 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -47.7 168.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.576 2.184 . . . . 0.0 112.364 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 5.1 mt-30 -142.11 154.28 44.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.165 0.507 . . . . 0.0 111.322 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 175.57 44.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.954 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 56.71 175.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.618 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 11' ' ' ALA . 27.2 m -166.5 152.35 8.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.636 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -93.79 97.63 10.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.705 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.658 HG22 ' HA3' ' A' ' 51' ' ' GLY . 24.1 t -93.74 122.11 44.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.294 0.568 . . . . 0.0 112.092 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.564 ' OE1' HG11 ' A' ' 5' ' ' VAL . 36.9 mt-30 -116.2 154.82 29.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.763 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 106' ' ' MET . 41.8 mt -103.36 151.0 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.61 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.28 122.48 47.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.047 0.451 . . . . 0.0 111.525 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.49 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 0.6 OUTLIER -101.13 91.33 4.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.113 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -101.55 88.51 1.19 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.508 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 63.0 Cg_endo -72.43 -19.55 24.99 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.34 2.027 . . . . 0.0 112.554 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.3 m -52.01 -26.66 11.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.664 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.44 8.56 5.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.2 t30 56.84 49.32 14.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.042 0.449 . . . . 0.0 110.266 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.526 ' HA ' HG12 ' A' ' 67' ' ' VAL . 71.4 m -136.22 165.4 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.29 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.773 ' CE2' HD23 ' A' ' 113' ' ' LEU . 56.9 m-85 -134.32 173.24 11.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.609 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.649 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 7.2 ttp180 -165.8 150.78 8.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.421 . . . . 0.0 111.56 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.674 HG13 HG12 ' A' ' 62' ' ' ILE . 5.8 p -106.71 135.55 44.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.239 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.91 118.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.974 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.658 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -138.3 143.56 14.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.934 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -126.09 148.91 49.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.749 0.309 . . . . 0.0 110.802 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -57.57 168.89 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -108.2 45.37 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -128.25 161.67 55.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.61 -31.03 23.49 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.668 2.246 . . . . 0.0 112.642 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -45.85 90.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.04 91.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.876 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -131.3 136.08 47.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.668 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 60' ' ' VAL . 13.2 m -72.71 122.01 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.735 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.564 HG23 HG21 ' A' ' 13' ' ' VAL . 3.3 m -93.71 -20.58 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.24 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.674 HG12 HG13 ' A' ' 49' ' ' VAL . 8.8 tt -140.59 138.79 35.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.626 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -163.38 69.44 0.21 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.689 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.408 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -131.56 135.03 46.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.889 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.649 ' HB2' ' HD3' ' A' ' 48' ' ' ARG . . . -78.02 141.11 39.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.593 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.539 HD13 ' SD ' ' A' ' 106' ' ' MET . 0.9 OUTLIER -120.87 124.76 73.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.781 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 46' ' ' SER . 16.1 m -138.59 110.06 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.904 0.383 . . . . 0.0 111.579 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.761 ' N ' HD12 ' A' ' 113' ' ' LEU . 1.1 ttt180 29.62 73.47 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.997 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.67 -36.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 119.76 -1.21 . . . . 0.0 113.612 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.818 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.8 t -87.95 139.1 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.032 0.444 . . . . 0.0 111.519 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.16 97.88 5.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.168 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.7 m-30 -43.99 115.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.713 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -111.46 93.0 4.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.878 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.32 92.44 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.035 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.7 90.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.979 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.519 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 2.7 p -134.57 159.23 73.0 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.335 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 1.2 Cg_endo -44.06 -27.48 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.881 2.388 . . . . 0.0 112.561 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -123.8 47.63 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 111.082 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.406 ' HB2' ' OG1' ' A' ' 76' ' ' THR . 1.5 t80 -155.24 141.71 18.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.955 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.551 ' CE1' ' O ' ' A' ' 99' ' ' ALA . 19.7 m80 -136.34 93.42 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.468 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 1.2 tm0? -104.19 140.58 37.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.213 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.818 ' HB2' HG13 ' A' ' 70' ' ' VAL . 48.7 p90 -143.07 147.28 34.79 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.144 0.497 . . . . 0.0 111.684 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.563 ' HG3' HG22 ' A' ' 88' ' ' VAL . 3.8 ttm180 -106.99 113.02 26.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.335 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.452 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 4.4 t70 -93.69 -91.05 0.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.78 -67.92 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 111.36 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -141.63 -8.08 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.512 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.54 -175.41 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.617 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' A' ' 83' ' ' ARG . 2.0 t -138.22 130.21 38.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.493 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.657 ' CE3' HD12 ' A' ' 62' ' ' ILE . 61.1 m95 -105.14 99.48 9.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.547 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -90.78 125.92 8.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.773 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.636 HD23 ' CH2' ' A' ' 82' ' ' TRP . 3.4 mm? -107.08 109.8 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.511 0.196 . . . . 0.0 111.43 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.508 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 15.8 t-20 -92.58 109.42 20.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 11' ' ' ALA . 14.7 m-85 -89.66 164.62 14.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.146 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.23 -40.74 5.39 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.555 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 162.33 25.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -31.13 70.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.946 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.37 -46.82 78.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -55.41 -58.86 6.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.961 0.41 . . . . 0.0 110.719 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.551 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . -55.93 -34.15 65.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.083 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.41 -39.99 62.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.635 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.5 tp-100 -67.12 -43.24 82.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.684 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.539 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 9.4 t80 -53.25 -51.87 60.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.904 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.48 ' HB2' ' NE2' ' A' ' 80' ' ' HIS . . . -65.1 -26.22 68.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.685 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -49.94 -62.92 1.29 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.898 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.57 -50.26 50.3 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.929 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' MET . . . . . 1.029 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.8 tpt -49.71 -60.96 2.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.943 0.401 . . . . 0.0 110.515 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.55 -36.78 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.139 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -41.47 91.0 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.674 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -61.05 -56.17 24.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.312 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.029 HD21 ' HE3' ' A' ' 106' ' ' MET . 8.0 mt -59.87 -20.48 57.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.946 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.54 -22.8 22.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.34 1.32 38.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.99 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.773 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -116.43 -32.7 5.17 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.131 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.453 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 21.0 mt-10 -105.34 -28.94 10.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.694 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.542 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.2 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.715 0.293 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 22.0 t -57.62 148.08 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.481 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -101.32 -67.66 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.775 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.51 -176.76 4.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.778 0.323 . . . . 0.0 111.558 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.446 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -152.45 124.23 7.91 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.186 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.475 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 13.3 t -133.72 149.17 51.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.794 0.33 . . . . 0.0 111.606 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 8.4 ttm105 -93.88 127.34 39.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.985 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.612 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -169.21 -176.2 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.925 0.393 . . . . 0.0 111.38 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -118.4 92.39 3.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.435 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.587 HG22 HD11 ' A' ' 91' ' ' LEU . 53.4 t -44.59 154.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 0.0 111.108 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.2 OUTLIER -152.77 143.42 22.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.978 -179.163 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.58 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 5.1 mt -120.67 114.4 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.311 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.2 t80 -72.43 151.74 42.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 111.738 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.74 86.66 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.305 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -52.1 -23.49 5.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.411 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.06 -42.07 86.57 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.285 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -126.98 15.62 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 110.82 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER 47.19 83.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.092 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.96 150.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.807 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.537 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 14.4 m95 -69.37 169.0 13.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.541 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.2 mt -165.44 114.17 0.82 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.508 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HD2' HD23 ' A' ' 24' ' ' LEU . 86.4 Cg_exo -41.7 100.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.695 2.263 . . . . 0.0 112.789 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.58 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -45.14 -43.97 10.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.536 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.99 -85.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.595 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.46 -80.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.744 0.307 . . . . 0.0 111.069 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -129.78 -70.0 0.12 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.543 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.42 170.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.554 2.169 . . . . 0.0 112.366 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -148.72 63.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.022 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.22 48.12 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 56.22 -178.03 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.707 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' ALA . 7.4 t -170.36 146.58 2.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.858 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -93.8 97.54 10.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.415 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.86 HG22 ' HA3' ' A' ' 51' ' ' GLY . 36.3 t -98.12 124.32 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.413 0.625 . . . . 0.0 112.022 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 22.2 mt-30 -115.06 160.59 19.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.419 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.538 HD13 ' HA ' ' A' ' 106' ' ' MET . 51.4 mt -108.51 147.45 13.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.32 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.7 m-85 -108.43 118.22 36.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.0 0.429 . . . . 0.0 111.081 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.536 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 t-80 -93.78 87.9 5.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.798 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.27 98.34 5.6 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.538 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 68.4 Cg_endo -85.32 -22.43 2.65 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.366 2.044 . . . . 0.0 112.598 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.9 p -48.28 -30.69 5.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.951 0.405 . . . . 0.0 110.61 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.59 4.5 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.244 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.88 48.59 5.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.237 0.541 . . . . 0.0 110.077 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 m -132.9 152.05 51.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.212 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.865 ' CE2' HD23 ' A' ' 113' ' ' LEU . 52.3 m-85 -120.82 163.53 18.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 31.6 mtt180 -147.54 149.61 32.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.152 0.501 . . . . 0.0 111.916 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.458 HG23 HG12 ' A' ' 62' ' ' ILE . 5.4 m -113.0 120.6 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.362 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.5 t -128.82 120.77 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 0.0 111.617 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.86 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -141.92 149.82 21.49 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.596 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 157.56 46.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 0.0 110.944 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HD3' HG11 ' A' ' 61' ' ' VAL . 21.4 mmtt -68.85 159.15 33.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.7 mtt -101.88 47.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -119.66 162.11 34.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.867 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.88 -26.02 17.12 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.555 2.17 . . . . 0.0 112.435 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.32 -42.47 59.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 60.55 99.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.808 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -137.92 137.57 38.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 60' ' ' VAL . 20.6 m -71.65 121.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.949 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.433 HG23 HG21 ' A' ' 13' ' ' VAL . 3.2 m -93.69 -21.34 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.005 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.757 HD12 ' CE3' ' A' ' 89' ' ' TRP . 16.8 tt -140.38 135.57 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.527 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -159.36 60.17 0.39 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.937 0.399 . . . . 0.0 110.907 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.6 167.91 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -111.84 128.97 56.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.235 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.75 143.56 18.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.07 0.462 . . . . 0.0 111.22 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.97 -170.01 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.336 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.757 ' H ' HD12 ' A' ' 113' ' ' LEU . 4.9 ttt-85 -56.12 92.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.474 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.72 -26.8 0.13 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.928 -1.129 . . . . 0.0 113.758 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.603 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.2 t -94.84 122.62 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 117.412 0.606 . . . . 0.0 111.255 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.799 ' HA ' HD13 ' A' ' 110' ' ' LEU . 20.7 tptm -126.07 117.33 22.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.721 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.559 ' OH ' ' CE2' ' A' ' 102' ' ' PHE . 1.8 m-30 -50.46 127.07 16.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.018 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.77 -29.41 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.105 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.67 77.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 110.682 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -54.5 -39.76 67.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.264 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.7 p -150.85 173.51 4.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.431 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 78.4 Cg_exo -50.74 -24.85 13.96 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.384 2.056 . . . . 0.0 112.274 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -132.12 52.15 2.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.789 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.2 t80 -160.32 104.11 1.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.235 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.957 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 4.3 m80 -102.58 104.96 15.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.004 0.431 . . . . 0.0 110.824 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -115.99 144.1 44.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.159 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.629 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 27.4 p90 -143.51 147.48 34.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.115 0.484 . . . . 0.0 111.743 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -109.3 112.64 24.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.987 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.504 ' HB2' HG21 ' A' ' 70' ' ' VAL . 16.8 t70 -93.67 -96.32 0.15 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.807 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.94 -70.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.936 0.398 . . . . 0.0 111.362 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -137.64 -9.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.696 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.18 173.2 6.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.065 0.46 . . . . 0.0 110.923 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.445 HG12 ' HG2' ' A' ' 81' ' ' GLN . 3.4 t -129.04 130.46 68.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.271 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.757 ' CE3' HD12 ' A' ' 62' ' ' ILE . 71.0 m95 -105.39 97.27 7.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.31 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.537 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -91.16 122.63 6.79 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.383 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.587 HD11 HG22 ' A' ' 13' ' ' VAL . 2.5 mm? -106.01 111.57 24.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.826 -0.22 . . . . 0.0 111.489 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 14.5 t-20 -92.66 103.25 15.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.333 0.587 . . . . 0.0 109.736 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.612 ' CD1' ' HB2' ' A' ' 11' ' ' ALA . 76.5 m-85 -72.85 154.17 40.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.95 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.89 -28.05 12.87 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.297 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 m -133.21 164.06 27.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.753 0.311 . . . . 0.0 110.797 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -29.78 70.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.019 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.79 -52.28 31.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.008 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -49.53 -57.25 7.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.421 . . . . 0.0 110.64 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -52.11 -41.83 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.546 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.29 -31.49 67.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.64 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.3 tp-100 -75.28 -47.59 27.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.239 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.559 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 3.3 t80 -51.54 -52.27 48.42 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.957 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -61.4 -32.49 72.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.91 0.386 . . . . 0.0 110.628 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.3 -66.13 0.44 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.189 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.13 -45.59 70.64 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.762 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.898 ' CE ' HD21 ' A' ' 110' ' ' LEU . 12.6 tpt -47.97 -60.62 2.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.908 0.385 . . . . 0.0 110.413 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.67 -36.43 11.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.004 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 t -64.82 -34.17 77.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.11 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.552 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -70.39 -51.25 31.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.589 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.898 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.7 OUTLIER -63.79 -18.14 63.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.183 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -98.52 -20.79 16.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.927 0.394 . . . . 0.0 111.88 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.75 -0.67 44.95 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.017 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.865 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -116.37 -32.79 5.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.315 -179.537 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 5.0 mt-10 -94.45 -28.07 15.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.53 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.813 0.34 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 6' ' ' ILE . 65.2 t -88.7 158.6 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.477 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.625 HG13 HG22 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -112.82 -60.4 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.831 0.348 . . . . 0.0 111.931 -179.144 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 38' ' ' ILE . 10.0 p -129.34 177.32 7.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.798 -178.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.436 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.5 OUTLIER -157.98 110.55 2.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.638 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 102' ' ' PHE . 4.6 m -128.69 163.55 24.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.208 0.528 . . . . 0.0 112.206 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.3 ttt85 -105.67 127.7 53.22 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.81 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.863 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -169.85 -177.73 2.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 111.049 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -114.89 89.35 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.353 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.673 HG11 ' HB ' ' A' ' 62' ' ' ILE . 97.8 t -45.56 137.19 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.159 0.504 . . . . 0.0 111.077 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.506 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -136.24 161.24 36.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.789 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 26' ' ' ALA . 5.0 mt -134.18 110.49 9.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.55 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.514 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.4 t80 -73.51 147.16 44.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.083 0.468 . . . . 0.0 111.672 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.67 88.04 2.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.356 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.45 -23.2 9.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.91 -36.18 72.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.545 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -133.83 13.44 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.664 0.269 . . . . 0.0 111.287 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 51.25 86.74 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.02 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.54 145.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.169 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.0 m95 -68.71 167.24 15.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.157 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.475 HD23 ' HD2' ' A' ' 25' ' ' PRO . 4.7 mt -161.3 131.55 3.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.689 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HD2' HD23 ' A' ' 24' ' ' LEU . 83.5 Cg_exo -45.85 92.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.643 2.228 . . . . 0.0 112.959 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.591 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -42.55 -66.66 0.34 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.772 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.61 -95.62 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.263 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.6 p -130.82 -85.03 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.657 0.265 . . . . 0.0 111.325 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.29 -88.38 0.35 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.708 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.32 161.95 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.616 2.211 . . . . 0.0 112.287 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -136.86 168.03 20.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.172 0.51 . . . . 0.0 111.594 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 166.96 44.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.626 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 62.41 -176.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.297 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -173.99 165.15 4.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.554 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 5.1 tmm_? -107.87 94.31 5.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.962 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.806 HG22 ' HA3' ' A' ' 51' ' ' GLY . 35.7 t -93.78 125.52 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.309 0.576 . . . . 0.0 111.908 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.467 ' HB3' HG13 ' A' ' 5' ' ' VAL . 33.7 mt-30 -119.02 155.29 31.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.884 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.625 HG22 HG13 ' A' ' 6' ' ' ILE . 72.4 mt -104.81 149.25 8.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.488 ' HB2' ' HG2' ' A' ' 48' ' ' ARG . 16.9 m-85 -115.37 126.01 53.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.061 0.458 . . . . 0.0 111.366 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.465 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.5 t-160 -93.76 98.46 11.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.168 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -102.46 89.52 1.77 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 72.2 Cg_endo -74.98 -20.61 16.74 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.22 1.947 . . . . 0.0 112.454 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -48.4 -31.21 5.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.068 0.461 . . . . 0.0 110.587 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.97 6.93 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.224 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.98 48.17 5.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.045 0.45 . . . . 0.0 110.005 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.7 t -129.79 179.66 5.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.642 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.488 ' CG ' ' HB1' ' A' ' 109' ' ' ALA . 81.9 m-85 -149.56 166.52 28.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.525 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -160.38 152.59 20.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.0 0.429 . . . . 0.0 111.539 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 62' ' ' ILE . 8.1 m -107.04 128.62 61.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 2.2 t -132.41 118.31 35.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.976 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.806 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -138.82 147.13 19.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.072 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -128.66 157.82 40.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.695 0.283 . . . . 0.0 110.52 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.566 ' HD2' HG11 ' A' ' 61' ' ' VAL . 1.5 tptt -73.38 161.9 29.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.946 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.554 ' HE2' ' HB2' ' A' ' 35' ' ' ARG . 1.1 mmt -98.33 42.82 1.08 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -96.99 163.36 20.21 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.983 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.74 -18.42 33.69 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.212 1.941 . . . . 0.0 111.371 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.39 -36.39 8.45 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.671 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 62.66 125.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.051 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -145.39 137.11 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.639 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 60' ' ' VAL . 18.0 m -65.97 119.49 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.414 . . . . 0.0 111.224 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.566 HG11 ' HD2' ' A' ' 53' ' ' LYS . 3.8 m -93.88 -27.31 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.673 ' HB ' HG11 ' A' ' 13' ' ' VAL . 15.5 tt -138.19 132.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.559 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -159.51 67.38 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.399 . . . . 0.0 110.807 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.2 t -126.08 161.53 27.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.796 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -104.19 148.3 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.613 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.558 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -119.74 142.92 32.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.832 179.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 67' ' ' VAL . 17.6 m -146.96 112.21 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.489 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.515 ' H ' HD13 ' A' ' 113' ' ' LEU . 1.0 OUTLIER 22.22 76.19 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.336 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.74 -33.26 0.06 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 119.643 -1.265 . . . . 0.0 114.12 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -93.64 125.37 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.386 0.593 . . . . 0.0 111.568 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 147.5 32.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.081 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.578 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.7 OUTLIER -86.14 104.14 15.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 0.0 111.238 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.04 98.06 10.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.629 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.54 83.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.047 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.12 -28.57 40.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 0.0 110.85 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.504 HG22 ' HB3' ' A' ' 79' ' ' PHE . 3.8 t -166.01 150.63 7.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.086 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 56.3 Cg_exo -37.63 -29.25 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.048 2.499 . . . . 0.0 113.589 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.49 50.34 1.41 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.769 0.319 . . . . 0.0 111.547 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.504 ' HB3' HG22 ' A' ' 76' ' ' THR . 7.2 t80 -170.0 127.51 0.87 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 111.424 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.946 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -118.02 111.83 19.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.287 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.516 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.5 tm0? -119.15 131.22 55.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.554 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.692 ' CH2' HD23 ' A' ' 91' ' ' LEU . 43.8 p90 -138.07 142.25 40.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.207 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.423 ' O ' HG22 ' A' ' 70' ' ' VAL . 10.2 ttm180 -88.22 105.81 17.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.457 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 32.0 t70 -105.04 130.02 53.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.734 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 61.93 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.466 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -136.33 -31.29 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.419 ' HG3' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -93.88 -168.86 1.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.961 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.516 HG12 ' HG2' ' A' ' 81' ' ' GLN . 2.1 t -137.87 124.86 28.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.651 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.49 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 78.5 m95 -93.78 98.83 11.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.522 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.829 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -80.6 161.91 44.88 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.031 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.863 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -148.22 106.99 3.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.474 0.178 . . . . 0.0 110.95 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -92.41 104.76 17.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.225 0.536 . . . . 0.0 110.016 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.669 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 78.7 m-85 -71.56 162.85 28.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.928 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.33 -26.2 5.51 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.258 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.47 159.8 40.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.879 0.371 . . . . 0.0 110.802 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -60.97 -40.36 93.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.03 -44.24 97.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.104 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -51.76 -68.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.011 0.434 . . . . 0.0 110.474 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.669 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -47.2 -31.47 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.687 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.51 -36.42 57.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.787 0.327 . . . . 0.0 111.38 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 3.9 tp-100 -77.65 -41.25 38.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.203 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.477 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 7.8 t80 -56.31 -50.78 70.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.014 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.946 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -65.46 -32.71 74.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.443 . . . . 0.0 110.867 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -47.03 -64.74 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.511 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.9 -51.87 49.86 Favored Glycine 0 CA--C 1.508 -0.354 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.159 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.941 ' CE ' HD21 ' A' ' 110' ' ' LEU . 12.2 tpt -46.68 -62.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.48 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.57 -33.27 2.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.451 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.38 -35.44 73.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.087 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.488 ' HB1' ' CG ' ' A' ' 47' ' ' PHE . . . -70.7 -46.35 63.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.721 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.941 HD21 ' CE ' ' A' ' 106' ' ' MET . 5.0 mt -67.68 -34.26 76.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.722 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -75.69 -20.38 58.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.19 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.17 2.68 29.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.601 0.715 . . . . 0.0 109.095 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.515 HD13 ' H ' ' A' ' 68' ' ' ARG . 6.9 mt -100.21 -38.37 8.53 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.954 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -105.36 -30.68 9.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.66 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.427 -1.207 . . . . 0.0 112.534 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 CA--C 1.527 0.062 0 CA-C-O 120.847 0.356 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 39' ' ' TYR . 52.4 t -84.56 158.33 3.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.559 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.488 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -103.59 -68.32 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.71 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 -170.65 2.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.353 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.51 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.4 OUTLIER -156.76 122.54 4.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.201 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.498 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 1.5 p -128.83 153.56 47.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 111.751 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -97.84 127.43 43.78 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.707 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.821 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -171.44 -175.09 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 111.4 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -117.3 95.47 4.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.427 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.686 HG21 HG23 ' A' ' 61' ' ' VAL . 86.4 t -45.82 156.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.096 0.474 . . . . 0.0 111.249 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.475 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -154.64 161.84 41.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.245 -179.29 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 1.8 mt -139.03 110.87 7.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.753 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 8.8 t80 -70.92 152.43 43.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.25 0.548 . . . . 0.0 112.044 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -123.26 79.67 1.7 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.063 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -47.24 -26.03 1.1 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.491 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.08 -38.31 89.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.356 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -121.81 2.85 10.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.672 0.272 . . . . 0.0 111.246 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 58.5 82.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.824 0.345 . . . . 0.0 110.928 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' NH2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER 176.25 158.36 0.28 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.599 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 18.0 m95 -74.76 170.25 16.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 110.599 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -163.84 117.66 1.06 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.424 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.62 ' HD2' HD23 ' A' ' 24' ' ' LEU . 98.3 Cg_exo -42.93 93.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.662 2.241 . . . . 0.0 112.789 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -44.8 -54.07 6.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.648 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.39 -94.05 0.01 OUTLIER Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.813 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -142.12 -79.65 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.845 0.355 . . . . 0.0 111.038 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.51 -71.59 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.504 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.41 170.51 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.552 2.168 . . . . 0.0 112.325 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -153.36 59.05 0.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.04 0.447 . . . . 0.0 111.154 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.97 51.39 1.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.543 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 59.62 -175.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.648 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -176.71 147.74 0.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.533 -179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.67 99.74 12.1 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.842 HG22 ' HA3' ' A' ' 51' ' ' GLY . 47.5 t -98.15 125.8 51.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.329 0.585 . . . . 0.0 112.121 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.51 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 25.4 mt-30 -115.36 156.4 25.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.191 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 106' ' ' MET . 45.3 mt -105.68 149.02 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.761 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CE1' HG22 ' A' ' 5' ' ' VAL . 6.6 m-85 -111.69 122.09 46.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.996 0.427 . . . . 0.0 111.396 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.574 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -98.19 89.15 4.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.202 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -97.41 99.77 6.89 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.755 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 79.4 Cg_endo -84.05 -21.62 3.81 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.331 2.021 . . . . 0.0 112.595 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.4 p -49.66 -32.66 13.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.945 0.402 . . . . 0.0 110.709 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.14 -2.23 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.327 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 67.53 45.05 1.61 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.19 0.519 . . . . 0.0 110.254 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.04 179.36 6.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.039 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.574 ' CD2' ' HA ' ' A' ' 40' ' ' HIS . 77.3 m-85 -142.07 179.99 6.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 1.1 ttp180 -164.95 150.38 9.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.073 0.463 . . . . 0.0 111.591 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.525 HG23 HG12 ' A' ' 62' ' ' ILE . 8.7 m -109.74 123.64 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.139 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.6 t -128.14 118.11 47.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.145 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.842 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -141.26 150.07 21.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.986 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -130.47 155.25 46.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.303 . . . . 0.0 110.613 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.38 165.76 7.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 10.4 mtp -107.12 47.13 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.915 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.24 163.5 29.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.29 -26.4 27.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.618 2.212 . . . . 0.0 112.503 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.88 -41.72 59.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.928 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 103.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.886 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -141.99 138.69 32.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 60' ' ' VAL . 17.2 m -68.73 118.72 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.686 HG23 HG21 ' A' ' 13' ' ' VAL . 3.2 m -93.77 -22.17 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.543 HD12 ' CE3' ' A' ' 89' ' ' TRP . 9.2 tt -137.79 131.01 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.51 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -158.99 69.16 0.46 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.878 0.37 . . . . 0.0 110.995 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.28 135.76 41.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -76.29 137.7 40.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.422 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.43 ' O ' HD11 ' A' ' 113' ' ' LEU . 1.0 OUTLIER -112.34 125.14 69.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.963 0.411 . . . . 0.0 111.095 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.712 ' C ' HD13 ' A' ' 113' ' ' LEU . 2.1 m -110.63 174.97 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.608 ' N ' HD22 ' A' ' 113' ' ' LEU . 23.4 ttm180 -48.55 94.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.054 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.24 -19.64 0.15 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.912 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -95.59 121.4 46.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 117.719 0.76 . . . . 0.0 111.142 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HA ' HD13 ' A' ' 110' ' ' LEU . 2.8 mmtt -108.04 175.48 5.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.294 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CE1' ' HG2' ' A' ' 106' ' ' MET . 0.4 OUTLIER -114.15 100.4 8.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 111.197 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.72 81.67 3.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.614 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.441 ' HG2' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -48.36 105.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.17 85.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -151.94 177.22 1.98 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 77.6 Cg_exo -50.53 -25.24 14.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.367 2.045 . . . . 0.0 112.131 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.87 65.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.781 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.6 t80 -168.16 109.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.944 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 3.3 m80 -108.66 119.46 39.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.9 0.381 . . . . 0.0 110.496 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.472 ' OE1' HG11 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -122.66 148.18 45.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.265 -179.103 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.735 ' HB2' HG13 ' A' ' 70' ' ' VAL . 32.9 p90 -147.24 133.55 19.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.684 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' O ' HG22 ' A' ' 70' ' ' VAL . 47.6 ttp85 -80.09 100.3 8.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.385 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 85' ' ' ALA . 20.4 t0 -102.08 125.0 48.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.175 0.512 . . . . 0.0 110.676 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 84' ' ' ASP . . . 68.24 -79.01 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.544 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -139.38 -34.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -93.86 -168.13 1.82 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.603 HG13 ' C ' ' A' ' 82' ' ' TRP . 11.4 t -137.41 136.03 46.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.947 0.403 . . . . 0.0 111.073 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.612 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 68.1 m95 -100.62 99.08 9.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.076 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.517 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -87.04 131.55 10.64 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.386 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.821 HD12 ' HB3' ' A' ' 11' ' ' ALA . 2.0 mm? -115.82 113.72 23.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.277 . . . . 0.0 111.691 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.408 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 11.2 t-20 -92.94 105.47 17.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.206 0.527 . . . . 0.0 109.673 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 80' ' ' HIS . 78.1 m-85 -73.53 153.94 40.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.952 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.98 -28.07 7.96 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.274 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 m -129.29 165.19 21.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 0.0 110.808 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.85 -28.52 66.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.064 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -71.57 -49.31 41.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -49.99 -58.71 4.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.992 0.425 . . . . 0.0 110.738 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -51.39 -41.65 60.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.686 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.54 -34.97 65.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.501 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.667 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.0 tp-100 -73.99 -45.23 51.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 111.24 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.498 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 2.7 t80 -52.62 -53.87 41.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.97 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.944 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -60.65 -31.71 70.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.423 . . . . 0.0 110.596 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.28 -66.33 0.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.197 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.57 -43.58 76.1 Favored Glycine 0 CA--C 1.507 -0.426 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.931 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.901 ' CE ' HD21 ' A' ' 110' ' ' LEU . 13.8 tpt -47.58 -59.55 3.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.908 0.385 . . . . 0.0 110.36 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 111' ' ' GLU . . . -47.5 -41.34 20.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.741 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -34.41 72.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.358 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . . . -70.95 -44.69 65.56 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 121.035 0.445 . . . . 0.0 110.725 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.901 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -72.71 -34.04 66.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.486 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 1.9 tt0 -75.1 -22.63 58.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.964 0.411 . . . . 0.0 111.45 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.39 -3.52 28.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.675 0.75 . . . . 0.0 109.088 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.712 HD13 ' C ' ' A' ' 67' ' ' VAL . 5.4 mt -92.21 -41.64 10.32 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.6 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -99.66 -31.23 11.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.852 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.506 179.937 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.0 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.73 0.3 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 37' ' ' GLN . 34.9 t -73.85 153.81 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.638 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.44 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -103.53 -69.48 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 -176.73 3.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.029 0.443 . . . . 0.0 111.935 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.535 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 6.2 p -155.89 121.91 5.05 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.065 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 38.7 t -134.23 155.77 49.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.971 0.415 . . . . 0.0 111.71 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.6 ttp85 -97.85 128.79 44.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.454 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.642 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -170.92 -175.89 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.217 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 m -119.53 96.85 5.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.415 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.711 HG21 HG23 ' A' ' 61' ' ' VAL . 41.1 t -48.88 151.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.116 0.484 . . . . 0.0 111.153 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 89' ' ' TRP . 0.6 OUTLIER -151.64 144.9 24.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.578 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.486 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 3.6 mt -121.8 116.22 24.06 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.7 t80 -81.19 141.35 34.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.145 0.497 . . . . 0.0 112.017 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.538 ' OD1' HD12 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -117.1 84.95 2.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.577 178.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.77 -23.55 4.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.609 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.17 -27.96 7.83 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.263 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -142.73 16.78 1.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.721 0.296 . . . . 0.0 110.947 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 48.19 87.1 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.93 0.395 . . . . 0.0 111.291 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.47 142.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.747 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.614 ' HH2' HE21 ' A' ' 81' ' ' GLN . 35.2 m95 -61.39 -178.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.538 HD12 ' OD1' ' A' ' 17' ' ' ASP . 3.0 mt -177.01 114.11 0.25 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.218 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -40.92 99.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.816 2.344 . . . . 0.0 112.917 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -44.03 -40.33 4.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.68 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.92 -102.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.476 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.684 HG23 ' HD2' ' A' ' 30' ' ' PRO . 2.1 t -133.42 -46.23 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.379 . . . . 0.0 110.886 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.75 -66.32 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.062 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HD2' HG23 ' A' ' 28' ' ' THR . 9.5 Cg_endo -53.62 163.16 2.92 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.723 2.282 . . . . 0.0 112.099 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -142.07 139.79 32.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.077 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -170.99 45.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 55.31 173.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.784 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' ALA . 24.4 m -167.14 151.35 6.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.645 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.75 98.62 11.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.72 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.833 HG22 ' HA3' ' A' ' 51' ' ' GLY . 23.7 t -97.34 119.92 46.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.259 0.552 . . . . 0.0 111.949 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.535 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 42.8 mt-30 -109.76 166.54 10.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.543 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.509 HD13 ' HA ' ' A' ' 106' ' ' MET . 55.1 mt -109.9 151.59 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.52 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.448 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.5 m-85 -112.65 117.13 31.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.991 0.424 . . . . 0.0 111.349 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.498 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 0.9 OUTLIER -93.88 90.97 6.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.634 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -103.14 86.85 1.13 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 83.1 Cg_endo -76.35 -19.7 14.91 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.339 2.026 . . . . 0.0 112.536 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -50.26 -32.1 15.91 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.991 0.424 . . . . 0.0 110.551 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.29 6.11 6.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.219 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.45 49.16 5.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.248 0.547 . . . . 0.0 110.039 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.5 m -136.64 150.44 48.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.207 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.833 ' CE2' HD23 ' A' ' 113' ' ' LEU . 59.2 m-85 -120.62 174.01 6.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.563 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.8 ttp180 -164.34 149.34 10.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.093 0.473 . . . . 0.0 111.592 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.498 HG23 HG12 ' A' ' 62' ' ' ILE . 5.3 m -109.42 126.31 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.798 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.8 t -129.69 121.09 51.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.802 0.334 . . . . 0.0 111.429 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.833 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -137.43 148.87 20.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.866 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.29 146.62 52.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 110.972 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm -54.08 157.4 2.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.159 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 5.8 mtt -103.52 46.4 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -129.0 163.31 46.56 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.04 -24.89 15.18 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.605 2.203 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.99 -44.45 69.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.932 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 60.37 99.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -142.05 138.2 31.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.72 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 60' ' ' VAL . 13.4 m -70.77 122.22 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.189 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.711 HG23 HG21 ' A' ' 13' ' ' VAL . 3.8 m -93.84 -29.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.493 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.755 HD12 ' CE3' ' A' ' 89' ' ' TRP . 17.2 tt -138.55 138.15 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.874 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -165.89 63.18 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 110.539 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.3 t -126.99 135.28 50.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.911 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -75.36 136.48 40.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.678 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -111.62 168.28 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.592 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 66' ' ' ILE . 19.0 m -157.06 -173.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.628 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.726 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -57.69 87.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.208 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.37 -30.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.686 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.88 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.6 t -83.14 133.42 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 117.38 0.59 . . . . 0.0 111.093 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.67 115.61 23.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.845 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.57 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -64.56 106.05 1.08 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -99.77 96.98 7.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.6 91.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -58.52 -37.79 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -151.49 176.35 2.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.405 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 74.3 Cg_exo -49.89 -25.71 12.6 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.289 1.993 . . . . 0.0 112.107 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -138.18 65.89 1.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.649 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.0 t80 -165.9 112.25 0.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.356 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.94 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 2.0 m80 -110.62 101.33 10.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.061 0.458 . . . . 0.0 110.555 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.757 ' HG3' HG12 ' A' ' 88' ' ' VAL . 6.2 tt0 -107.68 150.28 27.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.057 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.88 ' HB2' HG13 ' A' ' 70' ' ' VAL . 46.0 p90 -151.31 148.57 28.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.965 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -112.29 112.54 24.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.223 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -93.45 -92.07 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.453 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.82 -69.38 0.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.988 0.423 . . . . 0.0 110.979 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 22.7 ttp180 -144.49 11.02 1.46 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.055 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.57 159.69 28.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.108 0.48 . . . . 0.0 110.571 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.757 HG12 ' HG3' ' A' ' 81' ' ' GLN . 1.5 t -120.3 114.35 43.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.471 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.755 ' CE3' HD12 ' A' ' 62' ' ' ILE . 66.4 m95 -93.51 94.63 8.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.116 0.484 . . . . 0.0 111.301 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.501 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -86.13 118.48 4.87 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.664 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.68 HD23 ' CH2' ' A' ' 82' ' ' TRP . 2.7 mm? -104.39 110.59 22.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.599 0.238 . . . . 0.0 111.377 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.411 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 10.4 t-20 -92.49 106.3 18.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.219 0.533 . . . . 0.0 109.936 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 80.1 m-85 -73.81 159.27 33.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.135 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.83 -27.71 15.99 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.312 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.98 161.62 38.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 110.729 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -28.82 67.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.078 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.9 -55.4 14.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -48.63 -59.15 3.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.977 0.418 . . . . 0.0 110.42 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.573 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -47.45 -35.72 8.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.685 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.98 -30.02 62.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.366 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.601 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -76.79 -49.75 15.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.285 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.502 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 4.1 t80 -51.3 -53.31 36.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.94 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -62.28 -33.17 74.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.832 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.62 -67.64 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.208 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.1 -40.85 98.49 Favored Glycine 0 CA--C 1.506 -0.524 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.54 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.911 ' CE ' HD21 ' A' ' 110' ' ' LEU . 16.5 tpt -50.94 -58.57 5.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.93 0.395 . . . . 0.0 110.43 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.83 -37.63 6.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.777 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 t -64.37 -37.96 89.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.045 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.69 -53.05 46.31 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.684 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 106' ' ' MET . 10.0 mt -66.43 -15.22 63.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.054 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -98.79 -23.14 15.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.678 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . . . -97.35 -1.1 45.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.144 0.497 . . . . 0.0 109.91 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.833 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -115.93 -33.36 5.12 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.286 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 37.6 mt-10 -93.07 -28.7 16.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.708 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.362 -1.243 . . . . 0.0 112.536 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.883 0.373 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 37' ' ' GLN . 32.9 t -83.18 151.89 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.524 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.476 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -108.34 -66.86 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.243 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.506 ' SG ' HD12 ' A' ' 38' ' ' ILE . 29.3 p -118.61 178.46 4.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.716 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -157.76 106.63 2.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.453 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.498 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 28.2 t -126.21 151.55 47.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.022 0.439 . . . . 0.0 111.766 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -93.97 132.46 38.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.289 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.77 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -174.59 -179.82 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.89 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.585 HG21 ' CD ' ' A' ' 31' ' ' GLN . 1.3 m -116.89 89.98 3.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.35 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.719 HG12 ' CB ' ' A' ' 26' ' ' ALA . 93.7 t -46.07 139.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.213 0.53 . . . . 0.0 110.725 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.51 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -137.25 155.33 49.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.383 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD21 ' CE2' ' A' ' 89' ' ' TRP . 10.0 mt -128.01 112.42 14.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.352 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 15.9 t80 -76.13 147.5 38.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 111.633 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.14 86.03 2.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.106 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.33 -25.11 5.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.39 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.09 -27.87 23.97 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.407 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -138.33 12.15 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.559 0.219 . . . . 0.0 111.362 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 tttt 51.94 83.71 0.05 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.7 0.286 . . . . 0.0 111.197 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 178.24 168.79 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.981 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.547 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 25.7 m95 -88.15 172.6 9.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.698 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.765 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.8 mt -163.21 126.23 1.73 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.765 ' HD2' HD23 ' A' ' 24' ' ' LEU . 91.8 Cg_exo -41.95 101.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.784 2.323 . . . . 0.0 112.962 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.719 ' CB ' HG12 ' A' ' 13' ' ' VAL . . . -47.03 -48.77 21.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.534 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.12 -118.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.754 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.0 p -118.68 -81.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 0.0 111.147 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.51 -83.92 0.5 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.665 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.12 156.39 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.605 2.203 . . . . 0.0 112.396 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.585 ' CD ' HG21 ' A' ' 12' ' ' THR . 4.6 tt0 -143.26 142.47 31.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.189 0.518 . . . . 0.0 111.228 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' A' ' 31' ' ' GLN . . . -169.67 44.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.897 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 64.79 -175.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.201 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -173.45 159.33 3.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.036 0.446 . . . . 0.0 111.147 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.7 OUTLIER -98.86 95.35 7.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.417 178.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.824 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.9 t -94.22 122.4 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.45 0.643 . . . . 0.0 112.163 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.514 ' HB3' HG13 ' A' ' 5' ' ' VAL . 32.9 mt-30 -113.73 171.79 7.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.43 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.563 HD11 ' HB2' ' A' ' 106' ' ' MET . 88.9 mt -117.01 154.22 18.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.417 ' CE1' HG21 ' A' ' 50' ' ' VAL . 7.5 m-85 -112.86 119.55 38.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.025 0.44 . . . . 0.0 111.804 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.551 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 6.6 t-80 -93.82 89.56 6.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.825 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -99.95 93.74 2.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 98.6 Cg_endo -81.54 -23.25 5.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.35 2.033 . . . . 0.0 112.45 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -47.75 -30.26 3.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.98 6.53 4.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.296 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.8 t30 61.03 49.46 5.69 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.22 0.533 . . . . 0.0 109.916 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.567 ' HA ' HG12 ' A' ' 67' ' ' VAL . 57.9 m -133.53 154.43 50.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.432 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.789 ' CE2' HD23 ' A' ' 113' ' ' LEU . 59.6 m-85 -124.54 172.12 9.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.561 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.579 ' HD2' ' HB2' ' A' ' 65' ' ' ALA . 9.4 ttt-85 -162.97 150.97 13.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 0.0 111.584 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.588 HG13 HG12 ' A' ' 62' ' ' ILE . 4.9 p -108.75 131.09 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.242 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.417 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.5 t -139.03 121.86 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.033 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.824 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -142.82 142.14 11.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.83 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.1 158.84 35.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.743 0.306 . . . . 0.0 110.86 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -58.34 168.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.55 ' HE2' ' HB2' ' A' ' 35' ' ' ARG . 1.6 mtt -107.05 42.88 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.135 0.493 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -128.27 162.29 51.38 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.802 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.2 -31.24 11.93 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.604 2.202 . . . . 0.0 112.773 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.06 -50.51 61.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.797 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.04 94.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -125.39 125.21 43.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 60' ' ' VAL . 9.5 m -62.79 119.09 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 111.272 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.48 HG23 HG21 ' A' ' 13' ' ' VAL . 3.2 m -93.85 -20.4 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.588 HG12 HG13 ' A' ' 49' ' ' VAL . 10.8 tt -138.81 136.5 43.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.388 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -161.79 68.57 0.29 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.977 0.418 . . . . 0.0 110.819 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.437 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -131.31 134.7 46.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.915 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.579 ' HB2' ' HD2' ' A' ' 48' ' ' ARG . . . -77.47 142.08 39.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.692 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.4 125.63 74.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.851 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 46' ' ' SER . 17.8 m -140.14 111.06 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.65 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.699 ' N ' HD12 ' A' ' 113' ' ' LEU . 12.2 ttt-85 27.88 74.31 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.871 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.47 -34.82 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.683 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.5 t -92.46 140.68 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 111.331 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.84 108.68 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.468 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.557 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.5 m-30 -52.48 124.62 13.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.25 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.26 110.36 16.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.758 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 92.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.936 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.24 90.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.03 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.7 p -146.64 173.62 4.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.471 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 78.2 Cg_exo -50.8 -25.26 15.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.349 2.033 . . . . 0.0 112.292 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -142.43 61.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.731 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 4.5 t80 -163.39 105.72 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.186 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.923 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.1 m80 -97.73 115.93 28.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 110.459 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.682 ' HG3' HG12 ' A' ' 88' ' ' VAL . 27.7 tt0 -121.9 144.69 48.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.922 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.796 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.7 p90 -143.23 150.08 38.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.29 0.567 . . . . 0.0 112.098 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -112.86 117.59 32.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.229 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.61 -81.03 0.38 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.248 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.71 -66.39 0.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.966 0.413 . . . . 0.0 111.09 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 -139.67 -5.56 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.48 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.416 ' HG2' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -108.24 179.58 4.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.985 0.422 . . . . 0.0 110.761 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.682 HG12 ' HG3' ' A' ' 81' ' ' GLN . 2.1 t -139.03 116.1 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.378 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.539 ' CE2' HD21 ' A' ' 15' ' ' LEU . 72.9 m95 -93.67 83.86 4.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.289 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.798 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -70.41 159.28 53.6 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.228 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.798 HD22 ' O ' ' A' ' 90' ' ' GLY . 1.1 mm? -144.24 108.09 4.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.532 0.206 . . . . 0.0 110.984 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -92.31 102.43 14.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.28 0.562 . . . . 0.0 109.925 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.612 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 76.7 m-85 -69.17 159.99 31.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.864 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.55 18.84 19.87 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.341 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.43 163.23 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.74 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -69.57 -30.37 68.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.68 -49.28 48.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.966 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -49.97 -62.76 1.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.994 0.426 . . . . 0.0 110.582 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -49.43 -36.66 22.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.693 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.85 -33.96 64.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.243 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.479 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 55.3 tp60 -77.32 -42.68 35.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.388 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.498 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 6.3 t80 -54.88 -50.74 67.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.298 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.923 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -68.11 -30.06 69.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.965 0.412 . . . . 0.0 110.969 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -47.79 -64.95 0.65 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.268 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.3 -50.34 56.72 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.985 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.975 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.2 tpt -48.94 -60.82 2.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.9 0.381 . . . . 0.0 110.476 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.72 -36.24 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.08 -39.78 82.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.046 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -61.79 -57.04 13.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.618 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.975 HD21 ' HE3' ' A' ' 106' ' ' MET . 8.0 mt -58.54 -20.55 47.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -92.72 -23.41 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.611 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.16 1.21 44.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.216 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.789 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -113.71 -29.67 7.03 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.344 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 3.7 mt-10 -99.05 -30.34 12.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.335 -1.259 . . . . 0.0 112.499 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tmm? . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.891 0.377 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.23 107.77 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 1.6 mp0 51.14 -169.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.063 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.9 m -119.4 105.46 11.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.468 HG11 ' OE1' ' A' ' 37' ' ' GLN . 71.5 t -61.08 156.19 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.618 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -104.8 -62.04 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.714 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' HB2' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -139.96 -177.55 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.428 -179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.473 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 24.4 p -154.0 121.2 5.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 9.0 p -128.46 154.7 45.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.021 0.439 . . . . 0.0 111.743 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -94.26 120.99 35.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.582 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.961 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -174.1 156.15 2.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.983 0.421 . . . . 0.0 111.929 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -98.89 92.06 5.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.112 178.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.597 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 62.1 t -46.13 141.22 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.543 . . . . 0.0 112.065 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.596 ' CB ' ' O ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -134.32 140.92 46.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.06 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.719 HD21 ' CD2' ' A' ' 89' ' ' TRP . 11.8 mt -111.55 127.0 55.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.565 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.644 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.6 t80 -80.4 146.94 31.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.18 0.514 . . . . 0.0 111.705 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -120.4 77.21 1.24 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.934 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.51 -29.6 1.84 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.283 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.24 -28.97 62.28 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.881 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -121.16 -6.89 9.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.509 0.195 . . . . 0.0 111.214 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HG3' ' OH ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 64.33 76.75 0.34 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.737 0.303 . . . . 0.0 110.852 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.14 174.63 0.32 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.327 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.644 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 48.1 m95 -91.92 169.39 10.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.494 HD23 ' HD2' ' A' ' 25' ' ' PRO . 5.2 mt -165.62 126.8 1.36 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.803 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 24' ' ' LEU . 96.5 Cg_exo -40.7 110.73 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.734 2.289 . . . . 0.0 112.738 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.14 -67.21 0.29 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.528 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.25 -112.26 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.688 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.39 -160.4 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.634 0.254 . . . . 0.0 110.732 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 31' ' ' GLN . . . -73.59 -66.25 2.05 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.114 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.08 159.84 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.656 2.237 . . . . 0.0 112.317 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 1.6 mt-30 -145.15 163.03 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.161 0.505 . . . . 0.0 111.295 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 171.28 46.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.836 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.407 ' H ' HG23 ' A' ' 12' ' ' THR . 19.1 m-85 61.86 178.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.264 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.42 ' HG ' ' HA ' ' A' ' 53' ' ' LYS . 58.6 m -166.42 150.75 7.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.036 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -93.92 95.74 9.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.916 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.578 HG22 ' HA3' ' A' ' 51' ' ' GLY . 28.8 t -93.88 129.87 43.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.251 0.548 . . . . 0.0 111.74 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.473 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 35.7 mt-30 -126.08 148.79 49.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.062 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 106' ' ' MET . 55.7 mt -97.61 150.11 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.346 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.488 ' HB2' ' HG2' ' A' ' 48' ' ' ARG . 6.4 m-85 -111.46 124.0 51.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.921 0.391 . . . . 0.0 111.42 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.512 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 0.6 OUTLIER -101.09 89.38 3.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.243 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -101.43 87.57 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.435 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 64.2 Cg_endo -72.5 -17.89 26.38 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.448 2.098 . . . . 0.0 112.598 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 t -52.82 -26.14 13.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.966 0.412 . . . . 0.0 110.498 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.97 5.52 5.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.288 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.11 50.33 13.83 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.184 0.516 . . . . 0.0 110.126 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.9 m -141.42 159.56 41.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.998 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.864 ' CE2' HD23 ' A' ' 113' ' ' LEU . 75.9 m-85 -130.31 163.34 27.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -162.45 143.8 10.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.71 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.623 HG13 HG12 ' A' ' 62' ' ' ILE . 3.5 p -94.63 148.33 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.277 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -149.9 116.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.541 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.578 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -139.59 147.52 19.24 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.916 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.41 162.67 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.8 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -65.53 172.65 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.5 mmm -111.94 45.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -133.4 162.92 54.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.865 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.29 -26.15 10.99 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.694 2.263 . . . . 0.0 112.562 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.77 -48.32 79.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.21 85.83 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.028 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -128.37 134.34 48.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.622 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.1 m -73.52 122.0 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 0.0 111.0 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.494 HG23 ' CG2' ' A' ' 13' ' ' VAL . 3.5 m -93.8 -20.38 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.278 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.623 HG12 HG13 ' A' ' 49' ' ' VAL . 6.9 tt -139.06 138.16 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.615 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -162.92 66.12 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.52 166.64 14.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.836 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -111.47 140.2 46.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.981 0.419 . . . . 0.0 111.608 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.422 HD13 ' SD ' ' A' ' 106' ' ' MET . 0.8 OUTLIER -121.73 123.12 68.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.769 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 67' ' ' VAL . 28.2 m -138.3 110.61 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 111.669 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.657 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 26.92 46.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.207 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.79 -22.57 0.1 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.512 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.824 ' O ' HD22 ' A' ' 110' ' ' LEU . 2.5 t -105.64 137.86 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 117.201 0.5 . . . . 0.0 110.889 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.81 114.05 16.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.619 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.565 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.7 m-30 -50.53 127.98 19.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -93.86 -40.55 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.07 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.04 79.39 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.91 -50.59 72.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.203 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -135.53 173.35 5.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.638 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 53.3 Cg_exo -52.72 -24.33 22.99 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.453 2.102 . . . . 0.0 112.303 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -126.16 58.44 1.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -169.74 143.06 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.972 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.889 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.4 m170 -139.62 106.71 5.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.358 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.611 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.3 tm0? -117.32 121.11 40.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.413 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.806 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.7 p90 -125.42 147.14 49.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.04 0.448 . . . . 0.0 111.346 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -108.46 113.98 27.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.665 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.59 -87.55 0.24 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.255 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.73 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.966 0.412 . . . . 0.0 110.942 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.1 ttp85 -139.94 -4.4 1.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.382 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.94 177.99 4.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.03 0.443 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.611 HG12 ' HG2' ' A' ' 81' ' ' GLN . 0.6 OUTLIER -140.6 124.75 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.317 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.719 ' CD2' HD21 ' A' ' 15' ' ' LEU . 90.3 m95 -101.33 85.48 2.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.062 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.612 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -97.57 96.74 1.86 Allowed Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.192 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.961 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -93.79 133.36 37.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.177 0.513 . . . . 0.0 111.659 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.556 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 6.6 t-20 -93.46 129.02 39.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.367 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.459 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 7.3 m-85 -96.53 165.51 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.563 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.27 -37.15 2.72 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.978 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 m -120.45 160.73 22.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.198 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -62.16 -44.7 96.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.803 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -58.42 -35.39 72.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 9' ' ' SER . 17.4 m-20 -59.06 -66.46 0.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.988 0.423 . . . . 0.0 110.539 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.86 -30.34 63.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.265 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.09 -43.22 54.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.877 0.37 . . . . 0.0 110.951 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.667 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 3.5 tp-100 -68.11 -43.68 77.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.184 0.516 . . . . 0.0 110.812 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.487 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 4.5 t80 -51.98 -54.93 23.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.331 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.889 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -60.15 -29.17 68.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.747 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -49.21 -64.28 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.122 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 7' ' ' CYS . . . -65.21 -51.53 49.1 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.072 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . 1.102 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.6 tpt -47.21 -61.63 1.8 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.933 0.396 . . . . 0.0 110.705 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.11 -37.05 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.402 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 t -65.86 -40.22 91.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.141 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -62.92 -56.29 18.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.745 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.102 HD21 ' HE3' ' A' ' 106' ' ' MET . 6.3 mt -59.85 -16.95 32.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.616 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.09 -29.57 15.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.844 0.354 . . . . 0.0 111.916 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.42 1.11 54.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.592 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.864 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -111.06 -36.82 5.53 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.319 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -85.67 -32.11 22.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.576 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.407 -1.218 . . . . 0.0 112.475 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.91 139.96 7.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.67 -176.64 3.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.839 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.1 m -94.49 139.19 31.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.171 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 45.1 t -87.35 159.44 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.599 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.475 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -112.39 -69.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.25 -178.4 4.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.761 0.315 . . . . 0.0 111.601 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.482 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -155.44 121.82 5.23 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.307 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 20.0 t -134.51 156.78 48.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.584 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HD3' ' HE1' ' A' ' 54' ' ' MET . 31.5 ttp180 -98.06 129.41 44.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.122 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.892 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -173.21 179.33 2.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.399 . . . . 0.0 111.192 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 m -114.13 91.59 3.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.294 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.538 HG21 HG23 ' A' ' 61' ' ' VAL . 96.1 t -47.23 143.28 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.249 0.547 . . . . 0.0 111.136 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.515 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -139.71 159.98 40.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.735 -179.114 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.444 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 3.8 mt -130.61 112.43 13.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.691 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.556 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.1 t80 -75.47 145.67 41.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.122 0.487 . . . . 0.0 111.712 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.82 79.98 1.63 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.962 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.83 -26.28 3.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.286 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.53 -30.94 51.54 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.104 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -129.61 5.08 5.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.637 0.256 . . . . 0.0 111.208 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.56 83.78 0.09 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.831 0.348 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 173.85 157.03 0.13 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.952 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.556 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.4 m95 -74.81 175.23 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.455 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.791 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.4 mt -167.93 124.89 0.89 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.508 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.791 ' HD2' HD23 ' A' ' 24' ' ' LEU . 89.4 Cg_exo -44.06 97.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.544 2.162 . . . . 0.0 113.056 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.473 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -46.49 -59.28 3.08 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.008 0.432 . . . . 0.0 111.445 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.8 -97.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.927 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.7 p -136.86 -76.26 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.273 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.4 -73.17 0.08 OUTLIER Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.616 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -45.03 164.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.959 2.44 . . . . 0.0 112.284 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -149.69 57.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.032 0.444 . . . . 0.0 111.173 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.22 49.23 1.38 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 61.77 -176.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.481 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -172.95 149.02 1.84 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.555 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.83 98.95 11.42 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.529 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.2 t -94.51 135.03 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.234 0.54 . . . . 0.0 112.02 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.482 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 27.1 mt-30 -130.95 152.02 50.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.025 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 106' ' ' MET . 53.7 mt -99.39 157.69 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.395 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.476 ' N ' HG22 ' A' ' 38' ' ' ILE . 16.2 m-85 -122.72 120.22 33.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.485 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 t-160 -93.59 98.18 10.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.682 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -101.26 94.92 4.36 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.864 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 87.1 Cg_endo -80.83 -20.34 7.78 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.281 1.987 . . . . 0.0 112.52 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 m -48.67 -31.51 6.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.154 0.502 . . . . 0.0 110.524 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.36 6.75 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.168 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.95 48.87 4.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.21 0.529 . . . . 0.0 109.969 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.5 t -133.04 155.77 48.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.081 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.74 ' CE2' HD23 ' A' ' 113' ' ' LEU . 50.9 m-85 -120.09 174.72 6.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.691 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 ttt180 -164.39 152.81 12.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.429 . . . . 0.0 111.733 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.645 HG13 HG12 ' A' ' 62' ' ' ILE . 5.6 p -112.88 138.98 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.138 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.0 120.24 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.848 0.356 . . . . 0.0 110.82 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -140.79 146.25 17.44 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.792 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.91 156.94 29.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.815 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.567 ' HD3' HG11 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -82.22 161.51 22.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.624 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.41 ' HE1' ' HD3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -94.55 45.59 1.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.023 0.44 . . . . 0.0 110.588 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -94.52 163.94 21.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.946 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.23 -16.93 43.39 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.334 2.023 . . . . 0.0 111.535 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.75 -31.71 9.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.016 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.74 118.16 0.02 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.736 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -143.48 142.61 31.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.5 m -71.05 120.55 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.926 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.567 HG11 ' HD3' ' A' ' 53' ' ' LYS . 3.8 m -93.85 -18.58 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.645 HG12 HG13 ' A' ' 49' ' ' VAL . 7.0 tt -140.04 137.56 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.367 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -163.14 70.02 0.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.1 t -134.8 134.18 40.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.055 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -76.66 135.25 39.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.5 pt -108.03 166.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 0.0 111.071 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 66' ' ' ILE . 15.8 m -158.43 -173.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.554 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.742 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -61.19 87.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.203 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.65 -33.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.356 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.84 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -84.43 130.51 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 117.179 0.489 . . . . 0.0 111.173 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.44 101.77 8.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.421 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -47.56 106.3 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.326 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.71 97.34 8.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.85 88.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.47 80.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 11.4 p -136.0 162.81 54.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.744 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 75.1 Cg_exo -51.52 -22.9 13.43 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.591 2.194 . . . . 0.0 112.458 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.92 47.73 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.097 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 5.3 t80 -162.96 123.86 2.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.36 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.61 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.3 m170 -98.2 172.84 7.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.609 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.441 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.6 OUTLIER 177.15 118.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.658 0.266 . . . . 0.0 111.185 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.84 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.4 p90 -133.85 137.57 45.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 111.921 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -101.09 108.86 20.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.38 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 28.6 t70 -93.65 -102.24 0.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.664 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -72.91 0.1 Allowed 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.006 0.432 . . . . 0.0 111.075 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.6 ttm105 -140.81 -13.01 0.97 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.358 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -106.74 -176.89 3.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.897 0.38 . . . . 0.0 110.242 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.511 HG13 ' C ' ' A' ' 82' ' ' TRP . 1.3 t -136.97 122.91 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.45 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.57 ' CE3' HD12 ' A' ' 62' ' ' ILE . 71.3 m95 -94.0 91.61 6.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.842 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -72.19 164.61 54.39 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.268 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.892 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -150.44 108.8 3.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.631 0.253 . . . . 0.0 111.17 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 14.0 t-20 -92.55 102.44 14.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.26 0.553 . . . . 0.0 109.722 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.668 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 81.3 m-85 -70.16 163.72 25.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.198 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.57 -28.32 6.39 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.282 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.3 p -139.07 167.12 22.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -65.32 -40.6 93.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -43.74 97.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -52.09 -66.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 110.57 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.668 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -47.3 -32.81 5.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.517 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.33 -30.91 60.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 111.151 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.539 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -78.36 -48.54 15.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.517 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 4.7 t80 -51.4 -48.43 62.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.961 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.61 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -66.59 -33.82 76.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.986 0.422 . . . . 0.0 110.938 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -44.89 -67.66 0.27 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.7 -49.32 74.2 Favored Glycine 0 CA--C 1.508 -0.377 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.327 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.914 ' CE ' HD21 ' A' ' 110' ' ' LEU . 12.2 tpt -49.34 -60.27 2.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.865 0.364 . . . . 0.0 110.572 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.4 -36.34 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.224 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -40.93 82.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.023 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -58.34 -56.77 17.8 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.898 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.914 HD21 ' CE ' ' A' ' 106' ' ' MET . 6.3 mt -58.8 -26.23 63.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.181 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -88.65 -22.43 23.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.922 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.88 -3.41 45.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.027 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -109.44 -22.81 11.84 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.222 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.439 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 6.7 mt-10 -89.63 -38.97 13.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.335 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.463 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.786 0.327 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.27 -172.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.906 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -117.23 -171.61 2.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -128.57 115.8 18.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.742 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 39.4 t -67.15 153.48 8.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.584 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.504 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -101.36 -71.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.069 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.76 -173.89 3.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.589 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.537 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 10.2 p -154.71 122.88 5.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.374 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 40.3 t -131.52 155.99 46.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 111.36 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.76 128.89 44.14 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.584 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.896 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -170.66 -178.61 2.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.965 0.412 . . . . 0.0 111.167 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 m -116.41 89.4 3.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.138 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.506 HG22 HD21 ' A' ' 91' ' ' LEU . 89.0 t -45.74 143.43 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.213 0.53 . . . . 0.0 111.504 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.507 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -140.2 150.43 44.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.461 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.733 HD21 ' CE2' ' A' ' 89' ' ' TRP . 2.8 mt -122.8 114.58 20.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.489 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.2 t80 -73.98 151.84 40.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.189 0.518 . . . . 0.0 111.568 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.579 ' HB2' HD12 ' A' ' 24' ' ' LEU . 1.5 t70 -128.64 82.05 2.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.16 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.07 -26.59 4.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.202 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.2 -28.8 43.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.252 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -132.29 7.81 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.605 0.24 . . . . 0.0 111.234 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt 53.92 82.11 0.09 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.754 0.312 . . . . 0.0 111.191 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.55 172.79 0.42 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.978 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.539 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.5 m95 -89.12 171.86 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.543 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.579 HD12 ' HB2' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -162.27 125.27 1.79 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.547 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD2' HD23 ' A' ' 24' ' ' LEU . 91.1 Cg_exo -44.11 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.488 2.125 . . . . 0.0 112.741 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.476 ' HB1' ' CZ3' ' A' ' 89' ' ' TRP . . . -47.16 -56.8 5.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.625 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.64 -99.07 0.01 OUTLIER Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.943 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.7 -72.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.389 . . . . 0.0 111.219 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -132.16 -77.04 0.13 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.738 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.05 160.96 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.571 2.181 . . . . 0.0 112.413 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -142.03 57.42 1.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.072 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.39 48.9 1.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.493 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 61.62 -174.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.606 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -174.3 148.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.652 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.93 96.2 9.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.91 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.742 HG22 ' HA3' ' A' ' 51' ' ' GLY . 38.4 t -94.56 124.51 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.347 0.594 . . . . 0.0 112.082 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.537 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 34.2 mt-30 -114.51 164.29 14.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.42 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.536 HD13 ' HA ' ' A' ' 106' ' ' MET . 30.9 mt -111.76 151.84 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.872 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.521 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.3 m-85 -111.99 121.0 43.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.402 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -96.31 87.89 4.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.842 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.41 92.19 3.13 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.947 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 93.5 Cg_endo -78.49 -17.97 12.5 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.368 2.045 . . . . 0.0 112.601 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -47.47 -37.16 11.23 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.954 0.407 . . . . 0.0 110.854 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.89 -7.33 12.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.097 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.06 40.78 0.25 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.035 0.445 . . . . 0.0 110.39 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.75 170.37 16.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.732 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 40' ' ' HIS . 70.4 m-85 -130.95 171.91 12.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.855 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 1.2 ttt180 -151.59 146.24 25.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.087 0.47 . . . . 0.0 111.952 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.681 HG13 HG12 ' A' ' 62' ' ' ILE . 5.7 p -107.28 129.58 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.706 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.521 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.4 t -138.3 119.09 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.192 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.742 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -142.26 149.89 21.62 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.839 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -129.1 159.59 35.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 0.0 110.59 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 166.8 15.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.4 mtp -107.95 45.71 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 4.5 pt20 -123.19 160.8 48.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.853 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 7.4 Cg_endo -49.55 -25.4 10.78 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.857 2.371 . . . . 0.0 112.435 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.89 -43.42 58.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.838 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.32 102.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.01 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -141.04 138.58 33.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 60' ' ' VAL . 13.3 m -68.94 120.51 16.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.834 0.35 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.494 HG23 HG21 ' A' ' 13' ' ' VAL . 2.9 m -93.81 -21.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.681 HG12 HG13 ' A' ' 49' ' ' VAL . 8.6 tt -138.13 135.72 44.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.542 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -160.81 64.0 0.3 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.025 0.441 . . . . 0.0 110.894 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.472 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -128.86 147.16 50.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.926 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -85.14 135.73 33.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.56 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.449 ' O ' HD11 ' A' ' 113' ' ' LEU . 1.6 pt -108.45 114.54 46.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.618 ' C ' HD13 ' A' ' 113' ' ' LEU . 1.8 m -102.56 164.9 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.973 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.687 ' H ' HD22 ' A' ' 113' ' ' LEU . 1.2 ttm180 -46.44 97.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.178 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.29 -19.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.625 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.834 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.4 t -89.97 119.81 37.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 117.54 0.67 . . . . 0.0 111.183 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -110.8 110.3 20.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.552 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.569 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.6 OUTLIER -49.02 105.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.263 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.9 88.91 5.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.842 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.72 90.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.948 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.06 93.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.9 p -144.13 172.38 5.58 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.508 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 74.4 Cg_exo -50.1 -24.7 11.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.427 2.085 . . . . 0.0 112.398 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.64 57.75 1.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.767 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 1.1 t80 -159.73 113.29 2.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.475 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.746 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 22.1 m170 -107.91 104.79 14.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.317 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.531 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -116.37 127.26 54.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.512 -178.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.834 ' HB2' HG13 ' A' ' 70' ' ' VAL . 41.8 p90 -133.58 143.83 48.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 111.728 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.9 ttp85 -110.84 112.61 24.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.276 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.482 ' HB2' HG21 ' A' ' 70' ' ' VAL . 26.5 t70 -93.77 -102.38 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.73 -72.08 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 111.2 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.3 ttp-105 -140.97 -14.58 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.407 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -103.36 -177.79 3.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.531 HG12 ' HG2' ' A' ' 81' ' ' GLN . 1.8 t -136.17 129.04 46.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.553 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.733 ' CE2' HD21 ' A' ' 15' ' ' LEU . 77.3 m95 -101.25 97.98 8.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.538 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.823 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -78.84 159.63 46.0 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.002 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.896 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -148.41 106.01 3.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.77 0.285 . . . . 0.0 111.361 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -92.53 105.43 17.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.284 0.564 . . . . 0.0 109.902 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 62.1 m-85 -74.11 161.51 29.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.949 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.42 -32.72 7.57 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.467 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.95 157.96 45.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.777 0.322 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -28.56 65.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -68.29 -48.62 64.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -52.69 -61.39 2.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.608 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -50.0 -30.95 11.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.365 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.73 -35.92 62.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 0.0 111.038 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -74.2 -44.18 54.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.039 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.47 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 2.3 t80 -52.84 -50.3 64.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.746 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -63.86 -32.22 73.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 110.695 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -46.15 -65.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.089 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.26 -45.66 78.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.904 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.818 ' CE ' HD21 ' A' ' 110' ' ' LEU . 15.2 tpt -49.34 -59.77 3.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.924 0.393 . . . . 0.0 110.39 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.68 -38.89 7.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.867 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 t -63.56 -36.19 82.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.932 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . . . -66.41 -40.74 89.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.292 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.818 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.2 OUTLIER -76.31 -26.58 55.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.049 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.15 -22.83 41.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 0.0 111.5 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.13 -4.49 24.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.528 0.68 . . . . 0.0 109.321 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.687 HD22 ' H ' ' A' ' 68' ' ' ARG . 5.2 mt -88.07 -36.37 16.98 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.249 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 68' ' ' ARG . 6.2 mt-10 -104.64 -31.96 9.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.744 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.53 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mmm . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.857 0.361 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.58 115.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.485 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 1.4 mp0 -91.29 -168.6 2.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.676 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.0 m -113.81 101.77 9.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.98 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 50.2 t -60.31 155.16 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.578 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.524 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -105.62 -69.45 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -133.35 -172.17 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.731 0.3 . . . . 0.0 111.352 -179.036 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.529 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.3 OUTLIER -157.59 127.68 6.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 29.6 t -135.69 152.95 51.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.39 . . . . 0.0 111.525 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.543 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 24.2 ttt180 -94.85 126.94 40.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.345 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.692 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -168.73 -176.46 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.067 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 92' ' ' ASN . 1.3 m -119.79 95.65 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.105 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 61' ' ' VAL . 40.0 t -44.95 154.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.107 0.48 . . . . 0.0 111.199 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.501 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -154.53 150.8 28.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.39 -179.176 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.545 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -127.24 110.91 13.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.577 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.564 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.3 t80 -71.34 150.24 45.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.147 0.498 . . . . 0.0 111.851 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.81 88.13 2.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.138 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -53.5 -22.05 7.39 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.501 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.38 -44.14 76.5 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.411 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -128.7 16.11 6.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 0.0 111.001 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 3.4 mmtt 50.7 88.25 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.155 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.79 147.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.564 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 13.9 m95 -68.57 169.44 11.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.636 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.598 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -165.04 111.65 0.83 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.428 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.598 ' HD2' HD23 ' A' ' 24' ' ' LEU . 72.5 Cg_exo -40.08 95.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.864 2.376 . . . . 0.0 112.974 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.613 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -50.85 -35.86 34.71 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.378 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.22 -95.32 0.01 OUTLIER Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.806 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -173.79 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.07 -94.7 0.12 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.835 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.76 161.77 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.726 2.284 . . . . 0.0 112.479 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -142.98 55.81 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.047 0.451 . . . . 0.0 111.185 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.39 47.44 1.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.358 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 60.4 176.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.575 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.479 ' HG ' ' HA ' ' A' ' 53' ' ' LYS . 14.9 m -165.57 149.83 8.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.704 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.85 102.92 15.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.824 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.765 HG22 ' HA3' ' A' ' 51' ' ' GLY . 28.2 t -98.42 117.84 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.338 0.59 . . . . 0.0 112.128 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.529 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 26.0 mt-30 -107.7 151.83 25.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.446 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.534 HD13 ' HA ' ' A' ' 106' ' ' MET . 54.2 mt -97.64 154.61 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.91 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.52 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.6 m-85 -117.14 121.98 42.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.5 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 3.7 t-160 -99.98 89.37 4.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.024 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.427 ' OD1' ' HG2' ' A' ' 3' ' ' GLU . 3.3 m-80 -96.54 100.97 7.91 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.439 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 96.4 Cg_endo -81.67 -22.13 5.64 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.264 1.976 . . . . 0.0 112.692 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.7 p -50.37 -27.41 6.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 110.73 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.38 3.7 6.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.477 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 60.02 48.3 8.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.137 0.494 . . . . 0.0 110.123 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.557 ' HA ' HD21 ' A' ' 113' ' ' LEU . 14.2 m -136.27 -173.37 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.502 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CD2' HD11 ' A' ' 6' ' ' ILE . 78.5 m-85 -151.19 165.03 35.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.973 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 12.8 mtt180 -147.42 157.75 43.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.061 0.458 . . . . 0.0 111.658 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 62' ' ' ILE . 5.1 m -113.15 122.95 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.053 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.52 HG21 ' CE1' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -130.74 121.29 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.203 -179.211 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.765 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -141.56 140.5 10.26 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.734 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 15.7 ptp180 -123.24 147.1 47.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.799 0.333 . . . . 0.0 110.7 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.479 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -57.45 168.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.034 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.543 ' HE2' ' HG3' ' A' ' 10' ' ' ARG . 15.3 mtm -111.66 46.0 1.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.694 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -119.57 163.44 27.24 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.854 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.92 -24.67 14.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.603 2.202 . . . . 0.0 112.561 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.71 -43.96 21.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 60.78 105.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.036 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.51 ' NE2' HG12 ' A' ' 61' ' ' VAL . 2.0 pp0? -141.27 148.89 40.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.511 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.8 m -75.93 120.73 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 111.344 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 13' ' ' VAL . 4.2 m -93.91 -24.45 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.066 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.653 HD12 ' CE3' ' A' ' 89' ' ' TRP . 12.2 tt -137.71 134.7 45.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -158.96 65.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.92 0.391 . . . . 0.0 111.004 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.91 -170.86 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.757 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.545 ' HB2' ' HD3' ' A' ' 48' ' ' ARG . . . -131.44 150.31 52.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.318 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.468 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -126.55 133.73 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.067 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 67' ' ' VAL . 29.5 m -141.07 110.11 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.425 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' H ' HD13 ' A' ' 113' ' ' LEU . 1.4 ptt180 23.26 48.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.45 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.95 -23.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.841 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.885 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -95.82 130.26 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 117.373 0.587 . . . . 0.0 111.249 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -119.29 105.25 11.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.493 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.55 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.1 m-30 -47.59 105.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.405 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.54 95.18 6.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.09 97.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.36 92.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.191 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.434 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 0.8 OUTLIER -146.8 175.72 2.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 73.1 Cg_exo -51.32 -24.2 15.25 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.379 2.053 . . . . 0.0 112.501 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -140.48 62.72 1.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.02 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 3.1 t80 -162.42 130.4 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.12 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.597 ' NE2' ' HB2' ' A' ' 103' ' ' ALA . 1.8 m-70 -118.64 105.94 12.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.484 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.4 tm0? -116.01 128.35 55.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.878 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.885 ' HB2' HG13 ' A' ' 70' ' ' VAL . 49.0 p90 -134.82 146.11 48.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 111.843 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -107.7 110.75 22.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.33 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.428 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 14.3 t0 -93.67 -97.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.817 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.91 -71.29 0.26 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.992 0.425 . . . . 0.0 111.314 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -141.21 -9.26 0.99 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.66 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.17 -170.82 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.432 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG12 ' HG2' ' A' ' 81' ' ' GLN . 1.1 t -141.24 123.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.336 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.653 ' CE3' HD12 ' A' ' 62' ' ' ILE . 69.6 m95 -97.45 91.69 5.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.382 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.81 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -75.17 153.68 45.31 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.203 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 90' ' ' GLY . 1.9 mm? -140.46 106.99 5.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.576 0.227 . . . . 0.0 110.987 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 12' ' ' THR . 10.4 t-20 -92.72 108.73 20.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.236 0.541 . . . . 0.0 110.069 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.644 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 39.3 m-85 -80.32 159.46 25.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.828 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.18 -30.08 17.99 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.573 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.44 174.72 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -70.91 -32.1 68.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -50.62 66.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -52.53 -61.86 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 110.456 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.644 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -51.58 -33.22 31.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.365 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.1 -31.66 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.523 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -76.75 -44.99 30.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.246 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.479 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 2.8 t80 -53.52 -47.62 69.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.597 ' HB2' ' NE2' ' A' ' 80' ' ' HIS . . . -68.68 -31.03 69.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.948 0.404 . . . . 0.0 110.78 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -46.64 -65.83 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.073 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.59 -44.66 89.34 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.845 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . 1.095 ' HE3' HD21 ' A' ' 110' ' ' LEU . 15.0 tpt -50.43 -59.76 3.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.996 0.427 . . . . 0.0 110.374 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 111' ' ' GLU . . . -43.69 -41.63 4.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.124 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 t -62.02 -40.14 94.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.329 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.484 ' HB1' ' CG ' ' A' ' 47' ' ' PHE . . . -62.35 -51.62 66.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.095 HD21 ' HE3' ' A' ' 106' ' ' MET . 8.9 mt -65.85 -22.37 66.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.337 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 1.5 tt0 -84.68 -24.61 28.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.972 0.415 . . . . 0.0 111.313 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.71 3.64 34.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.754 0.788 . . . . 0.0 108.959 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 46' ' ' SER . 6.8 mt -95.45 -41.25 9.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.061 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.81 -31.97 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.743 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.34 -1.256 . . . . 0.0 112.529 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.822 0.344 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 t -147.64 69.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.438 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 2.0 mp0 55.08 -170.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.095 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.5 m -119.88 114.4 22.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.017 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 25.1 t -66.02 149.05 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.536 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.438 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -100.0 -72.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -121.61 179.67 4.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 111.445 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.501 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -154.33 122.95 6.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.948 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 35.7 t -133.1 153.61 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.052 0.453 . . . . 0.0 111.828 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.409 ' HD3' ' CG ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -95.37 128.77 42.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.961 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 93' ' ' PHE . . . -177.8 156.97 1.14 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.957 0.408 . . . . 0.0 111.761 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.5 m -93.94 90.66 6.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.134 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.692 HG13 HD12 ' A' ' 91' ' ' LEU . 77.4 t -42.21 157.48 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.453 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.542 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -156.45 143.36 18.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.256 -179.198 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.698 HD21 ' CD2' ' A' ' 89' ' ' TRP . 9.0 mt -119.59 123.54 44.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.265 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.0 t80 -79.7 143.23 34.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.179 0.514 . . . . 0.0 111.816 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.46 77.21 1.06 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.571 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.09 -29.01 1.35 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.429 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.78 -28.32 46.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.959 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -128.93 1.09 5.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.491 0.186 . . . . 0.0 111.329 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 5.5 tptt 58.54 82.14 0.14 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.809 0.338 . . . . 0.0 110.923 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER 175.84 161.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.589 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 35.5 m95 -81.25 172.5 13.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.682 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 24' ' ' LEU . 3.7 mt -172.86 116.27 0.38 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.669 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -39.91 117.52 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.9 2.4 . . . . 0.0 112.735 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.616 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -54.57 -53.47 54.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.697 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.22 -107.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 CA-C-N 115.866 -0.607 . . . . 0.0 113.224 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.4 m -129.11 -81.03 0.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.775 0.322 . . . . 0.0 111.174 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.447 ' O ' ' NE2' ' A' ' 31' ' ' GLN . . . -139.18 -70.7 0.05 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.726 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.75 154.14 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.657 2.238 . . . . 0.0 112.393 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.504 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 2.4 mt-30 -147.49 164.43 33.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.385 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 170.4 44.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.878 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.409 ' CG ' ' HD3' ' A' ' 10' ' ' ARG . 7.8 m-85 63.26 131.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.33 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 t -119.19 146.4 45.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.982 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.91 94.1 8.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.631 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.753 HG22 ' HA3' ' A' ' 51' ' ' GLY . 23.4 t -94.01 120.54 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.368 0.604 . . . . 0.0 112.027 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.501 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 24.3 mt-30 -113.58 169.07 9.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.599 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 38.0 mt -111.21 156.23 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.6 m-85 -114.5 116.88 29.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.37 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.502 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 2.2 t-80 -94.09 88.45 5.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -101.86 92.2 2.82 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.997 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 84.5 Cg_endo -79.76 -20.2 9.3 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.428 2.086 . . . . 0.0 112.544 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 p -48.7 -32.83 9.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.982 0.42 . . . . 0.0 110.638 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.6 2.55 8.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.211 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 62.93 48.53 3.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.212 0.53 . . . . 0.0 109.948 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.35 151.37 47.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.936 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.777 ' CE2' HD23 ' A' ' 113' ' ' LEU . 59.6 m-85 -118.51 174.18 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.836 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.9 ttt180 -164.19 150.55 11.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.109 0.481 . . . . 0.0 111.552 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.611 HG13 HG12 ' A' ' 62' ' ' ILE . 3.8 p -107.39 134.82 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.057 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.502 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.4 t -141.96 123.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.352 . . . . 0.0 111.033 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.753 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -140.87 144.86 15.23 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.738 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -129.13 142.79 50.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HD2' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -66.47 165.87 13.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtt -107.28 46.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.453 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 1.1 pt20 -105.79 162.99 18.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.732 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 55.4 Cg_endo -69.98 52.58 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.481 2.121 . . . . 0.0 112.195 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -160.98 -35.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 66.4 114.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.068 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -151.52 124.32 8.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.457 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 60' ' ' VAL . 17.8 m -65.55 125.29 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.635 HG23 HG21 ' A' ' 13' ' ' VAL . 10.9 m -93.82 -21.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.417 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.66 HD12 ' CE3' ' A' ' 89' ' ' TRP . 12.4 tt -141.42 140.46 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.619 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -164.43 66.7 0.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 110.875 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.8 t -128.72 131.78 47.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.957 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -75.55 136.49 40.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.396 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.5 pt -109.99 165.78 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.969 0.414 . . . . 0.0 111.079 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 66' ' ' ILE . 16.0 m -158.54 -176.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.556 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.74 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -58.73 89.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.57 -30.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.35 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.868 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -86.43 131.88 33.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 117.128 0.464 . . . . 0.0 110.743 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -119.49 114.94 23.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.777 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.609 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.0 OUTLIER -60.73 106.23 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.043 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.79 86.47 4.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.23 91.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.179 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.69 -57.54 12.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.3 p -129.09 160.47 63.58 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.348 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 6.0 Cg_endo -48.0 -26.17 7.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.714 2.276 . . . . 0.0 112.352 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -127.89 59.44 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.006 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' A' ' 92' ' ' ASN . 7.1 t80 -175.87 130.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.939 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -119.23 150.67 39.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.592 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.692 ' HG3' HG12 ' A' ' 88' ' ' VAL . 31.6 tt0 -158.56 150.72 21.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.246 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.944 ' CH2' HD21 ' A' ' 91' ' ' LEU . 19.7 p90 -151.29 165.5 33.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.344 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -121.74 114.15 20.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.728 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.44 -35.84 12.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 110.44 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.74 -67.25 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.285 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -141.78 16.93 2.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.262 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.463 ' HG3' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -128.22 114.19 16.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.692 HG12 ' HG3' ' A' ' 81' ' ' GLN . 2.4 t -93.54 108.93 21.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.865 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.698 ' CD2' HD21 ' A' ' 15' ' ' LEU . 84.6 m95 -93.78 85.91 4.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.91 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.859 ' C ' HD13 ' A' ' 91' ' ' LEU . . . -97.07 132.48 11.01 Favored Glycine 0 C--O 1.223 -0.544 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.84 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.944 HD21 ' CH2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -124.09 129.99 51.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.944 0.402 . . . . 0.0 111.679 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . 10.6 t-20 -92.64 110.67 22.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.641 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.623 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 89.0 m-85 -75.61 162.91 27.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.786 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.87 -27.56 28.6 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.378 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.4 m -148.54 179.42 7.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -34.14 67.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.989 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -63.16 -51.05 67.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -52.66 -58.71 5.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.672 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -52.81 -33.92 51.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.44 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.43 -32.93 62.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.283 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.661 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -74.49 -46.76 37.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.004 0.431 . . . . 0.0 111.03 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.506 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 21.5 t80 -51.6 -53.7 35.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.052 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.939 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -62.61 -29.89 70.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.024 0.44 . . . . 0.0 110.651 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -46.41 -65.82 0.5 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.052 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.33 -45.02 96.01 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.3 -0.952 . . . . 0.0 111.753 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.923 ' CE ' HD21 ' A' ' 110' ' ' LEU . 15.8 tpt -49.74 -59.46 3.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.924 0.392 . . . . 0.0 110.452 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.73 -37.74 2.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.931 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -38.58 89.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.033 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.524 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -62.63 -56.74 15.04 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.729 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.923 HD21 ' CE ' ' A' ' 106' ' ' MET . 11.5 mt -59.86 -20.36 56.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.304 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -94.61 -22.44 18.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.669 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.29 -1.82 43.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.103 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.777 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -112.58 -28.92 7.65 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.299 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.462 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 3.3 mm-40 -91.09 -33.93 15.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.453 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.382 -1.232 . . . . 0.0 112.513 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.793 0.33 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.52 150.96 44.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 4.5 mp0 -105.63 -168.73 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.5 m -126.19 105.39 8.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.917 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.634 HG11 ' OE1' ' A' ' 37' ' ' GLN . 41.1 t -61.33 145.35 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.737 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -97.53 -70.16 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.78 -176.91 4.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.86 0.362 . . . . 0.0 111.57 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.535 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 12.6 p -156.15 126.43 6.62 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.222 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.483 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 16.7 t -135.72 158.34 44.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.984 0.421 . . . . 0.0 111.615 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.413 ' HD3' ' CD1' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -102.03 124.67 48.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.397 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.59 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -167.03 -172.64 2.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.501 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' ASN . 18.8 m -124.67 91.49 3.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.149 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.683 HG21 HG23 ' A' ' 61' ' ' VAL . 78.9 t -42.32 156.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.476 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.484 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -153.96 134.59 13.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.778 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 2.9 mt -112.47 110.7 21.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 0.0 110.285 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 16.7 t80 -71.41 141.03 50.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.115 0.483 . . . . 0.0 111.668 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.46 80.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.932 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.38 -26.2 4.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.33 -32.81 22.78 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.87 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -138.68 15.09 2.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.763 0.316 . . . . 0.0 110.633 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 2.4 mmpt? 46.46 90.7 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.244 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.81 133.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.792 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 12.3 m95 -59.31 146.2 40.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -141.44 112.3 6.54 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.315 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -40.65 99.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.81 2.34 . . . . 0.0 112.96 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.538 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -46.95 -34.05 5.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.329 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.29 -108.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.642 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 29' ' ' GLY . 9.9 t -146.34 -47.54 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.743 0.306 . . . . 0.0 111.327 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 28' ' ' THR . . . -152.28 -87.57 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.737 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.03 166.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.736 2.291 . . . . 0.0 112.451 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -141.91 58.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.41 51.66 2.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.413 ' CD1' ' HD3' ' A' ' 10' ' ' ARG . 52.9 m-85 55.69 178.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.682 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -165.56 143.59 5.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.86 96.22 9.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.925 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.829 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.6 t -93.83 114.67 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.369 0.604 . . . . 0.0 112.263 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.634 ' OE1' HG11 ' A' ' 5' ' ' VAL . 36.5 mt-30 -107.91 156.88 18.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.487 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.478 HD11 ' HB2' ' A' ' 106' ' ' MET . 51.0 mt -102.93 148.12 8.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.457 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.1 m-85 -109.69 117.71 34.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 111.242 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.479 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 6.1 t-80 -95.41 88.61 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.11 101.84 9.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.53 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 89.5 Cg_endo -83.05 -21.03 4.87 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.342 2.028 . . . . 0.0 112.634 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.8 m -48.31 -29.66 4.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.041 0.448 . . . . 0.0 110.611 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.17 6.88 4.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.288 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.2 49.28 9.34 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.196 0.522 . . . . 0.0 110.028 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -130.87 166.57 20.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.408 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.809 ' CE2' HD23 ' A' ' 113' ' ' LEU . 53.4 m-85 -131.58 167.92 18.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.841 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -155.54 148.42 24.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.054 0.454 . . . . 0.0 111.832 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 64' ' ' CYS . 3.4 m -109.66 123.41 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.673 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -131.9 119.4 41.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.829 0.347 . . . . 0.0 111.224 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -136.67 144.58 16.28 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.652 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 1.9 ptt85 -131.21 149.77 52.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.659 0.266 . . . . 0.0 110.751 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HB3' ' HG2' ' A' ' 55' ' ' GLN . 10.8 tptt -62.24 157.03 20.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.009 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mmt -98.7 45.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.408 ' HG2' ' HB3' ' A' ' 53' ' ' LYS . 18.2 pt20 -121.5 160.93 44.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.795 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.05 -28.11 18.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.609 2.206 . . . . 0.0 112.435 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.52 -44.6 86.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 62.08 89.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.04 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 3.3 pt20 -131.46 150.12 52.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 60' ' ' VAL . 6.2 m -85.86 124.0 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.03 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.683 HG23 HG21 ' A' ' 13' ' ' VAL . 3.7 m -93.85 -24.43 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.751 HD12 ' CE3' ' A' ' 89' ' ' TRP . 15.9 tt -137.93 143.1 34.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.528 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -166.57 59.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.823 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.434 ' O ' HG22 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -119.53 140.37 50.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.726 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -83.51 134.41 34.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 111.475 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.497 HD13 ' SD ' ' A' ' 106' ' ' MET . 0.9 OUTLIER -113.03 127.33 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.84 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 67' ' ' VAL . 27.3 m -141.66 111.29 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.906 0.384 . . . . 0.0 111.52 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.683 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 27.22 48.17 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.0 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.27 -36.84 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.706 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.832 ' O ' HD22 ' A' ' 110' ' ' LEU . 2.5 t -91.08 141.81 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.472 . . . . 0.0 110.78 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.23 107.21 8.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.806 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 2.9 m-30 -53.55 118.3 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.69 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -93.94 -33.34 13.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.404 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.36 80.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.366 . . . . 0.0 110.601 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.65 -34.87 62.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.329 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.506 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 15.2 p -154.44 162.0 28.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.712 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 4.5 Cg_endo -46.78 -25.77 4.02 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.853 2.369 . . . . 0.0 112.307 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -122.12 35.21 4.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.216 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.421 ' HB2' ' OG1' ' A' ' 76' ' ' THR . 4.8 t80 -154.6 118.52 4.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 111.18 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.784 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.7 m80 -110.97 103.92 12.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.393 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.664 ' HG3' HG12 ' A' ' 88' ' ' VAL . 24.5 tt0 -113.07 144.63 42.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.362 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.761 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.4 p90 -144.88 161.26 39.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.708 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -118.57 114.96 23.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.498 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.431 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -93.66 -81.67 0.36 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.395 -178.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.85 -67.73 0.88 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.885 0.374 . . . . 0.0 111.287 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.2 ttm-85 -139.82 -0.59 1.69 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.777 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.62 163.37 19.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.908 0.385 . . . . 0.0 110.395 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.664 HG12 ' HG3' ' A' ' 81' ' ' GLN . 1.6 t -120.75 127.62 75.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.805 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.751 ' CE3' HD12 ' A' ' 62' ' ' ILE . 66.5 m95 -101.63 91.24 4.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.194 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.555 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -86.83 122.47 6.14 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.496 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.567 HD23 ' CH2' ' A' ' 82' ' ' TRP . 3.0 mm? -103.02 111.07 23.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.615 0.245 . . . . 0.0 111.51 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 12' ' ' THR . 14.1 t-20 -92.63 104.85 17.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.289 0.566 . . . . 0.0 109.625 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.652 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 60.5 m-85 -77.69 164.19 25.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.255 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.77 -26.93 30.66 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.191 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.2 t -150.64 161.25 42.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.794 0.33 . . . . 0.0 110.617 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -25.5 61.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.253 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -58.69 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.079 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.53 -56.24 8.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.052 0.453 . . . . 0.0 110.62 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.652 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -49.16 -33.86 13.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.621 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.44 -30.92 65.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.319 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.633 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -76.08 -50.45 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.267 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.501 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 12.1 t80 -49.08 -52.63 24.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.784 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -64.01 -31.38 72.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.827 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.45 -65.38 0.55 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.194 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.9 -47.77 79.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.945 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . 1.02 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.7 tpt -48.77 -60.67 2.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.969 0.414 . . . . 0.0 110.576 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.65 -37.71 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.314 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -37.78 85.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.968 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.3 -53.7 40.03 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.876 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.02 HD21 ' HE3' ' A' ' 106' ' ' MET . 10.1 mt -63.65 -15.63 58.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.244 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -92.42 -27.0 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.547 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.96 1.48 45.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.24 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.809 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -113.2 -37.18 4.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.314 -179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -94.61 -28.79 15.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.829 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.503 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.833 0.349 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 m 63.58 -170.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.81 -173.85 4.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.949 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.0 m -93.93 139.15 31.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.965 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.557 HG13 ' HB3' ' A' ' 37' ' ' GLN . 41.9 t -89.78 151.37 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.461 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -103.59 -69.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.959 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 -178.47 4.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.875 0.369 . . . . 0.0 111.634 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.518 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 9.4 p -152.35 126.21 9.02 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.163 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 39.1 t -135.03 165.77 24.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.007 0.432 . . . . 0.0 111.609 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -106.51 121.38 44.18 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.804 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -166.77 175.6 7.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 111.129 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -114.84 95.43 5.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.32 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 26' ' ' ALA . 70.4 t -46.31 151.13 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.496 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -149.67 146.59 27.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.742 -179.168 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 4.0 mt -123.18 108.8 13.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.42 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.8 t80 -71.54 153.17 42.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.22 0.533 . . . . 0.0 111.959 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.83 88.58 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.23 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -53.34 -22.38 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.321 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.38 -34.9 69.4 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.621 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -132.77 13.99 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.666 0.27 . . . . 0.0 111.303 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER 51.02 83.75 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.819 0.342 . . . . 0.0 111.036 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 179.11 155.31 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.061 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.56 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 28.8 m95 -73.27 172.63 10.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.53 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.768 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -164.8 115.91 0.91 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.377 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.768 ' HD2' HD23 ' A' ' 24' ' ' LEU . 83.4 Cg_exo -41.01 94.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.802 2.335 . . . . 0.0 113.002 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.586 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -44.31 -44.03 7.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.679 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.56 -105.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.629 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.0 p -123.32 -79.38 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 111.022 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.78 -76.86 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.19 -178.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.617 2.211 . . . . 0.0 112.322 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.402 ' HA ' ' HE2' ' A' ' 53' ' ' LYS . 1.1 mt-30 -146.63 152.2 38.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.503 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . . . -178.93 44.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.107 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 52.17 -175.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.418 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' ALA . 93.5 p -174.32 150.88 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.007 0.432 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -93.79 95.51 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.461 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.828 HG22 ' HA3' ' A' ' 51' ' ' GLY . 20.0 t -94.02 117.42 37.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.288 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.557 ' HB3' HG13 ' A' ' 5' ' ' VAL . 40.8 mt-30 -109.2 155.94 20.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.379 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 106' ' ' MET . 62.0 mt -101.02 149.01 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.391 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -112.97 119.91 39.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.99 0.424 . . . . 0.0 110.96 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.497 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -93.58 103.2 15.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.583 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -105.14 84.54 1.07 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.672 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 74.5 Cg_endo -74.97 -22.47 14.84 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.349 2.032 . . . . 0.0 112.432 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.5 p -51.66 -30.43 21.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.085 0.469 . . . . 0.0 110.487 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -129.32 7.39 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.139 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 61.35 48.83 5.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.138 0.494 . . . . 0.0 110.178 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.04 155.77 49.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.323 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.812 ' CE2' HD23 ' A' ' 113' ' ' LEU . 51.8 m-85 -124.42 178.14 5.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.623 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.1 ttm180 -167.38 157.3 10.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.059 0.456 . . . . 0.0 111.592 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.424 HG23 HG12 ' A' ' 62' ' ' ILE . 6.6 m -120.27 125.66 74.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.035 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.18 125.93 52.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.215 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.828 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -140.32 146.51 17.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.756 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -127.5 151.82 48.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.895 0.379 . . . . 0.0 111.146 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HD2' ' HB3' ' A' ' 32' ' ' ALA . 21.2 mmtp -55.58 158.88 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.8 mtp -98.81 45.39 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.569 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -130.44 163.24 49.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.706 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.01 -22.09 29.47 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 112.445 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -43.71 76.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.921 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 63.69 84.08 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -120.78 128.48 52.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.557 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 60' ' ' VAL . 5.8 m -70.96 120.09 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 0.0 110.631 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.554 HG23 HG21 ' A' ' 13' ' ' VAL . 3.1 m -93.67 -21.94 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.229 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.719 HD12 ' CE3' ' A' ' 89' ' ' TRP . 10.4 tt -138.67 139.7 40.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.376 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -165.34 69.13 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.025 0.44 . . . . 0.0 110.899 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 24.4 p -135.2 136.96 42.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -80.32 138.62 36.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.405 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -112.99 167.88 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 110.813 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 66' ' ' ILE . 21.4 m -156.5 -171.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.485 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.784 ' H ' HD12 ' A' ' 113' ' ' LEU . 9.6 ttt180 -60.3 83.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.287 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 67' ' ' VAL . . . -177.59 -32.7 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.571 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.859 HG13 ' HB2' ' A' ' 82' ' ' TRP . 3.2 t -82.43 133.31 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 117.342 0.571 . . . . 0.0 111.215 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.31 105.82 10.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.634 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.587 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.0 OUTLIER -53.88 104.4 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.284 -179.712 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -93.93 95.4 9.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.614 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.82 87.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.39 81.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.936 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 4.4 p -152.68 160.84 30.59 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.227 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 1.1 Cg_endo -43.28 -28.07 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.764 2.31 . . . . 0.0 112.377 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -128.74 57.76 1.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.76 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.0 t80 -166.47 113.19 0.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.149 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.887 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 2.7 m80 -111.21 101.99 10.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.043 0.449 . . . . 0.0 110.541 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.654 ' HG3' HG12 ' A' ' 88' ' ' VAL . 2.9 tt0 -108.41 156.42 19.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.036 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.859 ' HB2' HG13 ' A' ' 70' ' ' VAL . 46.7 p90 -156.4 151.82 26.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.347 0.594 . . . . 0.0 112.047 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.19 111.3 20.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.21 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 5.4 t0 -93.53 -90.92 0.19 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.353 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.02 -68.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.131 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -147.11 -4.01 0.55 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.669 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -105.34 179.98 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.342 . . . . 0.0 110.341 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.654 HG12 ' HG3' ' A' ' 81' ' ' GLN . 1.6 t -136.72 115.87 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.542 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.719 ' CE3' HD12 ' A' ' 62' ' ' ILE . 75.4 m95 -93.62 99.35 11.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.019 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.497 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -93.52 119.15 5.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.707 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.584 HD11 HG22 ' A' ' 13' ' ' VAL . 3.4 mm? -103.74 108.95 20.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.573 0.225 . . . . 0.0 111.506 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.42 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 10.5 t-20 -92.83 107.68 19.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 110.108 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.804 ' CD1' ' HB2' ' A' ' 11' ' ' ALA . 66.9 m-85 -78.09 161.91 27.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.119 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.69 -28.52 9.46 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.383 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.8 m -135.66 163.21 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.321 . . . . 0.0 110.769 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -63.86 -32.93 74.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -64.73 -53.17 51.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -48.58 -62.1 1.68 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.914 0.387 . . . . 0.0 110.469 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -46.17 -38.92 8.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.49 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.12 -29.45 62.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.488 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.626 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -75.9 -49.63 17.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.529 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 6.6 t80 -51.66 -53.45 38.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.887 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -61.94 -31.91 72.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 110.741 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.94 -66.69 0.37 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.061 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.08 -40.39 98.09 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.639 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.904 ' CE ' HD21 ' A' ' 110' ' ' LEU . 16.9 tpt -51.64 -58.54 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.97 0.414 . . . . 0.0 110.422 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.49 -37.92 5.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.905 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 t -64.98 -38.21 90.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.948 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -64.51 -53.19 51.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.908 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.904 HD21 ' CE ' ' A' ' 106' ' ' MET . 11.3 mt -65.46 -18.32 65.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.103 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -96.19 -21.37 17.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.712 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . . . -96.22 -3.43 44.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.348 0.594 . . . . 0.0 109.716 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.812 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -112.37 -27.94 8.09 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.252 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.477 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 41.3 mt-10 -87.94 -34.44 18.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.535 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.337 -1.257 . . . . 0.0 112.523 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 mtm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.6 p -66.07 114.03 4.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -72.85 -174.96 1.59 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.8 m -116.06 147.32 41.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.945 0.402 . . . . 0.0 111.405 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 24.4 t -89.28 159.75 2.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.393 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.487 HG13 HG22 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -112.32 -67.53 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.585 ' SG ' HD12 ' A' ' 38' ' ' ILE . 13.4 p -119.93 178.68 4.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.891 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -157.79 112.21 2.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.586 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 8.4 t -128.68 159.39 35.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 112.056 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -103.15 123.83 47.44 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.206 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.603 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -168.17 -173.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 111.24 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.4 m -120.72 93.25 3.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.174 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.694 HG21 HG23 ' A' ' 61' ' ' VAL . 54.3 t -43.43 154.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.245 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.485 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -152.06 158.79 43.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.621 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.524 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 2.4 mt -137.44 108.08 6.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.53 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 9.4 t80 -68.23 154.1 42.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.319 0.581 . . . . 0.0 111.949 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.24 81.8 2.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.06 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -48.33 -25.81 1.75 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.466 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.6 -28.99 57.16 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.528 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -134.53 10.59 3.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.613 0.244 . . . . 0.0 111.325 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.86 81.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.926 0.393 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.447 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 177.67 159.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.913 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 25.3 m95 -75.92 171.67 14.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.611 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.677 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -163.19 119.12 1.18 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.541 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.677 ' HD2' HD23 ' A' ' 24' ' ' LEU . 92.8 Cg_exo -43.18 93.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.682 2.254 . . . . 0.0 112.951 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -44.92 -51.55 9.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.617 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -46.6 -96.4 0.01 OUTLIER Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.088 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.71 -82.79 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.297 . . . . 0.0 111.185 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.08 -94.3 0.87 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.562 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.3 166.19 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.541 2.16 . . . . 0.0 112.16 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 0.7 OUTLIER -144.8 165.56 27.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.203 0.525 . . . . 0.0 111.473 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 173.28 43.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.583 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 62.53 -176.26 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' ALA . 2.0 t -175.04 153.91 1.72 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.741 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.68 96.83 10.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.82 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.9 t -97.43 122.7 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.066 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.486 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 31.6 mt-30 -114.02 172.22 7.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.384 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.585 HD12 ' SG ' ' A' ' 7' ' ' CYS . 68.7 mt -116.87 156.37 18.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.165 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.538 ' CE1' HG21 ' A' ' 50' ' ' VAL . 7.6 m-85 -114.75 120.12 38.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.0 111.466 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.481 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 12.9 t60 -93.71 86.62 5.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.74 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.81 96.83 7.06 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.843 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 74.3 Cg_endo -84.53 -23.18 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.54 2.16 . . . . 0.0 112.624 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.4 t -47.85 -30.6 4.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.946 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.85 -5.22 9.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.399 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.05 43.01 0.7 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.089 0.471 . . . . 0.0 110.207 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.51 171.91 13.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.817 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.478 ' CD1' HD11 ' A' ' 6' ' ' ILE . 65.0 m-85 -134.45 177.99 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.862 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -163.12 149.51 12.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.129 0.49 . . . . 0.0 111.63 -179.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.653 HG13 HG12 ' A' ' 62' ' ' ILE . 3.9 p -109.09 135.01 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.098 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.538 HG21 ' CE1' ' A' ' 39' ' ' TYR . 2.1 t -140.3 121.52 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.736 0.303 . . . . 0.0 111.306 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.82 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -143.62 147.45 18.79 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.85 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -132.47 150.78 52.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.757 0.313 . . . . 0.0 110.87 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.567 ' NZ ' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -58.46 163.44 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 17.1 mtp -106.71 46.76 0.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.414 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 7.7 pt20 -126.91 160.88 56.84 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.784 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 87.8 Cg_exo -47.55 -26.45 6.38 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.753 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.89 -44.98 68.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.829 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 59.91 93.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -134.38 136.86 43.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 60' ' ' VAL . 16.7 m -70.82 121.8 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.368 . . . . 0.0 110.863 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.694 HG23 HG21 ' A' ' 13' ' ' VAL . 3.9 m -93.75 -24.39 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.653 HG12 HG13 ' A' ' 49' ' ' VAL . 9.6 tt -138.28 135.28 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.471 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -161.9 71.88 0.37 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.917 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 18.0 t -136.81 144.9 43.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.037 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -83.82 130.91 34.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.48 ' O ' HD11 ' A' ' 113' ' ' LEU . 1.5 pt -102.72 117.0 47.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.869 0.366 . . . . 0.0 111.193 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.637 ' C ' HD13 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -106.43 165.95 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.521 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.675 ' H ' HD22 ' A' ' 113' ' ' LEU . 60.5 ttp85 -44.02 100.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.106 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.15 -23.52 0.21 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.087 -1.054 . . . . 0.0 113.847 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.56 HG11 ' CD1' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -100.09 123.54 53.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 117.617 0.709 . . . . 0.0 111.162 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.797 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -121.05 134.93 55.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.824 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.9 m-30 -67.6 126.75 30.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -95.09 -33.05 12.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.63 78.9 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.804 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.72 75.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.311 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 6.0 p -139.61 166.61 22.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.716 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 76.3 Cg_exo -51.02 -24.41 14.14 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.44 2.093 . . . . 0.0 112.368 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.71 33.09 5.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -148.43 125.22 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.959 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.696 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 6.1 m80 -125.22 98.71 5.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.295 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -112.76 146.59 38.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.768 -178.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.592 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 26.2 p90 -144.07 144.06 31.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.796 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.569 ' HG2' HG22 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -86.39 103.11 14.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.712 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.94 130.6 53.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 60.46 -82.57 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.725 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.44 -30.03 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.302 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -93.75 -168.89 1.98 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.884 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' A' ' 83' ' ' ARG . 2.4 t -137.07 129.68 43.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.977 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.598 ' CE3' HD12 ' A' ' 62' ' ' ILE . 74.2 m95 -97.61 100.89 12.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.182 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.46 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -94.44 130.87 10.48 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.566 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 11' ' ' ALA . 3.0 mm? -114.92 111.54 21.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.808 0.337 . . . . 0.0 111.857 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.481 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 12.8 t-20 -92.89 110.75 22.21 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.647 ' CD1' ' HB2' ' A' ' 99' ' ' ALA . 36.5 m-85 -86.69 159.79 19.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.331 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.66 -27.7 49.96 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.348 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 p -149.06 178.71 8.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.815 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -29.0 63.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.33 -56.87 12.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.999 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -52.21 -55.81 18.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.647 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -57.16 -28.15 62.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.276 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.85 63.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.1 tp-100 -76.39 -42.45 44.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.029 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 5.9 t80 -54.28 -48.42 71.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.696 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -65.47 -34.57 78.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.871 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.88 -65.5 0.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.53 -50.5 61.54 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.957 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.84 ' CE ' HD21 ' A' ' 110' ' ' LEU . 11.7 tpt -47.72 -60.98 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 110.661 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.57 -33.63 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.343 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -33.88 69.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.079 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 106' ' ' MET . . . -68.56 -42.26 78.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.524 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.84 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -75.51 -29.48 59.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.063 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -75.32 -25.42 57.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.36 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.14 -3.72 27.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.513 0.673 . . . . 0.0 109.481 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 68' ' ' ARG . 4.2 mt -90.05 -42.56 11.05 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.131 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.76 -33.84 11.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.68 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.403 -1.22 . . . . 0.0 112.492 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ttp . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.797 0.332 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.69 126.07 31.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.053 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.524 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 1.3 mp0 -71.02 -169.55 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.1 m -110.85 126.57 54.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.519 HG13 ' HB3' ' A' ' 37' ' ' GLN . 29.4 t -76.54 151.15 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.48 HG13 HG22 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -107.45 -68.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 38' ' ' ILE . 24.2 p -115.33 176.98 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.55 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.62 113.21 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.87 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 42.2 t -129.67 152.76 48.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.018 0.437 . . . . 0.0 111.879 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -95.13 130.63 41.76 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.031 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -176.29 161.14 2.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 0.0 111.688 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.2 m -93.76 83.93 4.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.741 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.677 HG12 ' HB3' ' A' ' 26' ' ' ALA . 88.0 t -40.12 140.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.311 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.544 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -129.62 179.08 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.361 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 88' ' ' VAL . 5.8 tp -160.64 113.78 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 0.0 110.225 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 8.7 t80 -73.53 149.3 42.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.392 0.615 . . . . 0.0 112.565 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.62 87.21 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.931 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -49.11 -23.53 1.27 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.618 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.64 -48.67 42.62 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.771 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -123.69 16.3 9.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.65 0.262 . . . . 0.0 111.164 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 1.1 mtmm 52.06 87.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 111.17 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.1 OUTLIER 178.01 161.91 0.59 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.036 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.546 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 20.5 m95 -80.91 171.14 15.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.566 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.485 HD23 ' HD2' ' A' ' 25' ' ' PRO . 4.6 mt -167.17 125.59 1.03 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.541 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.485 ' HD2' HD23 ' A' ' 24' ' ' LEU . 89.3 Cg_exo -43.83 102.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.587 2.191 . . . . 0.0 112.622 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.677 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -50.01 -38.47 37.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.384 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.81 -119.96 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.705 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.58 -68.04 0.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.852 0.358 . . . . 0.0 111.27 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.5 -72.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.769 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -47.95 167.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -145.53 56.62 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.026 0.441 . . . . 0.0 111.279 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.65 50.64 1.61 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.281 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 59.95 -176.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.433 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.92 142.64 2.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -93.85 94.34 8.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.055 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.779 HG22 ' HA3' ' A' ' 51' ' ' GLY . 39.2 t -93.85 146.14 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.342 0.591 . . . . 0.0 112.011 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.519 ' HB3' HG13 ' A' ' 5' ' ' VAL . 32.5 mt-30 -138.18 170.19 16.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.56 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 106' ' ' MET . 90.9 mt -112.06 153.9 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.301 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.524 ' CD2' ' HB2' ' A' ' 3' ' ' GLU . 3.5 m-85 -112.12 119.05 37.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.905 0.383 . . . . 0.0 111.785 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.514 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 1.9 t60 -93.72 92.23 7.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.676 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -101.81 87.03 0.91 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.722 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 73.4 Cg_endo -74.32 -21.51 17.43 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.293 1.995 . . . . 0.0 112.465 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -48.85 -29.28 4.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.041 0.448 . . . . 0.0 110.568 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.87 8.29 4.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.231 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.468 ' O ' HD21 ' A' ' 113' ' ' LEU . 0.1 OUTLIER 59.71 49.2 8.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.207 0.527 . . . . 0.0 109.9 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.46 ' HA ' HG12 ' A' ' 67' ' ' VAL . 5.7 t -129.45 163.82 25.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.335 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.727 ' CE2' HD23 ' A' ' 113' ' ' LEU . 51.6 m-85 -133.5 169.14 17.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.656 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 2.0 ttm180 -165.1 148.61 8.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.738 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.606 HG23 HG12 ' A' ' 62' ' ' ILE . 7.0 m -104.79 129.34 57.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.489 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.517 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -135.27 123.66 39.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.779 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -146.46 146.24 16.03 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.862 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -126.49 158.64 35.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 172.92 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.815 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.449 ' HE2' ' HB2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -108.51 47.52 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -128.27 158.13 72.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.12 -27.86 18.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.641 2.227 . . . . 0.0 112.454 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -42.24 85.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 60.19 99.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -135.98 132.71 36.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.761 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.4 m -70.42 120.94 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.045 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.641 ' CG2' HG21 ' A' ' 13' ' ' VAL . 5.9 m -93.84 -21.92 5.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.235 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.606 HG12 HG23 ' A' ' 49' ' ' VAL . 9.9 tt -138.04 134.05 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.479 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -160.16 63.67 0.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.943 0.402 . . . . 0.0 110.86 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.1 t -124.62 139.99 53.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.967 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -87.02 150.38 24.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.349 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.471 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -130.46 141.47 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 46' ' ' SER . 15.2 m -152.35 110.89 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.665 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.581 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 26.62 47.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.33 179.312 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.12 -27.7 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.177 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.843 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.6 t -100.14 138.88 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 111.338 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -126.35 110.61 13.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.569 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CE2' ' HG2' ' A' ' 106' ' ' MET . 1.5 m-30 -51.02 132.67 27.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.412 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.88 97.49 5.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.79 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.09 104.23 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.92 -34.66 64.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.022 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.4 p -150.28 174.36 3.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.524 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 65.3 Cg_exo -51.78 -24.54 18.52 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.382 2.055 . . . . 0.0 112.354 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -140.37 69.95 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.961 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -173.67 128.27 0.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.69 ' HB2' HD21 ' A' ' 91' ' ' LEU . 1.4 m-70 -117.04 146.89 42.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.714 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -154.91 138.25 15.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.984 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.843 ' HB2' HG13 ' A' ' 70' ' ' VAL . 15.5 p90 -145.96 142.05 28.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.145 0.498 . . . . 0.0 111.935 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.406 ' HD3' HG22 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -104.32 111.32 23.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.209 178.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.413 ' HB2' HG21 ' A' ' 70' ' ' VAL . 14.8 t70 -93.78 -93.43 0.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.608 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.18 -70.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.981 0.42 . . . . 0.0 111.402 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.01 -7.18 1.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.63 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 -168.86 1.43 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 110.621 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.714 HG12 ' HG2' ' A' ' 81' ' ' GLN . 0.9 OUTLIER -143.04 120.15 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.048 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.605 ' CZ3' ' HB1' ' A' ' 26' ' ' ALA . 59.1 m95 -92.69 105.76 17.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.249 0.547 . . . . 0.0 110.74 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.546 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -106.95 174.36 19.88 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.664 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' ' 80' ' ' HIS . 1.1 pt? -177.69 139.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.194 0.521 . . . . 0.0 111.54 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.406 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 6.6 t-20 -103.19 121.37 42.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.404 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 53.4 m-85 -85.46 160.25 19.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.117 0.484 . . . . 0.0 111.785 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.55 -27.51 63.16 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.31 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.63 169.97 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 110.775 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -26.01 65.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.15 -49.21 62.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.6 -55.58 32.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.072 0.463 . . . . 0.0 110.056 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.694 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -56.31 -29.17 60.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.367 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -31.22 64.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.384 . . . . 0.0 111.174 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.9 tp-100 -78.47 -43.41 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.144 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 5.1 t80 -54.41 -45.94 73.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.206 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.542 ' HB2' ' NE2' ' A' ' 80' ' ' HIS . . . -72.22 -29.31 63.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.69 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -47.28 -64.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.074 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.43 -49.17 58.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.995 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . 1.059 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.3 tpt -49.19 -60.74 2.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.393 . . . . 0.0 110.611 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.95 -37.4 3.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.313 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -36.67 79.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.031 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.619 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.13 -51.95 58.14 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.679 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.059 HD21 ' HE3' ' A' ' 106' ' ' MET . 6.8 mt -63.59 -18.07 63.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.873 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -94.85 -25.59 16.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.567 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.46 1.3 51.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.307 0.575 . . . . 0.0 110.083 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.727 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -112.42 -33.54 6.15 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.213 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -87.18 -32.77 19.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.322 -1.266 . . . . 0.0 112.434 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.814 0.34 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.3 p -58.73 -169.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.049 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.06 -169.31 2.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.794 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.4 m -129.34 106.51 8.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.983 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.564 HG11 ' OE1' ' A' ' 37' ' ' GLN . 44.0 t -60.66 146.66 10.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.658 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.521 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -98.23 -68.98 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.826 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -132.78 -175.41 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.505 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.51 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 14.9 p -153.36 118.11 5.02 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.199 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 7.2 p -120.26 159.98 23.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.121 0.486 . . . . 0.0 111.876 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -107.16 118.77 37.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.564 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -167.69 -171.88 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.09 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 92' ' ' ASN . 3.4 m -123.52 90.62 3.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.16 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.564 HG21 HG23 ' A' ' 61' ' ' VAL . 69.5 t -42.26 148.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.065 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.509 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -143.65 163.8 32.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.065 -178.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.534 HD21 ' CE2' ' A' ' 89' ' ' TRP . 5.1 mt -136.58 112.0 9.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.454 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.6 t80 -75.93 147.39 38.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.244 0.545 . . . . 0.0 111.934 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.8 89.79 3.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.15 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -52.79 -21.65 4.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.85 -50.76 48.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.62 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -125.08 18.23 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.677 0.275 . . . . 0.0 111.141 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 7.9 mtpt 51.49 91.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.155 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 177.89 151.92 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.585 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 20.6 m95 -76.22 167.94 20.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.565 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.7 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.6 mt -160.33 129.7 3.24 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.532 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.7 ' HD2' HD23 ' A' ' 24' ' ' LEU . 87.8 Cg_exo -47.73 94.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.554 2.17 . . . . 0.0 112.903 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.536 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -46.07 -42.94 14.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.464 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.32 -110.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.82 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 t -126.85 -52.82 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 111.253 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.44 -82.68 0.04 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.693 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -47.7 168.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.576 2.184 . . . . 0.0 112.364 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 5.1 mt-30 -142.11 154.28 44.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.165 0.507 . . . . 0.0 111.322 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 175.57 44.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.954 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 56.71 175.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.618 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 11' ' ' ALA . 27.2 m -166.5 152.35 8.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.636 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -93.79 97.63 10.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.705 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.658 HG22 ' HA3' ' A' ' 51' ' ' GLY . 24.1 t -93.74 122.11 44.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.294 0.568 . . . . 0.0 112.092 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.564 ' OE1' HG11 ' A' ' 5' ' ' VAL . 36.9 mt-30 -116.2 154.82 29.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.763 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 106' ' ' MET . 41.8 mt -103.36 151.0 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.61 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.28 122.48 47.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.047 0.451 . . . . 0.0 111.525 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.49 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 0.6 OUTLIER -101.13 91.33 4.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.113 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -101.55 88.51 1.19 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.508 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 63.0 Cg_endo -72.43 -19.55 24.99 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.34 2.027 . . . . 0.0 112.554 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.3 m -52.01 -26.66 11.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.664 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.44 8.56 5.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.2 t30 56.84 49.32 14.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.042 0.449 . . . . 0.0 110.266 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.526 ' HA ' HG12 ' A' ' 67' ' ' VAL . 71.4 m -136.22 165.4 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.29 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.773 ' CE2' HD23 ' A' ' 113' ' ' LEU . 56.9 m-85 -134.32 173.24 11.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.609 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.649 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 7.2 ttp180 -165.8 150.78 8.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.421 . . . . 0.0 111.56 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.674 HG13 HG12 ' A' ' 62' ' ' ILE . 5.8 p -106.71 135.55 44.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.239 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.91 118.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.974 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.658 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -138.3 143.56 14.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.934 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -126.09 148.91 49.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.749 0.309 . . . . 0.0 110.802 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -57.57 168.89 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -108.2 45.37 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -128.25 161.67 55.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.61 -31.03 23.49 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.668 2.246 . . . . 0.0 112.642 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -45.85 90.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.04 91.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.876 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -131.3 136.08 47.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.668 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 60' ' ' VAL . 13.2 m -72.71 122.01 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.735 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.564 HG23 HG21 ' A' ' 13' ' ' VAL . 3.3 m -93.71 -20.58 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.24 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.674 HG12 HG13 ' A' ' 49' ' ' VAL . 8.8 tt -140.59 138.79 35.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.626 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -163.38 69.44 0.21 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.689 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.408 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -131.56 135.03 46.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.889 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.649 ' HB2' ' HD3' ' A' ' 48' ' ' ARG . . . -78.02 141.11 39.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.593 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.539 HD13 ' SD ' ' A' ' 106' ' ' MET . 0.9 OUTLIER -120.87 124.76 73.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.781 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 46' ' ' SER . 16.1 m -138.59 110.06 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.904 0.383 . . . . 0.0 111.579 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.761 ' N ' HD12 ' A' ' 113' ' ' LEU . 1.1 ttt180 29.62 73.47 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.997 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.67 -36.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 119.76 -1.21 . . . . 0.0 113.612 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.818 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.8 t -87.95 139.1 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.032 0.444 . . . . 0.0 111.519 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.16 97.88 5.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.168 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.7 m-30 -43.99 115.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.713 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -111.46 93.0 4.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.878 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.32 92.44 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.035 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.7 90.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.979 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.519 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 2.7 p -134.57 159.23 73.0 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.335 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 1.2 Cg_endo -44.06 -27.48 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.881 2.388 . . . . 0.0 112.561 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -123.8 47.63 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 111.082 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.406 ' HB2' ' OG1' ' A' ' 76' ' ' THR . 1.5 t80 -155.24 141.71 18.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.955 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.551 ' CE1' ' O ' ' A' ' 99' ' ' ALA . 19.7 m80 -136.34 93.42 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.468 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 1.2 tm0? -104.19 140.58 37.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.213 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.818 ' HB2' HG13 ' A' ' 70' ' ' VAL . 48.7 p90 -143.07 147.28 34.79 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.144 0.497 . . . . 0.0 111.684 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.563 ' HG3' HG22 ' A' ' 88' ' ' VAL . 3.8 ttm180 -106.99 113.02 26.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.335 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.452 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 4.4 t70 -93.69 -91.05 0.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.78 -67.92 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 111.36 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -141.63 -8.08 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.512 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.54 -175.41 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.617 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' A' ' 83' ' ' ARG . 2.0 t -138.22 130.21 38.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.493 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.657 ' CE3' HD12 ' A' ' 62' ' ' ILE . 61.1 m95 -105.14 99.48 9.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.547 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -90.78 125.92 8.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.773 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.636 HD23 ' CH2' ' A' ' 82' ' ' TRP . 3.4 mm? -107.08 109.8 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.511 0.196 . . . . 0.0 111.43 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.508 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 15.8 t-20 -92.58 109.42 20.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 11' ' ' ALA . 14.7 m-85 -89.66 164.62 14.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.146 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.23 -40.74 5.39 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.555 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 162.33 25.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -31.13 70.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.946 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.37 -46.82 78.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -55.41 -58.86 6.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.961 0.41 . . . . 0.0 110.719 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.551 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . -55.93 -34.15 65.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.083 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.41 -39.99 62.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.635 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.5 tp-100 -67.12 -43.24 82.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.684 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.539 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 9.4 t80 -53.25 -51.87 60.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.904 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.48 ' HB2' ' NE2' ' A' ' 80' ' ' HIS . . . -65.1 -26.22 68.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.685 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -49.94 -62.92 1.29 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.898 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.57 -50.26 50.3 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.929 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . 1.029 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.8 tpt -49.71 -60.96 2.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.943 0.401 . . . . 0.0 110.515 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.55 -36.78 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.139 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -41.47 91.0 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.674 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -61.05 -56.17 24.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.312 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.029 HD21 ' HE3' ' A' ' 106' ' ' MET . 8.0 mt -59.87 -20.48 57.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.946 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.54 -22.8 22.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.34 1.32 38.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.99 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.773 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -116.43 -32.7 5.17 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.131 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.453 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 21.0 mt-10 -105.34 -28.94 10.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.694 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.542 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.859 0.361 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -132.26 46.38 2.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.776 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 56.84 -172.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.2 m -143.1 112.45 6.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 22.0 t -57.62 148.08 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.481 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -101.32 -67.66 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.775 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.51 -176.76 4.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.778 0.323 . . . . 0.0 111.558 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.446 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -152.45 124.23 7.91 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.186 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.475 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 13.3 t -133.72 149.17 51.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.794 0.33 . . . . 0.0 111.606 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 8.4 ttm105 -93.88 127.34 39.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.985 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.612 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -169.21 -176.2 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.925 0.393 . . . . 0.0 111.38 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -118.4 92.39 3.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.435 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.587 HG22 HD11 ' A' ' 91' ' ' LEU . 53.4 t -44.59 154.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 0.0 111.108 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.2 OUTLIER -152.77 143.42 22.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.978 -179.163 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.58 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 5.1 mt -120.67 114.4 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.311 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.2 t80 -72.43 151.74 42.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 111.738 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.74 86.66 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.305 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -52.1 -23.49 5.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.411 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.06 -42.07 86.57 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.285 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -126.98 15.62 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 110.82 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER 47.19 83.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.092 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.96 150.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.807 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.537 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 14.4 m95 -69.37 169.0 13.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.541 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.2 mt -165.44 114.17 0.82 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.508 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HD2' HD23 ' A' ' 24' ' ' LEU . 86.4 Cg_exo -41.7 100.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.695 2.263 . . . . 0.0 112.789 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.58 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -45.14 -43.97 10.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.536 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.99 -85.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.595 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.46 -80.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.744 0.307 . . . . 0.0 111.069 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -129.78 -70.0 0.12 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.543 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.42 170.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.554 2.169 . . . . 0.0 112.366 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -148.72 63.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.022 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.22 48.12 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 56.22 -178.03 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.707 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' ALA . 7.4 t -170.36 146.58 2.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.858 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -93.8 97.54 10.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.415 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.86 HG22 ' HA3' ' A' ' 51' ' ' GLY . 36.3 t -98.12 124.32 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.413 0.625 . . . . 0.0 112.022 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 22.2 mt-30 -115.06 160.59 19.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.419 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.538 HD13 ' HA ' ' A' ' 106' ' ' MET . 51.4 mt -108.51 147.45 13.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.32 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.7 m-85 -108.43 118.22 36.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.0 0.429 . . . . 0.0 111.081 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.536 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 t-80 -93.78 87.9 5.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.798 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.27 98.34 5.6 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.538 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 68.4 Cg_endo -85.32 -22.43 2.65 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.366 2.044 . . . . 0.0 112.598 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.9 p -48.28 -30.69 5.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.951 0.405 . . . . 0.0 110.61 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.59 4.5 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.244 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.88 48.59 5.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.237 0.541 . . . . 0.0 110.077 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 m -132.9 152.05 51.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.212 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.865 ' CE2' HD23 ' A' ' 113' ' ' LEU . 52.3 m-85 -120.82 163.53 18.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 31.6 mtt180 -147.54 149.61 32.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.152 0.501 . . . . 0.0 111.916 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.458 HG23 HG12 ' A' ' 62' ' ' ILE . 5.4 m -113.0 120.6 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.362 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.5 t -128.82 120.77 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 0.0 111.617 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.86 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -141.92 149.82 21.49 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.596 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 157.56 46.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 0.0 110.944 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HD3' HG11 ' A' ' 61' ' ' VAL . 21.4 mmtt -68.85 159.15 33.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.7 mtt -101.88 47.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -119.66 162.11 34.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.867 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.88 -26.02 17.12 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.555 2.17 . . . . 0.0 112.435 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.32 -42.47 59.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 60.55 99.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.808 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -137.92 137.57 38.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 60' ' ' VAL . 20.6 m -71.65 121.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.949 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.433 HG23 HG21 ' A' ' 13' ' ' VAL . 3.2 m -93.69 -21.34 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.005 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.757 HD12 ' CE3' ' A' ' 89' ' ' TRP . 16.8 tt -140.38 135.57 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.527 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -159.36 60.17 0.39 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.937 0.399 . . . . 0.0 110.907 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.6 167.91 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -111.84 128.97 56.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.235 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.75 143.56 18.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.07 0.462 . . . . 0.0 111.22 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.97 -170.01 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.336 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.757 ' H ' HD12 ' A' ' 113' ' ' LEU . 4.9 ttt-85 -56.12 92.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.474 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.72 -26.8 0.13 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.928 -1.129 . . . . 0.0 113.758 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.603 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.2 t -94.84 122.62 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 117.412 0.606 . . . . 0.0 111.255 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.799 ' HA ' HD13 ' A' ' 110' ' ' LEU . 20.7 tptm -126.07 117.33 22.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.721 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.559 ' OH ' ' CE2' ' A' ' 102' ' ' PHE . 1.8 m-30 -50.46 127.07 16.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.018 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.77 -29.41 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.105 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.67 77.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 110.682 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -54.5 -39.76 67.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.264 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.7 p -150.85 173.51 4.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.431 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 78.4 Cg_exo -50.74 -24.85 13.96 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.384 2.056 . . . . 0.0 112.274 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -132.12 52.15 2.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.789 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.2 t80 -160.32 104.11 1.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.235 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.957 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 4.3 m80 -102.58 104.96 15.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.004 0.431 . . . . 0.0 110.824 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -115.99 144.1 44.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.159 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.629 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 27.4 p90 -143.51 147.48 34.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.115 0.484 . . . . 0.0 111.743 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -109.3 112.64 24.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.987 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.504 ' HB2' HG21 ' A' ' 70' ' ' VAL . 16.8 t70 -93.67 -96.32 0.15 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.807 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.94 -70.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.936 0.398 . . . . 0.0 111.362 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -137.64 -9.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.696 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.18 173.2 6.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.065 0.46 . . . . 0.0 110.923 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.445 HG12 ' HG2' ' A' ' 81' ' ' GLN . 3.4 t -129.04 130.46 68.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.271 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.757 ' CE3' HD12 ' A' ' 62' ' ' ILE . 71.0 m95 -105.39 97.27 7.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.31 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.537 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -91.16 122.63 6.79 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.383 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.587 HD11 HG22 ' A' ' 13' ' ' VAL . 2.5 mm? -106.01 111.57 24.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.826 -0.22 . . . . 0.0 111.489 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 14.5 t-20 -92.66 103.25 15.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.333 0.587 . . . . 0.0 109.736 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.612 ' CD1' ' HB2' ' A' ' 11' ' ' ALA . 76.5 m-85 -72.85 154.17 40.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.95 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.89 -28.05 12.87 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.297 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 m -133.21 164.06 27.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.753 0.311 . . . . 0.0 110.797 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -29.78 70.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.019 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.79 -52.28 31.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.008 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -49.53 -57.25 7.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.421 . . . . 0.0 110.64 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -52.11 -41.83 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.546 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.29 -31.49 67.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.64 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.3 tp-100 -75.28 -47.59 27.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.239 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.559 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 3.3 t80 -51.54 -52.27 48.42 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.957 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -61.4 -32.49 72.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.91 0.386 . . . . 0.0 110.628 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.3 -66.13 0.44 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.189 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.13 -45.59 70.64 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.762 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.898 ' CE ' HD21 ' A' ' 110' ' ' LEU . 12.6 tpt -47.97 -60.62 2.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.908 0.385 . . . . 0.0 110.413 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.67 -36.43 11.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.004 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 t -64.82 -34.17 77.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.11 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.552 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -70.39 -51.25 31.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.589 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.898 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.7 OUTLIER -63.79 -18.14 63.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.183 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -98.52 -20.79 16.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.927 0.394 . . . . 0.0 111.88 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.75 -0.67 44.95 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.017 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.865 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -116.37 -32.79 5.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.315 -179.537 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 5.0 mt-10 -94.45 -28.07 15.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.53 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 mtm . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.789 0.328 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t 63.62 133.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.981 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -114.83 -176.88 3.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.3 m -96.34 142.18 28.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.16 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 6' ' ' ILE . 65.2 t -88.7 158.6 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.477 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.625 HG13 HG22 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -112.82 -60.4 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.831 0.348 . . . . 0.0 111.931 -179.144 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 38' ' ' ILE . 10.0 p -129.34 177.32 7.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.798 -178.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.436 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.5 OUTLIER -157.98 110.55 2.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.638 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 102' ' ' PHE . 4.6 m -128.69 163.55 24.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.208 0.528 . . . . 0.0 112.206 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.3 ttt85 -105.67 127.7 53.22 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.81 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.863 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -169.85 -177.73 2.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 111.049 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -114.89 89.35 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.353 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.673 HG11 ' HB ' ' A' ' 62' ' ' ILE . 97.8 t -45.56 137.19 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.159 0.504 . . . . 0.0 111.077 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.506 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -136.24 161.24 36.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.789 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 26' ' ' ALA . 5.0 mt -134.18 110.49 9.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.55 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.514 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.4 t80 -73.51 147.16 44.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.083 0.468 . . . . 0.0 111.672 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.67 88.04 2.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.356 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.45 -23.2 9.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.91 -36.18 72.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.545 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -133.83 13.44 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.664 0.269 . . . . 0.0 111.287 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 51.25 86.74 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.02 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.54 145.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.169 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.0 m95 -68.71 167.24 15.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.157 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.475 HD23 ' HD2' ' A' ' 25' ' ' PRO . 4.7 mt -161.3 131.55 3.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.689 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HD2' HD23 ' A' ' 24' ' ' LEU . 83.5 Cg_exo -45.85 92.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.643 2.228 . . . . 0.0 112.959 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.591 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -42.55 -66.66 0.34 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.772 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.61 -95.62 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.263 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.6 p -130.82 -85.03 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.657 0.265 . . . . 0.0 111.325 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.29 -88.38 0.35 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.708 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.32 161.95 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.616 2.211 . . . . 0.0 112.287 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -136.86 168.03 20.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.172 0.51 . . . . 0.0 111.594 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 166.96 44.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.626 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 62.41 -176.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.297 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -173.99 165.15 4.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.554 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 5.1 tmm_? -107.87 94.31 5.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.962 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.806 HG22 ' HA3' ' A' ' 51' ' ' GLY . 35.7 t -93.78 125.52 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.309 0.576 . . . . 0.0 111.908 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.467 ' HB3' HG13 ' A' ' 5' ' ' VAL . 33.7 mt-30 -119.02 155.29 31.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.884 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.625 HG22 HG13 ' A' ' 6' ' ' ILE . 72.4 mt -104.81 149.25 8.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.488 ' HB2' ' HG2' ' A' ' 48' ' ' ARG . 16.9 m-85 -115.37 126.01 53.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.061 0.458 . . . . 0.0 111.366 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.465 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.5 t-160 -93.76 98.46 11.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.168 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -102.46 89.52 1.77 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 72.2 Cg_endo -74.98 -20.61 16.74 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.22 1.947 . . . . 0.0 112.454 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -48.4 -31.21 5.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.068 0.461 . . . . 0.0 110.587 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.97 6.93 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.224 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.98 48.17 5.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.045 0.45 . . . . 0.0 110.005 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.7 t -129.79 179.66 5.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.642 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.488 ' CG ' ' HB1' ' A' ' 109' ' ' ALA . 81.9 m-85 -149.56 166.52 28.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.525 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -160.38 152.59 20.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.0 0.429 . . . . 0.0 111.539 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 62' ' ' ILE . 8.1 m -107.04 128.62 61.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 2.2 t -132.41 118.31 35.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.976 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.806 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -138.82 147.13 19.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.072 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -128.66 157.82 40.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.695 0.283 . . . . 0.0 110.52 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.566 ' HD2' HG11 ' A' ' 61' ' ' VAL . 1.5 tptt -73.38 161.9 29.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.946 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.554 ' HE2' ' HB2' ' A' ' 35' ' ' ARG . 1.1 mmt -98.33 42.82 1.08 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -96.99 163.36 20.21 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.983 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.74 -18.42 33.69 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.212 1.941 . . . . 0.0 111.371 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.39 -36.39 8.45 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.671 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 62.66 125.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.051 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -145.39 137.11 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.639 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 60' ' ' VAL . 18.0 m -65.97 119.49 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.414 . . . . 0.0 111.224 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.566 HG11 ' HD2' ' A' ' 53' ' ' LYS . 3.8 m -93.88 -27.31 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.673 ' HB ' HG11 ' A' ' 13' ' ' VAL . 15.5 tt -138.19 132.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.559 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -159.51 67.38 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.399 . . . . 0.0 110.807 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.2 t -126.08 161.53 27.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.796 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -104.19 148.3 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.613 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.558 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -119.74 142.92 32.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.832 179.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 67' ' ' VAL . 17.6 m -146.96 112.21 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.489 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.515 ' H ' HD13 ' A' ' 113' ' ' LEU . 1.0 OUTLIER 22.22 76.19 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.336 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.74 -33.26 0.06 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 119.643 -1.265 . . . . 0.0 114.12 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -93.64 125.37 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.386 0.593 . . . . 0.0 111.568 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 147.5 32.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.081 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.578 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.7 OUTLIER -86.14 104.14 15.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 0.0 111.238 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.04 98.06 10.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.629 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.54 83.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.047 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.12 -28.57 40.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 0.0 110.85 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.504 HG22 ' HB3' ' A' ' 79' ' ' PHE . 3.8 t -166.01 150.63 7.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.086 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 56.3 Cg_exo -37.63 -29.25 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.048 2.499 . . . . 0.0 113.589 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.49 50.34 1.41 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.769 0.319 . . . . 0.0 111.547 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.504 ' HB3' HG22 ' A' ' 76' ' ' THR . 7.2 t80 -170.0 127.51 0.87 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 111.424 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.946 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -118.02 111.83 19.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.287 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.516 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.5 tm0? -119.15 131.22 55.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.554 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.692 ' CH2' HD23 ' A' ' 91' ' ' LEU . 43.8 p90 -138.07 142.25 40.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.207 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.423 ' O ' HG22 ' A' ' 70' ' ' VAL . 10.2 ttm180 -88.22 105.81 17.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.457 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 32.0 t70 -105.04 130.02 53.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.734 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 61.93 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.466 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -136.33 -31.29 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.419 ' HG3' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -93.88 -168.86 1.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.961 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.516 HG12 ' HG2' ' A' ' 81' ' ' GLN . 2.1 t -137.87 124.86 28.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.651 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.49 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 78.5 m95 -93.78 98.83 11.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.522 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.829 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -80.6 161.91 44.88 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.031 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.863 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -148.22 106.99 3.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.474 0.178 . . . . 0.0 110.95 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -92.41 104.76 17.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.225 0.536 . . . . 0.0 110.016 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.669 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 78.7 m-85 -71.56 162.85 28.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.928 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.33 -26.2 5.51 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.258 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.47 159.8 40.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.879 0.371 . . . . 0.0 110.802 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -60.97 -40.36 93.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.03 -44.24 97.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.104 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -51.76 -68.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.011 0.434 . . . . 0.0 110.474 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.669 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -47.2 -31.47 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.687 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.51 -36.42 57.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.787 0.327 . . . . 0.0 111.38 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 3.9 tp-100 -77.65 -41.25 38.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.203 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.477 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 7.8 t80 -56.31 -50.78 70.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.014 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.946 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -65.46 -32.71 74.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.443 . . . . 0.0 110.867 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -47.03 -64.74 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.511 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.9 -51.87 49.86 Favored Glycine 0 CA--C 1.508 -0.354 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.159 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.941 ' CE ' HD21 ' A' ' 110' ' ' LEU . 12.2 tpt -46.68 -62.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.48 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.57 -33.27 2.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.451 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.38 -35.44 73.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.087 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.488 ' HB1' ' CG ' ' A' ' 47' ' ' PHE . . . -70.7 -46.35 63.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.721 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.941 HD21 ' CE ' ' A' ' 106' ' ' MET . 5.0 mt -67.68 -34.26 76.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.722 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -75.69 -20.38 58.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.19 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.17 2.68 29.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.601 0.715 . . . . 0.0 109.095 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.515 HD13 ' H ' ' A' ' 68' ' ' ARG . 6.9 mt -100.21 -38.37 8.53 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.954 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -105.36 -30.68 9.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.66 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.427 -1.207 . . . . 0.0 112.534 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.841 0.353 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 t -146.68 175.5 10.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.979 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' HB2' ' HD2' ' A' ' 39' ' ' TYR . 2.0 mp0 -97.22 -169.62 1.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.6 m -111.65 131.95 54.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.153 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 39' ' ' TYR . 52.4 t -84.56 158.33 3.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.559 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.488 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -103.59 -68.32 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.71 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 -170.65 2.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.353 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.51 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.4 OUTLIER -156.76 122.54 4.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.201 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.498 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 1.5 p -128.83 153.56 47.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 111.751 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -97.84 127.43 43.78 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.707 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.821 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -171.44 -175.09 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 111.4 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -117.3 95.47 4.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.427 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.686 HG21 HG23 ' A' ' 61' ' ' VAL . 86.4 t -45.82 156.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.096 0.474 . . . . 0.0 111.249 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.475 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -154.64 161.84 41.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.245 -179.29 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 1.8 mt -139.03 110.87 7.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.753 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 8.8 t80 -70.92 152.43 43.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.25 0.548 . . . . 0.0 112.044 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -123.26 79.67 1.7 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.063 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -47.24 -26.03 1.1 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.491 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.08 -38.31 89.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.356 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -121.81 2.85 10.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.672 0.272 . . . . 0.0 111.246 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 58.5 82.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.824 0.345 . . . . 0.0 110.928 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' NH2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER 176.25 158.36 0.28 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.599 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 18.0 m95 -74.76 170.25 16.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 110.599 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -163.84 117.66 1.06 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.424 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.62 ' HD2' HD23 ' A' ' 24' ' ' LEU . 98.3 Cg_exo -42.93 93.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.662 2.241 . . . . 0.0 112.789 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -44.8 -54.07 6.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.648 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.39 -94.05 0.01 OUTLIER Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.813 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -142.12 -79.65 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.845 0.355 . . . . 0.0 111.038 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.51 -71.59 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.504 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.41 170.51 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.552 2.168 . . . . 0.0 112.325 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -153.36 59.05 0.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.04 0.447 . . . . 0.0 111.154 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.97 51.39 1.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.543 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 59.62 -175.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.648 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -176.71 147.74 0.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.533 -179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.67 99.74 12.1 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.842 HG22 ' HA3' ' A' ' 51' ' ' GLY . 47.5 t -98.15 125.8 51.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.329 0.585 . . . . 0.0 112.121 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.51 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 25.4 mt-30 -115.36 156.4 25.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.191 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 106' ' ' MET . 45.3 mt -105.68 149.02 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.761 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CE1' HG22 ' A' ' 5' ' ' VAL . 6.6 m-85 -111.69 122.09 46.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.996 0.427 . . . . 0.0 111.396 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.574 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -98.19 89.15 4.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.202 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -97.41 99.77 6.89 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.755 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 79.4 Cg_endo -84.05 -21.62 3.81 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.331 2.021 . . . . 0.0 112.595 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.4 p -49.66 -32.66 13.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.945 0.402 . . . . 0.0 110.709 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.14 -2.23 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.327 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 67.53 45.05 1.61 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.19 0.519 . . . . 0.0 110.254 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.04 179.36 6.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.039 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.574 ' CD2' ' HA ' ' A' ' 40' ' ' HIS . 77.3 m-85 -142.07 179.99 6.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 1.1 ttp180 -164.95 150.38 9.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.073 0.463 . . . . 0.0 111.591 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.525 HG23 HG12 ' A' ' 62' ' ' ILE . 8.7 m -109.74 123.64 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.139 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.6 t -128.14 118.11 47.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.145 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.842 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -141.26 150.07 21.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.986 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -130.47 155.25 46.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.303 . . . . 0.0 110.613 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.38 165.76 7.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 10.4 mtp -107.12 47.13 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.915 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.24 163.5 29.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.29 -26.4 27.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.618 2.212 . . . . 0.0 112.503 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.88 -41.72 59.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.928 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 103.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.886 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -141.99 138.69 32.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 60' ' ' VAL . 17.2 m -68.73 118.72 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.686 HG23 HG21 ' A' ' 13' ' ' VAL . 3.2 m -93.77 -22.17 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.543 HD12 ' CE3' ' A' ' 89' ' ' TRP . 9.2 tt -137.79 131.01 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.51 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -158.99 69.16 0.46 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.878 0.37 . . . . 0.0 110.995 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.28 135.76 41.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -76.29 137.7 40.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.422 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.43 ' O ' HD11 ' A' ' 113' ' ' LEU . 1.0 OUTLIER -112.34 125.14 69.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.963 0.411 . . . . 0.0 111.095 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.712 ' C ' HD13 ' A' ' 113' ' ' LEU . 2.1 m -110.63 174.97 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.608 ' N ' HD22 ' A' ' 113' ' ' LEU . 23.4 ttm180 -48.55 94.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.054 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.24 -19.64 0.15 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.912 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -95.59 121.4 46.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 117.719 0.76 . . . . 0.0 111.142 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HA ' HD13 ' A' ' 110' ' ' LEU . 2.8 mmtt -108.04 175.48 5.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.294 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CE1' ' HG2' ' A' ' 106' ' ' MET . 0.4 OUTLIER -114.15 100.4 8.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 111.197 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.72 81.67 3.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.614 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.441 ' HG2' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -48.36 105.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.17 85.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -151.94 177.22 1.98 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 77.6 Cg_exo -50.53 -25.24 14.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.367 2.045 . . . . 0.0 112.131 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.87 65.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.781 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.6 t80 -168.16 109.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.944 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 3.3 m80 -108.66 119.46 39.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.9 0.381 . . . . 0.0 110.496 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.472 ' OE1' HG11 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -122.66 148.18 45.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.265 -179.103 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.735 ' HB2' HG13 ' A' ' 70' ' ' VAL . 32.9 p90 -147.24 133.55 19.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.684 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' O ' HG22 ' A' ' 70' ' ' VAL . 47.6 ttp85 -80.09 100.3 8.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.385 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 85' ' ' ALA . 20.4 t0 -102.08 125.0 48.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.175 0.512 . . . . 0.0 110.676 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 84' ' ' ASP . . . 68.24 -79.01 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.544 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -139.38 -34.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -93.86 -168.13 1.82 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.603 HG13 ' C ' ' A' ' 82' ' ' TRP . 11.4 t -137.41 136.03 46.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.947 0.403 . . . . 0.0 111.073 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.612 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 68.1 m95 -100.62 99.08 9.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.076 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.517 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -87.04 131.55 10.64 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.386 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.821 HD12 ' HB3' ' A' ' 11' ' ' ALA . 2.0 mm? -115.82 113.72 23.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.277 . . . . 0.0 111.691 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.408 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 11.2 t-20 -92.94 105.47 17.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.206 0.527 . . . . 0.0 109.673 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 80' ' ' HIS . 78.1 m-85 -73.53 153.94 40.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.952 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.98 -28.07 7.96 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.274 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 m -129.29 165.19 21.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 0.0 110.808 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.85 -28.52 66.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.064 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -71.57 -49.31 41.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -49.99 -58.71 4.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.992 0.425 . . . . 0.0 110.738 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -51.39 -41.65 60.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.686 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.54 -34.97 65.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.501 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.667 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.0 tp-100 -73.99 -45.23 51.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 111.24 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.498 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 2.7 t80 -52.62 -53.87 41.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.97 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.944 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -60.65 -31.71 70.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.423 . . . . 0.0 110.596 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.28 -66.33 0.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.197 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.57 -43.58 76.1 Favored Glycine 0 CA--C 1.507 -0.426 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.931 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.901 ' CE ' HD21 ' A' ' 110' ' ' LEU . 13.8 tpt -47.58 -59.55 3.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.908 0.385 . . . . 0.0 110.36 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 111' ' ' GLU . . . -47.5 -41.34 20.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.741 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -34.41 72.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.358 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . . . -70.95 -44.69 65.56 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 121.035 0.445 . . . . 0.0 110.725 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.901 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -72.71 -34.04 66.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.486 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 1.9 tt0 -75.1 -22.63 58.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.964 0.411 . . . . 0.0 111.45 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.39 -3.52 28.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.675 0.75 . . . . 0.0 109.088 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.712 HD13 ' C ' ' A' ' 67' ' ' VAL . 5.4 mt -92.21 -41.64 10.32 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.6 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -99.66 -31.23 11.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.852 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.506 179.937 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.797 0.332 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 p -140.5 140.27 35.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -143.82 -170.53 3.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.0 m -121.87 123.78 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG13 ' HB3' ' A' ' 37' ' ' GLN . 34.9 t -73.85 153.81 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.638 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.44 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -103.53 -69.48 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 -176.73 3.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.029 0.443 . . . . 0.0 111.935 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.535 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 6.2 p -155.89 121.91 5.05 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.065 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 38.7 t -134.23 155.77 49.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.971 0.415 . . . . 0.0 111.71 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.6 ttp85 -97.85 128.79 44.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.454 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.642 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -170.92 -175.89 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.217 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 m -119.53 96.85 5.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.415 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.711 HG21 HG23 ' A' ' 61' ' ' VAL . 41.1 t -48.88 151.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.116 0.484 . . . . 0.0 111.153 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 89' ' ' TRP . 0.6 OUTLIER -151.64 144.9 24.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.578 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.486 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 3.6 mt -121.8 116.22 24.06 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.7 t80 -81.19 141.35 34.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.145 0.497 . . . . 0.0 112.017 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.538 ' OD1' HD12 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -117.1 84.95 2.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.577 178.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.77 -23.55 4.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.609 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.17 -27.96 7.83 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.263 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -142.73 16.78 1.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.721 0.296 . . . . 0.0 110.947 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 48.19 87.1 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.93 0.395 . . . . 0.0 111.291 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.47 142.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.747 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.614 ' HH2' HE21 ' A' ' 81' ' ' GLN . 35.2 m95 -61.39 -178.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.538 HD12 ' OD1' ' A' ' 17' ' ' ASP . 3.0 mt -177.01 114.11 0.25 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.218 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -40.92 99.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.816 2.344 . . . . 0.0 112.917 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -44.03 -40.33 4.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.68 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.92 -102.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.476 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.684 HG23 ' HD2' ' A' ' 30' ' ' PRO . 2.1 t -133.42 -46.23 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.379 . . . . 0.0 110.886 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.75 -66.32 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.062 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HD2' HG23 ' A' ' 28' ' ' THR . 9.5 Cg_endo -53.62 163.16 2.92 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.723 2.282 . . . . 0.0 112.099 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -142.07 139.79 32.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.077 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -170.99 45.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 55.31 173.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.784 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' ALA . 24.4 m -167.14 151.35 6.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.645 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.75 98.62 11.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.72 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.833 HG22 ' HA3' ' A' ' 51' ' ' GLY . 23.7 t -97.34 119.92 46.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.259 0.552 . . . . 0.0 111.949 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.535 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 42.8 mt-30 -109.76 166.54 10.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.543 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.509 HD13 ' HA ' ' A' ' 106' ' ' MET . 55.1 mt -109.9 151.59 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.52 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.448 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.5 m-85 -112.65 117.13 31.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.991 0.424 . . . . 0.0 111.349 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.498 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 0.9 OUTLIER -93.88 90.97 6.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.634 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -103.14 86.85 1.13 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 83.1 Cg_endo -76.35 -19.7 14.91 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.339 2.026 . . . . 0.0 112.536 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -50.26 -32.1 15.91 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.991 0.424 . . . . 0.0 110.551 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.29 6.11 6.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.219 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.45 49.16 5.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.248 0.547 . . . . 0.0 110.039 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.5 m -136.64 150.44 48.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.207 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.833 ' CE2' HD23 ' A' ' 113' ' ' LEU . 59.2 m-85 -120.62 174.01 6.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.563 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.8 ttp180 -164.34 149.34 10.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.093 0.473 . . . . 0.0 111.592 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.498 HG23 HG12 ' A' ' 62' ' ' ILE . 5.3 m -109.42 126.31 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.798 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.8 t -129.69 121.09 51.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.802 0.334 . . . . 0.0 111.429 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.833 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -137.43 148.87 20.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.866 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.29 146.62 52.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 110.972 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm -54.08 157.4 2.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.159 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 5.8 mtt -103.52 46.4 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -129.0 163.31 46.56 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.04 -24.89 15.18 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.605 2.203 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.99 -44.45 69.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.932 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 60.37 99.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -142.05 138.2 31.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.72 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 60' ' ' VAL . 13.4 m -70.77 122.22 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.189 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.711 HG23 HG21 ' A' ' 13' ' ' VAL . 3.8 m -93.84 -29.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.493 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.755 HD12 ' CE3' ' A' ' 89' ' ' TRP . 17.2 tt -138.55 138.15 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.874 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -165.89 63.18 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 110.539 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.3 t -126.99 135.28 50.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.911 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -75.36 136.48 40.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.678 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -111.62 168.28 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.592 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 66' ' ' ILE . 19.0 m -157.06 -173.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.628 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.726 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -57.69 87.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.208 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.37 -30.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.686 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.88 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.6 t -83.14 133.42 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 117.38 0.59 . . . . 0.0 111.093 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.67 115.61 23.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.845 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.57 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -64.56 106.05 1.08 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -99.77 96.98 7.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.6 91.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -58.52 -37.79 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -151.49 176.35 2.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.405 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 74.3 Cg_exo -49.89 -25.71 12.6 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.289 1.993 . . . . 0.0 112.107 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -138.18 65.89 1.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.649 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.0 t80 -165.9 112.25 0.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.356 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.94 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 2.0 m80 -110.62 101.33 10.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.061 0.458 . . . . 0.0 110.555 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.757 ' HG3' HG12 ' A' ' 88' ' ' VAL . 6.2 tt0 -107.68 150.28 27.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.057 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.88 ' HB2' HG13 ' A' ' 70' ' ' VAL . 46.0 p90 -151.31 148.57 28.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.965 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -112.29 112.54 24.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.223 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -93.45 -92.07 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.453 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.82 -69.38 0.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.988 0.423 . . . . 0.0 110.979 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 22.7 ttp180 -144.49 11.02 1.46 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.055 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.57 159.69 28.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.108 0.48 . . . . 0.0 110.571 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.757 HG12 ' HG3' ' A' ' 81' ' ' GLN . 1.5 t -120.3 114.35 43.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.471 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.755 ' CE3' HD12 ' A' ' 62' ' ' ILE . 66.4 m95 -93.51 94.63 8.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.116 0.484 . . . . 0.0 111.301 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.501 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -86.13 118.48 4.87 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.664 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.68 HD23 ' CH2' ' A' ' 82' ' ' TRP . 2.7 mm? -104.39 110.59 22.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.599 0.238 . . . . 0.0 111.377 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.411 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 10.4 t-20 -92.49 106.3 18.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.219 0.533 . . . . 0.0 109.936 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 80.1 m-85 -73.81 159.27 33.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.135 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.83 -27.71 15.99 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.312 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.98 161.62 38.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 110.729 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -28.82 67.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.078 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.9 -55.4 14.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -48.63 -59.15 3.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.977 0.418 . . . . 0.0 110.42 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.573 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -47.45 -35.72 8.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.685 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.98 -30.02 62.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.366 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.601 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp-100 -76.79 -49.75 15.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.285 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.502 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 4.1 t80 -51.3 -53.31 36.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.94 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -62.28 -33.17 74.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.832 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.62 -67.64 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.208 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.1 -40.85 98.49 Favored Glycine 0 CA--C 1.506 -0.524 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.54 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.911 ' CE ' HD21 ' A' ' 110' ' ' LEU . 16.5 tpt -50.94 -58.57 5.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.93 0.395 . . . . 0.0 110.43 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.83 -37.63 6.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.777 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 t -64.37 -37.96 89.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.045 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.69 -53.05 46.31 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.684 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 106' ' ' MET . 10.0 mt -66.43 -15.22 63.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.054 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -98.79 -23.14 15.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.678 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . . . -97.35 -1.1 45.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.144 0.497 . . . . 0.0 109.91 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.833 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -115.93 -33.36 5.12 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.286 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 37.6 mt-10 -93.07 -28.7 16.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.708 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.362 -1.243 . . . . 0.0 112.536 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttp . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.844 0.354 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.18 117.35 7.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 61.45 -172.19 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.7 m -135.56 146.57 48.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.091 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 37' ' ' GLN . 32.9 t -83.18 151.89 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.524 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.476 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -108.34 -66.86 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.243 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.506 ' SG ' HD12 ' A' ' 38' ' ' ILE . 29.3 p -118.61 178.46 4.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.716 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -157.76 106.63 2.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.453 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.498 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 28.2 t -126.21 151.55 47.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.022 0.439 . . . . 0.0 111.766 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -93.97 132.46 38.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.289 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.77 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -174.59 -179.82 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.89 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.585 HG21 ' CD ' ' A' ' 31' ' ' GLN . 1.3 m -116.89 89.98 3.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.35 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.719 HG12 ' CB ' ' A' ' 26' ' ' ALA . 93.7 t -46.07 139.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.213 0.53 . . . . 0.0 110.725 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.51 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -137.25 155.33 49.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.383 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD21 ' CE2' ' A' ' 89' ' ' TRP . 10.0 mt -128.01 112.42 14.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.352 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 15.9 t80 -76.13 147.5 38.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 111.633 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.14 86.03 2.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.106 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.33 -25.11 5.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.39 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.09 -27.87 23.97 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.407 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -138.33 12.15 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.559 0.219 . . . . 0.0 111.362 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 tttt 51.94 83.71 0.05 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.7 0.286 . . . . 0.0 111.197 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 178.24 168.79 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.981 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.547 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 25.7 m95 -88.15 172.6 9.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.698 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.765 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.8 mt -163.21 126.23 1.73 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.765 ' HD2' HD23 ' A' ' 24' ' ' LEU . 91.8 Cg_exo -41.95 101.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.784 2.323 . . . . 0.0 112.962 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.719 ' CB ' HG12 ' A' ' 13' ' ' VAL . . . -47.03 -48.77 21.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.534 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.12 -118.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.754 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.0 p -118.68 -81.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 0.0 111.147 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.51 -83.92 0.5 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.665 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.12 156.39 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.605 2.203 . . . . 0.0 112.396 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.585 ' CD ' HG21 ' A' ' 12' ' ' THR . 4.6 tt0 -143.26 142.47 31.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.189 0.518 . . . . 0.0 111.228 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' A' ' 31' ' ' GLN . . . -169.67 44.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.897 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 64.79 -175.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.201 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -173.45 159.33 3.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.036 0.446 . . . . 0.0 111.147 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.7 OUTLIER -98.86 95.35 7.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.417 178.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.824 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.9 t -94.22 122.4 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.45 0.643 . . . . 0.0 112.163 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.514 ' HB3' HG13 ' A' ' 5' ' ' VAL . 32.9 mt-30 -113.73 171.79 7.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.43 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.563 HD11 ' HB2' ' A' ' 106' ' ' MET . 88.9 mt -117.01 154.22 18.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.417 ' CE1' HG21 ' A' ' 50' ' ' VAL . 7.5 m-85 -112.86 119.55 38.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.025 0.44 . . . . 0.0 111.804 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.551 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 6.6 t-80 -93.82 89.56 6.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.825 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -99.95 93.74 2.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 98.6 Cg_endo -81.54 -23.25 5.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.35 2.033 . . . . 0.0 112.45 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -47.75 -30.26 3.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.98 6.53 4.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.296 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.8 t30 61.03 49.46 5.69 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.22 0.533 . . . . 0.0 109.916 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.567 ' HA ' HG12 ' A' ' 67' ' ' VAL . 57.9 m -133.53 154.43 50.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.432 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.789 ' CE2' HD23 ' A' ' 113' ' ' LEU . 59.6 m-85 -124.54 172.12 9.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.561 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.579 ' HD2' ' HB2' ' A' ' 65' ' ' ALA . 9.4 ttt-85 -162.97 150.97 13.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 0.0 111.584 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.588 HG13 HG12 ' A' ' 62' ' ' ILE . 4.9 p -108.75 131.09 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.242 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.5 t -139.03 121.86 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.033 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.824 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -142.82 142.14 11.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.83 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.1 158.84 35.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.743 0.306 . . . . 0.0 110.86 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -58.34 168.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.55 ' HE2' ' HB2' ' A' ' 35' ' ' ARG . 1.6 mtt -107.05 42.88 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.135 0.493 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -128.27 162.29 51.38 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.802 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.2 -31.24 11.93 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.604 2.202 . . . . 0.0 112.773 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.06 -50.51 61.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.797 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.04 94.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -125.39 125.21 43.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 60' ' ' VAL . 9.5 m -62.79 119.09 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 111.272 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.48 HG23 HG21 ' A' ' 13' ' ' VAL . 3.2 m -93.85 -20.4 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.588 HG12 HG13 ' A' ' 49' ' ' VAL . 10.8 tt -138.81 136.5 43.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.388 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -161.79 68.57 0.29 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.977 0.418 . . . . 0.0 110.819 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.437 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -131.31 134.7 46.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.915 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.579 ' HB2' ' HD2' ' A' ' 48' ' ' ARG . . . -77.47 142.08 39.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.692 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.4 125.63 74.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.851 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 46' ' ' SER . 17.8 m -140.14 111.06 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.65 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.699 ' N ' HD12 ' A' ' 113' ' ' LEU . 12.2 ttt-85 27.88 74.31 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.871 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.47 -34.82 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.683 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.5 t -92.46 140.68 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 111.331 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.84 108.68 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.468 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.557 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.5 m-30 -52.48 124.62 13.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.25 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.26 110.36 16.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.758 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 92.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.936 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.24 90.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.03 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.7 p -146.64 173.62 4.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.471 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 78.2 Cg_exo -50.8 -25.26 15.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.349 2.033 . . . . 0.0 112.292 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -142.43 61.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.731 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 4.5 t80 -163.39 105.72 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.186 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.923 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.1 m80 -97.73 115.93 28.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 110.459 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.682 ' HG3' HG12 ' A' ' 88' ' ' VAL . 27.7 tt0 -121.9 144.69 48.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.922 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.796 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.7 p90 -143.23 150.08 38.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.29 0.567 . . . . 0.0 112.098 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -112.86 117.59 32.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.229 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.61 -81.03 0.38 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.248 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.71 -66.39 0.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.966 0.413 . . . . 0.0 111.09 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 -139.67 -5.56 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.48 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.416 ' HG2' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -108.24 179.58 4.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.985 0.422 . . . . 0.0 110.761 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.682 HG12 ' HG3' ' A' ' 81' ' ' GLN . 2.1 t -139.03 116.1 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.378 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.539 ' CE2' HD21 ' A' ' 15' ' ' LEU . 72.9 m95 -93.67 83.86 4.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.289 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.798 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -70.41 159.28 53.6 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.228 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.798 HD22 ' O ' ' A' ' 90' ' ' GLY . 1.1 mm? -144.24 108.09 4.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.532 0.206 . . . . 0.0 110.984 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -92.31 102.43 14.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.28 0.562 . . . . 0.0 109.925 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.612 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 76.7 m-85 -69.17 159.99 31.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.864 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.55 18.84 19.87 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.341 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.43 163.23 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.74 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -69.57 -30.37 68.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.68 -49.28 48.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.966 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -49.97 -62.76 1.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.994 0.426 . . . . 0.0 110.582 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -49.43 -36.66 22.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.693 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.85 -33.96 64.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.243 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.479 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 55.3 tp60 -77.32 -42.68 35.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.388 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.498 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 6.3 t80 -54.88 -50.74 67.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.298 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.923 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -68.11 -30.06 69.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.965 0.412 . . . . 0.0 110.969 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -47.79 -64.95 0.65 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.268 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.3 -50.34 56.72 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.985 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.975 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.2 tpt -48.94 -60.82 2.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.9 0.381 . . . . 0.0 110.476 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.72 -36.24 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.08 -39.78 82.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.046 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -61.79 -57.04 13.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.618 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.975 HD21 ' HE3' ' A' ' 106' ' ' MET . 8.0 mt -58.54 -20.55 47.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -92.72 -23.41 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.611 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.16 1.21 44.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.216 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.789 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -113.71 -29.67 7.03 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.344 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 3.7 mt-10 -99.05 -30.34 12.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.335 -1.259 . . . . 0.0 112.499 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.9 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.778 0.323 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.614 HG11 ' NE2' ' A' ' 37' ' ' GLN . 71.5 t -61.08 156.19 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.618 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -104.8 -62.04 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.714 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' HB2' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -139.96 -177.55 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.428 -179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.473 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 24.4 p -154.0 121.2 5.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 9.0 p -128.46 154.7 45.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.021 0.439 . . . . 0.0 111.743 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -94.26 120.99 35.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.582 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.961 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -174.1 156.15 2.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.983 0.421 . . . . 0.0 111.929 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -98.89 92.06 5.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.112 178.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.597 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 62.1 t -46.13 141.22 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.543 . . . . 0.0 112.065 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.596 ' CB ' ' O ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -134.32 140.92 46.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.06 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.719 HD21 ' CD2' ' A' ' 89' ' ' TRP . 11.8 mt -111.55 127.0 55.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.565 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.644 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.6 t80 -80.4 146.94 31.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.18 0.514 . . . . 0.0 111.705 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -120.4 77.21 1.24 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.934 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.51 -29.6 1.84 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.283 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.24 -28.97 62.28 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.881 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -121.16 -6.89 9.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.509 0.195 . . . . 0.0 111.214 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HG3' ' OH ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 64.33 76.75 0.34 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.737 0.303 . . . . 0.0 110.852 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.14 174.63 0.32 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.327 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.644 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 48.1 m95 -91.92 169.39 10.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.494 HD23 ' HD2' ' A' ' 25' ' ' PRO . 5.2 mt -165.62 126.8 1.36 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.803 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 24' ' ' LEU . 96.5 Cg_exo -40.7 110.73 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.734 2.289 . . . . 0.0 112.738 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.14 -67.21 0.29 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.528 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.25 -112.26 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.688 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.39 -160.4 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.634 0.254 . . . . 0.0 110.732 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.59 -66.25 2.05 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.114 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.08 159.84 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.656 2.237 . . . . 0.0 112.317 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -145.15 163.03 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.161 0.505 . . . . 0.0 111.295 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 171.28 46.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.836 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.407 ' H ' HG23 ' A' ' 12' ' ' THR . 19.1 m-85 61.86 178.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.264 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.42 ' HG ' ' HA ' ' A' ' 53' ' ' LYS . 58.6 m -166.42 150.75 7.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.036 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -93.92 95.74 9.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.916 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.578 HG22 ' HA3' ' A' ' 51' ' ' GLY . 28.8 t -93.88 129.87 43.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.251 0.548 . . . . 0.0 111.74 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.614 ' NE2' HG11 ' A' ' 5' ' ' VAL . 53.6 mt-30 -126.08 148.79 49.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.062 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 106' ' ' MET . 55.7 mt -97.61 150.11 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.346 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.488 ' HB2' ' HG2' ' A' ' 48' ' ' ARG . 6.4 m-85 -111.46 124.0 51.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.921 0.391 . . . . 0.0 111.42 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.512 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 15.3 t-160 -101.09 89.38 3.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.243 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -101.43 87.57 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.435 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 64.2 Cg_endo -72.5 -17.89 26.38 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.448 2.098 . . . . 0.0 112.598 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 t -52.82 -26.14 13.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.966 0.412 . . . . 0.0 110.498 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.97 5.52 5.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.288 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.11 50.33 13.83 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.184 0.516 . . . . 0.0 110.126 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.9 m -141.42 159.56 41.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.998 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.864 ' CE2' HD23 ' A' ' 113' ' ' LEU . 75.9 m-85 -130.31 163.34 27.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -162.45 143.8 10.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.71 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.623 HG13 HG12 ' A' ' 62' ' ' ILE . 3.5 p -94.63 148.33 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.277 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -149.9 116.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.541 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.578 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -139.59 147.52 19.24 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.916 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.41 162.67 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.8 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -65.53 172.65 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.5 mmm -111.94 45.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -133.4 162.92 54.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.865 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.29 -26.15 10.99 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.694 2.263 . . . . 0.0 112.562 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.77 -48.32 79.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.21 85.83 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.028 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -128.37 134.34 48.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.622 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.1 m -73.52 122.0 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 0.0 111.0 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.494 HG23 ' CG2' ' A' ' 13' ' ' VAL . 3.5 m -93.8 -20.38 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.278 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.623 HG12 HG13 ' A' ' 49' ' ' VAL . 6.9 tt -139.06 138.16 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.615 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -162.92 66.12 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.52 166.64 14.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.836 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -111.47 140.2 46.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.981 0.419 . . . . 0.0 111.608 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.422 HD13 ' SD ' ' A' ' 106' ' ' MET . 0.8 OUTLIER -121.73 123.12 68.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.769 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 67' ' ' VAL . 28.2 m -138.3 110.61 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 111.669 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.657 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 26.92 46.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.207 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.79 -22.57 0.1 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.512 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.824 ' O ' HD22 ' A' ' 110' ' ' LEU . 2.5 t -105.64 137.86 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 117.201 0.5 . . . . 0.0 110.889 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.81 114.05 16.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.619 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.565 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.7 m-30 -50.53 127.98 19.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -93.86 -40.55 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.07 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 59.04 79.39 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.91 -50.59 72.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.203 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -135.53 173.35 5.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.638 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 53.3 Cg_exo -52.72 -24.33 22.99 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.453 2.102 . . . . 0.0 112.303 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -126.16 58.44 1.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -169.74 143.06 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.972 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.889 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.4 m170 -139.62 106.71 5.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.358 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.611 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.3 tm0? -117.32 121.11 40.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.413 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.806 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.7 p90 -125.42 147.14 49.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.04 0.448 . . . . 0.0 111.346 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -108.46 113.98 27.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.665 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.59 -87.55 0.24 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.255 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.73 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.966 0.412 . . . . 0.0 110.942 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.1 ttp85 -139.94 -4.4 1.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.382 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.94 177.99 4.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.03 0.443 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.611 HG12 ' HG2' ' A' ' 81' ' ' GLN . 0.6 OUTLIER -140.6 124.75 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.317 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.719 ' CD2' HD21 ' A' ' 15' ' ' LEU . 90.3 m95 -101.33 85.48 2.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.062 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.612 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -97.57 96.74 1.86 Allowed Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.192 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.961 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -93.79 133.36 37.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.177 0.513 . . . . 0.0 111.659 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.556 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -93.46 129.02 39.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.367 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.459 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 7.3 m-85 -96.53 165.51 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.563 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.27 -37.15 2.72 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.978 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 m -120.45 160.73 22.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.198 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -62.16 -44.7 96.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.803 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -58.42 -35.39 72.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 9' ' ' SER . 17.4 m-20 -59.06 -66.46 0.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.988 0.423 . . . . 0.0 110.539 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.86 -30.34 63.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.265 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.09 -43.22 54.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.877 0.37 . . . . 0.0 110.951 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.667 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp60 -68.11 -43.68 77.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.184 0.516 . . . . 0.0 110.812 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.487 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 4.5 t80 -51.98 -54.93 23.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.331 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.889 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -60.15 -29.17 68.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.747 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -49.21 -64.28 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.122 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 7' ' ' CYS . . . -65.21 -51.53 49.1 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.072 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 1.102 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.6 tpt -47.21 -61.63 1.8 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.933 0.396 . . . . 0.0 110.705 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.11 -37.05 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.402 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 t -65.86 -40.22 91.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.141 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -62.92 -56.29 18.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.745 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.102 HD21 ' HE3' ' A' ' 106' ' ' MET . 6.3 mt -59.85 -16.95 32.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.616 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.09 -29.57 15.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.844 0.354 . . . . 0.0 111.916 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.42 1.11 54.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.592 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.864 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -111.06 -36.82 5.53 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.319 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -85.67 -32.11 22.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.576 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.407 -1.218 . . . . 0.0 112.475 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.1 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.865 0.364 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 45.1 t -87.35 159.44 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.599 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.475 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -112.39 -69.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.25 -178.4 4.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.761 0.315 . . . . 0.0 111.601 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.482 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -155.44 121.82 5.23 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.307 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 20.0 t -134.51 156.78 48.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.584 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HD3' ' HE1' ' A' ' 54' ' ' MET . 31.5 ttp180 -98.06 129.41 44.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.122 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.892 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -173.21 179.33 2.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.399 . . . . 0.0 111.192 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 m -114.13 91.59 3.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.294 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.538 HG21 HG23 ' A' ' 61' ' ' VAL . 96.1 t -47.23 143.28 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.249 0.547 . . . . 0.0 111.136 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.515 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -139.71 159.98 40.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.735 -179.114 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.444 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 3.8 mt -130.61 112.43 13.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.691 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.556 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.1 t80 -75.47 145.67 41.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.122 0.487 . . . . 0.0 111.712 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.82 79.98 1.63 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.962 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.83 -26.28 3.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.286 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.53 -30.94 51.54 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.104 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -129.61 5.08 5.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.637 0.256 . . . . 0.0 111.208 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.56 83.78 0.09 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.831 0.348 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 173.85 157.03 0.13 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.952 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.556 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.4 m95 -74.81 175.23 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.455 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.791 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.4 mt -167.93 124.89 0.89 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.508 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.791 ' HD2' HD23 ' A' ' 24' ' ' LEU . 89.4 Cg_exo -44.06 97.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.544 2.162 . . . . 0.0 113.056 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.473 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -46.49 -59.28 3.08 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.008 0.432 . . . . 0.0 111.445 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.8 -97.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.927 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.7 p -136.86 -76.26 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.273 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.4 -73.17 0.08 OUTLIER Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.616 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -45.03 164.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.959 2.44 . . . . 0.0 112.284 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -149.69 57.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.032 0.444 . . . . 0.0 111.173 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.22 49.23 1.38 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 61.77 -176.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.481 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -172.95 149.02 1.84 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.555 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.83 98.95 11.42 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.529 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.2 t -94.51 135.03 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.234 0.54 . . . . 0.0 112.02 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.482 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 47.4 mt-30 -130.95 152.02 50.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.025 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 106' ' ' MET . 53.7 mt -99.39 157.69 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.395 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.476 ' N ' HG22 ' A' ' 38' ' ' ILE . 16.2 m-85 -122.72 120.22 33.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.485 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 t-160 -93.59 98.18 10.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.682 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -101.26 94.92 4.36 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.864 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 87.1 Cg_endo -80.83 -20.34 7.78 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.281 1.987 . . . . 0.0 112.52 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 m -48.67 -31.51 6.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.154 0.502 . . . . 0.0 110.524 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.36 6.75 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.168 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.95 48.87 4.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.21 0.529 . . . . 0.0 109.969 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.5 t -133.04 155.77 48.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.081 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.74 ' CE2' HD23 ' A' ' 113' ' ' LEU . 50.9 m-85 -120.09 174.72 6.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.691 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 ttt180 -164.39 152.81 12.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.429 . . . . 0.0 111.733 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.645 HG13 HG12 ' A' ' 62' ' ' ILE . 5.6 p -112.88 138.98 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.138 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.0 120.24 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.848 0.356 . . . . 0.0 110.82 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -140.79 146.25 17.44 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.792 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.91 156.94 29.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.815 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.567 ' HD3' HG11 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -82.22 161.51 22.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.624 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.41 ' HE1' ' HD3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -94.55 45.59 1.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.023 0.44 . . . . 0.0 110.588 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -94.52 163.94 21.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.946 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.23 -16.93 43.39 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.334 2.023 . . . . 0.0 111.535 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.75 -31.71 9.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.016 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.74 118.16 0.02 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.736 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -143.48 142.61 31.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.5 m -71.05 120.55 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.926 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.567 HG11 ' HD3' ' A' ' 53' ' ' LYS . 3.8 m -93.85 -18.58 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.645 HG12 HG13 ' A' ' 49' ' ' VAL . 7.0 tt -140.04 137.56 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.367 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -163.14 70.02 0.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.1 t -134.8 134.18 40.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.055 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -76.66 135.25 39.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.5 pt -108.03 166.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 0.0 111.071 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 66' ' ' ILE . 15.8 m -158.43 -173.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.554 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.742 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -61.19 87.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.203 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.65 -33.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.356 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.84 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -84.43 130.51 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 117.179 0.489 . . . . 0.0 111.173 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.44 101.77 8.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.421 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -47.56 106.3 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.326 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.71 97.34 8.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.85 88.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.47 80.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 11.4 p -136.0 162.81 54.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.744 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 75.1 Cg_exo -51.52 -22.9 13.43 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.591 2.194 . . . . 0.0 112.458 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.92 47.73 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.097 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 5.3 t80 -162.96 123.86 2.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.36 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.61 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.3 m170 -98.2 172.84 7.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.609 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.441 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.6 OUTLIER 177.15 118.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.658 0.266 . . . . 0.0 111.185 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.84 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.4 p90 -133.85 137.57 45.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 111.921 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -101.09 108.86 20.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.38 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 28.6 t70 -93.65 -102.24 0.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.664 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -72.91 0.1 Allowed 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.006 0.432 . . . . 0.0 111.075 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.6 ttm105 -140.81 -13.01 0.97 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.358 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -106.74 -176.89 3.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.897 0.38 . . . . 0.0 110.242 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.511 HG13 ' C ' ' A' ' 82' ' ' TRP . 1.3 t -136.97 122.91 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.45 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.57 ' CE3' HD12 ' A' ' 62' ' ' ILE . 71.3 m95 -94.0 91.61 6.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.842 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -72.19 164.61 54.39 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.268 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.892 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -150.44 108.8 3.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.631 0.253 . . . . 0.0 111.17 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.55 102.44 14.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.26 0.553 . . . . 0.0 109.722 178.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.668 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 81.3 m-85 -70.16 163.72 25.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.198 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.57 -28.32 6.39 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.282 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.3 p -139.07 167.12 22.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -65.32 -40.6 93.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -43.74 97.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -52.09 -66.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 110.57 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.668 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -47.3 -32.81 5.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.517 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.33 -30.91 60.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 111.151 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.539 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 7.3 tp60 -78.36 -48.54 15.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.517 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 4.7 t80 -51.4 -48.43 62.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.961 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.61 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -66.59 -33.82 76.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.986 0.422 . . . . 0.0 110.938 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -44.89 -67.66 0.27 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.7 -49.32 74.2 Favored Glycine 0 CA--C 1.508 -0.377 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.327 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.914 ' CE ' HD21 ' A' ' 110' ' ' LEU . 12.2 tpt -49.34 -60.27 2.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.865 0.364 . . . . 0.0 110.572 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.4 -36.34 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.224 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -40.93 82.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.023 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.539 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -58.34 -56.77 17.8 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.898 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.914 HD21 ' CE ' ' A' ' 106' ' ' MET . 6.3 mt -58.8 -26.23 63.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.181 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -88.65 -22.43 23.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.922 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.88 -3.41 45.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.027 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -109.44 -22.81 11.84 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.222 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.439 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 6.7 mt-10 -89.63 -38.97 13.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.335 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.463 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.714 0.292 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.595 HG11 ' NE2' ' A' ' 37' ' ' GLN . 39.4 t -67.15 153.48 8.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.584 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.504 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -101.36 -71.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.069 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.76 -173.89 3.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.589 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.537 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 10.2 p -154.71 122.88 5.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.374 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 40.3 t -131.52 155.99 46.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 111.36 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.76 128.89 44.14 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.584 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.896 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -170.66 -178.61 2.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.965 0.412 . . . . 0.0 111.167 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 m -116.41 89.4 3.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.138 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.506 HG22 HD21 ' A' ' 91' ' ' LEU . 89.0 t -45.74 143.43 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.213 0.53 . . . . 0.0 111.504 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.507 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -140.2 150.43 44.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.461 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.733 HD21 ' CE2' ' A' ' 89' ' ' TRP . 2.8 mt -122.8 114.58 20.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.489 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.2 t80 -73.98 151.84 40.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.189 0.518 . . . . 0.0 111.568 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.579 ' HB2' HD12 ' A' ' 24' ' ' LEU . 1.5 t70 -128.64 82.05 2.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.16 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.07 -26.59 4.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.202 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.2 -28.8 43.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.252 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -132.29 7.81 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.605 0.24 . . . . 0.0 111.234 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt 53.92 82.11 0.09 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.754 0.312 . . . . 0.0 111.191 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.55 172.79 0.42 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.978 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.539 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.5 m95 -89.12 171.86 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.543 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.579 HD12 ' HB2' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -162.27 125.27 1.79 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.547 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD2' HD23 ' A' ' 24' ' ' LEU . 91.1 Cg_exo -44.11 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.488 2.125 . . . . 0.0 112.741 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.476 ' HB1' ' CZ3' ' A' ' 89' ' ' TRP . . . -47.16 -56.8 5.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.625 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.64 -99.07 0.01 OUTLIER Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.943 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.7 -72.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.389 . . . . 0.0 111.219 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -132.16 -77.04 0.13 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.738 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.05 160.96 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.571 2.181 . . . . 0.0 112.413 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -142.03 57.42 1.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.072 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.39 48.9 1.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.493 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 61.62 -174.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.606 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -174.3 148.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.652 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.93 96.2 9.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.91 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.742 HG22 ' HA3' ' A' ' 51' ' ' GLY . 38.4 t -94.56 124.51 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.347 0.594 . . . . 0.0 112.082 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.595 ' NE2' HG11 ' A' ' 5' ' ' VAL . 53.1 mt-30 -114.51 164.29 14.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.42 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.536 HD13 ' HA ' ' A' ' 106' ' ' MET . 30.9 mt -111.76 151.84 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.872 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.521 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.3 m-85 -111.99 121.0 43.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.402 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 15.5 t-160 -96.31 87.89 4.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.842 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.41 92.19 3.13 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.947 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 93.5 Cg_endo -78.49 -17.97 12.5 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.368 2.045 . . . . 0.0 112.601 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -47.47 -37.16 11.23 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.954 0.407 . . . . 0.0 110.854 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.89 -7.33 12.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.097 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.06 40.78 0.25 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.035 0.445 . . . . 0.0 110.39 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.75 170.37 16.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.732 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 40' ' ' HIS . 70.4 m-85 -130.95 171.91 12.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.855 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 1.2 ttt180 -151.59 146.24 25.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.087 0.47 . . . . 0.0 111.952 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.681 HG13 HG12 ' A' ' 62' ' ' ILE . 5.7 p -107.28 129.58 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.706 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.521 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.4 t -138.3 119.09 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.192 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.742 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -142.26 149.89 21.62 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.839 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -129.1 159.59 35.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 0.0 110.59 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 166.8 15.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.4 mtp -107.95 45.71 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 4.5 pt20 -123.19 160.8 48.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.853 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 7.4 Cg_endo -49.55 -25.4 10.78 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.857 2.371 . . . . 0.0 112.435 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.89 -43.42 58.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.838 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.32 102.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.01 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -141.04 138.58 33.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 60' ' ' VAL . 13.3 m -68.94 120.51 16.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.834 0.35 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.494 HG23 HG21 ' A' ' 13' ' ' VAL . 2.9 m -93.81 -21.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.681 HG12 HG13 ' A' ' 49' ' ' VAL . 8.6 tt -138.13 135.72 44.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.542 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -160.81 64.0 0.3 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.025 0.441 . . . . 0.0 110.894 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.472 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -128.86 147.16 50.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.926 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -85.14 135.73 33.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.56 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.449 ' O ' HD11 ' A' ' 113' ' ' LEU . 1.6 pt -108.45 114.54 46.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.618 ' C ' HD13 ' A' ' 113' ' ' LEU . 1.8 m -102.56 164.9 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.973 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.687 ' H ' HD22 ' A' ' 113' ' ' LEU . 1.2 ttm180 -46.44 97.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.178 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.29 -19.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.625 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.834 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.4 t -89.97 119.81 37.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 117.54 0.67 . . . . 0.0 111.183 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -110.8 110.3 20.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.552 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.569 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.6 OUTLIER -49.02 105.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.263 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.9 88.91 5.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.842 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.449 ' NE2' ' CD2' ' A' ' 80' ' ' HIS . 2.1 tp60 -58.72 90.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.948 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.06 93.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.9 p -144.13 172.38 5.58 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.508 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 74.4 Cg_exo -50.1 -24.7 11.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.427 2.085 . . . . 0.0 112.398 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.64 57.75 1.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.767 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 1.1 t80 -159.73 113.29 2.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.475 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.746 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 22.1 m170 -107.91 104.79 14.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.317 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.531 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -116.37 127.26 54.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.512 -178.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.834 ' HB2' HG13 ' A' ' 70' ' ' VAL . 41.8 p90 -133.58 143.83 48.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 111.728 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.9 ttp85 -110.84 112.61 24.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.276 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.482 ' HB2' HG21 ' A' ' 70' ' ' VAL . 26.5 t70 -93.77 -102.38 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.73 -72.08 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 111.2 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.3 ttp-105 -140.97 -14.58 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.407 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -103.36 -177.79 3.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.531 HG12 ' HG2' ' A' ' 81' ' ' GLN . 1.8 t -136.17 129.04 46.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.553 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.733 ' CE2' HD21 ' A' ' 15' ' ' LEU . 77.3 m95 -101.25 97.98 8.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.538 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.823 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -78.84 159.63 46.0 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.002 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.896 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -148.41 106.01 3.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.77 0.285 . . . . 0.0 111.361 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.53 105.43 17.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.284 0.564 . . . . 0.0 109.902 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 62.1 m-85 -74.11 161.51 29.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.949 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.42 -32.72 7.57 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.467 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.95 157.96 45.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.777 0.322 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -28.56 65.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -68.29 -48.62 64.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -52.69 -61.39 2.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.608 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -50.0 -30.95 11.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.365 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.73 -35.92 62.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 0.0 111.038 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.7 tp60 -74.2 -44.18 54.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.039 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.47 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 2.3 t80 -52.84 -50.3 64.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.746 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -63.86 -32.22 73.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 110.695 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -46.15 -65.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.089 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.26 -45.66 78.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.904 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.818 ' CE ' HD21 ' A' ' 110' ' ' LEU . 15.2 tpt -49.34 -59.77 3.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.924 0.393 . . . . 0.0 110.39 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.68 -38.89 7.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.867 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 t -63.56 -36.19 82.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.932 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . . . -66.41 -40.74 89.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.292 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.818 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.2 OUTLIER -76.31 -26.58 55.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.049 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.15 -22.83 41.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 0.0 111.5 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.13 -4.49 24.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.528 0.68 . . . . 0.0 109.321 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.687 HD22 ' H ' ' A' ' 68' ' ' ARG . 5.2 mt -88.07 -36.37 16.98 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.249 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 68' ' ' ARG . 6.2 mt-10 -104.64 -31.96 9.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.744 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.53 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.0 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.686 0.279 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.501 HG11 ' NE2' ' A' ' 37' ' ' GLN . 50.2 t -60.31 155.16 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.578 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.524 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -105.62 -69.45 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -133.35 -172.17 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.731 0.3 . . . . 0.0 111.352 -179.036 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.529 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.3 OUTLIER -157.59 127.68 6.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 29.6 t -135.69 152.95 51.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.39 . . . . 0.0 111.525 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.543 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 24.2 ttt180 -94.85 126.94 40.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.345 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.692 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -168.73 -176.46 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.067 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 92' ' ' ASN . 1.3 m -119.79 95.65 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.105 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 61' ' ' VAL . 40.0 t -44.95 154.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.107 0.48 . . . . 0.0 111.199 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.501 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -154.53 150.8 28.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.39 -179.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.545 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -127.24 110.91 13.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.577 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.564 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.3 t80 -71.34 150.24 45.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.147 0.498 . . . . 0.0 111.851 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.81 88.13 2.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.138 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -53.5 -22.05 7.39 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.501 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.38 -44.14 76.5 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.411 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -128.7 16.11 6.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 0.0 111.001 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 3.4 mmtt 50.7 88.25 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.155 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.79 147.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.564 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 13.9 m95 -68.57 169.44 11.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.636 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.598 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -165.04 111.65 0.83 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.428 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.598 ' HD2' HD23 ' A' ' 24' ' ' LEU . 72.5 Cg_exo -40.08 95.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.864 2.376 . . . . 0.0 112.974 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.613 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -50.85 -35.86 34.71 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.378 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.22 -95.32 0.01 OUTLIER Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.806 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -173.79 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.07 -94.7 0.12 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.835 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.76 161.77 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.726 2.284 . . . . 0.0 112.479 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -142.98 55.81 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.047 0.451 . . . . 0.0 111.185 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.39 47.44 1.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.358 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 60.4 176.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.575 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.479 ' HG ' ' HA ' ' A' ' 53' ' ' LYS . 14.9 m -165.57 149.83 8.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.704 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.85 102.92 15.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.824 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.765 HG22 ' HA3' ' A' ' 51' ' ' GLY . 28.2 t -98.42 117.84 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.338 0.59 . . . . 0.0 112.128 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.529 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 47.8 mt-30 -107.7 151.83 25.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.446 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.534 HD13 ' HA ' ' A' ' 106' ' ' MET . 54.2 mt -97.64 154.61 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.91 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.52 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.6 m-85 -117.14 121.98 42.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.5 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 3.7 t-160 -99.98 89.37 4.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.024 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -96.54 100.97 7.91 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.439 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 96.4 Cg_endo -81.67 -22.13 5.64 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.264 1.976 . . . . 0.0 112.692 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.7 p -50.37 -27.41 6.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 110.73 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.38 3.7 6.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.477 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 60.02 48.3 8.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.137 0.494 . . . . 0.0 110.123 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.557 ' HA ' HD21 ' A' ' 113' ' ' LEU . 14.2 m -136.27 -173.37 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.502 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CD2' HD11 ' A' ' 6' ' ' ILE . 78.5 m-85 -151.19 165.03 35.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.973 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 12.8 mtt180 -147.42 157.75 43.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.061 0.458 . . . . 0.0 111.658 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 62' ' ' ILE . 5.1 m -113.15 122.95 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.053 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.52 HG21 ' CE1' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -130.74 121.29 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.203 -179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.765 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -141.56 140.5 10.26 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.734 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 15.7 ptp180 -123.24 147.1 47.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.799 0.333 . . . . 0.0 110.7 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.479 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -57.45 168.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.034 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.543 ' HE2' ' HG3' ' A' ' 10' ' ' ARG . 15.3 mtm -111.66 46.0 1.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.694 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -119.57 163.44 27.24 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.854 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.92 -24.67 14.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.603 2.202 . . . . 0.0 112.561 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.71 -43.96 21.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 60.78 105.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.036 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.51 ' NE2' HG12 ' A' ' 61' ' ' VAL . 2.0 pp0? -141.27 148.89 40.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.511 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.8 m -75.93 120.73 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 111.344 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 13' ' ' VAL . 4.2 m -93.91 -24.45 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.066 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.653 HD12 ' CE3' ' A' ' 89' ' ' TRP . 12.2 tt -137.71 134.7 45.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -158.96 65.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.92 0.391 . . . . 0.0 111.004 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.91 -170.86 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.757 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.545 ' HB2' ' HD3' ' A' ' 48' ' ' ARG . . . -131.44 150.31 52.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.318 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.468 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -126.55 133.73 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.067 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 67' ' ' VAL . 29.5 m -141.07 110.11 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.425 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.534 ' H ' HD13 ' A' ' 113' ' ' LEU . 1.4 ptt180 23.26 48.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.45 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.95 -23.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.841 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.885 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -95.82 130.26 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 117.373 0.587 . . . . 0.0 111.249 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -119.29 105.25 11.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.493 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.55 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.1 m-30 -47.59 105.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.405 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.54 95.18 6.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -59.09 97.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.36 92.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.191 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.434 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 0.8 OUTLIER -146.8 175.72 2.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 73.1 Cg_exo -51.32 -24.2 15.25 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.379 2.053 . . . . 0.0 112.501 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -140.48 62.72 1.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.02 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 3.1 t80 -162.42 130.4 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.12 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.797 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 30.4 m170 -118.64 105.94 12.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.484 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.4 tm0? -116.01 128.35 55.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.878 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.885 ' HB2' HG13 ' A' ' 70' ' ' VAL . 49.0 p90 -134.82 146.11 48.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 111.843 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -107.7 110.75 22.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.33 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.428 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 14.3 t0 -93.67 -97.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.817 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.91 -71.29 0.26 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.992 0.425 . . . . 0.0 111.314 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -141.21 -9.26 0.99 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.66 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.17 -170.82 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.432 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG12 ' HG2' ' A' ' 81' ' ' GLN . 1.1 t -141.24 123.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.336 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.653 ' CE3' HD12 ' A' ' 62' ' ' ILE . 69.6 m95 -97.45 91.69 5.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.382 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.81 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -75.17 153.68 45.31 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.203 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 90' ' ' GLY . 1.9 mm? -140.46 106.99 5.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.576 0.227 . . . . 0.0 110.987 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -92.72 108.73 20.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.236 0.541 . . . . 0.0 110.069 179.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.644 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 39.3 m-85 -80.32 159.46 25.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.828 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.18 -30.08 17.99 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.573 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.44 174.72 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -70.91 -32.1 68.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -50.62 66.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -52.53 -61.86 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 110.456 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.644 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -51.58 -33.22 31.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.365 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.1 -31.66 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.523 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 7.1 tp60 -76.75 -44.99 30.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.246 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.479 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 2.8 t80 -53.52 -47.62 69.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.797 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -68.68 -31.03 69.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.948 0.404 . . . . 0.0 110.78 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -46.64 -65.83 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.073 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.59 -44.66 89.34 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.845 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 1.095 ' HE3' HD21 ' A' ' 110' ' ' LEU . 15.0 tpt -50.43 -59.76 3.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.996 0.427 . . . . 0.0 110.374 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 111' ' ' GLU . . . -43.69 -41.63 4.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.124 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 t -62.02 -40.14 94.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.329 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.484 ' HB1' ' CG ' ' A' ' 47' ' ' PHE . . . -62.35 -51.62 66.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.095 HD21 ' HE3' ' A' ' 106' ' ' MET . 8.9 mt -65.85 -22.37 66.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.337 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 1.5 tt0 -84.68 -24.61 28.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.972 0.415 . . . . 0.0 111.313 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.71 3.64 34.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.754 0.788 . . . . 0.0 108.959 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 46' ' ' SER . 6.8 mt -95.45 -41.25 9.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.061 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.81 -31.97 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.743 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.34 -1.256 . . . . 0.0 112.529 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.5 m . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.772 0.32 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.578 HG11 ' NE2' ' A' ' 37' ' ' GLN . 25.1 t -66.02 149.05 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.536 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.438 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -100.0 -72.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -121.61 179.67 4.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 111.445 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.501 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -154.33 122.95 6.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.948 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 35.7 t -133.1 153.61 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.052 0.453 . . . . 0.0 111.828 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.409 ' HD3' ' CG ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -95.37 128.77 42.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.961 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 93' ' ' PHE . . . -177.8 156.97 1.14 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.957 0.408 . . . . 0.0 111.761 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.5 m -93.94 90.66 6.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.134 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.692 HG13 HD12 ' A' ' 91' ' ' LEU . 77.4 t -42.21 157.48 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.453 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.542 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -156.45 143.36 18.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.256 -179.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.698 HD21 ' CD2' ' A' ' 89' ' ' TRP . 9.0 mt -119.59 123.54 44.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.265 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.0 t80 -79.7 143.23 34.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.179 0.514 . . . . 0.0 111.816 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.46 77.21 1.06 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.571 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.09 -29.01 1.35 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.429 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.78 -28.32 46.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.959 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -128.93 1.09 5.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.491 0.186 . . . . 0.0 111.329 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 5.5 tptt 58.54 82.14 0.14 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.809 0.338 . . . . 0.0 110.923 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER 175.84 161.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.589 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 35.5 m95 -81.25 172.5 13.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.682 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 24' ' ' LEU . 3.7 mt -172.86 116.27 0.38 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.669 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -39.91 117.52 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.9 2.4 . . . . 0.0 112.735 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.616 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -54.57 -53.47 54.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.697 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.22 -107.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 CA-C-N 115.866 -0.607 . . . . 0.0 113.224 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.4 m -129.11 -81.03 0.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.775 0.322 . . . . 0.0 111.174 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.18 -70.7 0.05 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.726 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.75 154.14 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.657 2.238 . . . . 0.0 112.393 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.504 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 1.7 mt-30 -147.49 164.43 33.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.385 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 170.4 44.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.878 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.409 ' CG ' ' HD3' ' A' ' 10' ' ' ARG . 7.8 m-85 63.26 131.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.33 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 t -119.19 146.4 45.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.982 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.91 94.1 8.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.631 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.753 HG22 ' HA3' ' A' ' 51' ' ' GLY . 23.4 t -94.01 120.54 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.368 0.604 . . . . 0.0 112.027 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.578 ' NE2' HG11 ' A' ' 5' ' ' VAL . 9.2 mt-30 -113.58 169.07 9.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.599 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 38.0 mt -111.21 156.23 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.6 m-85 -114.5 116.88 29.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.37 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.502 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.2 t-160 -94.09 88.45 5.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -101.86 92.2 2.82 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.997 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 84.5 Cg_endo -79.76 -20.2 9.3 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.428 2.086 . . . . 0.0 112.544 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 p -48.7 -32.83 9.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.982 0.42 . . . . 0.0 110.638 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.6 2.55 8.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.211 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 62.93 48.53 3.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.212 0.53 . . . . 0.0 109.948 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.35 151.37 47.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.936 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.777 ' CE2' HD23 ' A' ' 113' ' ' LEU . 59.6 m-85 -118.51 174.18 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.836 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.9 ttt180 -164.19 150.55 11.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.109 0.481 . . . . 0.0 111.552 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.611 HG13 HG12 ' A' ' 62' ' ' ILE . 3.8 p -107.39 134.82 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.057 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.502 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.4 t -141.96 123.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.352 . . . . 0.0 111.033 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.753 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -140.87 144.86 15.23 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.738 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -129.13 142.79 50.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HD2' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -66.47 165.87 13.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtt -107.28 46.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.453 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 1.1 pt20 -105.79 162.99 18.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.732 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 55.4 Cg_endo -69.98 52.58 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.481 2.121 . . . . 0.0 112.195 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -160.98 -35.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 66.4 114.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.068 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -151.52 124.32 8.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 60' ' ' VAL . 17.8 m -65.55 125.29 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.635 HG23 HG21 ' A' ' 13' ' ' VAL . 10.9 m -93.82 -21.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.417 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.66 HD12 ' CE3' ' A' ' 89' ' ' TRP . 12.4 tt -141.42 140.46 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.619 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -164.43 66.7 0.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 110.875 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.8 t -128.72 131.78 47.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.957 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -75.55 136.49 40.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.396 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.5 pt -109.99 165.78 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.969 0.414 . . . . 0.0 111.079 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 66' ' ' ILE . 16.0 m -158.54 -176.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.556 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.74 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -58.73 89.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.57 -30.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.35 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.868 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -86.43 131.88 33.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 117.128 0.464 . . . . 0.0 110.743 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -119.49 114.94 23.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.777 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.609 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.0 OUTLIER -60.73 106.23 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.043 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.79 86.47 4.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.23 91.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.179 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.69 -57.54 12.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.3 p -129.09 160.47 63.58 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.348 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 6.0 Cg_endo -48.0 -26.17 7.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.714 2.276 . . . . 0.0 112.352 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -127.89 59.44 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.006 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' A' ' 92' ' ' ASN . 7.1 t80 -175.87 130.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.939 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -119.23 150.67 39.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.592 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.692 ' HG3' HG12 ' A' ' 88' ' ' VAL . 31.6 tt0 -158.56 150.72 21.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.246 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.944 ' CH2' HD21 ' A' ' 91' ' ' LEU . 19.7 p90 -151.29 165.5 33.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.344 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -121.74 114.15 20.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.728 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.44 -35.84 12.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 110.44 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.74 -67.25 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.285 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -141.78 16.93 2.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.262 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.463 ' HG3' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -128.22 114.19 16.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.692 HG12 ' HG3' ' A' ' 81' ' ' GLN . 2.4 t -93.54 108.93 21.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.865 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.698 ' CD2' HD21 ' A' ' 15' ' ' LEU . 84.6 m95 -93.78 85.91 4.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.91 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.859 ' C ' HD13 ' A' ' 91' ' ' LEU . . . -97.07 132.48 11.01 Favored Glycine 0 C--O 1.223 -0.544 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.84 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.944 HD21 ' CH2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -124.09 129.99 51.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.944 0.402 . . . . 0.0 111.679 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -92.64 110.67 22.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.641 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.623 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 89.0 m-85 -75.61 162.91 27.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.786 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.87 -27.56 28.6 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.378 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.4 m -148.54 179.42 7.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -34.14 67.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.989 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -63.16 -51.05 67.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -52.66 -58.71 5.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.672 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -52.81 -33.92 51.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.44 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.43 -32.93 62.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.283 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.661 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.8 tp60 -74.49 -46.76 37.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.004 0.431 . . . . 0.0 111.03 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.506 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 21.5 t80 -51.6 -53.7 35.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.052 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.939 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -62.61 -29.89 70.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.024 0.44 . . . . 0.0 110.651 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -46.41 -65.82 0.5 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.052 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.33 -45.02 96.01 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.3 -0.952 . . . . 0.0 111.753 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.923 ' CE ' HD21 ' A' ' 110' ' ' LEU . 15.8 tpt -49.74 -59.46 3.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.924 0.392 . . . . 0.0 110.452 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.73 -37.74 2.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.931 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -38.58 89.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.033 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.524 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -62.63 -56.74 15.04 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.729 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.923 HD21 ' CE ' ' A' ' 106' ' ' MET . 11.5 mt -59.86 -20.36 56.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.304 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -94.61 -22.44 18.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.669 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.29 -1.82 43.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.103 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.777 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -112.58 -28.92 7.65 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.299 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.462 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 3.3 mm-40 -91.09 -33.93 15.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.453 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.382 -1.232 . . . . 0.0 112.513 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.5 m . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.798 HG11 ' NE2' ' A' ' 37' ' ' GLN . 41.1 t -61.33 145.35 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.737 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -97.53 -70.16 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.78 -176.91 4.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.86 0.362 . . . . 0.0 111.57 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.535 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 12.6 p -156.15 126.43 6.62 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.222 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.483 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 16.7 t -135.72 158.34 44.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.984 0.421 . . . . 0.0 111.615 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.413 ' HD3' ' CD1' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -102.03 124.67 48.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.397 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.59 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -167.03 -172.64 2.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.501 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' ASN . 18.8 m -124.67 91.49 3.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.149 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.683 HG21 HG23 ' A' ' 61' ' ' VAL . 78.9 t -42.32 156.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.476 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.484 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -153.96 134.59 13.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.778 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 2.9 mt -112.47 110.7 21.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 0.0 110.285 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 16.7 t80 -71.41 141.03 50.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.115 0.483 . . . . 0.0 111.668 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.46 80.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.932 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.38 -26.2 4.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.33 -32.81 22.78 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.87 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -138.68 15.09 2.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.763 0.316 . . . . 0.0 110.633 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 2.4 mmpt? 46.46 90.7 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.244 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.81 133.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.792 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 12.3 m95 -59.31 146.2 40.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -141.44 112.3 6.54 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.315 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -40.65 99.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.81 2.34 . . . . 0.0 112.96 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.538 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -46.95 -34.05 5.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.329 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.29 -108.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.642 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 29' ' ' GLY . 9.9 t -146.34 -47.54 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.743 0.306 . . . . 0.0 111.327 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 28' ' ' THR . . . -152.28 -87.57 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.737 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.03 166.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.736 2.291 . . . . 0.0 112.451 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -141.91 58.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.41 51.66 2.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.413 ' CD1' ' HD3' ' A' ' 10' ' ' ARG . 52.9 m-85 55.69 178.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.682 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -165.56 143.59 5.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.86 96.22 9.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.925 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.829 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.6 t -93.83 114.67 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.369 0.604 . . . . 0.0 112.263 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.798 ' NE2' HG11 ' A' ' 5' ' ' VAL . 45.7 mt-30 -107.91 156.88 18.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.487 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.478 HD11 ' HB2' ' A' ' 106' ' ' MET . 51.0 mt -102.93 148.12 8.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.457 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.1 m-85 -109.69 117.71 34.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 111.242 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.479 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.3 t-160 -95.41 88.61 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.11 101.84 9.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.53 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 89.5 Cg_endo -83.05 -21.03 4.87 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.342 2.028 . . . . 0.0 112.634 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.8 m -48.31 -29.66 4.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.041 0.448 . . . . 0.0 110.611 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.17 6.88 4.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.288 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.2 49.28 9.34 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.196 0.522 . . . . 0.0 110.028 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -130.87 166.57 20.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.408 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.809 ' CE2' HD23 ' A' ' 113' ' ' LEU . 53.4 m-85 -131.58 167.92 18.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.841 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -155.54 148.42 24.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.054 0.454 . . . . 0.0 111.832 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 64' ' ' CYS . 3.4 m -109.66 123.41 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.673 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -131.9 119.4 41.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.829 0.347 . . . . 0.0 111.224 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -136.67 144.58 16.28 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.652 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 1.9 ptt85 -131.21 149.77 52.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.659 0.266 . . . . 0.0 110.751 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HB3' ' HG2' ' A' ' 55' ' ' GLN . 10.8 tptt -62.24 157.03 20.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.009 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mmt -98.7 45.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.408 ' HG2' ' HB3' ' A' ' 53' ' ' LYS . 18.2 pt20 -121.5 160.93 44.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.795 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.05 -28.11 18.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.609 2.206 . . . . 0.0 112.435 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.52 -44.6 86.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 62.08 89.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.04 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 3.3 pt20 -131.46 150.12 52.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 60' ' ' VAL . 6.2 m -85.86 124.0 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.03 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.683 HG23 HG21 ' A' ' 13' ' ' VAL . 3.7 m -93.85 -24.43 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.751 HD12 ' CE3' ' A' ' 89' ' ' TRP . 15.9 tt -137.93 143.1 34.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.528 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -166.57 59.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.823 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.434 ' O ' HG22 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -119.53 140.37 50.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.726 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -83.51 134.41 34.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 111.475 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.497 HD13 ' SD ' ' A' ' 106' ' ' MET . 0.9 OUTLIER -113.03 127.33 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.84 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 67' ' ' VAL . 27.3 m -141.66 111.29 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.906 0.384 . . . . 0.0 111.52 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.683 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 27.22 48.17 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.0 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.27 -36.84 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.706 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.832 ' O ' HD22 ' A' ' 110' ' ' LEU . 2.5 t -91.08 141.81 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.472 . . . . 0.0 110.78 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.23 107.21 8.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.806 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 2.9 m-30 -53.55 118.3 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.69 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -93.94 -33.34 13.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.404 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 65.36 80.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.366 . . . . 0.0 110.601 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.65 -34.87 62.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.329 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.506 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 15.2 p -154.44 162.0 28.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.712 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 4.5 Cg_endo -46.78 -25.77 4.02 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.853 2.369 . . . . 0.0 112.307 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -122.12 35.21 4.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.216 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.421 ' HB2' ' OG1' ' A' ' 76' ' ' THR . 4.8 t80 -154.6 118.52 4.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 111.18 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.784 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.7 m80 -110.97 103.92 12.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.393 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.664 ' HG3' HG12 ' A' ' 88' ' ' VAL . 24.5 tt0 -113.07 144.63 42.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.362 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.761 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.4 p90 -144.88 161.26 39.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.708 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -118.57 114.96 23.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.498 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.431 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -93.66 -81.67 0.36 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.395 -178.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.85 -67.73 0.88 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.885 0.374 . . . . 0.0 111.287 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.2 ttm-85 -139.82 -0.59 1.69 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.777 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.62 163.37 19.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.908 0.385 . . . . 0.0 110.395 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.664 HG12 ' HG3' ' A' ' 81' ' ' GLN . 1.6 t -120.75 127.62 75.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.805 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.751 ' CE3' HD12 ' A' ' 62' ' ' ILE . 66.5 m95 -101.63 91.24 4.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.194 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.555 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -86.83 122.47 6.14 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.496 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.567 HD23 ' CH2' ' A' ' 82' ' ' TRP . 3.0 mm? -103.02 111.07 23.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.615 0.245 . . . . 0.0 111.51 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -92.63 104.85 17.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.289 0.566 . . . . 0.0 109.625 178.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.652 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 60.5 m-85 -77.69 164.19 25.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.255 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.77 -26.93 30.66 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.191 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.2 t -150.64 161.25 42.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.794 0.33 . . . . 0.0 110.617 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -25.5 61.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.253 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -58.69 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.079 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.53 -56.24 8.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.052 0.453 . . . . 0.0 110.62 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.652 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -49.16 -33.86 13.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.621 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.44 -30.92 65.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.319 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.633 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 7.2 tp60 -76.08 -50.45 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.267 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.501 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 12.1 t80 -49.08 -52.63 24.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.784 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -64.01 -31.38 72.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.827 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.45 -65.38 0.55 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.194 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.9 -47.77 79.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.945 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 1.02 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.7 tpt -48.77 -60.67 2.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.969 0.414 . . . . 0.0 110.576 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.65 -37.71 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.314 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -37.78 85.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.968 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.3 -53.7 40.03 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.876 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.02 HD21 ' HE3' ' A' ' 106' ' ' MET . 10.1 mt -63.65 -15.63 58.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.244 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -92.42 -27.0 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.547 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.96 1.48 45.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.24 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.809 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -113.2 -37.18 4.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.314 -179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -94.61 -28.79 15.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.829 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.503 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.0 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.754 0.311 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.663 HG11 ' NE2' ' A' ' 37' ' ' GLN . 41.9 t -89.78 151.37 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.461 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -103.59 -69.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.959 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 -178.47 4.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.875 0.369 . . . . 0.0 111.634 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.518 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 9.4 p -152.35 126.21 9.02 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.163 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 39.1 t -135.03 165.77 24.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.007 0.432 . . . . 0.0 111.609 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -106.51 121.38 44.18 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.804 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -166.77 175.6 7.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 111.129 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -114.84 95.43 5.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.32 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 26' ' ' ALA . 70.4 t -46.31 151.13 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.496 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -149.67 146.59 27.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.742 -179.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 4.0 mt -123.18 108.8 13.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.42 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.8 t80 -71.54 153.17 42.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.22 0.533 . . . . 0.0 111.959 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.83 88.58 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.23 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -53.34 -22.38 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.321 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.38 -34.9 69.4 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.621 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -132.77 13.99 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.666 0.27 . . . . 0.0 111.303 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER 51.02 83.75 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.819 0.342 . . . . 0.0 111.036 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 179.11 155.31 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.061 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.56 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 28.8 m95 -73.27 172.63 10.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.53 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.768 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -164.8 115.91 0.91 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.377 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.768 ' HD2' HD23 ' A' ' 24' ' ' LEU . 83.4 Cg_exo -41.01 94.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.802 2.335 . . . . 0.0 113.002 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.586 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -44.31 -44.03 7.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.679 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.56 -105.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.629 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.0 p -123.32 -79.38 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 111.022 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.78 -76.86 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.19 -178.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.617 2.211 . . . . 0.0 112.322 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.402 ' HA ' ' HE2' ' A' ' 53' ' ' LYS . 1.1 mt-30 -146.63 152.2 38.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.503 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . . . -178.93 44.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.107 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 52.17 -175.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.418 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' ALA . 93.5 p -174.32 150.88 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.007 0.432 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -93.79 95.51 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.461 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.828 HG22 ' HA3' ' A' ' 51' ' ' GLY . 20.0 t -94.02 117.42 37.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.288 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.663 ' NE2' HG11 ' A' ' 5' ' ' VAL . 50.3 mt-30 -109.2 155.94 20.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.379 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 106' ' ' MET . 62.0 mt -101.02 149.01 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.391 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -112.97 119.91 39.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.99 0.424 . . . . 0.0 110.96 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.497 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 10.7 t-160 -93.58 103.2 15.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.583 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -105.14 84.54 1.07 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.672 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 74.5 Cg_endo -74.97 -22.47 14.84 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.349 2.032 . . . . 0.0 112.432 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.5 p -51.66 -30.43 21.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.085 0.469 . . . . 0.0 110.487 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -129.32 7.39 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.139 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 61.35 48.83 5.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.138 0.494 . . . . 0.0 110.178 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.04 155.77 49.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.323 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.812 ' CE2' HD23 ' A' ' 113' ' ' LEU . 51.8 m-85 -124.42 178.14 5.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.623 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.1 ttm180 -167.38 157.3 10.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.059 0.456 . . . . 0.0 111.592 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.424 HG23 HG12 ' A' ' 62' ' ' ILE . 6.6 m -120.27 125.66 74.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.035 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.18 125.93 52.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.215 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.828 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -140.32 146.51 17.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.756 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -127.5 151.82 48.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.895 0.379 . . . . 0.0 111.146 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HD2' ' HB3' ' A' ' 32' ' ' ALA . 21.2 mmtp -55.58 158.88 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.8 mtp -98.81 45.39 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.569 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -130.44 163.24 49.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.706 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.01 -22.09 29.47 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 112.445 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -43.71 76.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.921 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 63.69 84.08 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -120.78 128.48 52.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.557 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 60' ' ' VAL . 5.8 m -70.96 120.09 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 0.0 110.631 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.554 HG23 HG21 ' A' ' 13' ' ' VAL . 3.1 m -93.67 -21.94 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.229 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.719 HD12 ' CE3' ' A' ' 89' ' ' TRP . 10.4 tt -138.67 139.7 40.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.376 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -165.34 69.13 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.025 0.44 . . . . 0.0 110.899 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 24.4 p -135.2 136.96 42.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -80.32 138.62 36.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.405 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -112.99 167.88 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 110.813 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 66' ' ' ILE . 21.4 m -156.5 -171.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.485 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.784 ' H ' HD12 ' A' ' 113' ' ' LEU . 9.6 ttt180 -60.3 83.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.287 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 67' ' ' VAL . . . -177.59 -32.7 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.571 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.859 HG13 ' HB2' ' A' ' 82' ' ' TRP . 3.2 t -82.43 133.31 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 117.342 0.571 . . . . 0.0 111.215 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.31 105.82 10.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.634 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.587 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.0 OUTLIER -53.88 104.4 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.284 -179.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -93.93 95.4 9.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.614 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.82 87.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.39 81.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.936 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 4.4 p -152.68 160.84 30.59 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.227 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 1.1 Cg_endo -43.28 -28.07 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.764 2.31 . . . . 0.0 112.377 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -128.74 57.76 1.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.76 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.0 t80 -166.47 113.19 0.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.149 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.887 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 2.7 m80 -111.21 101.99 10.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.043 0.449 . . . . 0.0 110.541 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.654 ' HG3' HG12 ' A' ' 88' ' ' VAL . 2.9 tt0 -108.41 156.42 19.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.036 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.859 ' HB2' HG13 ' A' ' 70' ' ' VAL . 46.7 p90 -156.4 151.82 26.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.347 0.594 . . . . 0.0 112.047 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.19 111.3 20.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.21 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 5.4 t0 -93.53 -90.92 0.19 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.353 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.02 -68.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.131 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -147.11 -4.01 0.55 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.669 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -105.34 179.98 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.342 . . . . 0.0 110.341 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.654 HG12 ' HG3' ' A' ' 81' ' ' GLN . 1.6 t -136.72 115.87 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.542 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.719 ' CE3' HD12 ' A' ' 62' ' ' ILE . 75.4 m95 -93.62 99.35 11.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.019 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.497 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -93.52 119.15 5.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.707 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.584 HD11 HG22 ' A' ' 13' ' ' VAL . 3.4 mm? -103.74 108.95 20.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.573 0.225 . . . . 0.0 111.506 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.42 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.83 107.68 19.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 110.108 178.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.804 ' CD1' ' HB2' ' A' ' 11' ' ' ALA . 66.9 m-85 -78.09 161.91 27.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.119 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.69 -28.52 9.46 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.383 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.8 m -135.66 163.21 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.321 . . . . 0.0 110.769 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -63.86 -32.93 74.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -64.73 -53.17 51.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -48.58 -62.1 1.68 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.914 0.387 . . . . 0.0 110.469 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -46.17 -38.92 8.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.49 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.12 -29.45 62.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.488 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.626 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 7.1 tp60 -75.9 -49.63 17.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.529 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 6.6 t80 -51.66 -53.45 38.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.887 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -61.94 -31.91 72.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 110.741 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.94 -66.69 0.37 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.061 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.08 -40.39 98.09 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.639 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.904 ' CE ' HD21 ' A' ' 110' ' ' LEU . 16.9 tpt -51.64 -58.54 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.97 0.414 . . . . 0.0 110.422 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.49 -37.92 5.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.905 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 t -64.98 -38.21 90.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.948 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -64.51 -53.19 51.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.908 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.904 HD21 ' CE ' ' A' ' 106' ' ' MET . 11.3 mt -65.46 -18.32 65.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.103 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -96.19 -21.37 17.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.712 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . . . -96.22 -3.43 44.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.348 0.594 . . . . 0.0 109.716 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.812 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -112.37 -27.94 8.09 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.252 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.477 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 41.3 mt-10 -87.94 -34.44 18.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.535 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.337 -1.257 . . . . 0.0 112.523 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.8 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.945 0.402 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 24.4 t -89.28 159.75 2.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.393 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.487 HG13 HG22 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -112.32 -67.53 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.585 ' SG ' HD12 ' A' ' 38' ' ' ILE . 13.4 p -119.93 178.68 4.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.891 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -157.79 112.21 2.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.586 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 8.4 t -128.68 159.39 35.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 112.056 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -103.15 123.83 47.44 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.206 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.603 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -168.17 -173.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 111.24 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.4 m -120.72 93.25 3.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.174 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.694 HG21 HG23 ' A' ' 61' ' ' VAL . 54.3 t -43.43 154.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.245 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.485 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -152.06 158.79 43.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.621 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.524 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 2.4 mt -137.44 108.08 6.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.53 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 9.4 t80 -68.23 154.1 42.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.319 0.581 . . . . 0.0 111.949 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.24 81.8 2.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.06 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -48.33 -25.81 1.75 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.466 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.6 -28.99 57.16 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.528 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -134.53 10.59 3.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.613 0.244 . . . . 0.0 111.325 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.86 81.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.926 0.393 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.447 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 177.67 159.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.913 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 25.3 m95 -75.92 171.67 14.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.611 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.677 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -163.19 119.12 1.18 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.541 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.677 ' HD2' HD23 ' A' ' 24' ' ' LEU . 92.8 Cg_exo -43.18 93.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.682 2.254 . . . . 0.0 112.951 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -44.92 -51.55 9.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.617 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -46.6 -96.4 0.01 OUTLIER Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.088 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.71 -82.79 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.297 . . . . 0.0 111.185 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.08 -94.3 0.87 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.562 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.3 166.19 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.541 2.16 . . . . 0.0 112.16 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 0.7 OUTLIER -144.8 165.56 27.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.203 0.525 . . . . 0.0 111.473 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 173.28 43.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.583 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 62.53 -176.26 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' ALA . 2.0 t -175.04 153.91 1.72 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.741 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.68 96.83 10.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.82 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.9 t -97.43 122.7 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.066 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.499 ' NE2' HG11 ' A' ' 5' ' ' VAL . 15.9 mt-30 -114.02 172.22 7.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.384 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.585 HD12 ' SG ' ' A' ' 7' ' ' CYS . 68.7 mt -116.87 156.37 18.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.165 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.538 ' CE1' HG21 ' A' ' 50' ' ' VAL . 7.6 m-85 -114.75 120.12 38.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.0 111.466 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.481 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 12.9 t60 -93.71 86.62 5.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.74 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.81 96.83 7.06 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.843 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 74.3 Cg_endo -84.53 -23.18 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.54 2.16 . . . . 0.0 112.624 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.4 t -47.85 -30.6 4.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.946 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.85 -5.22 9.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.399 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.05 43.01 0.7 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.089 0.471 . . . . 0.0 110.207 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.51 171.91 13.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.817 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.478 ' CD1' HD11 ' A' ' 6' ' ' ILE . 65.0 m-85 -134.45 177.99 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.862 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -163.12 149.51 12.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.129 0.49 . . . . 0.0 111.63 -179.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.653 HG13 HG12 ' A' ' 62' ' ' ILE . 3.9 p -109.09 135.01 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.098 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.538 HG21 ' CE1' ' A' ' 39' ' ' TYR . 2.1 t -140.3 121.52 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.736 0.303 . . . . 0.0 111.306 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.82 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -143.62 147.45 18.79 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.85 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -132.47 150.78 52.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.757 0.313 . . . . 0.0 110.87 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.567 ' NZ ' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -58.46 163.44 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 17.1 mtp -106.71 46.76 0.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.414 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 7.7 pt20 -126.91 160.88 56.84 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.784 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 87.8 Cg_exo -47.55 -26.45 6.38 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.753 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.89 -44.98 68.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.829 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.91 93.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -134.38 136.86 43.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 60' ' ' VAL . 16.7 m -70.82 121.8 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.368 . . . . 0.0 110.863 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.694 HG23 HG21 ' A' ' 13' ' ' VAL . 3.9 m -93.75 -24.39 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.653 HG12 HG13 ' A' ' 49' ' ' VAL . 9.6 tt -138.28 135.28 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.471 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -161.9 71.88 0.37 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.917 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 18.0 t -136.81 144.9 43.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.037 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -83.82 130.91 34.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.48 ' O ' HD11 ' A' ' 113' ' ' LEU . 1.5 pt -102.72 117.0 47.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.869 0.366 . . . . 0.0 111.193 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.637 ' C ' HD13 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -106.43 165.95 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.521 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.675 ' H ' HD22 ' A' ' 113' ' ' LEU . 60.5 ttp85 -44.02 100.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.106 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.15 -23.52 0.21 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.087 -1.054 . . . . 0.0 113.847 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.56 HG11 ' CD1' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -100.09 123.54 53.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 117.617 0.709 . . . . 0.0 111.162 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.797 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -121.05 134.93 55.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.824 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.54 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.9 m-30 -67.6 126.75 30.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -95.09 -33.05 12.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 58.63 78.9 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.804 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.72 75.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.311 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 6.0 p -139.61 166.61 22.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.716 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 76.3 Cg_exo -51.02 -24.41 14.14 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.44 2.093 . . . . 0.0 112.368 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.71 33.09 5.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -148.43 125.22 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.959 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.775 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 13.3 m-70 -125.22 98.71 5.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.295 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -112.76 146.59 38.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.768 -178.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.592 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 26.2 p90 -144.07 144.06 31.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.796 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.569 ' HG2' HG22 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -86.39 103.11 14.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.712 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.94 130.6 53.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 60.46 -82.57 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.725 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.44 -30.03 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.302 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -93.75 -168.89 1.98 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.884 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' A' ' 83' ' ' ARG . 2.4 t -137.07 129.68 43.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.977 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.598 ' CE3' HD12 ' A' ' 62' ' ' ILE . 74.2 m95 -97.61 100.89 12.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.182 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.46 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -94.44 130.87 10.48 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.566 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 11' ' ' ALA . 3.0 mm? -114.92 111.54 21.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.808 0.337 . . . . 0.0 111.857 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.481 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -92.89 110.75 22.21 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.647 ' CD1' ' HB2' ' A' ' 99' ' ' ALA . 36.5 m-85 -86.69 159.79 19.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.331 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.66 -27.7 49.96 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.348 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 p -149.06 178.71 8.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.815 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -29.0 63.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.33 -56.87 12.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.999 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -52.21 -55.81 18.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.647 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -57.16 -28.15 62.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.276 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.85 63.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 18.5 tp60 -76.39 -42.45 44.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.029 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 5.9 t80 -54.28 -48.42 71.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.775 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -65.47 -34.57 78.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.871 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.88 -65.5 0.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.53 -50.5 61.54 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.957 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.84 ' CE ' HD21 ' A' ' 110' ' ' LEU . 11.7 tpt -47.72 -60.98 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 110.661 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.57 -33.63 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.343 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -33.88 69.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.079 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 106' ' ' MET . . . -68.56 -42.26 78.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.524 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.84 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -75.51 -29.48 59.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.063 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -75.32 -25.42 57.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.36 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.14 -3.72 27.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.513 0.673 . . . . 0.0 109.481 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 68' ' ' ARG . 4.2 mt -90.05 -42.56 11.05 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.131 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.76 -33.84 11.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.68 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.403 -1.22 . . . . 0.0 112.492 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.458 -0.035 0 CA-C-O 120.856 0.36 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.637 HG11 ' NE2' ' A' ' 37' ' ' GLN . 29.4 t -76.54 151.15 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.48 HG13 HG22 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -107.45 -68.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 38' ' ' ILE . 24.2 p -115.33 176.98 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.55 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.62 113.21 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.87 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 42.2 t -129.67 152.76 48.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.018 0.437 . . . . 0.0 111.879 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -95.13 130.63 41.76 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.031 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -176.29 161.14 2.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 0.0 111.688 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.2 m -93.76 83.93 4.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.741 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.677 HG12 ' HB3' ' A' ' 26' ' ' ALA . 88.0 t -40.12 140.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.311 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.544 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -129.62 179.08 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.361 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 88' ' ' VAL . 5.8 tp -160.64 113.78 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 0.0 110.225 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 8.7 t80 -73.53 149.3 42.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.392 0.615 . . . . 0.0 112.565 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.62 87.21 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.931 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -49.11 -23.53 1.27 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.618 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.64 -48.67 42.62 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.771 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -123.69 16.3 9.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.65 0.262 . . . . 0.0 111.164 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 1.1 mtmm 52.06 87.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 111.17 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.1 OUTLIER 178.01 161.91 0.59 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.036 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.546 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 20.5 m95 -80.91 171.14 15.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.566 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.485 HD23 ' HD2' ' A' ' 25' ' ' PRO . 4.6 mt -167.17 125.59 1.03 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.541 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.485 ' HD2' HD23 ' A' ' 24' ' ' LEU . 89.3 Cg_exo -43.83 102.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.587 2.191 . . . . 0.0 112.622 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.677 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -50.01 -38.47 37.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.384 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.81 -119.96 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.705 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.58 -68.04 0.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.852 0.358 . . . . 0.0 111.27 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.5 -72.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.769 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -47.95 167.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -145.53 56.62 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.026 0.441 . . . . 0.0 111.279 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.65 50.64 1.61 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.281 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 59.95 -176.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.433 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.92 142.64 2.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -93.85 94.34 8.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.055 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.779 HG22 ' HA3' ' A' ' 51' ' ' GLY . 39.2 t -93.85 146.14 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.342 0.591 . . . . 0.0 112.011 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.637 ' NE2' HG11 ' A' ' 5' ' ' VAL . 17.3 mt-30 -138.18 170.19 16.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.56 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 106' ' ' MET . 90.9 mt -112.06 153.9 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.301 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.517 ' CE1' HG21 ' A' ' 50' ' ' VAL . 3.5 m-85 -112.12 119.05 37.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.905 0.383 . . . . 0.0 111.785 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.514 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 23.2 t-160 -93.72 92.23 7.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.676 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -101.81 87.03 0.91 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.722 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 73.4 Cg_endo -74.32 -21.51 17.43 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.293 1.995 . . . . 0.0 112.465 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -48.85 -29.28 4.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.041 0.448 . . . . 0.0 110.568 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.87 8.29 4.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.231 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.468 ' O ' HD21 ' A' ' 113' ' ' LEU . 0.1 OUTLIER 59.71 49.2 8.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.207 0.527 . . . . 0.0 109.9 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.46 ' HA ' HG12 ' A' ' 67' ' ' VAL . 5.7 t -129.45 163.82 25.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.335 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.727 ' CE2' HD23 ' A' ' 113' ' ' LEU . 51.6 m-85 -133.5 169.14 17.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.656 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 2.0 ttm180 -165.1 148.61 8.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.738 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.606 HG23 HG12 ' A' ' 62' ' ' ILE . 7.0 m -104.79 129.34 57.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.489 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.517 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -135.27 123.66 39.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.779 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -146.46 146.24 16.03 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.862 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -126.49 158.64 35.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 172.92 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.815 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.449 ' HE2' ' HB2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -108.51 47.52 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -128.27 158.13 72.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.12 -27.86 18.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.641 2.227 . . . . 0.0 112.454 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -42.24 85.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 60.19 99.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -135.98 132.71 36.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.761 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.4 m -70.42 120.94 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.045 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.641 ' CG2' HG21 ' A' ' 13' ' ' VAL . 5.9 m -93.84 -21.92 5.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.235 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.606 HG12 HG23 ' A' ' 49' ' ' VAL . 9.9 tt -138.04 134.05 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.479 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -160.16 63.67 0.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.943 0.402 . . . . 0.0 110.86 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.1 t -124.62 139.99 53.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.967 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -87.02 150.38 24.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.349 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.471 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -130.46 141.47 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 46' ' ' SER . 15.2 m -152.35 110.89 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.665 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.581 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 26.62 47.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.33 179.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.12 -27.7 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.177 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.843 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.6 t -100.14 138.88 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 111.338 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -126.35 110.61 13.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.569 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CE2' ' HG2' ' A' ' 106' ' ' MET . 1.5 m-30 -51.02 132.67 27.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.412 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.88 97.49 5.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.79 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.09 104.23 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.92 -34.66 64.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.022 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.4 p -150.28 174.36 3.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.524 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 65.3 Cg_exo -51.78 -24.54 18.52 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.382 2.055 . . . . 0.0 112.354 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -140.37 69.95 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.961 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -173.67 128.27 0.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.737 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 32.1 m170 -117.04 146.89 42.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.714 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -154.91 138.25 15.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.984 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.843 ' HB2' HG13 ' A' ' 70' ' ' VAL . 15.5 p90 -145.96 142.05 28.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.145 0.498 . . . . 0.0 111.935 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.406 ' HD3' HG22 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -104.32 111.32 23.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.209 178.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.413 ' HB2' HG21 ' A' ' 70' ' ' VAL . 14.8 t70 -93.78 -93.43 0.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.608 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.18 -70.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.981 0.42 . . . . 0.0 111.402 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.01 -7.18 1.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.63 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 -168.86 1.43 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 110.621 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.714 HG12 ' HG2' ' A' ' 81' ' ' GLN . 0.9 OUTLIER -143.04 120.15 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.048 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.605 ' CZ3' ' HB1' ' A' ' 26' ' ' ALA . 59.1 m95 -92.69 105.76 17.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.249 0.547 . . . . 0.0 110.74 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.546 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -106.95 174.36 19.88 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.664 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' ' 80' ' ' HIS . 1.1 pt? -177.69 139.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.194 0.521 . . . . 0.0 111.54 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.406 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -103.19 121.37 42.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.404 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 53.4 m-85 -85.46 160.25 19.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.117 0.484 . . . . 0.0 111.785 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.55 -27.51 63.16 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.31 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.63 169.97 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 110.775 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -26.01 65.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.15 -49.21 62.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.6 -55.58 32.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.072 0.463 . . . . 0.0 110.056 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.694 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -56.31 -29.17 60.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.367 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -31.22 64.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.384 . . . . 0.0 111.174 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 31.2 tp60 -78.47 -43.41 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.144 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 5.1 t80 -54.41 -45.94 73.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.206 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.737 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -72.22 -29.31 63.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.69 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -47.28 -64.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.074 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.43 -49.17 58.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.995 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 1.059 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.3 tpt -49.19 -60.74 2.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.393 . . . . 0.0 110.611 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.95 -37.4 3.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.313 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -36.67 79.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.031 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.619 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.13 -51.95 58.14 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.679 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.059 HD21 ' HE3' ' A' ' 106' ' ' MET . 6.8 mt -63.59 -18.07 63.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.873 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -94.85 -25.59 16.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.567 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.46 1.3 51.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.307 0.575 . . . . 0.0 110.083 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.727 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -112.42 -33.54 6.15 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.213 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -87.18 -32.77 19.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.322 -1.266 . . . . 0.0 112.434 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.4 m . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.81 0.338 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.727 HG11 ' NE2' ' A' ' 37' ' ' GLN . 44.0 t -60.66 146.66 10.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.658 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.521 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -98.23 -68.98 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.826 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -132.78 -175.41 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.505 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.51 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 14.9 p -153.36 118.11 5.02 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.199 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 7.2 p -120.26 159.98 23.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.121 0.486 . . . . 0.0 111.876 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -107.16 118.77 37.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.564 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -167.69 -171.88 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.09 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 92' ' ' ASN . 3.4 m -123.52 90.62 3.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.16 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.564 HG21 HG23 ' A' ' 61' ' ' VAL . 69.5 t -42.26 148.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.065 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.509 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -143.65 163.8 32.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.065 -178.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.534 HD21 ' CE2' ' A' ' 89' ' ' TRP . 5.1 mt -136.58 112.0 9.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.454 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.6 t80 -75.93 147.39 38.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.244 0.545 . . . . 0.0 111.934 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.8 89.79 3.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.15 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -52.79 -21.65 4.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.85 -50.76 48.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.62 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -125.08 18.23 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.677 0.275 . . . . 0.0 111.141 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 7.9 mtpt 51.49 91.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.155 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 177.89 151.92 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.585 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 20.6 m95 -76.22 167.94 20.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.565 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.7 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.6 mt -160.33 129.7 3.24 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.532 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.7 ' HD2' HD23 ' A' ' 24' ' ' LEU . 87.8 Cg_exo -47.73 94.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.554 2.17 . . . . 0.0 112.903 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.536 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -46.07 -42.94 14.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.464 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.32 -110.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.82 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 t -126.85 -52.82 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 111.253 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.44 -82.68 0.04 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.693 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -47.7 168.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.576 2.184 . . . . 0.0 112.364 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 5.1 mt-30 -142.11 154.28 44.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.165 0.507 . . . . 0.0 111.322 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 175.57 44.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.954 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 56.71 175.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.618 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 11' ' ' ALA . 27.2 m -166.5 152.35 8.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.636 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -93.79 97.63 10.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.705 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.658 HG22 ' HA3' ' A' ' 51' ' ' GLY . 24.1 t -93.74 122.11 44.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.294 0.568 . . . . 0.0 112.092 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.727 ' NE2' HG11 ' A' ' 5' ' ' VAL . 47.1 mt-30 -116.2 154.82 29.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.763 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 106' ' ' MET . 41.8 mt -103.36 151.0 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.61 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.28 122.48 47.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.047 0.451 . . . . 0.0 111.525 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.49 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 16.6 t-160 -101.13 91.33 4.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.113 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -101.55 88.51 1.19 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.508 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 63.0 Cg_endo -72.43 -19.55 24.99 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.34 2.027 . . . . 0.0 112.554 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.3 m -52.01 -26.66 11.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.664 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.44 8.56 5.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.84 49.32 14.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.042 0.449 . . . . 0.0 110.266 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.526 ' HA ' HG12 ' A' ' 67' ' ' VAL . 71.4 m -136.22 165.4 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.29 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.773 ' CE2' HD23 ' A' ' 113' ' ' LEU . 56.9 m-85 -134.32 173.24 11.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.609 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.649 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 7.2 ttp180 -165.8 150.78 8.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.421 . . . . 0.0 111.56 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.674 HG13 HG12 ' A' ' 62' ' ' ILE . 5.8 p -106.71 135.55 44.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.239 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.91 118.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.974 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.658 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -138.3 143.56 14.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.934 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -126.09 148.91 49.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.749 0.309 . . . . 0.0 110.802 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -57.57 168.89 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -108.2 45.37 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -128.25 161.67 55.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.61 -31.03 23.49 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.668 2.246 . . . . 0.0 112.642 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -45.85 90.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.04 91.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.876 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -131.3 136.08 47.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.668 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 60' ' ' VAL . 13.2 m -72.71 122.01 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.735 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.564 HG23 HG21 ' A' ' 13' ' ' VAL . 3.3 m -93.71 -20.58 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.24 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.674 HG12 HG13 ' A' ' 49' ' ' VAL . 8.8 tt -140.59 138.79 35.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.626 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -163.38 69.44 0.21 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.689 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.408 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -131.56 135.03 46.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.889 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.649 ' HB2' ' HD3' ' A' ' 48' ' ' ARG . . . -78.02 141.11 39.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.593 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.539 HD13 ' SD ' ' A' ' 106' ' ' MET . 0.9 OUTLIER -120.87 124.76 73.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.781 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 46' ' ' SER . 16.1 m -138.59 110.06 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.904 0.383 . . . . 0.0 111.579 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.761 ' N ' HD12 ' A' ' 113' ' ' LEU . 1.1 ttt180 29.62 73.47 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.997 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.67 -36.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 119.76 -1.21 . . . . 0.0 113.612 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.818 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.8 t -87.95 139.1 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.032 0.444 . . . . 0.0 111.519 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.16 97.88 5.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.168 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.7 m-30 -43.99 115.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.713 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -111.46 93.0 4.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.878 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.32 92.44 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.035 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.7 90.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.979 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.519 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 2.7 p -134.57 159.23 73.0 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.335 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 1.2 Cg_endo -44.06 -27.48 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.881 2.388 . . . . 0.0 112.561 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -123.8 47.63 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 111.082 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.406 ' HB2' ' OG1' ' A' ' 76' ' ' THR . 1.5 t80 -155.24 141.71 18.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.955 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.68 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 15.6 m-70 -136.34 93.42 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.468 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 1.2 tm0? -104.19 140.58 37.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.213 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.818 ' HB2' HG13 ' A' ' 70' ' ' VAL . 48.7 p90 -143.07 147.28 34.79 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.144 0.497 . . . . 0.0 111.684 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.563 ' HG3' HG22 ' A' ' 88' ' ' VAL . 3.8 ttm180 -106.99 113.02 26.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.335 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.452 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 4.4 t70 -93.69 -91.05 0.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.78 -67.92 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 111.36 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -141.63 -8.08 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.512 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.54 -175.41 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.617 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' A' ' 83' ' ' ARG . 2.0 t -138.22 130.21 38.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.493 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.657 ' CE3' HD12 ' A' ' 62' ' ' ILE . 61.1 m95 -105.14 99.48 9.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.547 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -90.78 125.92 8.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.773 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.636 HD23 ' CH2' ' A' ' 82' ' ' TRP . 3.4 mm? -107.08 109.8 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.511 0.196 . . . . 0.0 111.43 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.508 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -92.58 109.42 20.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.404 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 11' ' ' ALA . 14.7 m-85 -89.66 164.62 14.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.146 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.23 -40.74 5.39 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.555 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 162.33 25.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -31.13 70.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.946 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.37 -46.82 78.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -55.41 -58.86 6.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.961 0.41 . . . . 0.0 110.719 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.445 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -55.93 -34.15 65.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.083 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.41 -39.99 62.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.635 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 7.3 tp60 -67.12 -43.24 82.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.684 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.539 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 9.4 t80 -53.25 -51.87 60.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.904 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.68 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -65.1 -26.22 68.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.685 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -49.94 -62.92 1.29 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.898 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.57 -50.26 50.3 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.929 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 1.029 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.8 tpt -49.71 -60.96 2.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.943 0.401 . . . . 0.0 110.515 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.55 -36.78 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.139 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -41.47 91.0 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.674 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -61.05 -56.17 24.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.312 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.029 HD21 ' HE3' ' A' ' 106' ' ' MET . 8.0 mt -59.87 -20.48 57.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.946 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.54 -22.8 22.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.34 1.32 38.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.99 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.773 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -116.43 -32.7 5.17 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.131 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.453 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 21.0 mt-10 -105.34 -28.94 10.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.694 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.542 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.2 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.715 0.293 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 22.0 t -57.62 148.08 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.481 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -101.32 -67.66 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.775 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.51 -176.76 4.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.778 0.323 . . . . 0.0 111.558 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.446 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -152.45 124.23 7.91 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.186 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.475 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 13.3 t -133.72 149.17 51.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.794 0.33 . . . . 0.0 111.606 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 8.4 ttm105 -93.88 127.34 39.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.985 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.612 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -169.21 -176.2 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.925 0.393 . . . . 0.0 111.38 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -118.4 92.39 3.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.435 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.587 HG22 HD11 ' A' ' 91' ' ' LEU . 53.4 t -44.59 154.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 0.0 111.108 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.2 OUTLIER -152.77 143.42 22.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.978 -179.163 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.58 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 5.1 mt -120.67 114.4 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.311 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.2 t80 -72.43 151.74 42.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 111.738 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.74 86.66 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.305 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -52.1 -23.49 5.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.411 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.06 -42.07 86.57 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.285 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -126.98 15.62 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 110.82 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER 47.19 83.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.092 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.96 150.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.807 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.537 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 14.4 m95 -69.37 169.0 13.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.541 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.2 mt -165.44 114.17 0.82 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.508 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HD2' HD23 ' A' ' 24' ' ' LEU . 86.4 Cg_exo -41.7 100.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.695 2.263 . . . . 0.0 112.789 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.58 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -45.14 -43.97 10.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.536 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.99 -85.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.595 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.46 -80.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.744 0.307 . . . . 0.0 111.069 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -129.78 -70.0 0.12 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.543 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.42 170.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.554 2.169 . . . . 0.0 112.366 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -148.72 63.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.022 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.22 48.12 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 56.22 -178.03 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.707 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' ALA . 7.4 t -170.36 146.58 2.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.858 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -93.8 97.54 10.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.415 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.86 HG22 ' HA3' ' A' ' 51' ' ' GLY . 36.3 t -98.12 124.32 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.413 0.625 . . . . 0.0 112.022 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 55.5 mt-30 -115.06 160.59 19.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.419 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.538 HD13 ' HA ' ' A' ' 106' ' ' MET . 51.4 mt -108.51 147.45 13.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.32 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.7 m-85 -108.43 118.22 36.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.0 0.429 . . . . 0.0 111.081 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.536 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 t-160 -93.78 87.9 5.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.798 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.27 98.34 5.6 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.538 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 68.4 Cg_endo -85.32 -22.43 2.65 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.366 2.044 . . . . 0.0 112.598 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.9 p -48.28 -30.69 5.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.951 0.405 . . . . 0.0 110.61 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.59 4.5 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.244 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.88 48.59 5.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.237 0.541 . . . . 0.0 110.077 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 m -132.9 152.05 51.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.212 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.865 ' CE2' HD23 ' A' ' 113' ' ' LEU . 52.3 m-85 -120.82 163.53 18.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 31.6 mtt180 -147.54 149.61 32.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.152 0.501 . . . . 0.0 111.916 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.458 HG23 HG12 ' A' ' 62' ' ' ILE . 5.4 m -113.0 120.6 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.362 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.5 t -128.82 120.77 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 0.0 111.617 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.86 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -141.92 149.82 21.49 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.596 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 157.56 46.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 0.0 110.944 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HD3' HG11 ' A' ' 61' ' ' VAL . 21.4 mmtt -68.85 159.15 33.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.7 mtt -101.88 47.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -119.66 162.11 34.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.867 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.88 -26.02 17.12 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.555 2.17 . . . . 0.0 112.435 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.32 -42.47 59.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 60.55 99.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.808 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -137.92 137.57 38.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 60' ' ' VAL . 20.6 m -71.65 121.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.949 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.433 HG23 HG21 ' A' ' 13' ' ' VAL . 3.2 m -93.69 -21.34 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.005 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.757 HD12 ' CE3' ' A' ' 89' ' ' TRP . 16.8 tt -140.38 135.57 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.527 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -159.36 60.17 0.39 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.937 0.399 . . . . 0.0 110.907 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.6 167.91 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -111.84 128.97 56.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.235 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.75 143.56 18.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.07 0.462 . . . . 0.0 111.22 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.97 -170.01 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.336 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.757 ' H ' HD12 ' A' ' 113' ' ' LEU . 4.9 ttt-85 -56.12 92.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.474 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.72 -26.8 0.13 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.928 -1.129 . . . . 0.0 113.758 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.603 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.2 t -94.84 122.62 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 117.412 0.606 . . . . 0.0 111.255 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.799 ' HA ' HD13 ' A' ' 110' ' ' LEU . 20.7 tptm -126.07 117.33 22.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.721 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.559 ' OH ' ' CE2' ' A' ' 102' ' ' PHE . 1.8 m-30 -50.46 127.07 16.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.018 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.77 -29.41 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.105 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.67 77.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 110.682 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -54.5 -39.76 67.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.264 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.7 p -150.85 173.51 4.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.431 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 78.4 Cg_exo -50.74 -24.85 13.96 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.384 2.056 . . . . 0.0 112.274 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -132.12 52.15 2.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.789 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.2 t80 -160.32 104.11 1.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.235 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.957 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 4.3 m80 -102.58 104.96 15.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.004 0.431 . . . . 0.0 110.824 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -115.99 144.1 44.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.159 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.629 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 27.4 p90 -143.51 147.48 34.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.115 0.484 . . . . 0.0 111.743 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -109.3 112.64 24.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.987 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.504 ' HB2' HG21 ' A' ' 70' ' ' VAL . 16.8 t70 -93.67 -96.32 0.15 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.807 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.94 -70.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.936 0.398 . . . . 0.0 111.362 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -137.64 -9.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.696 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -110.18 173.2 6.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.065 0.46 . . . . 0.0 110.923 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.445 HG12 ' HG2' ' A' ' 81' ' ' GLN . 3.4 t -129.04 130.46 68.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.271 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.757 ' CE3' HD12 ' A' ' 62' ' ' ILE . 71.0 m95 -105.39 97.27 7.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.31 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.537 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -91.16 122.63 6.79 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.383 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.587 HD11 HG22 ' A' ' 13' ' ' VAL . 2.5 mm? -106.01 111.57 24.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.826 -0.22 . . . . 0.0 111.489 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.66 103.25 15.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.333 0.587 . . . . 0.0 109.736 178.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.612 ' CD1' ' HB2' ' A' ' 11' ' ' ALA . 76.5 m-85 -72.85 154.17 40.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.95 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.89 -28.05 12.87 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.297 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 m -133.21 164.06 27.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.753 0.311 . . . . 0.0 110.797 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -29.78 70.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.019 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.79 -52.28 31.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.008 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -49.53 -57.25 7.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.421 . . . . 0.0 110.64 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -52.11 -41.83 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.546 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.29 -31.49 67.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.64 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.8 tp60 -75.28 -47.59 27.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.239 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.559 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 3.3 t80 -51.54 -52.27 48.42 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.957 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -61.4 -32.49 72.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.91 0.386 . . . . 0.0 110.628 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.3 -66.13 0.44 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.189 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.13 -45.59 70.64 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.762 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.898 ' CE ' HD21 ' A' ' 110' ' ' LEU . 12.6 tpt -47.97 -60.62 2.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.908 0.385 . . . . 0.0 110.413 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.67 -36.43 11.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.004 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 t -64.82 -34.17 77.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.11 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.552 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -70.39 -51.25 31.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.589 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.898 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.7 OUTLIER -63.79 -18.14 63.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.183 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -98.52 -20.79 16.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.927 0.394 . . . . 0.0 111.88 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.75 -0.67 44.95 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.017 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.865 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -116.37 -32.79 5.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.315 -179.537 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 5.0 mt-10 -94.45 -28.07 15.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.53 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.3 m . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.813 0.34 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.591 HG11 ' NE2' ' A' ' 37' ' ' GLN . 65.2 t -88.7 158.6 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.477 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.625 HG13 HG22 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -112.82 -60.4 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.831 0.348 . . . . 0.0 111.931 -179.144 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 38' ' ' ILE . 10.0 p -129.34 177.32 7.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.798 -178.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.436 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.5 OUTLIER -157.98 110.55 2.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.638 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 102' ' ' PHE . 4.6 m -128.69 163.55 24.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.208 0.528 . . . . 0.0 112.206 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.3 ttt85 -105.67 127.7 53.22 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.81 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.863 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -169.85 -177.73 2.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 111.049 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -114.89 89.35 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.353 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.673 HG11 ' HB ' ' A' ' 62' ' ' ILE . 97.8 t -45.56 137.19 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.159 0.504 . . . . 0.0 111.077 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.506 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -136.24 161.24 36.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.789 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 26' ' ' ALA . 5.0 mt -134.18 110.49 9.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.55 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.514 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.4 t80 -73.51 147.16 44.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.083 0.468 . . . . 0.0 111.672 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.67 88.04 2.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.356 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.45 -23.2 9.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.91 -36.18 72.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.545 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -133.83 13.44 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.664 0.269 . . . . 0.0 111.287 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 51.25 86.74 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.02 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.54 145.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.169 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.0 m95 -68.71 167.24 15.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.157 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.475 HD23 ' HD2' ' A' ' 25' ' ' PRO . 4.7 mt -161.3 131.55 3.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.689 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HD2' HD23 ' A' ' 24' ' ' LEU . 83.5 Cg_exo -45.85 92.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.643 2.228 . . . . 0.0 112.959 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.591 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -42.55 -66.66 0.34 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.772 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.61 -95.62 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.263 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.6 p -130.82 -85.03 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.657 0.265 . . . . 0.0 111.325 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.29 -88.38 0.35 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.708 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.32 161.95 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.616 2.211 . . . . 0.0 112.287 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -136.86 168.03 20.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.172 0.51 . . . . 0.0 111.594 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 166.96 44.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.626 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 62.41 -176.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.297 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -173.99 165.15 4.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.554 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 5.1 tmm_? -107.87 94.31 5.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.962 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.806 HG22 ' HA3' ' A' ' 51' ' ' GLY . 35.7 t -93.78 125.52 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.309 0.576 . . . . 0.0 111.908 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.591 ' NE2' HG11 ' A' ' 5' ' ' VAL . 48.8 mt-30 -119.02 155.29 31.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.884 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.625 HG22 HG13 ' A' ' 6' ' ' ILE . 72.4 mt -104.81 149.25 8.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.488 ' HB2' ' HG2' ' A' ' 48' ' ' ARG . 16.9 m-85 -115.37 126.01 53.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.061 0.458 . . . . 0.0 111.366 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.465 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.5 t-160 -93.76 98.46 11.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.168 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -102.46 89.52 1.77 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 72.2 Cg_endo -74.98 -20.61 16.74 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.22 1.947 . . . . 0.0 112.454 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -48.4 -31.21 5.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.068 0.461 . . . . 0.0 110.587 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.97 6.93 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.224 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.98 48.17 5.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.045 0.45 . . . . 0.0 110.005 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.7 t -129.79 179.66 5.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.642 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.488 ' CG ' ' HB1' ' A' ' 109' ' ' ALA . 81.9 m-85 -149.56 166.52 28.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.525 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -160.38 152.59 20.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.0 0.429 . . . . 0.0 111.539 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 62' ' ' ILE . 8.1 m -107.04 128.62 61.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 2.2 t -132.41 118.31 35.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.976 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.806 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -138.82 147.13 19.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.072 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -128.66 157.82 40.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.695 0.283 . . . . 0.0 110.52 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.566 ' HD2' HG11 ' A' ' 61' ' ' VAL . 1.5 tptt -73.38 161.9 29.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.946 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.554 ' HE2' ' HB2' ' A' ' 35' ' ' ARG . 1.1 mmt -98.33 42.82 1.08 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -96.99 163.36 20.21 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.983 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.74 -18.42 33.69 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.212 1.941 . . . . 0.0 111.371 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.39 -36.39 8.45 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.671 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 62.66 125.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.051 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -145.39 137.11 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.639 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 60' ' ' VAL . 18.0 m -65.97 119.49 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.414 . . . . 0.0 111.224 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.566 HG11 ' HD2' ' A' ' 53' ' ' LYS . 3.8 m -93.88 -27.31 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.673 ' HB ' HG11 ' A' ' 13' ' ' VAL . 15.5 tt -138.19 132.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.559 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -159.51 67.38 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.399 . . . . 0.0 110.807 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.2 t -126.08 161.53 27.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.796 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -104.19 148.3 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.613 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.558 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -119.74 142.92 32.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.832 179.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 67' ' ' VAL . 17.6 m -146.96 112.21 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.489 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.515 ' H ' HD13 ' A' ' 113' ' ' LEU . 1.0 OUTLIER 22.22 76.19 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.336 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.74 -33.26 0.06 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 119.643 -1.265 . . . . 0.0 114.12 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -93.64 125.37 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.386 0.593 . . . . 0.0 111.568 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 147.5 32.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.081 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.578 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.7 OUTLIER -86.14 104.14 15.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 0.0 111.238 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.04 98.06 10.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.629 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.54 83.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.047 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.12 -28.57 40.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 0.0 110.85 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.504 HG22 ' HB3' ' A' ' 79' ' ' PHE . 3.8 t -166.01 150.63 7.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.086 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 56.3 Cg_exo -37.63 -29.25 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.048 2.499 . . . . 0.0 113.589 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -121.49 50.34 1.41 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.769 0.319 . . . . 0.0 111.547 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.504 ' HB3' HG22 ' A' ' 76' ' ' THR . 7.2 t80 -170.0 127.51 0.87 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 111.424 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.946 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -118.02 111.83 19.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.287 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.516 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.5 tm0? -119.15 131.22 55.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.554 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.692 ' CH2' HD23 ' A' ' 91' ' ' LEU . 43.8 p90 -138.07 142.25 40.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.207 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.423 ' O ' HG22 ' A' ' 70' ' ' VAL . 10.2 ttm180 -88.22 105.81 17.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.457 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 32.0 t70 -105.04 130.02 53.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.734 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 61.93 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.466 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -136.33 -31.29 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.419 ' HG3' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -93.88 -168.86 1.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.961 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.516 HG12 ' HG2' ' A' ' 81' ' ' GLN . 2.1 t -137.87 124.86 28.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.651 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.49 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 78.5 m95 -93.78 98.83 11.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.522 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.829 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -80.6 161.91 44.88 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.031 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.863 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -148.22 106.99 3.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.474 0.178 . . . . 0.0 110.95 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.41 104.76 17.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.225 0.536 . . . . 0.0 110.016 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.669 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 78.7 m-85 -71.56 162.85 28.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.928 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.33 -26.2 5.51 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.258 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.47 159.8 40.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.879 0.371 . . . . 0.0 110.802 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -60.97 -40.36 93.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.03 -44.24 97.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.104 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -51.76 -68.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.011 0.434 . . . . 0.0 110.474 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.669 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -47.2 -31.47 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.687 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.51 -36.42 57.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.787 0.327 . . . . 0.0 111.38 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.0 tp60 -77.65 -41.25 38.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.203 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.477 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 7.8 t80 -56.31 -50.78 70.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.014 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.946 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -65.46 -32.71 74.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.443 . . . . 0.0 110.867 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -47.03 -64.74 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.511 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.9 -51.87 49.86 Favored Glycine 0 CA--C 1.508 -0.354 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.159 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.941 ' CE ' HD21 ' A' ' 110' ' ' LEU . 12.2 tpt -46.68 -62.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.48 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.57 -33.27 2.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.451 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.38 -35.44 73.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.087 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.488 ' HB1' ' CG ' ' A' ' 47' ' ' PHE . . . -70.7 -46.35 63.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.721 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.941 HD21 ' CE ' ' A' ' 106' ' ' MET . 5.0 mt -67.68 -34.26 76.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.722 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -75.69 -20.38 58.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.19 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.17 2.68 29.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.601 0.715 . . . . 0.0 109.095 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.515 HD13 ' H ' ' A' ' 68' ' ' ARG . 6.9 mt -100.21 -38.37 8.53 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.954 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -105.36 -30.68 9.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.66 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.427 -1.207 . . . . 0.0 112.534 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 CA--C 1.527 0.062 0 CA-C-O 120.847 0.356 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 39' ' ' TYR . 52.4 t -84.56 158.33 3.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.559 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.488 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -103.59 -68.32 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.71 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 -170.65 2.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.353 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.51 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.4 OUTLIER -156.76 122.54 4.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.201 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.498 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 1.5 p -128.83 153.56 47.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 111.751 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -97.84 127.43 43.78 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.707 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.821 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -171.44 -175.09 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 111.4 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -117.3 95.47 4.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.427 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.686 HG21 HG23 ' A' ' 61' ' ' VAL . 86.4 t -45.82 156.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.096 0.474 . . . . 0.0 111.249 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.475 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -154.64 161.84 41.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.245 -179.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 1.8 mt -139.03 110.87 7.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.753 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 8.8 t80 -70.92 152.43 43.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.25 0.548 . . . . 0.0 112.044 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -123.26 79.67 1.7 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.063 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -47.24 -26.03 1.1 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.491 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.08 -38.31 89.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.356 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.81 2.85 10.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.672 0.272 . . . . 0.0 111.246 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 58.5 82.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.824 0.345 . . . . 0.0 110.928 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' NH2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER 176.25 158.36 0.28 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.599 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 18.0 m95 -74.76 170.25 16.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 110.599 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -163.84 117.66 1.06 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.424 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.62 ' HD2' HD23 ' A' ' 24' ' ' LEU . 98.3 Cg_exo -42.93 93.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.662 2.241 . . . . 0.0 112.789 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -44.8 -54.07 6.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.648 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.39 -94.05 0.01 OUTLIER Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.813 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -142.12 -79.65 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.845 0.355 . . . . 0.0 111.038 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.51 -71.59 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.504 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.41 170.51 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.552 2.168 . . . . 0.0 112.325 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -153.36 59.05 0.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.04 0.447 . . . . 0.0 111.154 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.97 51.39 1.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.543 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 59.62 -175.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.648 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -176.71 147.74 0.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.533 -179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.67 99.74 12.1 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.842 HG22 ' HA3' ' A' ' 51' ' ' GLY . 47.5 t -98.15 125.8 51.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.329 0.585 . . . . 0.0 112.121 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.51 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 49.0 mt-30 -115.36 156.4 25.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.191 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 106' ' ' MET . 45.3 mt -105.68 149.02 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.761 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CE1' HG22 ' A' ' 5' ' ' VAL . 6.6 m-85 -111.69 122.09 46.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.996 0.427 . . . . 0.0 111.396 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.574 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 15.9 t-160 -98.19 89.15 4.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.202 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.41 99.77 6.89 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.755 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 79.4 Cg_endo -84.05 -21.62 3.81 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.331 2.021 . . . . 0.0 112.595 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.4 p -49.66 -32.66 13.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.945 0.402 . . . . 0.0 110.709 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.14 -2.23 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.327 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 67.53 45.05 1.61 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.19 0.519 . . . . 0.0 110.254 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.04 179.36 6.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.039 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.574 ' CD2' ' HA ' ' A' ' 40' ' ' HIS . 77.3 m-85 -142.07 179.99 6.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 1.1 ttp180 -164.95 150.38 9.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.073 0.463 . . . . 0.0 111.591 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.525 HG23 HG12 ' A' ' 62' ' ' ILE . 8.7 m -109.74 123.64 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.139 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.6 t -128.14 118.11 47.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.145 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.842 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -141.26 150.07 21.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.986 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -130.47 155.25 46.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.303 . . . . 0.0 110.613 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.38 165.76 7.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 10.4 mtp -107.12 47.13 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.915 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.24 163.5 29.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.29 -26.4 27.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.618 2.212 . . . . 0.0 112.503 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.88 -41.72 59.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.928 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 103.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.886 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -141.99 138.69 32.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 60' ' ' VAL . 17.2 m -68.73 118.72 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.686 HG23 HG21 ' A' ' 13' ' ' VAL . 3.2 m -93.77 -22.17 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.543 HD12 ' CE3' ' A' ' 89' ' ' TRP . 9.2 tt -137.79 131.01 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.51 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -158.99 69.16 0.46 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.878 0.37 . . . . 0.0 110.995 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.28 135.76 41.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -76.29 137.7 40.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.422 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.43 ' O ' HD11 ' A' ' 113' ' ' LEU . 1.0 OUTLIER -112.34 125.14 69.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.963 0.411 . . . . 0.0 111.095 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.712 ' C ' HD13 ' A' ' 113' ' ' LEU . 2.1 m -110.63 174.97 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.608 ' N ' HD22 ' A' ' 113' ' ' LEU . 23.4 ttm180 -48.55 94.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.054 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.24 -19.64 0.15 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.912 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -95.59 121.4 46.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 117.719 0.76 . . . . 0.0 111.142 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HA ' HD13 ' A' ' 110' ' ' LEU . 2.8 mmtt -108.04 175.48 5.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.294 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CE1' ' HG2' ' A' ' 106' ' ' MET . 0.4 OUTLIER -114.15 100.4 8.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 111.197 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.72 81.67 3.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.614 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.441 ' HG2' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -48.36 105.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.17 85.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -151.94 177.22 1.98 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 77.6 Cg_exo -50.53 -25.24 14.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.367 2.045 . . . . 0.0 112.131 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.87 65.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.781 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.6 t80 -168.16 109.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.944 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 3.3 m80 -108.66 119.46 39.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.9 0.381 . . . . 0.0 110.496 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.735 HE21 HG11 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -122.66 148.18 45.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.265 -179.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.735 ' HB2' HG13 ' A' ' 70' ' ' VAL . 32.9 p90 -147.24 133.55 19.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.684 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' O ' HG22 ' A' ' 70' ' ' VAL . 47.6 ttp85 -80.09 100.3 8.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.385 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 85' ' ' ALA . 20.4 t0 -102.08 125.0 48.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.175 0.512 . . . . 0.0 110.676 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 84' ' ' ASP . . . 68.24 -79.01 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.544 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -139.38 -34.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -93.86 -168.13 1.82 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.735 HG11 HE21 ' A' ' 81' ' ' GLN . 11.4 t -137.41 136.03 46.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.947 0.403 . . . . 0.0 111.073 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.612 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 68.1 m95 -100.62 99.08 9.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.076 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.517 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -87.04 131.55 10.64 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.386 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.821 HD12 ' HB3' ' A' ' 11' ' ' ALA . 2.0 mm? -115.82 113.72 23.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.277 . . . . 0.0 111.691 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.408 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.94 105.47 17.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.206 0.527 . . . . 0.0 109.673 178.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 80' ' ' HIS . 78.1 m-85 -73.53 153.94 40.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.952 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.98 -28.07 7.96 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.274 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 m -129.29 165.19 21.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 0.0 110.808 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.85 -28.52 66.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.064 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -71.57 -49.31 41.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -49.99 -58.71 4.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.992 0.425 . . . . 0.0 110.738 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -51.39 -41.65 60.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.686 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.54 -34.97 65.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.501 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.667 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.4 tp60 -73.99 -45.23 51.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 111.24 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.498 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 2.7 t80 -52.62 -53.87 41.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.97 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.944 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -60.65 -31.71 70.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.423 . . . . 0.0 110.596 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.28 -66.33 0.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.197 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.57 -43.58 76.1 Favored Glycine 0 CA--C 1.507 -0.426 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.931 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.901 ' CE ' HD21 ' A' ' 110' ' ' LEU . 13.8 tpt -47.58 -59.55 3.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.908 0.385 . . . . 0.0 110.36 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 111' ' ' GLU . . . -47.5 -41.34 20.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.741 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -34.41 72.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.358 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . . . -70.95 -44.69 65.56 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 121.035 0.445 . . . . 0.0 110.725 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.901 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -72.71 -34.04 66.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.486 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 1.9 tt0 -75.1 -22.63 58.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.964 0.411 . . . . 0.0 111.45 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.39 -3.52 28.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.675 0.75 . . . . 0.0 109.088 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.712 HD13 ' C ' ' A' ' 67' ' ' VAL . 5.4 mt -92.21 -41.64 10.32 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.6 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -99.66 -31.23 11.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.852 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.506 179.937 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.0 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.73 0.3 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.637 HG11 ' NE2' ' A' ' 37' ' ' GLN . 34.9 t -73.85 153.81 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.638 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.44 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -103.53 -69.48 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 -176.73 3.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.029 0.443 . . . . 0.0 111.935 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.535 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 6.2 p -155.89 121.91 5.05 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.065 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 38.7 t -134.23 155.77 49.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.971 0.415 . . . . 0.0 111.71 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.6 ttp85 -97.85 128.79 44.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.454 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.642 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -170.92 -175.89 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.217 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 m -119.53 96.85 5.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.415 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.711 HG21 HG23 ' A' ' 61' ' ' VAL . 41.1 t -48.88 151.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.116 0.484 . . . . 0.0 111.153 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 89' ' ' TRP . 0.6 OUTLIER -151.64 144.9 24.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.578 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.486 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 3.6 mt -121.8 116.22 24.06 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.7 t80 -81.19 141.35 34.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.145 0.497 . . . . 0.0 112.017 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.538 ' OD1' HD12 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -117.1 84.95 2.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.577 178.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.77 -23.55 4.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.609 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.17 -27.96 7.83 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.263 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -142.73 16.78 1.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.721 0.296 . . . . 0.0 110.947 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 48.19 87.1 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.93 0.395 . . . . 0.0 111.291 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.47 142.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.747 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 35.2 m95 -61.39 -178.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.538 HD12 ' OD1' ' A' ' 17' ' ' ASP . 3.0 mt -177.01 114.11 0.25 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.218 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -40.92 99.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.816 2.344 . . . . 0.0 112.917 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -44.03 -40.33 4.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.68 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.92 -102.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.476 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.684 HG23 ' HD2' ' A' ' 30' ' ' PRO . 2.1 t -133.42 -46.23 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.379 . . . . 0.0 110.886 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.75 -66.32 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.062 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HD2' HG23 ' A' ' 28' ' ' THR . 9.5 Cg_endo -53.62 163.16 2.92 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.723 2.282 . . . . 0.0 112.099 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -142.07 139.79 32.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.077 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -170.99 45.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 55.31 173.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.784 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' ALA . 24.4 m -167.14 151.35 6.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.645 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.75 98.62 11.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.72 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.833 HG22 ' HA3' ' A' ' 51' ' ' GLY . 23.7 t -97.34 119.92 46.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.259 0.552 . . . . 0.0 111.949 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.637 ' NE2' HG11 ' A' ' 5' ' ' VAL . 47.8 mt-30 -109.76 166.54 10.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.543 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.509 HD13 ' HA ' ' A' ' 106' ' ' MET . 55.1 mt -109.9 151.59 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.52 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.448 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.5 m-85 -112.65 117.13 31.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.991 0.424 . . . . 0.0 111.349 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.498 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 5.0 t-160 -93.88 90.97 6.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.634 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -103.14 86.85 1.13 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 83.1 Cg_endo -76.35 -19.7 14.91 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.339 2.026 . . . . 0.0 112.536 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -50.26 -32.1 15.91 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.991 0.424 . . . . 0.0 110.551 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.29 6.11 6.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.219 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.45 49.16 5.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.248 0.547 . . . . 0.0 110.039 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.5 m -136.64 150.44 48.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.207 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.833 ' CE2' HD23 ' A' ' 113' ' ' LEU . 59.2 m-85 -120.62 174.01 6.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.563 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.8 ttp180 -164.34 149.34 10.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.093 0.473 . . . . 0.0 111.592 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.498 HG23 HG12 ' A' ' 62' ' ' ILE . 5.3 m -109.42 126.31 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.798 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.8 t -129.69 121.09 51.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.802 0.334 . . . . 0.0 111.429 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.833 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -137.43 148.87 20.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.866 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.29 146.62 52.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 110.972 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm -54.08 157.4 2.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.159 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 5.8 mtt -103.52 46.4 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -129.0 163.31 46.56 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.04 -24.89 15.18 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.605 2.203 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.99 -44.45 69.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.932 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 60.37 99.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -142.05 138.2 31.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.72 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 60' ' ' VAL . 13.4 m -70.77 122.22 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.189 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.711 HG23 HG21 ' A' ' 13' ' ' VAL . 3.8 m -93.84 -29.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.493 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.755 HD12 ' CE3' ' A' ' 89' ' ' TRP . 17.2 tt -138.55 138.15 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.874 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -165.89 63.18 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 110.539 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.3 t -126.99 135.28 50.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.911 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -75.36 136.48 40.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.678 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -111.62 168.28 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.592 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 66' ' ' ILE . 19.0 m -157.06 -173.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.628 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.726 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -57.69 87.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.208 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.37 -30.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.686 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.88 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.6 t -83.14 133.42 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 117.38 0.59 . . . . 0.0 111.093 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.67 115.61 23.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.845 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.57 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -64.56 106.05 1.08 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -99.77 96.98 7.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 91.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -58.52 -37.79 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -151.49 176.35 2.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.405 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 74.3 Cg_exo -49.89 -25.71 12.6 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.289 1.993 . . . . 0.0 112.107 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -138.18 65.89 1.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.649 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.0 t80 -165.9 112.25 0.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.356 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.94 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 2.0 m80 -110.62 101.33 10.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.061 0.458 . . . . 0.0 110.555 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.757 ' HG3' HG12 ' A' ' 88' ' ' VAL . 6.1 tt0 -107.68 150.28 27.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.057 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.88 ' HB2' HG13 ' A' ' 70' ' ' VAL . 46.0 p90 -151.31 148.57 28.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.965 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -112.29 112.54 24.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.223 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -93.45 -92.07 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.453 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.82 -69.38 0.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.988 0.423 . . . . 0.0 110.979 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 22.7 ttp180 -144.49 11.02 1.46 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.055 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.57 159.69 28.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.108 0.48 . . . . 0.0 110.571 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.757 HG12 ' HG3' ' A' ' 81' ' ' GLN . 1.5 t -120.3 114.35 43.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.471 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.755 ' CE3' HD12 ' A' ' 62' ' ' ILE . 66.4 m95 -93.51 94.63 8.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.116 0.484 . . . . 0.0 111.301 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.501 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -86.13 118.48 4.87 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.664 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.68 HD23 ' CH2' ' A' ' 82' ' ' TRP . 2.7 mm? -104.39 110.59 22.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.599 0.238 . . . . 0.0 111.377 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.411 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.49 106.3 18.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.219 0.533 . . . . 0.0 109.936 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 80.1 m-85 -73.81 159.27 33.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.135 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.83 -27.71 15.99 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.312 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.98 161.62 38.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 110.729 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -28.82 67.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.078 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.9 -55.4 14.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -48.63 -59.15 3.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.977 0.418 . . . . 0.0 110.42 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.573 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -47.45 -35.72 8.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.685 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.98 -30.02 62.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.366 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.601 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 7.1 tp60 -76.79 -49.75 15.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.285 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.502 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 4.1 t80 -51.3 -53.31 36.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.94 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -62.28 -33.17 74.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.832 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.62 -67.64 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.208 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.1 -40.85 98.49 Favored Glycine 0 CA--C 1.506 -0.524 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.54 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.911 ' CE ' HD21 ' A' ' 110' ' ' LEU . 16.5 tpt -50.94 -58.57 5.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.93 0.395 . . . . 0.0 110.43 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.83 -37.63 6.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.777 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 t -64.37 -37.96 89.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.045 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.69 -53.05 46.31 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.684 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 106' ' ' MET . 10.0 mt -66.43 -15.22 63.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.054 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -98.79 -23.14 15.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.678 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . . . -97.35 -1.1 45.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.144 0.497 . . . . 0.0 109.91 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.833 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -115.93 -33.36 5.12 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.286 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 37.6 mt-10 -93.07 -28.7 16.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.708 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.362 -1.243 . . . . 0.0 112.536 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.883 0.373 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.647 HG11 ' NE2' ' A' ' 37' ' ' GLN . 32.9 t -83.18 151.89 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.524 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.476 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -108.34 -66.86 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.506 ' SG ' HD12 ' A' ' 38' ' ' ILE . 29.3 p -118.61 178.46 4.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.716 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -157.76 106.63 2.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.453 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.498 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 28.2 t -126.21 151.55 47.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.022 0.439 . . . . 0.0 111.766 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -93.97 132.46 38.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.289 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.77 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -174.59 -179.82 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.89 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.585 HG21 ' CD ' ' A' ' 31' ' ' GLN . 1.3 m -116.89 89.98 3.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.35 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.719 HG12 ' CB ' ' A' ' 26' ' ' ALA . 93.7 t -46.07 139.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.213 0.53 . . . . 0.0 110.725 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.51 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -137.25 155.33 49.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.383 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD21 ' CE2' ' A' ' 89' ' ' TRP . 10.0 mt -128.01 112.42 14.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.352 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 15.9 t80 -76.13 147.5 38.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 111.633 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.14 86.03 2.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.106 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.33 -25.11 5.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.39 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.09 -27.87 23.97 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.407 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -138.33 12.15 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.559 0.219 . . . . 0.0 111.362 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 tttt 51.94 83.71 0.05 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.7 0.286 . . . . 0.0 111.197 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 178.24 168.79 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.981 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.547 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 25.7 m95 -88.15 172.6 9.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.698 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.765 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.8 mt -163.21 126.23 1.73 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.765 ' HD2' HD23 ' A' ' 24' ' ' LEU . 91.8 Cg_exo -41.95 101.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.784 2.323 . . . . 0.0 112.962 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.719 ' CB ' HG12 ' A' ' 13' ' ' VAL . . . -47.03 -48.77 21.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.534 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.12 -118.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.754 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.0 p -118.68 -81.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 0.0 111.147 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.51 -83.92 0.5 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.665 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.12 156.39 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.605 2.203 . . . . 0.0 112.396 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.585 ' CD ' HG21 ' A' ' 12' ' ' THR . 4.6 tt0 -143.26 142.47 31.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.189 0.518 . . . . 0.0 111.228 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' A' ' 31' ' ' GLN . . . -169.67 44.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.897 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 64.79 -175.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.201 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -173.45 159.33 3.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.036 0.446 . . . . 0.0 111.147 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.7 OUTLIER -98.86 95.35 7.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.417 178.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.824 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.9 t -94.22 122.4 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.45 0.643 . . . . 0.0 112.163 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.647 ' NE2' HG11 ' A' ' 5' ' ' VAL . 19.4 mt-30 -113.73 171.79 7.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.43 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.563 HD11 ' HB2' ' A' ' 106' ' ' MET . 88.9 mt -117.01 154.22 18.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.417 ' CE1' HG21 ' A' ' 50' ' ' VAL . 7.5 m-85 -112.86 119.55 38.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.025 0.44 . . . . 0.0 111.804 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.551 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.7 t-160 -93.82 89.56 6.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.825 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -99.95 93.74 2.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 98.6 Cg_endo -81.54 -23.25 5.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.35 2.033 . . . . 0.0 112.45 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -47.75 -30.26 3.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.98 6.53 4.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.296 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.439 ' ND2' HD22 ' A' ' 113' ' ' LEU . 8.4 t-20 61.03 49.46 5.69 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.22 0.533 . . . . 0.0 109.916 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.567 ' HA ' HG12 ' A' ' 67' ' ' VAL . 57.9 m -133.53 154.43 50.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.432 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.789 ' CE2' HD23 ' A' ' 113' ' ' LEU . 59.6 m-85 -124.54 172.12 9.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.561 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.579 ' HD2' ' HB2' ' A' ' 65' ' ' ALA . 9.4 ttt-85 -162.97 150.97 13.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 0.0 111.584 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.588 HG13 HG12 ' A' ' 62' ' ' ILE . 4.9 p -108.75 131.09 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.242 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.417 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.5 t -139.03 121.86 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.033 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.824 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -142.82 142.14 11.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.83 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.1 158.84 35.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.743 0.306 . . . . 0.0 110.86 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -58.34 168.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.55 ' HE2' ' HB2' ' A' ' 35' ' ' ARG . 1.6 mtt -107.05 42.88 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.135 0.493 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -128.27 162.29 51.38 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.802 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.2 -31.24 11.93 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.604 2.202 . . . . 0.0 112.773 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.06 -50.51 61.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.797 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.04 94.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -125.39 125.21 43.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 60' ' ' VAL . 9.5 m -62.79 119.09 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 111.272 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.48 HG23 HG21 ' A' ' 13' ' ' VAL . 3.2 m -93.85 -20.4 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.588 HG12 HG13 ' A' ' 49' ' ' VAL . 10.8 tt -138.81 136.5 43.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.388 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -161.79 68.57 0.29 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.977 0.418 . . . . 0.0 110.819 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.437 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -131.31 134.7 46.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.915 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.579 ' HB2' ' HD2' ' A' ' 48' ' ' ARG . . . -77.47 142.08 39.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.692 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.4 125.63 74.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.851 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 46' ' ' SER . 17.8 m -140.14 111.06 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.65 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.699 ' N ' HD12 ' A' ' 113' ' ' LEU . 12.2 ttt-85 27.88 74.31 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.871 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.47 -34.82 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.683 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.5 t -92.46 140.68 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 111.331 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.84 108.68 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.468 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.557 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.5 m-30 -52.48 124.62 13.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.25 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.26 110.36 16.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.758 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.64 92.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.936 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.24 90.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.03 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.7 p -146.64 173.62 4.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.471 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 78.2 Cg_exo -50.8 -25.26 15.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.349 2.033 . . . . 0.0 112.292 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -142.43 61.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.731 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 4.5 t80 -163.39 105.72 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.186 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.923 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.1 m80 -97.73 115.93 28.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 110.459 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.682 ' HG3' HG12 ' A' ' 88' ' ' VAL . 27.7 tt0 -121.9 144.69 48.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.922 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.796 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.7 p90 -143.23 150.08 38.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.29 0.567 . . . . 0.0 112.098 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -112.86 117.59 32.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.229 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.61 -81.03 0.38 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.248 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.71 -66.39 0.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.966 0.413 . . . . 0.0 111.09 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 -139.67 -5.56 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.48 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.416 ' HG2' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -108.24 179.58 4.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.985 0.422 . . . . 0.0 110.761 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.682 HG12 ' HG3' ' A' ' 81' ' ' GLN . 2.1 t -139.03 116.1 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.378 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.539 ' CE2' HD21 ' A' ' 15' ' ' LEU . 72.9 m95 -93.67 83.86 4.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.289 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.798 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -70.41 159.28 53.6 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.228 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.798 HD22 ' O ' ' A' ' 90' ' ' GLY . 1.1 mm? -144.24 108.09 4.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.532 0.206 . . . . 0.0 110.984 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.31 102.43 14.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.28 0.562 . . . . 0.0 109.925 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.612 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 76.7 m-85 -69.17 159.99 31.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.864 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.55 18.84 19.87 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.341 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.43 163.23 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.74 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -69.57 -30.37 68.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.68 -49.28 48.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.966 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -49.97 -62.76 1.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.994 0.426 . . . . 0.0 110.582 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -49.43 -36.66 22.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.693 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.85 -33.96 64.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.243 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.479 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 55.3 tp60 -77.32 -42.68 35.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.388 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.498 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 6.3 t80 -54.88 -50.74 67.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.298 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.923 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -68.11 -30.06 69.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.965 0.412 . . . . 0.0 110.969 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -47.79 -64.95 0.65 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.268 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.3 -50.34 56.72 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.985 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.975 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.2 tpt -48.94 -60.82 2.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.9 0.381 . . . . 0.0 110.476 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.72 -36.24 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.08 -39.78 82.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.046 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -61.79 -57.04 13.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.618 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.975 HD21 ' HE3' ' A' ' 106' ' ' MET . 8.0 mt -58.54 -20.55 47.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -92.72 -23.41 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.611 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.16 1.21 44.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.216 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.789 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -113.71 -29.67 7.03 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.344 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 3.7 mt-10 -99.05 -30.34 12.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.335 -1.259 . . . . 0.0 112.499 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tmm? . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.891 0.377 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.23 107.77 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 1.6 mp0 51.14 -169.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.063 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.9 m -119.4 105.46 11.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.614 HG11 ' NE2' ' A' ' 37' ' ' GLN . 71.5 t -61.08 156.19 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.618 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -104.8 -62.04 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.714 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' HB2' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -139.96 -177.55 5.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.428 -179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.473 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 24.4 p -154.0 121.2 5.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 9.0 p -128.46 154.7 45.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.021 0.439 . . . . 0.0 111.743 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -94.26 120.99 35.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.582 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.961 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -174.1 156.15 2.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.983 0.421 . . . . 0.0 111.929 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -98.89 92.06 5.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.112 178.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.597 ' HA ' ' CB ' ' A' ' 91' ' ' LEU . 62.1 t -46.13 141.22 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.543 . . . . 0.0 112.065 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.596 ' CB ' ' O ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -134.32 140.92 46.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.06 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.719 HD21 ' CD2' ' A' ' 89' ' ' TRP . 11.8 mt -111.55 127.0 55.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.565 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.644 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.6 t80 -80.4 146.94 31.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.18 0.514 . . . . 0.0 111.705 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -120.4 77.21 1.24 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.934 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.51 -29.6 1.84 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.283 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.24 -28.97 62.28 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.881 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -121.16 -6.89 9.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.509 0.195 . . . . 0.0 111.214 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HG3' ' OH ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 64.33 76.75 0.34 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.737 0.303 . . . . 0.0 110.852 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.14 174.63 0.32 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.327 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.644 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 48.1 m95 -91.92 169.39 10.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.484 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.494 HD23 ' HD2' ' A' ' 25' ' ' PRO . 5.2 mt -165.62 126.8 1.36 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.803 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 24' ' ' LEU . 96.5 Cg_exo -40.7 110.73 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.734 2.289 . . . . 0.0 112.738 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.14 -67.21 0.29 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.528 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.25 -112.26 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.688 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.39 -160.4 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.634 0.254 . . . . 0.0 110.732 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.59 -66.25 2.05 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.114 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.08 159.84 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.656 2.237 . . . . 0.0 112.317 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -145.15 163.03 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.161 0.505 . . . . 0.0 111.295 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 171.28 46.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.836 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.407 ' H ' HG23 ' A' ' 12' ' ' THR . 19.1 m-85 61.86 178.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.264 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.42 ' HG ' ' HA ' ' A' ' 53' ' ' LYS . 58.6 m -166.42 150.75 7.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.036 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -93.92 95.74 9.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.916 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.578 HG22 ' HA3' ' A' ' 51' ' ' GLY . 28.8 t -93.88 129.87 43.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.251 0.548 . . . . 0.0 111.74 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.614 ' NE2' HG11 ' A' ' 5' ' ' VAL . 53.6 mt-30 -126.08 148.79 49.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.062 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 106' ' ' MET . 55.7 mt -97.61 150.11 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.346 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.488 ' HB2' ' HG2' ' A' ' 48' ' ' ARG . 6.4 m-85 -111.46 124.0 51.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.921 0.391 . . . . 0.0 111.42 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.512 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 15.3 t-160 -101.09 89.38 3.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.243 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -101.43 87.57 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.435 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 64.2 Cg_endo -72.5 -17.89 26.38 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.448 2.098 . . . . 0.0 112.598 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 t -52.82 -26.14 13.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.966 0.412 . . . . 0.0 110.498 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.97 5.52 5.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.288 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.11 50.33 13.83 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.184 0.516 . . . . 0.0 110.126 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.9 m -141.42 159.56 41.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.998 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.864 ' CE2' HD23 ' A' ' 113' ' ' LEU . 75.9 m-85 -130.31 163.34 27.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -162.45 143.8 10.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.71 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.623 HG13 HG12 ' A' ' 62' ' ' ILE . 3.5 p -94.63 148.33 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.277 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -149.9 116.13 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.541 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.578 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -139.59 147.52 19.24 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.916 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.41 162.67 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.8 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -65.53 172.65 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.5 mmm -111.94 45.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.801 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -133.4 162.92 54.72 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.865 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.29 -26.15 10.99 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.694 2.263 . . . . 0.0 112.562 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.77 -48.32 79.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.21 85.83 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.028 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -128.37 134.34 48.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.622 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.1 m -73.52 122.0 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 0.0 111.0 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.494 HG23 ' CG2' ' A' ' 13' ' ' VAL . 3.5 m -93.8 -20.38 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.278 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.623 HG12 HG13 ' A' ' 49' ' ' VAL . 6.9 tt -139.06 138.16 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.615 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -162.92 66.12 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.52 166.64 14.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.836 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -111.47 140.2 46.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.981 0.419 . . . . 0.0 111.608 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.422 HD13 ' SD ' ' A' ' 106' ' ' MET . 0.8 OUTLIER -121.73 123.12 68.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.769 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 67' ' ' VAL . 28.2 m -138.3 110.61 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 111.669 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.657 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 26.92 46.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.207 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.79 -22.57 0.1 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.512 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.824 ' O ' HD22 ' A' ' 110' ' ' LEU . 2.5 t -105.64 137.86 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 117.201 0.5 . . . . 0.0 110.889 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.81 114.05 16.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.619 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.565 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.7 m-30 -50.53 127.98 19.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -93.86 -40.55 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.07 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 59.04 79.39 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.91 -50.59 72.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.203 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -135.53 173.35 5.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.638 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 53.3 Cg_exo -52.72 -24.33 22.99 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.453 2.102 . . . . 0.0 112.303 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -126.16 58.44 1.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -169.74 143.06 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.972 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.889 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.4 m170 -139.62 106.71 5.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.358 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.611 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.3 tm0? -117.32 121.11 40.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.413 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.806 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.7 p90 -125.42 147.14 49.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.04 0.448 . . . . 0.0 111.346 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -108.46 113.98 27.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.665 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.59 -87.55 0.24 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.255 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.73 -69.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.966 0.412 . . . . 0.0 110.942 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.1 ttp85 -139.94 -4.4 1.37 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.382 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.94 177.99 4.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.03 0.443 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.611 HG12 ' HG2' ' A' ' 81' ' ' GLN . 0.6 OUTLIER -140.6 124.75 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.317 179.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.719 ' CD2' HD21 ' A' ' 15' ' ' LEU . 90.3 m95 -101.33 85.48 2.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.062 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.612 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -97.57 96.74 1.86 Allowed Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.192 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.961 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -93.79 133.36 37.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.177 0.513 . . . . 0.0 111.659 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.556 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -93.46 129.02 39.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.367 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.459 ' CE1' ' HG ' ' A' ' 91' ' ' LEU . 7.3 m-85 -96.53 165.51 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.563 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.27 -37.15 2.72 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.978 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 m -120.45 160.73 22.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.198 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -62.16 -44.7 96.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.803 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -58.42 -35.39 72.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 9' ' ' SER . 17.4 m-20 -59.06 -66.46 0.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.988 0.423 . . . . 0.0 110.539 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.86 -30.34 63.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.265 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.09 -43.22 54.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.877 0.37 . . . . 0.0 110.951 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.667 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 4.4 tp60 -68.11 -43.68 77.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.184 0.516 . . . . 0.0 110.812 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.487 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 4.5 t80 -51.98 -54.93 23.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.331 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.889 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -60.15 -29.17 68.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.747 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -49.21 -64.28 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.122 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 7' ' ' CYS . . . -65.21 -51.53 49.1 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.072 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 1.102 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.6 tpt -47.21 -61.63 1.8 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.933 0.396 . . . . 0.0 110.705 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.11 -37.05 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.402 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 t -65.86 -40.22 91.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.141 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -62.92 -56.29 18.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.745 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.102 HD21 ' HE3' ' A' ' 106' ' ' MET . 6.3 mt -59.85 -16.95 32.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.616 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.09 -29.57 15.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.844 0.354 . . . . 0.0 111.916 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.42 1.11 54.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.592 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.864 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -111.06 -36.82 5.53 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.319 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -85.67 -32.11 22.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.576 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.407 -1.218 . . . . 0.0 112.475 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.91 139.96 7.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.67 -176.64 3.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.839 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.1 m -94.49 139.19 31.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.171 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 45.1 t -87.35 159.44 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.599 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.475 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -112.39 -69.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.25 -178.4 4.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.761 0.315 . . . . 0.0 111.601 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.482 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -155.44 121.82 5.23 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.307 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 20.0 t -134.51 156.78 48.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.935 0.398 . . . . 0.0 111.584 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HD3' ' HE1' ' A' ' 54' ' ' MET . 31.5 ttp180 -98.06 129.41 44.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.122 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.892 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -173.21 179.33 2.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.399 . . . . 0.0 111.192 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 m -114.13 91.59 3.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.294 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.538 HG21 HG23 ' A' ' 61' ' ' VAL . 96.1 t -47.23 143.28 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.249 0.547 . . . . 0.0 111.136 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.515 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -139.71 159.98 40.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.735 -179.114 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.444 ' HG ' ' CB ' ' A' ' 26' ' ' ALA . 3.8 mt -130.61 112.43 13.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.691 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.556 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.1 t80 -75.47 145.67 41.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.122 0.487 . . . . 0.0 111.712 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.82 79.98 1.63 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.962 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.83 -26.28 3.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.286 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.53 -30.94 51.54 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.104 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -129.61 5.08 5.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.637 0.256 . . . . 0.0 111.208 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.56 83.78 0.09 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.831 0.348 . . . . 0.0 111.094 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 173.85 157.03 0.13 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.952 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.556 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.4 m95 -74.81 175.23 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.455 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.791 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.4 mt -167.93 124.89 0.89 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.508 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.791 ' HD2' HD23 ' A' ' 24' ' ' LEU . 89.4 Cg_exo -44.06 97.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.544 2.162 . . . . 0.0 113.056 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.473 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -46.49 -59.28 3.08 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.008 0.432 . . . . 0.0 111.445 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.8 -97.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.927 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.7 p -136.86 -76.26 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.273 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.4 -73.17 0.08 OUTLIER Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.616 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -45.03 164.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.959 2.44 . . . . 0.0 112.284 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -149.69 57.54 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.032 0.444 . . . . 0.0 111.173 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.22 49.23 1.38 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 61.77 -176.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.481 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -172.95 149.02 1.84 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.555 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.83 98.95 11.42 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.529 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.2 t -94.51 135.03 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.234 0.54 . . . . 0.0 112.02 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.482 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 47.4 mt-30 -130.95 152.02 50.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.025 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 106' ' ' MET . 53.7 mt -99.39 157.69 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.395 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.476 ' N ' HG22 ' A' ' 38' ' ' ILE . 16.2 m-85 -122.72 120.22 33.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.485 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 t-160 -93.59 98.18 10.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.682 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -101.26 94.92 4.36 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.864 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 87.1 Cg_endo -80.83 -20.34 7.78 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.281 1.987 . . . . 0.0 112.52 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 m -48.67 -31.51 6.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.154 0.502 . . . . 0.0 110.524 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.36 6.75 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.168 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.95 48.87 4.96 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.21 0.529 . . . . 0.0 109.969 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.5 t -133.04 155.77 48.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.081 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.74 ' CE2' HD23 ' A' ' 113' ' ' LEU . 50.9 m-85 -120.09 174.72 6.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.691 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 ttt180 -164.39 152.81 12.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.429 . . . . 0.0 111.733 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.645 HG13 HG12 ' A' ' 62' ' ' ILE . 5.6 p -112.88 138.98 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.138 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.0 120.24 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.848 0.356 . . . . 0.0 110.82 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -140.79 146.25 17.44 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.792 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.91 156.94 29.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.815 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.567 ' HD3' HG11 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -82.22 161.51 22.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.624 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.41 ' HE1' ' HD3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -94.55 45.59 1.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.023 0.44 . . . . 0.0 110.588 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -94.52 163.94 21.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.946 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.23 -16.93 43.39 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.334 2.023 . . . . 0.0 111.535 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.75 -31.71 9.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.016 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.74 118.16 0.02 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.736 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -143.48 142.61 31.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.5 m -71.05 120.55 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.926 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.567 HG11 ' HD3' ' A' ' 53' ' ' LYS . 3.8 m -93.85 -18.58 6.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.645 HG12 HG13 ' A' ' 49' ' ' VAL . 7.0 tt -140.04 137.56 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.367 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -163.14 70.02 0.24 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.899 0.38 . . . . 0.0 110.871 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.1 t -134.8 134.18 40.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.055 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -76.66 135.25 39.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.5 pt -108.03 166.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 0.0 111.071 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 66' ' ' ILE . 15.8 m -158.43 -173.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.554 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.742 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -61.19 87.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.203 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.65 -33.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.356 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.84 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -84.43 130.51 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 117.179 0.489 . . . . 0.0 111.173 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.44 101.77 8.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.421 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.566 ' CD2' ' CE1' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -47.56 106.3 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.326 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.71 97.34 8.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.017 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.85 88.67 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.47 80.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 11.4 p -136.0 162.81 54.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.744 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 75.1 Cg_exo -51.52 -22.9 13.43 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.591 2.194 . . . . 0.0 112.458 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.92 47.73 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.097 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 5.3 t80 -162.96 123.86 2.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.36 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.61 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.3 m170 -98.2 172.84 7.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.609 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.441 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.6 OUTLIER 177.15 118.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.658 0.266 . . . . 0.0 111.185 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.84 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.4 p90 -133.85 137.57 45.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 111.921 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -101.09 108.86 20.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.38 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 28.6 t70 -93.65 -102.24 0.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.664 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -72.91 0.1 Allowed 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.006 0.432 . . . . 0.0 111.075 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.6 ttm105 -140.81 -13.01 0.97 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.358 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -106.74 -176.89 3.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.897 0.38 . . . . 0.0 110.242 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.511 HG13 ' C ' ' A' ' 82' ' ' TRP . 1.3 t -136.97 122.91 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.45 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.57 ' CE3' HD12 ' A' ' 62' ' ' ILE . 71.3 m95 -94.0 91.61 6.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.842 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -72.19 164.61 54.39 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.268 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.892 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -150.44 108.8 3.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.631 0.253 . . . . 0.0 111.17 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.55 102.44 14.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.26 0.553 . . . . 0.0 109.722 178.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.668 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 81.3 m-85 -70.16 163.72 25.74 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.198 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.57 -28.32 6.39 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.282 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.3 p -139.07 167.12 22.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -65.32 -40.6 93.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -43.74 97.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -52.09 -66.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 110.57 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.668 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -47.3 -32.81 5.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.517 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.33 -30.91 60.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 111.151 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.539 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 7.3 tp60 -78.36 -48.54 15.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.517 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 4.7 t80 -51.4 -48.43 62.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.961 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.61 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -66.59 -33.82 76.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.986 0.422 . . . . 0.0 110.938 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -44.89 -67.66 0.27 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.7 -49.32 74.2 Favored Glycine 0 CA--C 1.508 -0.377 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.327 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.914 ' CE ' HD21 ' A' ' 110' ' ' LEU . 12.2 tpt -49.34 -60.27 2.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.865 0.364 . . . . 0.0 110.572 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -42.4 -36.34 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.224 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -40.93 82.41 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.023 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -58.34 -56.77 17.8 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.898 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.914 HD21 ' CE ' ' A' ' 106' ' ' MET . 6.3 mt -58.8 -26.23 63.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.181 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -88.65 -22.43 23.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.922 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.88 -3.41 45.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.027 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -109.44 -22.81 11.84 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.222 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.439 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 6.7 mt-10 -89.63 -38.97 13.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.335 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.463 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.786 0.327 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.27 -172.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.906 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -117.23 -171.61 2.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -128.57 115.8 18.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.742 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.595 HG11 ' NE2' ' A' ' 37' ' ' GLN . 39.4 t -67.15 153.48 8.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.584 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.504 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -101.36 -71.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.069 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.76 -173.89 3.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.589 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.537 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 10.2 p -154.71 122.88 5.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.374 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 40.3 t -131.52 155.99 46.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 111.36 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.76 128.89 44.14 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.584 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.896 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -170.66 -178.61 2.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.965 0.412 . . . . 0.0 111.167 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 m -116.41 89.4 3.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.138 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.506 HG22 HD21 ' A' ' 91' ' ' LEU . 89.0 t -45.74 143.43 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.213 0.53 . . . . 0.0 111.504 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.507 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -140.2 150.43 44.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.461 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.733 HD21 ' CE2' ' A' ' 89' ' ' TRP . 2.8 mt -122.8 114.58 20.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.489 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.2 t80 -73.98 151.84 40.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.189 0.518 . . . . 0.0 111.568 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.579 ' HB2' HD12 ' A' ' 24' ' ' LEU . 1.5 t70 -128.64 82.05 2.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.16 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -50.07 -26.59 4.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.202 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.2 -28.8 43.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.252 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -132.29 7.81 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.605 0.24 . . . . 0.0 111.234 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt 53.92 82.11 0.09 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.754 0.312 . . . . 0.0 111.191 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.55 172.79 0.42 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.978 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.539 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.5 m95 -89.12 171.86 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.543 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.579 HD12 ' HB2' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -162.27 125.27 1.79 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.547 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD2' HD23 ' A' ' 24' ' ' LEU . 91.1 Cg_exo -44.11 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.488 2.125 . . . . 0.0 112.741 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.476 ' HB1' ' CZ3' ' A' ' 89' ' ' TRP . . . -47.16 -56.8 5.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.625 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.64 -99.07 0.01 OUTLIER Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.943 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.7 -72.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.389 . . . . 0.0 111.219 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -132.16 -77.04 0.13 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.738 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.05 160.96 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.571 2.181 . . . . 0.0 112.413 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -142.03 57.42 1.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.072 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.39 48.9 1.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.493 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 61.62 -174.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.606 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -174.3 148.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.652 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.93 96.2 9.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.91 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.742 HG22 ' HA3' ' A' ' 51' ' ' GLY . 38.4 t -94.56 124.51 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.347 0.594 . . . . 0.0 112.082 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.595 ' NE2' HG11 ' A' ' 5' ' ' VAL . 53.1 mt-30 -114.51 164.29 14.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.42 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.536 HD13 ' HA ' ' A' ' 106' ' ' MET . 30.9 mt -111.76 151.84 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.872 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.521 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.3 m-85 -111.99 121.0 43.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.402 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 15.5 t-160 -96.31 87.89 4.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.842 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.41 92.19 3.13 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.947 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 93.5 Cg_endo -78.49 -17.97 12.5 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.368 2.045 . . . . 0.0 112.601 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -47.47 -37.16 11.23 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.954 0.407 . . . . 0.0 110.854 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.89 -7.33 12.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.097 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.06 40.78 0.25 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.035 0.445 . . . . 0.0 110.39 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.75 170.37 16.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.732 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 40' ' ' HIS . 70.4 m-85 -130.95 171.91 12.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.855 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 1.2 ttt180 -151.59 146.24 25.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.087 0.47 . . . . 0.0 111.952 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.681 HG13 HG12 ' A' ' 62' ' ' ILE . 5.7 p -107.28 129.58 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.706 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.521 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.4 t -138.3 119.09 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.192 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.742 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -142.26 149.89 21.62 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.839 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -129.1 159.59 35.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 0.0 110.59 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 166.8 15.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.4 mtp -107.95 45.71 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 4.5 pt20 -123.19 160.8 48.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.853 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 7.4 Cg_endo -49.55 -25.4 10.78 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.857 2.371 . . . . 0.0 112.435 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.89 -43.42 58.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.838 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.32 102.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.01 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -141.04 138.58 33.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.805 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 60' ' ' VAL . 13.3 m -68.94 120.51 16.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.834 0.35 . . . . 0.0 110.918 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.494 HG23 HG21 ' A' ' 13' ' ' VAL . 2.9 m -93.81 -21.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.104 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.681 HG12 HG13 ' A' ' 49' ' ' VAL . 8.6 tt -138.13 135.72 44.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.542 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -160.81 64.0 0.3 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.025 0.441 . . . . 0.0 110.894 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.472 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -128.86 147.16 50.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.926 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -85.14 135.73 33.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.56 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.449 ' O ' HD11 ' A' ' 113' ' ' LEU . 1.6 pt -108.45 114.54 46.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.618 ' C ' HD13 ' A' ' 113' ' ' LEU . 1.8 m -102.56 164.9 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.973 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.687 ' H ' HD22 ' A' ' 113' ' ' LEU . 1.2 ttm180 -46.44 97.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.178 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.29 -19.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.625 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.834 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.4 t -89.97 119.81 37.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 117.54 0.67 . . . . 0.0 111.183 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -110.8 110.3 20.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.552 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.569 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.6 OUTLIER -49.02 105.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.263 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.9 88.91 5.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.842 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.449 ' NE2' ' CD2' ' A' ' 80' ' ' HIS . 2.1 tp60 -58.72 90.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.948 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.06 93.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.9 p -144.13 172.38 5.58 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.508 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 74.4 Cg_exo -50.1 -24.7 11.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.427 2.085 . . . . 0.0 112.398 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.64 57.75 1.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.767 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 1.1 t80 -159.73 113.29 2.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.475 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.746 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 22.1 m170 -107.91 104.79 14.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.317 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.531 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -116.37 127.26 54.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.512 -178.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.834 ' HB2' HG13 ' A' ' 70' ' ' VAL . 41.8 p90 -133.58 143.83 48.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.033 0.444 . . . . 0.0 111.728 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.9 ttp85 -110.84 112.61 24.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.276 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.482 ' HB2' HG21 ' A' ' 70' ' ' VAL . 26.5 t70 -93.77 -102.38 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.73 -72.08 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 111.2 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.3 ttp-105 -140.97 -14.58 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.407 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -103.36 -177.79 3.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.531 HG12 ' HG2' ' A' ' 81' ' ' GLN . 1.8 t -136.17 129.04 46.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.553 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.733 ' CE2' HD21 ' A' ' 15' ' ' LEU . 77.3 m95 -101.25 97.98 8.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.538 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.823 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -78.84 159.63 46.0 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.002 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.896 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -148.41 106.01 3.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.77 0.285 . . . . 0.0 111.361 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.53 105.43 17.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.284 0.564 . . . . 0.0 109.902 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 62.1 m-85 -74.11 161.51 29.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.949 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -93.42 -32.72 7.57 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.467 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.95 157.96 45.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.777 0.322 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -28.56 65.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -68.29 -48.62 64.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -52.69 -61.39 2.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.608 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -50.0 -30.95 11.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.365 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.73 -35.92 62.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 0.0 111.038 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.7 tp60 -74.2 -44.18 54.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.039 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.47 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 2.3 t80 -52.84 -50.3 64.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.964 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.746 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -63.86 -32.22 73.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 110.695 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -46.15 -65.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.089 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.26 -45.66 78.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.904 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.818 ' CE ' HD21 ' A' ' 110' ' ' LEU . 15.2 tpt -49.34 -59.77 3.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.924 0.393 . . . . 0.0 110.39 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.68 -38.89 7.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.867 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.4 t -63.56 -36.19 82.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.932 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . . . -66.41 -40.74 89.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.292 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.818 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.2 OUTLIER -76.31 -26.58 55.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.049 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.15 -22.83 41.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.996 0.427 . . . . 0.0 111.5 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.13 -4.49 24.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.528 0.68 . . . . 0.0 109.321 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.687 HD22 ' H ' ' A' ' 68' ' ' ARG . 5.2 mt -88.07 -36.37 16.98 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.249 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 68' ' ' ARG . 6.2 mt-10 -104.64 -31.96 9.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.744 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.53 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mmm . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.857 0.361 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.58 115.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.485 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 1.4 mp0 -91.29 -168.6 2.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.676 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.0 m -113.81 101.77 9.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.98 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.501 HG11 ' NE2' ' A' ' 37' ' ' GLN . 50.2 t -60.31 155.16 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.578 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.524 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -105.62 -69.45 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -133.35 -172.17 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.731 0.3 . . . . 0.0 111.352 -179.036 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.529 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.3 OUTLIER -157.59 127.68 6.23 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.185 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 29.6 t -135.69 152.95 51.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.39 . . . . 0.0 111.525 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.543 ' HG3' ' HE2' ' A' ' 54' ' ' MET . 24.2 ttt180 -94.85 126.94 40.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.345 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.692 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -168.73 -176.46 2.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.067 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 92' ' ' ASN . 1.3 m -119.79 95.65 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.105 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 61' ' ' VAL . 40.0 t -44.95 154.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.107 0.48 . . . . 0.0 111.199 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.501 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -154.53 150.8 28.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.39 -179.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.545 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -127.24 110.91 13.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.577 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.564 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.3 t80 -71.34 150.24 45.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.147 0.498 . . . . 0.0 111.851 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.81 88.13 2.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.138 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -53.5 -22.05 7.39 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.501 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.38 -44.14 76.5 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.411 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -128.7 16.11 6.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 0.0 111.001 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 3.4 mmtt 50.7 88.25 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.155 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.79 147.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.564 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 13.9 m95 -68.57 169.44 11.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.636 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.598 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -165.04 111.65 0.83 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.428 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.598 ' HD2' HD23 ' A' ' 24' ' ' LEU . 72.5 Cg_exo -40.08 95.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.864 2.376 . . . . 0.0 112.974 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.613 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -50.85 -35.86 34.71 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.378 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.22 -95.32 0.01 OUTLIER Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.806 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -173.79 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 111.397 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.07 -94.7 0.12 Allowed Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.835 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.76 161.77 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.726 2.284 . . . . 0.0 112.479 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -142.98 55.81 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.047 0.451 . . . . 0.0 111.185 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.39 47.44 1.13 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.358 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 60.4 176.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.575 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.479 ' HG ' ' HA ' ' A' ' 53' ' ' LYS . 14.9 m -165.57 149.83 8.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.704 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.85 102.92 15.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.824 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.765 HG22 ' HA3' ' A' ' 51' ' ' GLY . 28.2 t -98.42 117.84 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.338 0.59 . . . . 0.0 112.128 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.529 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 47.8 mt-30 -107.7 151.83 25.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.446 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.534 HD13 ' HA ' ' A' ' 106' ' ' MET . 54.2 mt -97.64 154.61 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.91 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.52 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.6 m-85 -117.14 121.98 42.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.5 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 3.7 t-160 -99.98 89.37 4.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.024 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.427 ' OD1' ' HG2' ' A' ' 3' ' ' GLU . 3.3 m-80 -96.54 100.97 7.91 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.439 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 96.4 Cg_endo -81.67 -22.13 5.64 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.264 1.976 . . . . 0.0 112.692 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.7 p -50.37 -27.41 6.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 110.73 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.38 3.7 6.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.477 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 60.02 48.3 8.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.137 0.494 . . . . 0.0 110.123 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.557 ' HA ' HD21 ' A' ' 113' ' ' LEU . 14.2 m -136.27 -173.37 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.502 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CD2' HD11 ' A' ' 6' ' ' ILE . 78.5 m-85 -151.19 165.03 35.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.973 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 12.8 mtt180 -147.42 157.75 43.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.061 0.458 . . . . 0.0 111.658 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 62' ' ' ILE . 5.1 m -113.15 122.95 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.053 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.52 HG21 ' CE1' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -130.74 121.29 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.203 -179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.765 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -141.56 140.5 10.26 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.734 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 15.7 ptp180 -123.24 147.1 47.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.799 0.333 . . . . 0.0 110.7 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.479 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -57.45 168.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.034 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.543 ' HE2' ' HG3' ' A' ' 10' ' ' ARG . 15.3 mtm -111.66 46.0 1.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.694 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -119.57 163.44 27.24 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.854 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.92 -24.67 14.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.603 2.202 . . . . 0.0 112.561 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.71 -43.96 21.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 60.78 105.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.036 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.51 ' NE2' HG12 ' A' ' 61' ' ' VAL . 2.0 pp0? -141.27 148.89 40.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.511 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.8 m -75.93 120.73 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 111.344 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 13' ' ' VAL . 4.2 m -93.91 -24.45 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.066 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.653 HD12 ' CE3' ' A' ' 89' ' ' TRP . 12.2 tt -137.71 134.7 45.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -158.96 65.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.92 0.391 . . . . 0.0 111.004 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.91 -170.86 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.757 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.545 ' HB2' ' HD3' ' A' ' 48' ' ' ARG . . . -131.44 150.31 52.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.318 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.468 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -126.55 133.73 67.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.067 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 67' ' ' VAL . 29.5 m -141.07 110.11 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.425 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' H ' HD13 ' A' ' 113' ' ' LEU . 1.4 ptt180 23.26 48.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.45 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.95 -23.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.841 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.885 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -95.82 130.26 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 117.373 0.587 . . . . 0.0 111.249 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -119.29 105.25 11.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.493 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.55 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.1 m-30 -47.59 105.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.405 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.54 95.18 6.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -59.09 97.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.36 92.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.191 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.434 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 0.8 OUTLIER -146.8 175.72 2.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 73.1 Cg_exo -51.32 -24.2 15.25 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.379 2.053 . . . . 0.0 112.501 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -140.48 62.72 1.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.02 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 92' ' ' ASN . 3.1 t80 -162.42 130.4 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.12 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.797 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 30.4 m170 -118.64 105.94 12.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.484 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.4 tm0? -116.01 128.35 55.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.878 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.885 ' HB2' HG13 ' A' ' 70' ' ' VAL . 49.0 p90 -134.82 146.11 48.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 111.843 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -107.7 110.75 22.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.33 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.428 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 14.3 t0 -93.67 -97.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.817 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.91 -71.29 0.26 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.992 0.425 . . . . 0.0 111.314 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -141.21 -9.26 0.99 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.66 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.17 -170.82 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.432 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG12 ' HG2' ' A' ' 81' ' ' GLN . 1.1 t -141.24 123.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.336 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.653 ' CE3' HD12 ' A' ' 62' ' ' ILE . 69.6 m95 -97.45 91.69 5.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.382 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.81 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -75.17 153.68 45.31 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.203 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 90' ' ' GLY . 1.9 mm? -140.46 106.99 5.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.576 0.227 . . . . 0.0 110.987 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -92.72 108.73 20.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.236 0.541 . . . . 0.0 110.069 179.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.644 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 39.3 m-85 -80.32 159.46 25.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.828 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.18 -30.08 17.99 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.573 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.44 174.72 10.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -70.91 -32.1 68.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -50.62 66.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -52.53 -61.86 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 110.456 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.644 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -51.58 -33.22 31.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.365 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.1 -31.66 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.523 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 7.1 tp60 -76.75 -44.99 30.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.246 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.479 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 2.8 t80 -53.52 -47.62 69.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.797 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -68.68 -31.03 69.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.948 0.404 . . . . 0.0 110.78 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -46.64 -65.83 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.073 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.59 -44.66 89.34 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.845 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 1.095 ' HE3' HD21 ' A' ' 110' ' ' LEU . 15.0 tpt -50.43 -59.76 3.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.996 0.427 . . . . 0.0 110.374 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 111' ' ' GLU . . . -43.69 -41.63 4.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.124 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 t -62.02 -40.14 94.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.329 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.484 ' HB1' ' CG ' ' A' ' 47' ' ' PHE . . . -62.35 -51.62 66.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.095 HD21 ' HE3' ' A' ' 106' ' ' MET . 8.9 mt -65.85 -22.37 66.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.337 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 1.5 tt0 -84.68 -24.61 28.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.972 0.415 . . . . 0.0 111.313 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.71 3.64 34.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.754 0.788 . . . . 0.0 108.959 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 46' ' ' SER . 6.8 mt -95.45 -41.25 9.07 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.061 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.81 -31.97 10.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.743 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.34 -1.256 . . . . 0.0 112.529 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.822 0.344 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.6 t -147.64 69.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.438 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 2.0 mp0 55.08 -170.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.095 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.5 m -119.88 114.4 22.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.017 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.578 HG11 ' NE2' ' A' ' 37' ' ' GLN . 25.1 t -66.02 149.05 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.536 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.438 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -100.0 -72.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -121.61 179.67 4.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 111.445 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.501 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -154.33 122.95 6.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.948 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 35.7 t -133.1 153.61 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.052 0.453 . . . . 0.0 111.828 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.409 ' HD3' ' CG ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -95.37 128.77 42.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.961 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 93' ' ' PHE . . . -177.8 156.97 1.14 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.957 0.408 . . . . 0.0 111.761 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.5 m -93.94 90.66 6.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.134 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.692 HG13 HD12 ' A' ' 91' ' ' LEU . 77.4 t -42.21 157.48 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.453 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.542 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -156.45 143.36 18.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.256 -179.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.698 HD21 ' CD2' ' A' ' 89' ' ' TRP . 9.0 mt -119.59 123.54 44.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.265 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.0 t80 -79.7 143.23 34.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.179 0.514 . . . . 0.0 111.816 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.46 77.21 1.06 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.571 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.09 -29.01 1.35 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.429 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.78 -28.32 46.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.959 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -128.93 1.09 5.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.491 0.186 . . . . 0.0 111.329 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 5.5 tptt 58.54 82.14 0.14 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.809 0.338 . . . . 0.0 110.923 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER 175.84 161.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.589 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 35.5 m95 -81.25 172.5 13.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.682 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 24' ' ' LEU . 3.7 mt -172.86 116.27 0.38 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.669 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -39.91 117.52 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.9 2.4 . . . . 0.0 112.735 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.616 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -54.57 -53.47 54.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.697 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.22 -107.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 CA-C-N 115.866 -0.607 . . . . 0.0 113.224 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.4 m -129.11 -81.03 0.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.775 0.322 . . . . 0.0 111.174 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.18 -70.7 0.05 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.726 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.75 154.14 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.657 2.238 . . . . 0.0 112.393 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.504 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 1.7 mt-30 -147.49 164.43 33.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.385 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 170.4 44.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.878 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.409 ' CG ' ' HD3' ' A' ' 10' ' ' ARG . 7.8 m-85 63.26 131.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.33 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 t -119.19 146.4 45.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.982 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.91 94.1 8.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.631 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.753 HG22 ' HA3' ' A' ' 51' ' ' GLY . 23.4 t -94.01 120.54 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.368 0.604 . . . . 0.0 112.027 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.578 ' NE2' HG11 ' A' ' 5' ' ' VAL . 9.2 mt-30 -113.58 169.07 9.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.599 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 38.0 mt -111.21 156.23 12.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.6 m-85 -114.5 116.88 29.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.37 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.502 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.2 t-160 -94.09 88.45 5.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -101.86 92.2 2.82 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.997 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 84.5 Cg_endo -79.76 -20.2 9.3 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.428 2.086 . . . . 0.0 112.544 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.5 p -48.7 -32.83 9.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.982 0.42 . . . . 0.0 110.638 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -124.6 2.55 8.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.211 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 62.93 48.53 3.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.212 0.53 . . . . 0.0 109.948 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.35 151.37 47.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.936 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.777 ' CE2' HD23 ' A' ' 113' ' ' LEU . 59.6 m-85 -118.51 174.18 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.836 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.9 ttt180 -164.19 150.55 11.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.109 0.481 . . . . 0.0 111.552 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.611 HG13 HG12 ' A' ' 62' ' ' ILE . 3.8 p -107.39 134.82 47.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.057 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.502 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.4 t -141.96 123.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.352 . . . . 0.0 111.033 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.753 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -140.87 144.86 15.23 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.738 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -129.13 142.79 50.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HD2' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -66.47 165.87 13.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtt -107.28 46.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.453 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 1.1 pt20 -105.79 162.99 18.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.732 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 55.4 Cg_endo -69.98 52.58 1.08 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.481 2.121 . . . . 0.0 112.195 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -160.98 -35.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 66.4 114.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.068 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -151.52 124.32 8.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 60' ' ' VAL . 17.8 m -65.55 125.29 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.929 0.395 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.635 HG23 HG21 ' A' ' 13' ' ' VAL . 10.9 m -93.82 -21.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.417 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.66 HD12 ' CE3' ' A' ' 89' ' ' TRP . 12.4 tt -141.42 140.46 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.619 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -164.43 66.7 0.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 110.875 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.8 t -128.72 131.78 47.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.957 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -75.55 136.49 40.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.396 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.5 pt -109.99 165.78 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.969 0.414 . . . . 0.0 111.079 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 66' ' ' ILE . 16.0 m -158.54 -176.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.556 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.74 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -58.73 89.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.57 -30.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.35 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.868 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.7 t -86.43 131.88 33.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 117.128 0.464 . . . . 0.0 110.743 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -119.49 114.94 23.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.777 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.609 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.0 OUTLIER -60.73 106.23 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.043 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.79 86.47 4.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.72 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.23 91.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.179 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.69 -57.54 12.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.3 p -129.09 160.47 63.58 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.348 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 6.0 Cg_endo -48.0 -26.17 7.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.714 2.276 . . . . 0.0 112.352 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -127.89 59.44 1.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.006 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' A' ' 92' ' ' ASN . 7.1 t80 -175.87 130.51 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.939 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -119.23 150.67 39.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.592 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.692 ' HG3' HG12 ' A' ' 88' ' ' VAL . 31.6 tt0 -158.56 150.72 21.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.246 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.944 ' CH2' HD21 ' A' ' 91' ' ' LEU . 19.7 p90 -151.29 165.5 33.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.344 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -121.74 114.15 20.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.728 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.44 -35.84 12.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 110.44 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -166.74 -67.25 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.285 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -141.78 16.93 2.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.262 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.463 ' HG3' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -128.22 114.19 16.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.692 HG12 ' HG3' ' A' ' 81' ' ' GLN . 2.4 t -93.54 108.93 21.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.865 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.698 ' CD2' HD21 ' A' ' 15' ' ' LEU . 84.6 m95 -93.78 85.91 4.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.91 -178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.859 ' C ' HD13 ' A' ' 91' ' ' LEU . . . -97.07 132.48 11.01 Favored Glycine 0 C--O 1.223 -0.544 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.84 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.944 HD21 ' CH2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -124.09 129.99 51.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.944 0.402 . . . . 0.0 111.679 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.432 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -92.64 110.67 22.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.641 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.623 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 89.0 m-85 -75.61 162.91 27.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.786 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.87 -27.56 28.6 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.378 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.4 m -148.54 179.42 7.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -34.14 67.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.989 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -63.16 -51.05 67.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -52.66 -58.71 5.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.672 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -52.81 -33.92 51.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.44 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.43 -32.93 62.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.283 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.661 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.8 tp60 -74.49 -46.76 37.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.004 0.431 . . . . 0.0 111.03 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.506 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 21.5 t80 -51.6 -53.7 35.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.052 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.939 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -62.61 -29.89 70.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.024 0.44 . . . . 0.0 110.651 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -46.41 -65.82 0.5 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.052 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.33 -45.02 96.01 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.3 -0.952 . . . . 0.0 111.753 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.923 ' CE ' HD21 ' A' ' 110' ' ' LEU . 15.8 tpt -49.74 -59.46 3.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.924 0.392 . . . . 0.0 110.452 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.73 -37.74 2.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.931 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -38.58 89.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.033 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.524 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -62.63 -56.74 15.04 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.729 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.923 HD21 ' CE ' ' A' ' 106' ' ' MET . 11.5 mt -59.86 -20.36 56.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.304 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -94.61 -22.44 18.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.669 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.29 -1.82 43.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.103 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.777 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -112.58 -28.92 7.65 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.299 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.462 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 3.3 mm-40 -91.09 -33.93 15.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.453 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.382 -1.232 . . . . 0.0 112.513 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.793 0.33 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.52 150.96 44.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 4.5 mp0 -105.63 -168.73 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.5 m -126.19 105.39 8.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.917 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.798 HG11 ' NE2' ' A' ' 37' ' ' GLN . 41.1 t -61.33 145.35 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.737 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -97.53 -70.16 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.78 -176.91 4.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.86 0.362 . . . . 0.0 111.57 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.535 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 12.6 p -156.15 126.43 6.62 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.222 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.483 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 16.7 t -135.72 158.34 44.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.984 0.421 . . . . 0.0 111.615 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.413 ' HD3' ' CD1' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -102.03 124.67 48.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.397 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.59 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -167.03 -172.64 2.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.501 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 92' ' ' ASN . 18.8 m -124.67 91.49 3.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.149 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.683 HG21 HG23 ' A' ' 61' ' ' VAL . 78.9 t -42.32 156.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.476 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.484 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -153.96 134.59 13.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.778 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 2.9 mt -112.47 110.7 21.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 0.0 110.285 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 16.7 t80 -71.41 141.03 50.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.115 0.483 . . . . 0.0 111.668 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.46 80.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.932 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.38 -26.2 4.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.37 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.33 -32.81 22.78 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.87 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -138.68 15.09 2.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.763 0.316 . . . . 0.0 110.633 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 2.4 mmpt? 46.46 90.7 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.244 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.81 133.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.792 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 12.3 m95 -59.31 146.2 40.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.662 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -141.44 112.3 6.54 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.315 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -40.65 99.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.81 2.34 . . . . 0.0 112.96 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.538 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -46.95 -34.05 5.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.329 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.29 -108.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.642 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 29' ' ' GLY . 9.9 t -146.34 -47.54 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.743 0.306 . . . . 0.0 111.327 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 28' ' ' THR . . . -152.28 -87.57 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.737 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.03 166.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.736 2.291 . . . . 0.0 112.451 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -141.91 58.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.41 51.66 2.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.413 ' CD1' ' HD3' ' A' ' 10' ' ' ARG . 52.9 m-85 55.69 178.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.682 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.6 OUTLIER -165.56 143.59 5.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.86 96.22 9.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.925 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.829 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.6 t -93.83 114.67 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.369 0.604 . . . . 0.0 112.263 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.798 ' NE2' HG11 ' A' ' 5' ' ' VAL . 45.7 mt-30 -107.91 156.88 18.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.487 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.478 HD11 ' HB2' ' A' ' 106' ' ' MET . 51.0 mt -102.93 148.12 8.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.457 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.1 m-85 -109.69 117.71 34.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 111.242 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.479 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.3 t-160 -95.41 88.61 5.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.11 101.84 9.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.53 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 89.5 Cg_endo -83.05 -21.03 4.87 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.342 2.028 . . . . 0.0 112.634 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.8 m -48.31 -29.66 4.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.041 0.448 . . . . 0.0 110.611 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.17 6.88 4.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.288 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.2 49.28 9.34 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.196 0.522 . . . . 0.0 110.028 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -130.87 166.57 20.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.408 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.809 ' CE2' HD23 ' A' ' 113' ' ' LEU . 53.4 m-85 -131.58 167.92 18.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.841 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -155.54 148.42 24.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.054 0.454 . . . . 0.0 111.832 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 64' ' ' CYS . 3.4 m -109.66 123.41 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.673 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -131.9 119.4 41.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.829 0.347 . . . . 0.0 111.224 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -136.67 144.58 16.28 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.652 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 1.9 ptt85 -131.21 149.77 52.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.659 0.266 . . . . 0.0 110.751 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HB3' ' HG2' ' A' ' 55' ' ' GLN . 10.8 tptt -62.24 157.03 20.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.009 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 mmt -98.7 45.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.408 ' HG2' ' HB3' ' A' ' 53' ' ' LYS . 18.2 pt20 -121.5 160.93 44.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.795 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.05 -28.11 18.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.609 2.206 . . . . 0.0 112.435 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.52 -44.6 86.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 62.08 89.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.04 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 3.3 pt20 -131.46 150.12 52.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 60' ' ' VAL . 6.2 m -85.86 124.0 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.03 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.683 HG23 HG21 ' A' ' 13' ' ' VAL . 3.7 m -93.85 -24.43 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.751 HD12 ' CE3' ' A' ' 89' ' ' TRP . 15.9 tt -137.93 143.1 34.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.528 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -166.57 59.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.823 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.434 ' O ' HG22 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -119.53 140.37 50.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.726 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -83.51 134.41 34.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 111.475 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.497 HD13 ' SD ' ' A' ' 106' ' ' MET . 0.9 OUTLIER -113.03 127.33 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.84 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 67' ' ' VAL . 27.3 m -141.66 111.29 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.906 0.384 . . . . 0.0 111.52 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.683 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 27.22 48.17 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.0 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.27 -36.84 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.706 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.832 ' O ' HD22 ' A' ' 110' ' ' LEU . 2.5 t -91.08 141.81 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.472 . . . . 0.0 110.78 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.23 107.21 8.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.806 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 2.9 m-30 -53.55 118.3 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.69 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -93.94 -33.34 13.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.404 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 65.36 80.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.366 . . . . 0.0 110.601 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.65 -34.87 62.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.329 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.506 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 15.2 p -154.44 162.0 28.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.712 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 4.5 Cg_endo -46.78 -25.77 4.02 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.853 2.369 . . . . 0.0 112.307 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -122.12 35.21 4.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.216 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.421 ' HB2' ' OG1' ' A' ' 76' ' ' THR . 4.8 t80 -154.6 118.52 4.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 111.18 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.784 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.7 m80 -110.97 103.92 12.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.393 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.664 ' HG3' HG12 ' A' ' 88' ' ' VAL . 24.5 tt0 -113.07 144.63 42.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.362 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.761 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.4 p90 -144.88 161.26 39.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.708 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -118.57 114.96 23.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.498 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.431 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -93.66 -81.67 0.36 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.395 -178.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.85 -67.73 0.88 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.885 0.374 . . . . 0.0 111.287 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.2 ttm-85 -139.82 -0.59 1.69 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.777 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.62 163.37 19.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.908 0.385 . . . . 0.0 110.395 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.664 HG12 ' HG3' ' A' ' 81' ' ' GLN . 1.6 t -120.75 127.62 75.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.805 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.751 ' CE3' HD12 ' A' ' 62' ' ' ILE . 66.5 m95 -101.63 91.24 4.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.194 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.555 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -86.83 122.47 6.14 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.496 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.567 HD23 ' CH2' ' A' ' 82' ' ' TRP . 3.0 mm? -103.02 111.07 23.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.615 0.245 . . . . 0.0 111.51 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -92.63 104.85 17.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.289 0.566 . . . . 0.0 109.625 178.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.652 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 60.5 m-85 -77.69 164.19 25.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.255 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.77 -26.93 30.66 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.191 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.2 t -150.64 161.25 42.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.794 0.33 . . . . 0.0 110.617 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -25.5 61.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.253 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -58.69 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.079 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.53 -56.24 8.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.052 0.453 . . . . 0.0 110.62 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.652 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -49.16 -33.86 13.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.621 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.44 -30.92 65.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.319 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.633 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 7.2 tp60 -76.08 -50.45 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.267 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.501 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 12.1 t80 -49.08 -52.63 24.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.784 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -64.01 -31.38 72.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.827 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.45 -65.38 0.55 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.194 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.9 -47.77 79.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.552 -0.833 . . . . 0.0 111.945 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 1.02 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.7 tpt -48.77 -60.67 2.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.969 0.414 . . . . 0.0 110.576 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.65 -37.71 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.314 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -37.78 85.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.968 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.3 -53.7 40.03 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.876 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.02 HD21 ' HE3' ' A' ' 106' ' ' MET . 10.1 mt -63.65 -15.63 58.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.244 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -92.42 -27.0 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.547 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.96 1.48 45.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.24 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.809 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -113.2 -37.18 4.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.314 -179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -94.61 -28.79 15.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.829 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.503 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.833 0.349 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 m 63.58 -170.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.81 -173.85 4.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.949 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.0 m -93.93 139.15 31.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.965 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.663 HG11 ' NE2' ' A' ' 37' ' ' GLN . 41.9 t -89.78 151.37 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.461 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -103.59 -69.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.959 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 -178.47 4.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.875 0.369 . . . . 0.0 111.634 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.518 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 9.4 p -152.35 126.21 9.02 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.163 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 39.1 t -135.03 165.77 24.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.007 0.432 . . . . 0.0 111.609 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -106.51 121.38 44.18 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.804 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -166.77 175.6 7.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 111.129 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -114.84 95.43 5.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.32 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 26' ' ' ALA . 70.4 t -46.31 151.13 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.496 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -149.67 146.59 27.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.742 -179.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 4.0 mt -123.18 108.8 13.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.42 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 12.8 t80 -71.54 153.17 42.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.22 0.533 . . . . 0.0 111.959 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.83 88.58 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.23 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -53.34 -22.38 7.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.321 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.38 -34.9 69.4 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.621 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -132.77 13.99 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.666 0.27 . . . . 0.0 111.303 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.8 OUTLIER 51.02 83.75 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.819 0.342 . . . . 0.0 111.036 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 179.11 155.31 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.061 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.56 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 28.8 m95 -73.27 172.63 10.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.53 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.768 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -164.8 115.91 0.91 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.377 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.768 ' HD2' HD23 ' A' ' 24' ' ' LEU . 83.4 Cg_exo -41.01 94.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.802 2.335 . . . . 0.0 113.002 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.586 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -44.31 -44.03 7.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.679 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.56 -105.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.629 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.0 p -123.32 -79.38 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 111.022 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.78 -76.86 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -51.19 -178.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.617 2.211 . . . . 0.0 112.322 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.402 ' HA ' ' HE2' ' A' ' 53' ' ' LYS . 1.1 mt-30 -146.63 152.2 38.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.503 ' HB3' ' HD2' ' A' ' 53' ' ' LYS . . . -178.93 44.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.107 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 52.17 -175.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.418 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' ALA . 93.5 p -174.32 150.88 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.007 0.432 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -93.79 95.51 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.461 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.828 HG22 ' HA3' ' A' ' 51' ' ' GLY . 20.0 t -94.02 117.42 37.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.288 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.663 ' NE2' HG11 ' A' ' 5' ' ' VAL . 50.3 mt-30 -109.2 155.94 20.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.379 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 106' ' ' MET . 62.0 mt -101.02 149.01 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.391 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -112.97 119.91 39.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.99 0.424 . . . . 0.0 110.96 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.497 ' HA ' ' CD1' ' A' ' 47' ' ' PHE . 10.7 t-160 -93.58 103.2 15.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.583 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -105.14 84.54 1.07 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.672 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 74.5 Cg_endo -74.97 -22.47 14.84 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.349 2.032 . . . . 0.0 112.432 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.5 p -51.66 -30.43 21.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.085 0.469 . . . . 0.0 110.487 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -129.32 7.39 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.139 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 61.35 48.83 5.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.138 0.494 . . . . 0.0 110.178 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.04 155.77 49.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.323 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.812 ' CE2' HD23 ' A' ' 113' ' ' LEU . 51.8 m-85 -124.42 178.14 5.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.623 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.1 ttm180 -167.38 157.3 10.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.059 0.456 . . . . 0.0 111.592 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.424 HG23 HG12 ' A' ' 62' ' ' ILE . 6.6 m -120.27 125.66 74.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.035 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.18 125.93 52.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.215 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.828 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -140.32 146.51 17.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.756 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -127.5 151.82 48.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.895 0.379 . . . . 0.0 111.146 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HD2' ' HB3' ' A' ' 32' ' ' ALA . 21.2 mmtp -55.58 158.88 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.8 mtp -98.81 45.39 1.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.569 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -130.44 163.24 49.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.706 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.01 -22.09 29.47 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.621 2.214 . . . . 0.0 112.445 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -43.71 76.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.921 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 63.69 84.08 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -120.78 128.48 52.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.557 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 60' ' ' VAL . 5.8 m -70.96 120.09 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 0.0 110.631 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.554 HG23 HG21 ' A' ' 13' ' ' VAL . 3.1 m -93.67 -21.94 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.229 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.719 HD12 ' CE3' ' A' ' 89' ' ' TRP . 10.4 tt -138.67 139.7 40.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.376 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -165.34 69.13 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.025 0.44 . . . . 0.0 110.899 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 24.4 p -135.2 136.96 42.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -80.32 138.62 36.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.405 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -112.99 167.88 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 110.813 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 66' ' ' ILE . 21.4 m -156.5 -171.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.485 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.784 ' H ' HD12 ' A' ' 113' ' ' LEU . 9.6 ttt180 -60.3 83.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.287 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 67' ' ' VAL . . . -177.59 -32.7 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.571 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.859 HG13 ' HB2' ' A' ' 82' ' ' TRP . 3.2 t -82.43 133.31 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 117.342 0.571 . . . . 0.0 111.215 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.31 105.82 10.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.634 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.587 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.0 OUTLIER -53.88 104.4 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.284 -179.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -93.93 95.4 9.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.614 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.82 87.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.39 81.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.936 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 4.4 p -152.68 160.84 30.59 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.227 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.553 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 1.1 Cg_endo -43.28 -28.07 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.764 2.31 . . . . 0.0 112.377 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -128.74 57.76 1.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.76 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.0 t80 -166.47 113.19 0.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.149 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.887 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 2.7 m80 -111.21 101.99 10.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.043 0.449 . . . . 0.0 110.541 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.654 ' HG3' HG12 ' A' ' 88' ' ' VAL . 2.9 tt0 -108.41 156.42 19.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.036 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.859 ' HB2' HG13 ' A' ' 70' ' ' VAL . 46.7 p90 -156.4 151.82 26.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.347 0.594 . . . . 0.0 112.047 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.19 111.3 20.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.21 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 5.4 t0 -93.53 -90.92 0.19 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.353 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.02 -68.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.131 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -147.11 -4.01 0.55 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.669 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -105.34 179.98 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.342 . . . . 0.0 110.341 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.654 HG12 ' HG3' ' A' ' 81' ' ' GLN . 1.6 t -136.72 115.87 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.542 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.719 ' CE3' HD12 ' A' ' 62' ' ' ILE . 75.4 m95 -93.62 99.35 11.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.019 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.497 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -93.52 119.15 5.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.707 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.584 HD11 HG22 ' A' ' 13' ' ' VAL . 3.4 mm? -103.74 108.95 20.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.573 0.225 . . . . 0.0 111.506 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.42 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.83 107.68 19.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 110.108 178.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.804 ' CD1' ' HB2' ' A' ' 11' ' ' ALA . 66.9 m-85 -78.09 161.91 27.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.119 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.69 -28.52 9.46 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.383 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.8 m -135.66 163.21 30.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.321 . . . . 0.0 110.769 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -63.86 -32.93 74.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -64.73 -53.17 51.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -48.58 -62.1 1.68 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.914 0.387 . . . . 0.0 110.469 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -46.17 -38.92 8.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.49 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.12 -29.45 62.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.488 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.626 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 7.1 tp60 -75.9 -49.63 17.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.529 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 6.6 t80 -51.66 -53.45 38.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.112 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.887 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -61.94 -31.91 72.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 110.741 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.94 -66.69 0.37 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.061 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.08 -40.39 98.09 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.639 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.904 ' CE ' HD21 ' A' ' 110' ' ' LEU . 16.9 tpt -51.64 -58.54 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.97 0.414 . . . . 0.0 110.422 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.49 -37.92 5.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.905 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 t -64.98 -38.21 90.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.948 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -64.51 -53.19 51.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.908 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.904 HD21 ' CE ' ' A' ' 106' ' ' MET . 11.3 mt -65.46 -18.32 65.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.103 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -96.19 -21.37 17.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.712 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . . . -96.22 -3.43 44.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.348 0.594 . . . . 0.0 109.716 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.812 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -112.37 -27.94 8.09 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.252 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.477 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 41.3 mt-10 -87.94 -34.44 18.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.535 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.337 -1.257 . . . . 0.0 112.523 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 mtm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.6 p -66.07 114.03 4.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -72.85 -174.96 1.59 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.8 m -116.06 147.32 41.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.945 0.402 . . . . 0.0 111.405 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 24.4 t -89.28 159.75 2.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.393 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.487 HG13 HG22 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -112.32 -67.53 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.585 ' SG ' HD12 ' A' ' 38' ' ' ILE . 13.4 p -119.93 178.68 4.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.891 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -157.79 112.21 2.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.586 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 8.4 t -128.68 159.39 35.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 112.056 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -103.15 123.83 47.44 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.206 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.603 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -168.17 -173.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 111.24 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.4 m -120.72 93.25 3.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.174 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.694 HG21 HG23 ' A' ' 61' ' ' VAL . 54.3 t -43.43 154.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.245 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.485 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -152.06 158.79 43.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.621 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.524 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 2.4 mt -137.44 108.08 6.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.53 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 9.4 t80 -68.23 154.1 42.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.319 0.581 . . . . 0.0 111.949 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.24 81.8 2.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.06 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -48.33 -25.81 1.75 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.466 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.6 -28.99 57.16 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.528 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -134.53 10.59 3.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.613 0.244 . . . . 0.0 111.325 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.86 81.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.926 0.393 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.447 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 177.67 159.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.913 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 25.3 m95 -75.92 171.67 14.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.611 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.677 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -163.19 119.12 1.18 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.541 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.677 ' HD2' HD23 ' A' ' 24' ' ' LEU . 92.8 Cg_exo -43.18 93.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.682 2.254 . . . . 0.0 112.951 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -44.92 -51.55 9.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.617 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -46.6 -96.4 0.01 OUTLIER Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.088 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.71 -82.79 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.297 . . . . 0.0 111.185 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.08 -94.3 0.87 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.562 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.3 166.19 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.541 2.16 . . . . 0.0 112.16 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 0.7 OUTLIER -144.8 165.56 27.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.203 0.525 . . . . 0.0 111.473 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 173.28 43.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.583 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 62.53 -176.26 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' ALA . 2.0 t -175.04 153.91 1.72 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.741 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.68 96.83 10.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.82 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.9 t -97.43 122.7 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.066 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.499 ' NE2' HG11 ' A' ' 5' ' ' VAL . 15.9 mt-30 -114.02 172.22 7.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.384 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.585 HD12 ' SG ' ' A' ' 7' ' ' CYS . 68.7 mt -116.87 156.37 18.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.165 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.538 ' CE1' HG21 ' A' ' 50' ' ' VAL . 7.6 m-85 -114.75 120.12 38.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.0 111.466 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.481 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 12.9 t60 -93.71 86.62 5.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.74 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.81 96.83 7.06 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.843 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 74.3 Cg_endo -84.53 -23.18 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.54 2.16 . . . . 0.0 112.624 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.4 t -47.85 -30.6 4.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.946 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.85 -5.22 9.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.399 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.05 43.01 0.7 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.089 0.471 . . . . 0.0 110.207 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.51 171.91 13.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.817 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.478 ' CD1' HD11 ' A' ' 6' ' ' ILE . 65.0 m-85 -134.45 177.99 7.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.862 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 0.7 OUTLIER -163.12 149.51 12.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.129 0.49 . . . . 0.0 111.63 -179.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.653 HG13 HG12 ' A' ' 62' ' ' ILE . 3.9 p -109.09 135.01 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.098 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.538 HG21 ' CE1' ' A' ' 39' ' ' TYR . 2.1 t -140.3 121.52 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.736 0.303 . . . . 0.0 111.306 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.82 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -143.62 147.45 18.79 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.85 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -132.47 150.78 52.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.757 0.313 . . . . 0.0 110.87 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.567 ' NZ ' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -58.46 163.44 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 17.1 mtp -106.71 46.76 0.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.414 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 7.7 pt20 -126.91 160.88 56.84 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.784 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 55' ' ' GLN . 87.8 Cg_exo -47.55 -26.45 6.38 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.753 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.89 -44.98 68.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.829 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.91 93.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -134.38 136.86 43.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 60' ' ' VAL . 16.7 m -70.82 121.8 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.368 . . . . 0.0 110.863 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.694 HG23 HG21 ' A' ' 13' ' ' VAL . 3.9 m -93.75 -24.39 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.653 HG12 HG13 ' A' ' 49' ' ' VAL . 9.6 tt -138.28 135.28 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.471 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -161.9 71.88 0.37 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.917 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 18.0 t -136.81 144.9 43.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.037 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -83.82 130.91 34.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.48 ' O ' HD11 ' A' ' 113' ' ' LEU . 1.5 pt -102.72 117.0 47.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.869 0.366 . . . . 0.0 111.193 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.637 ' C ' HD13 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -106.43 165.95 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.521 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.675 ' H ' HD22 ' A' ' 113' ' ' LEU . 60.5 ttp85 -44.02 100.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.106 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.15 -23.52 0.21 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.087 -1.054 . . . . 0.0 113.847 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.56 HG11 ' CD1' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -100.09 123.54 53.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 117.617 0.709 . . . . 0.0 111.162 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.797 ' HA ' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -121.05 134.93 55.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.824 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.9 m-30 -67.6 126.75 30.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -95.09 -33.05 12.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 58.63 78.9 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.804 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.72 75.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.311 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 6.0 p -139.61 166.61 22.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.716 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 76.3 Cg_exo -51.02 -24.41 14.14 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.44 2.093 . . . . 0.0 112.368 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -120.71 33.09 5.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -148.43 125.22 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.959 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.775 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 13.3 m-70 -125.22 98.71 5.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.295 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -112.76 146.59 38.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.768 -178.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.592 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 26.2 p90 -144.07 144.06 31.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.796 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.569 ' HG2' HG22 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -86.39 103.11 14.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.712 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.94 130.6 53.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 60.46 -82.57 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.725 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.44 -30.03 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.302 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -93.75 -168.89 1.98 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.884 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' A' ' 83' ' ' ARG . 2.4 t -137.07 129.68 43.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.977 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.598 ' CE3' HD12 ' A' ' 62' ' ' ILE . 74.2 m95 -97.61 100.89 12.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.182 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.46 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -94.44 130.87 10.48 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.566 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 11' ' ' ALA . 3.0 mm? -114.92 111.54 21.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.808 0.337 . . . . 0.0 111.857 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.481 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -92.89 110.75 22.21 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.647 ' CD1' ' HB2' ' A' ' 99' ' ' ALA . 36.5 m-85 -86.69 159.79 19.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.331 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.66 -27.7 49.96 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.348 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 p -149.06 178.71 8.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.815 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -29.0 63.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.33 -56.87 12.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.999 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -52.21 -55.81 18.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.977 0.418 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.647 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -57.16 -28.15 62.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.276 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.85 63.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 18.5 tp60 -76.39 -42.45 44.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.029 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 5.9 t80 -54.28 -48.42 71.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.775 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -65.47 -34.57 78.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.871 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.88 -65.5 0.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.53 -50.5 61.54 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.957 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.84 ' CE ' HD21 ' A' ' 110' ' ' LEU . 11.7 tpt -47.72 -60.98 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 110.661 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.57 -33.63 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.343 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -33.88 69.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.079 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 106' ' ' MET . . . -68.56 -42.26 78.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.524 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.84 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -75.51 -29.48 59.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.063 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -75.32 -25.42 57.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.36 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.14 -3.72 27.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.513 0.673 . . . . 0.0 109.481 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 68' ' ' ARG . 4.2 mt -90.05 -42.56 11.05 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.131 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.76 -33.84 11.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.68 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.403 -1.22 . . . . 0.0 112.492 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ttp . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.797 0.332 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.69 126.07 31.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.053 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.524 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 1.3 mp0 -71.02 -169.55 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.1 m -110.85 126.57 54.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.637 HG11 ' NE2' ' A' ' 37' ' ' GLN . 29.4 t -76.54 151.15 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.48 HG13 HG22 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -107.45 -68.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 38' ' ' ILE . 24.2 p -115.33 176.98 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.55 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.62 113.21 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.87 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 42.2 t -129.67 152.76 48.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.018 0.437 . . . . 0.0 111.879 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -95.13 130.63 41.76 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.031 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -176.29 161.14 2.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 0.0 111.688 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.2 m -93.76 83.93 4.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.741 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.677 HG12 ' HB3' ' A' ' 26' ' ' ALA . 88.0 t -40.12 140.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.311 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.544 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -129.62 179.08 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.361 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 88' ' ' VAL . 5.8 tp -160.64 113.78 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 0.0 110.225 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 8.7 t80 -73.53 149.3 42.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.392 0.615 . . . . 0.0 112.565 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.62 87.21 2.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.931 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -49.11 -23.53 1.27 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.618 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -50.64 -48.67 42.62 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.771 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -123.69 16.3 9.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.65 0.262 . . . . 0.0 111.164 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 1.1 mtmm 52.06 87.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 111.17 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' N ' ' CZ ' ' A' ' 16' ' ' TYR . 0.1 OUTLIER 178.01 161.91 0.59 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.036 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.546 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 20.5 m95 -80.91 171.14 15.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.566 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.485 HD23 ' HD2' ' A' ' 25' ' ' PRO . 4.6 mt -167.17 125.59 1.03 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.541 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.485 ' HD2' HD23 ' A' ' 24' ' ' LEU . 89.3 Cg_exo -43.83 102.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.587 2.191 . . . . 0.0 112.622 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.677 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -50.01 -38.47 37.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.384 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.81 -119.96 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.705 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.58 -68.04 0.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.852 0.358 . . . . 0.0 111.27 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.5 -72.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.769 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -47.95 167.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -145.53 56.62 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.026 0.441 . . . . 0.0 111.279 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.65 50.64 1.61 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.281 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 59.95 -176.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.433 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.92 142.64 2.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.0 OUTLIER -93.85 94.34 8.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.055 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.779 HG22 ' HA3' ' A' ' 51' ' ' GLY . 39.2 t -93.85 146.14 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.342 0.591 . . . . 0.0 112.011 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.637 ' NE2' HG11 ' A' ' 5' ' ' VAL . 17.3 mt-30 -138.18 170.19 16.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.56 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 106' ' ' MET . 90.9 mt -112.06 153.9 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.301 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.524 ' CD2' ' HB2' ' A' ' 3' ' ' GLU . 3.5 m-85 -112.12 119.05 37.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.905 0.383 . . . . 0.0 111.785 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.514 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 23.2 t-160 -93.72 92.23 7.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.676 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -101.81 87.03 0.91 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.722 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 73.4 Cg_endo -74.32 -21.51 17.43 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.293 1.995 . . . . 0.0 112.465 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -48.85 -29.28 4.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.041 0.448 . . . . 0.0 110.568 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.87 8.29 4.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.231 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.468 ' O ' HD21 ' A' ' 113' ' ' LEU . 0.1 OUTLIER 59.71 49.2 8.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.207 0.527 . . . . 0.0 109.9 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.46 ' HA ' HG12 ' A' ' 67' ' ' VAL . 5.7 t -129.45 163.82 25.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.335 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.727 ' CE2' HD23 ' A' ' 113' ' ' LEU . 51.6 m-85 -133.5 169.14 17.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.656 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 2.0 ttm180 -165.1 148.61 8.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.871 0.367 . . . . 0.0 111.738 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.606 HG23 HG12 ' A' ' 62' ' ' ILE . 7.0 m -104.79 129.34 57.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.489 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.517 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -135.27 123.66 39.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.244 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.779 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -146.46 146.24 16.03 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.862 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -126.49 158.64 35.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 172.92 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.815 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.449 ' HE2' ' HB2' ' A' ' 35' ' ' ARG . 0.7 OUTLIER -108.51 47.52 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -128.27 158.13 72.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.12 -27.86 18.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.641 2.227 . . . . 0.0 112.454 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -42.24 85.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 60.19 99.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -135.98 132.71 36.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.761 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 60' ' ' VAL . 12.4 m -70.42 120.94 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.045 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.641 ' CG2' HG21 ' A' ' 13' ' ' VAL . 5.9 m -93.84 -21.92 5.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.235 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.606 HG12 HG23 ' A' ' 49' ' ' VAL . 9.9 tt -138.04 134.05 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.479 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -160.16 63.67 0.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.943 0.402 . . . . 0.0 110.86 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.1 t -124.62 139.99 53.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.967 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -87.02 150.38 24.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.349 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.471 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -130.46 141.47 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 46' ' ' SER . 15.2 m -152.35 110.89 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.665 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.581 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 26.62 47.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.33 179.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.12 -27.7 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.177 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.843 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.6 t -100.14 138.88 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 111.338 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.8 tmmt? -126.35 110.61 13.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.569 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.479 ' CE2' ' HG2' ' A' ' 106' ' ' MET . 1.5 m-30 -51.02 132.67 27.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.412 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.88 97.49 5.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.79 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.09 104.23 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.936 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.92 -34.66 64.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.022 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.4 p -150.28 174.36 3.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.524 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 65.3 Cg_exo -51.78 -24.54 18.52 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.382 2.055 . . . . 0.0 112.354 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -140.37 69.95 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.961 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -173.67 128.27 0.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.737 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 32.1 m170 -117.04 146.89 42.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.714 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -154.91 138.25 15.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.984 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.843 ' HB2' HG13 ' A' ' 70' ' ' VAL . 15.5 p90 -145.96 142.05 28.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.145 0.498 . . . . 0.0 111.935 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.406 ' HD3' HG22 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -104.32 111.32 23.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.209 178.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.413 ' HB2' HG21 ' A' ' 70' ' ' VAL . 14.8 t70 -93.78 -93.43 0.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.608 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.18 -70.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.981 0.42 . . . . 0.0 111.402 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.01 -7.18 1.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.63 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 -168.86 1.43 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 110.621 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.714 HG12 ' HG2' ' A' ' 81' ' ' GLN . 0.9 OUTLIER -143.04 120.15 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.048 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.605 ' CZ3' ' HB1' ' A' ' 26' ' ' ALA . 59.1 m95 -92.69 105.76 17.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.249 0.547 . . . . 0.0 110.74 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.546 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -106.95 174.36 19.88 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.664 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' ' 80' ' ' HIS . 1.1 pt? -177.69 139.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.194 0.521 . . . . 0.0 111.54 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.406 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -103.19 121.37 42.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.404 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 53.4 m-85 -85.46 160.25 19.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.117 0.484 . . . . 0.0 111.785 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.55 -27.51 63.16 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.31 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.63 169.97 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 110.775 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -26.01 65.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.038 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.15 -49.21 62.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.6 -55.58 32.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.072 0.463 . . . . 0.0 110.056 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.694 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -56.31 -29.17 60.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.367 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -31.22 64.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.384 . . . . 0.0 111.174 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 31.2 tp60 -78.47 -43.41 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.144 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 5.1 t80 -54.41 -45.94 73.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.206 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.737 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -72.22 -29.31 63.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.69 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -47.28 -64.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.074 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.43 -49.17 58.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.995 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 1.059 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.3 tpt -49.19 -60.74 2.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.393 . . . . 0.0 110.611 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.95 -37.4 3.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.313 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -36.67 79.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.031 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.619 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.13 -51.95 58.14 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.679 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.059 HD21 ' HE3' ' A' ' 106' ' ' MET . 6.8 mt -63.59 -18.07 63.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.873 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -94.85 -25.59 16.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.567 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.46 1.3 51.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.307 0.575 . . . . 0.0 110.083 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.727 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -112.42 -33.54 6.15 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.213 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -87.18 -32.77 19.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.322 -1.266 . . . . 0.0 112.434 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.814 0.34 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.3 p -58.73 -169.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.049 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.06 -169.31 2.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.794 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.4 m -129.34 106.51 8.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.983 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.727 HG11 ' NE2' ' A' ' 37' ' ' GLN . 44.0 t -60.66 146.66 10.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.658 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.521 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -98.23 -68.98 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.826 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -132.78 -175.41 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.505 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.51 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 14.9 p -153.36 118.11 5.02 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.199 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 7.2 p -120.26 159.98 23.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.121 0.486 . . . . 0.0 111.876 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -107.16 118.77 37.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.564 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -167.69 -171.88 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.09 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 92' ' ' ASN . 3.4 m -123.52 90.62 3.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.16 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.564 HG21 HG23 ' A' ' 61' ' ' VAL . 69.5 t -42.26 148.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.065 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.509 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -143.65 163.8 32.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.065 -178.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.534 HD21 ' CE2' ' A' ' 89' ' ' TRP . 5.1 mt -136.58 112.0 9.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.454 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.6 t80 -75.93 147.39 38.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.244 0.545 . . . . 0.0 111.934 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.8 89.79 3.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.15 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -52.79 -21.65 4.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.464 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.85 -50.76 48.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.62 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -125.08 18.23 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.677 0.275 . . . . 0.0 111.141 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 7.9 mtpt 51.49 91.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.155 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 177.89 151.92 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.585 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 20.6 m95 -76.22 167.94 20.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.565 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.7 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.6 mt -160.33 129.7 3.24 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.532 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.7 ' HD2' HD23 ' A' ' 24' ' ' LEU . 87.8 Cg_exo -47.73 94.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.554 2.17 . . . . 0.0 112.903 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.536 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -46.07 -42.94 14.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.464 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.32 -110.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.82 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 t -126.85 -52.82 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 111.253 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.44 -82.68 0.04 OUTLIER Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.693 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -47.7 168.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.576 2.184 . . . . 0.0 112.364 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 5.1 mt-30 -142.11 154.28 44.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.165 0.507 . . . . 0.0 111.322 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 175.57 44.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.954 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 56.71 175.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.618 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 11' ' ' ALA . 27.2 m -166.5 152.35 8.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.636 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -93.79 97.63 10.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.705 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.658 HG22 ' HA3' ' A' ' 51' ' ' GLY . 24.1 t -93.74 122.11 44.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.294 0.568 . . . . 0.0 112.092 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.727 ' NE2' HG11 ' A' ' 5' ' ' VAL . 47.1 mt-30 -116.2 154.82 29.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.763 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 106' ' ' MET . 41.8 mt -103.36 151.0 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.61 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.28 122.48 47.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.047 0.451 . . . . 0.0 111.525 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.49 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 16.6 t-160 -101.13 91.33 4.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.113 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -101.55 88.51 1.19 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.508 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 63.0 Cg_endo -72.43 -19.55 24.99 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.34 2.027 . . . . 0.0 112.554 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.3 m -52.01 -26.66 11.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.664 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.44 8.56 5.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.84 49.32 14.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.042 0.449 . . . . 0.0 110.266 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.526 ' HA ' HG12 ' A' ' 67' ' ' VAL . 71.4 m -136.22 165.4 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.29 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.773 ' CE2' HD23 ' A' ' 113' ' ' LEU . 56.9 m-85 -134.32 173.24 11.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.609 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.649 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 7.2 ttp180 -165.8 150.78 8.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.421 . . . . 0.0 111.56 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.674 HG13 HG12 ' A' ' 62' ' ' ILE . 5.8 p -106.71 135.55 44.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.239 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.91 118.95 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.974 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.658 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -138.3 143.56 14.47 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.934 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -126.09 148.91 49.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.749 0.309 . . . . 0.0 110.802 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -57.57 168.89 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -108.2 45.37 1.02 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -128.25 161.67 55.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.61 -31.03 23.49 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.668 2.246 . . . . 0.0 112.642 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -45.85 90.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.04 91.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.876 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -131.3 136.08 47.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.668 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 60' ' ' VAL . 13.2 m -72.71 122.01 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.735 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.564 HG23 HG21 ' A' ' 13' ' ' VAL . 3.3 m -93.71 -20.58 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.24 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.674 HG12 HG13 ' A' ' 49' ' ' VAL . 8.8 tt -140.59 138.79 35.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.626 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -163.38 69.44 0.21 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.689 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.408 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -131.56 135.03 46.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.889 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.649 ' HB2' ' HD3' ' A' ' 48' ' ' ARG . . . -78.02 141.11 39.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.593 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.539 HD13 ' SD ' ' A' ' 106' ' ' MET . 0.9 OUTLIER -120.87 124.76 73.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.781 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 46' ' ' SER . 16.1 m -138.59 110.06 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.904 0.383 . . . . 0.0 111.579 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.761 ' N ' HD12 ' A' ' 113' ' ' LEU . 1.1 ttt180 29.62 73.47 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.997 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.67 -36.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 119.76 -1.21 . . . . 0.0 113.612 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.818 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.8 t -87.95 139.1 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.032 0.444 . . . . 0.0 111.519 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.16 97.88 5.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.168 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.563 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.7 m-30 -43.99 115.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.713 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -111.46 93.0 4.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.878 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.32 92.44 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.035 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.7 90.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.979 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.519 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 2.7 p -134.57 159.23 73.0 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.335 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 1.2 Cg_endo -44.06 -27.48 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.881 2.388 . . . . 0.0 112.561 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -123.8 47.63 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 111.082 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.406 ' HB2' ' OG1' ' A' ' 76' ' ' THR . 1.5 t80 -155.24 141.71 18.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.955 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.68 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 15.6 m-70 -136.34 93.42 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.468 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 1.2 tm0? -104.19 140.58 37.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.213 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.818 ' HB2' HG13 ' A' ' 70' ' ' VAL . 48.7 p90 -143.07 147.28 34.79 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.144 0.497 . . . . 0.0 111.684 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.563 ' HG3' HG22 ' A' ' 88' ' ' VAL . 3.8 ttm180 -106.99 113.02 26.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.335 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.452 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 4.4 t70 -93.69 -91.05 0.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.78 -67.92 0.75 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 111.36 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -141.63 -8.08 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.512 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.54 -175.41 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.617 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' A' ' 83' ' ' ARG . 2.0 t -138.22 130.21 38.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.493 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.657 ' CE3' HD12 ' A' ' 62' ' ' ILE . 61.1 m95 -105.14 99.48 9.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.547 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -90.78 125.92 8.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.773 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.636 HD23 ' CH2' ' A' ' 82' ' ' TRP . 3.4 mm? -107.08 109.8 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.511 0.196 . . . . 0.0 111.43 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.508 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -92.58 109.42 20.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.404 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 11' ' ' ALA . 14.7 m-85 -89.66 164.62 14.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.146 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.23 -40.74 5.39 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.555 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 162.33 25.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -31.13 70.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.946 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.37 -46.82 78.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -55.41 -58.86 6.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.961 0.41 . . . . 0.0 110.719 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.445 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -55.93 -34.15 65.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.083 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.41 -39.99 62.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.635 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 7.3 tp60 -67.12 -43.24 82.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.684 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.539 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 9.4 t80 -53.25 -51.87 60.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.904 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.68 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -65.1 -26.22 68.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.685 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -49.94 -62.92 1.29 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.898 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.57 -50.26 50.3 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.929 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 1.029 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.8 tpt -49.71 -60.96 2.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.943 0.401 . . . . 0.0 110.515 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.55 -36.78 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.139 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -41.47 91.0 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.674 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -61.05 -56.17 24.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.312 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.029 HD21 ' HE3' ' A' ' 106' ' ' MET . 8.0 mt -59.87 -20.48 57.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.946 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.54 -22.8 22.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.34 1.32 38.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.99 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.773 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -116.43 -32.7 5.17 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.131 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.453 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 21.0 mt-10 -105.34 -28.94 10.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.694 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.542 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.859 0.361 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -132.26 46.38 2.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.776 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 56.84 -172.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.2 m -143.1 112.45 6.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 22.0 t -57.62 148.08 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.481 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -101.32 -67.66 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.775 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.51 -176.76 4.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.778 0.323 . . . . 0.0 111.558 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.446 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -152.45 124.23 7.91 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.186 -179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.475 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 13.3 t -133.72 149.17 51.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.794 0.33 . . . . 0.0 111.606 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 8.4 ttm105 -93.88 127.34 39.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.985 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.612 ' HB2' ' CD1' ' A' ' 93' ' ' PHE . . . -169.21 -176.2 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.925 0.393 . . . . 0.0 111.38 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -118.4 92.39 3.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.435 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.587 HG22 HD11 ' A' ' 91' ' ' LEU . 53.4 t -44.59 154.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.038 0.447 . . . . 0.0 111.108 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.2 OUTLIER -152.77 143.42 22.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.978 -179.163 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.58 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 5.1 mt -120.67 114.4 21.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.311 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.2 t80 -72.43 151.74 42.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 111.738 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.74 86.66 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.305 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -52.1 -23.49 5.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.411 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.06 -42.07 86.57 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.285 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -126.98 15.62 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 110.82 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER 47.19 83.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.092 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.96 150.25 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.807 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.537 ' CH2' ' HA3' ' A' ' 90' ' ' GLY . 14.4 m95 -69.37 169.0 13.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.541 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.2 mt -165.44 114.17 0.82 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.508 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HD2' HD23 ' A' ' 24' ' ' LEU . 86.4 Cg_exo -41.7 100.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.695 2.263 . . . . 0.0 112.789 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.58 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -45.14 -43.97 10.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.536 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.99 -85.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.595 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.46 -80.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.744 0.307 . . . . 0.0 111.069 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -129.78 -70.0 0.12 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.543 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.42 170.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.554 2.169 . . . . 0.0 112.366 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -148.72 63.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.022 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.22 48.12 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 56.22 -178.03 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.707 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' ALA . 7.4 t -170.36 146.58 2.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.858 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -93.8 97.54 10.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.415 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.86 HG22 ' HA3' ' A' ' 51' ' ' GLY . 36.3 t -98.12 124.32 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.413 0.625 . . . . 0.0 112.022 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 55.5 mt-30 -115.06 160.59 19.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.419 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.538 HD13 ' HA ' ' A' ' 106' ' ' MET . 51.4 mt -108.51 147.45 13.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.32 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 50' ' ' VAL . 6.7 m-85 -108.43 118.22 36.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.0 0.429 . . . . 0.0 111.081 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.536 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 t-160 -93.78 87.9 5.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.798 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.27 98.34 5.6 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.538 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 68.4 Cg_endo -85.32 -22.43 2.65 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.366 2.044 . . . . 0.0 112.598 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.9 p -48.28 -30.69 5.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.951 0.405 . . . . 0.0 110.61 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -128.59 4.5 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.244 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.88 48.59 5.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.237 0.541 . . . . 0.0 110.077 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 m -132.9 152.05 51.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.212 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.865 ' CE2' HD23 ' A' ' 113' ' ' LEU . 52.3 m-85 -120.82 163.53 18.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 31.6 mtt180 -147.54 149.61 32.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.152 0.501 . . . . 0.0 111.916 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.458 HG23 HG12 ' A' ' 62' ' ' ILE . 5.4 m -113.0 120.6 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.362 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.5 t -128.82 120.77 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 0.0 111.617 -178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.86 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -141.92 149.82 21.49 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.596 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 157.56 46.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 0.0 110.944 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HD3' HG11 ' A' ' 61' ' ' VAL . 21.4 mmtt -68.85 159.15 33.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.7 mtt -101.88 47.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -119.66 162.11 34.36 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.867 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.88 -26.02 17.12 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.555 2.17 . . . . 0.0 112.435 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.32 -42.47 59.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 60.55 99.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.808 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -137.92 137.57 38.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 60' ' ' VAL . 20.6 m -71.65 121.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.949 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.433 HG23 HG21 ' A' ' 13' ' ' VAL . 3.2 m -93.69 -21.34 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.005 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.757 HD12 ' CE3' ' A' ' 89' ' ' TRP . 16.8 tt -140.38 135.57 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.527 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -159.36 60.17 0.39 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.937 0.399 . . . . 0.0 110.907 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.6 167.91 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -111.84 128.97 56.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.235 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.75 143.56 18.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.07 0.462 . . . . 0.0 111.22 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.97 -170.01 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.336 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.757 ' H ' HD12 ' A' ' 113' ' ' LEU . 4.9 ttt-85 -56.12 92.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.474 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.72 -26.8 0.13 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.928 -1.129 . . . . 0.0 113.758 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.603 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.2 t -94.84 122.62 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 117.412 0.606 . . . . 0.0 111.255 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.799 ' HA ' HD13 ' A' ' 110' ' ' LEU . 20.7 tptm -126.07 117.33 22.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.721 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.559 ' OH ' ' CE2' ' A' ' 102' ' ' PHE . 1.8 m-30 -50.46 127.07 16.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.018 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.77 -29.41 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.105 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.67 77.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 110.682 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -54.5 -39.76 67.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.264 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.7 p -150.85 173.51 4.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.431 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 78.4 Cg_exo -50.74 -24.85 13.96 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.384 2.056 . . . . 0.0 112.274 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -132.12 52.15 2.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.789 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.2 t80 -160.32 104.11 1.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.235 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.957 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 4.3 m80 -102.58 104.96 15.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.004 0.431 . . . . 0.0 110.824 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG2' HG12 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -115.99 144.1 44.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.159 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.629 ' CE2' ' HB2' ' A' ' 89' ' ' TRP . 27.4 p90 -143.51 147.48 34.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.115 0.484 . . . . 0.0 111.743 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -109.3 112.64 24.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.987 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.504 ' HB2' HG21 ' A' ' 70' ' ' VAL . 16.8 t70 -93.67 -96.32 0.15 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.807 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.94 -70.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.936 0.398 . . . . 0.0 111.362 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -137.64 -9.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.696 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -110.18 173.2 6.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.065 0.46 . . . . 0.0 110.923 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.445 HG12 ' HG2' ' A' ' 81' ' ' GLN . 3.4 t -129.04 130.46 68.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.271 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.757 ' CE3' HD12 ' A' ' 62' ' ' ILE . 71.0 m95 -105.39 97.27 7.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.31 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.537 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -91.16 122.63 6.79 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.383 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.587 HD11 HG22 ' A' ' 13' ' ' VAL . 2.5 mm? -106.01 111.57 24.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.826 -0.22 . . . . 0.0 111.489 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.66 103.25 15.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.333 0.587 . . . . 0.0 109.736 178.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.612 ' CD1' ' HB2' ' A' ' 11' ' ' ALA . 76.5 m-85 -72.85 154.17 40.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.95 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.89 -28.05 12.87 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.297 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 m -133.21 164.06 27.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.753 0.311 . . . . 0.0 110.797 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -29.78 70.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.019 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.79 -52.28 31.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.008 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -49.53 -57.25 7.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.421 . . . . 0.0 110.64 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -52.11 -41.83 62.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.546 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.29 -31.49 67.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.64 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.8 tp60 -75.28 -47.59 27.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.239 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.559 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 3.3 t80 -51.54 -52.27 48.42 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.957 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -61.4 -32.49 72.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.91 0.386 . . . . 0.0 110.628 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.3 -66.13 0.44 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.189 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.13 -45.59 70.64 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.762 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.898 ' CE ' HD21 ' A' ' 110' ' ' LEU . 12.6 tpt -47.97 -60.62 2.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.908 0.385 . . . . 0.0 110.413 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.67 -36.43 11.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.004 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 t -64.82 -34.17 77.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.11 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.552 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . . . -70.39 -51.25 31.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.589 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.898 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.7 OUTLIER -63.79 -18.14 63.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.183 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -98.52 -20.79 16.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.927 0.394 . . . . 0.0 111.88 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.75 -0.67 44.95 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.017 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.865 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -116.37 -32.79 5.16 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.315 -179.537 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 5.0 mt-10 -94.45 -28.07 15.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.53 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 mtm . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.789 0.328 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t 63.62 133.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.981 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -114.83 -176.88 3.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.3 m -96.34 142.18 28.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.16 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.591 HG11 ' NE2' ' A' ' 37' ' ' GLN . 65.2 t -88.7 158.6 3.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.477 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.625 HG13 HG22 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -112.82 -60.4 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.831 0.348 . . . . 0.0 111.931 -179.144 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 38' ' ' ILE . 10.0 p -129.34 177.32 7.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.798 -178.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.436 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.5 OUTLIER -157.98 110.55 2.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.638 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 102' ' ' PHE . 4.6 m -128.69 163.55 24.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.208 0.528 . . . . 0.0 112.206 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 45.3 ttt85 -105.67 127.7 53.22 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.81 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.863 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -169.85 -177.73 2.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 111.049 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -114.89 89.35 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.353 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.673 HG11 ' HB ' ' A' ' 62' ' ' ILE . 97.8 t -45.56 137.19 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.159 0.504 . . . . 0.0 111.077 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.506 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -136.24 161.24 36.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.789 -179.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 26' ' ' ALA . 5.0 mt -134.18 110.49 9.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.55 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.514 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 14.4 t80 -73.51 147.16 44.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.083 0.468 . . . . 0.0 111.672 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.67 88.04 2.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.356 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.45 -23.2 9.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.91 -36.18 72.02 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.545 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -133.83 13.44 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.664 0.269 . . . . 0.0 111.287 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 51.25 86.74 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.02 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.54 145.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.169 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 21.0 m95 -68.71 167.24 15.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.157 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.475 HD23 ' HD2' ' A' ' 25' ' ' PRO . 4.7 mt -161.3 131.55 3.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.689 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HD2' HD23 ' A' ' 24' ' ' LEU . 83.5 Cg_exo -45.85 92.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.643 2.228 . . . . 0.0 112.959 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.591 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -42.55 -66.66 0.34 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.772 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.61 -95.62 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.263 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.6 p -130.82 -85.03 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.657 0.265 . . . . 0.0 111.325 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.29 -88.38 0.35 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.708 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.32 161.95 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.616 2.211 . . . . 0.0 112.287 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -136.86 168.03 20.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.172 0.51 . . . . 0.0 111.594 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 31' ' ' GLN . . . 166.96 44.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.626 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 62.41 -176.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.297 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -173.99 165.15 4.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.84 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.554 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 5.1 tmm_? -107.87 94.31 5.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.962 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.806 HG22 ' HA3' ' A' ' 51' ' ' GLY . 35.7 t -93.78 125.52 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.309 0.576 . . . . 0.0 111.908 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.591 ' NE2' HG11 ' A' ' 5' ' ' VAL . 48.8 mt-30 -119.02 155.29 31.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.884 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.625 HG22 HG13 ' A' ' 6' ' ' ILE . 72.4 mt -104.81 149.25 8.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.488 ' HB2' ' HG2' ' A' ' 48' ' ' ARG . 16.9 m-85 -115.37 126.01 53.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.061 0.458 . . . . 0.0 111.366 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.465 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.5 t-160 -93.76 98.46 11.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.168 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -102.46 89.52 1.77 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 72.2 Cg_endo -74.98 -20.61 16.74 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.22 1.947 . . . . 0.0 112.454 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -48.4 -31.21 5.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.068 0.461 . . . . 0.0 110.587 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.97 6.93 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.224 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.98 48.17 5.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.045 0.45 . . . . 0.0 110.005 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.7 t -129.79 179.66 5.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.642 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.488 ' CG ' ' HB1' ' A' ' 109' ' ' ALA . 81.9 m-85 -149.56 166.52 28.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.525 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -160.38 152.59 20.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.0 0.429 . . . . 0.0 111.539 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 62' ' ' ILE . 8.1 m -107.04 128.62 61.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 2.2 t -132.41 118.31 35.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.976 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.806 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -138.82 147.13 19.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.072 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -128.66 157.82 40.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.695 0.283 . . . . 0.0 110.52 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.566 ' HD2' HG11 ' A' ' 61' ' ' VAL . 1.5 tptt -73.38 161.9 29.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.946 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.554 ' HE2' ' HB2' ' A' ' 35' ' ' ARG . 1.1 mmt -98.33 42.82 1.08 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.519 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -96.99 163.36 20.21 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.983 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.74 -18.42 33.69 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.212 1.941 . . . . 0.0 111.371 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.39 -36.39 8.45 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.671 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 62.66 125.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.051 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -145.39 137.11 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.639 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 60' ' ' VAL . 18.0 m -65.97 119.49 11.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.414 . . . . 0.0 111.224 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.566 HG11 ' HD2' ' A' ' 53' ' ' LYS . 3.8 m -93.88 -27.31 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.673 ' HB ' HG11 ' A' ' 13' ' ' VAL . 15.5 tt -138.19 132.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.559 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -159.51 67.38 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.939 0.399 . . . . 0.0 110.807 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.2 t -126.08 161.53 27.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.796 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -104.19 148.3 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.613 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.558 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -119.74 142.92 32.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.832 179.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 67' ' ' VAL . 17.6 m -146.96 112.21 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.489 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.515 ' H ' HD13 ' A' ' 113' ' ' LEU . 1.0 OUTLIER 22.22 76.19 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.336 179.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.74 -33.26 0.06 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 119.643 -1.265 . . . . 0.0 114.12 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -93.64 125.37 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.386 0.593 . . . . 0.0 111.568 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 147.5 32.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.081 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.578 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.7 OUTLIER -86.14 104.14 15.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 0.0 111.238 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.04 98.06 10.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.629 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.54 83.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.047 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.12 -28.57 40.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 0.0 110.85 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.504 HG22 ' HB3' ' A' ' 79' ' ' PHE . 3.8 t -166.01 150.63 7.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.086 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 56.3 Cg_exo -37.63 -29.25 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.048 2.499 . . . . 0.0 113.589 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -121.49 50.34 1.41 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.769 0.319 . . . . 0.0 111.547 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.504 ' HB3' HG22 ' A' ' 76' ' ' THR . 7.2 t80 -170.0 127.51 0.87 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 111.424 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.946 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -118.02 111.83 19.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.287 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.516 ' HG2' HG12 ' A' ' 88' ' ' VAL . 1.5 tm0? -119.15 131.22 55.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.554 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.692 ' CH2' HD23 ' A' ' 91' ' ' LEU . 43.8 p90 -138.07 142.25 40.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.207 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.423 ' O ' HG22 ' A' ' 70' ' ' VAL . 10.2 ttm180 -88.22 105.81 17.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.457 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 32.0 t70 -105.04 130.02 53.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.734 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 61.93 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.466 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -136.33 -31.29 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.419 ' HG3' HD22 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -93.88 -168.86 1.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.961 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.516 HG12 ' HG2' ' A' ' 81' ' ' GLN . 2.1 t -137.87 124.86 28.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.651 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.49 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 78.5 m95 -93.78 98.83 11.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.522 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.829 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -80.6 161.91 44.88 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.031 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.863 HD12 ' HB3' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -148.22 106.99 3.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.474 0.178 . . . . 0.0 110.95 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.41 104.76 17.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.225 0.536 . . . . 0.0 110.016 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.669 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 78.7 m-85 -71.56 162.85 28.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.928 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.33 -26.2 5.51 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.258 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.47 159.8 40.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.879 0.371 . . . . 0.0 110.802 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -60.97 -40.36 93.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.03 -44.24 97.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.104 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -51.76 -68.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.011 0.434 . . . . 0.0 110.474 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.669 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -47.2 -31.47 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.687 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.51 -36.42 57.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.787 0.327 . . . . 0.0 111.38 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.0 tp60 -77.65 -41.25 38.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.203 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.477 ' CE2' ' OH ' ' A' ' 72' ' ' TYR . 7.8 t80 -56.31 -50.78 70.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.014 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.946 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -65.46 -32.71 74.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.443 . . . . 0.0 110.867 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -47.03 -64.74 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.511 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.9 -51.87 49.86 Favored Glycine 0 CA--C 1.508 -0.354 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.159 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.941 ' CE ' HD21 ' A' ' 110' ' ' LEU . 12.2 tpt -46.68 -62.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.48 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.57 -33.27 2.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.451 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.38 -35.44 73.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.087 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.488 ' HB1' ' CG ' ' A' ' 47' ' ' PHE . . . -70.7 -46.35 63.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.721 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.941 HD21 ' CE ' ' A' ' 106' ' ' MET . 5.0 mt -67.68 -34.26 76.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.722 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -75.69 -20.38 58.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.19 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.17 2.68 29.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.601 0.715 . . . . 0.0 109.095 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.515 HD13 ' H ' ' A' ' 68' ' ' ARG . 6.9 mt -100.21 -38.37 8.53 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.954 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -105.36 -30.68 9.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.66 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.427 -1.207 . . . . 0.0 112.534 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.841 0.353 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 t -146.68 175.5 10.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.979 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.463 ' HB3' ' ND2' ' A' ' 41' ' ' ASN . 2.0 mp0 -97.22 -169.62 1.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.6 m -111.65 131.95 54.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.153 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 39' ' ' TYR . 52.4 t -84.56 158.33 3.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.559 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.488 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -103.59 -68.32 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.71 -179.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 -170.65 2.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.353 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.51 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 0.4 OUTLIER -156.76 122.54 4.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.201 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.498 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 1.5 p -128.83 153.56 47.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 111.751 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -97.84 127.43 43.78 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.707 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.821 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -171.44 -175.09 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 111.4 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -117.3 95.47 4.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.427 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.686 HG21 HG23 ' A' ' 61' ' ' VAL . 86.4 t -45.82 156.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.096 0.474 . . . . 0.0 111.249 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.475 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -154.64 161.84 41.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.245 -179.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 1.8 mt -139.03 110.87 7.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.753 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 8.8 t80 -70.92 152.43 43.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.25 0.548 . . . . 0.0 112.044 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -123.26 79.67 1.7 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.063 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -47.24 -26.03 1.1 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.491 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.08 -38.31 89.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.356 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -121.81 2.85 10.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.672 0.272 . . . . 0.0 111.246 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 58.5 82.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.824 0.345 . . . . 0.0 110.928 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' NH2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER 176.25 158.36 0.28 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.826 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.599 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 18.0 m95 -74.76 170.25 16.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 110.599 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -163.84 117.66 1.06 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.424 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.62 ' HD2' HD23 ' A' ' 24' ' ' LEU . 98.3 Cg_exo -42.93 93.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.662 2.241 . . . . 0.0 112.789 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB2' ' HG ' ' A' ' 15' ' ' LEU . . . -44.8 -54.07 6.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.648 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.39 -94.05 0.01 OUTLIER Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.813 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -142.12 -79.65 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.845 0.355 . . . . 0.0 111.038 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.51 -71.59 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.504 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.41 170.51 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.552 2.168 . . . . 0.0 112.325 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -153.36 59.05 0.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.04 0.447 . . . . 0.0 111.154 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.97 51.39 1.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.543 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 59.62 -175.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.648 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -176.71 147.74 0.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.533 -179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.67 99.74 12.1 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.842 HG22 ' HA3' ' A' ' 51' ' ' GLY . 47.5 t -98.15 125.8 51.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.329 0.585 . . . . 0.0 112.121 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.51 ' HG2' ' CB ' ' A' ' 8' ' ' SER . 49.0 mt-30 -115.36 156.4 25.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.191 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 106' ' ' MET . 45.3 mt -105.68 149.02 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.761 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CE1' HG22 ' A' ' 5' ' ' VAL . 6.6 m-85 -111.69 122.09 46.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.996 0.427 . . . . 0.0 111.396 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.574 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 15.9 t-160 -98.19 89.15 4.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.202 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 3' ' ' GLU . 2.4 m120 -97.41 99.77 6.89 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.755 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 79.4 Cg_endo -84.05 -21.62 3.81 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.331 2.021 . . . . 0.0 112.595 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.4 p -49.66 -32.66 13.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.945 0.402 . . . . 0.0 110.709 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.14 -2.23 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.327 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 67.53 45.05 1.61 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.19 0.519 . . . . 0.0 110.254 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.04 179.36 6.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.039 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.574 ' CD2' ' HA ' ' A' ' 40' ' ' HIS . 77.3 m-85 -142.07 179.99 6.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 1.1 ttp180 -164.95 150.38 9.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.073 0.463 . . . . 0.0 111.591 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.525 HG23 HG12 ' A' ' 62' ' ' ILE . 8.7 m -109.74 123.64 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.139 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.6 t -128.14 118.11 47.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.145 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.842 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -141.26 150.07 21.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.986 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -130.47 155.25 46.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.303 . . . . 0.0 110.613 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.38 165.76 7.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 10.4 mtp -107.12 47.13 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.915 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.24 163.5 29.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.29 -26.4 27.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.618 2.212 . . . . 0.0 112.503 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.88 -41.72 59.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.928 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 103.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.886 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -141.99 138.69 32.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 60' ' ' VAL . 17.2 m -68.73 118.72 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.981 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.686 HG23 HG21 ' A' ' 13' ' ' VAL . 3.2 m -93.77 -22.17 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.543 HD12 ' CE3' ' A' ' 89' ' ' TRP . 9.2 tt -137.79 131.01 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.51 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -158.99 69.16 0.46 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.878 0.37 . . . . 0.0 110.995 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.28 135.76 41.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -76.29 137.7 40.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.422 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.43 ' O ' HD11 ' A' ' 113' ' ' LEU . 1.0 OUTLIER -112.34 125.14 69.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.963 0.411 . . . . 0.0 111.095 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.712 ' C ' HD13 ' A' ' 113' ' ' LEU . 2.1 m -110.63 174.97 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.752 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.608 ' N ' HD22 ' A' ' 113' ' ' LEU . 23.4 ttm180 -48.55 94.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.054 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.24 -19.64 0.15 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.912 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.735 HG13 ' HB2' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -95.59 121.4 46.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 117.719 0.76 . . . . 0.0 111.142 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HA ' HD13 ' A' ' 110' ' ' LEU . 2.8 mmtt -108.04 175.48 5.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.294 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CE1' ' HG2' ' A' ' 106' ' ' MET . 0.4 OUTLIER -114.15 100.4 8.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 111.197 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.72 81.67 3.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.614 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.441 ' HG2' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -48.36 105.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.17 85.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -151.94 177.22 1.98 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 77.6 Cg_exo -50.53 -25.24 14.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.367 2.045 . . . . 0.0 112.131 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.87 65.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.781 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.6 t80 -168.16 109.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.944 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 3.3 m80 -108.66 119.46 39.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.9 0.381 . . . . 0.0 110.496 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.735 HE21 HG11 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -122.66 148.18 45.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.265 -179.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.735 ' HB2' HG13 ' A' ' 70' ' ' VAL . 32.9 p90 -147.24 133.55 19.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.684 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' O ' HG22 ' A' ' 70' ' ' VAL . 47.6 ttp85 -80.09 100.3 8.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.385 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 85' ' ' ALA . 20.4 t0 -102.08 125.0 48.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.175 0.512 . . . . 0.0 110.676 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 84' ' ' ASP . . . 68.24 -79.01 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.544 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -139.38 -34.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -93.86 -168.13 1.82 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.735 HG11 HE21 ' A' ' 81' ' ' GLN . 11.4 t -137.41 136.03 46.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.947 0.403 . . . . 0.0 111.073 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.612 ' HB2' ' CE2' ' A' ' 82' ' ' TRP . 68.1 m95 -100.62 99.08 9.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.076 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.517 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -87.04 131.55 10.64 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.386 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.821 HD12 ' HB3' ' A' ' 11' ' ' ALA . 2.0 mm? -115.82 113.72 23.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.277 . . . . 0.0 111.691 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.408 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.94 105.47 17.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.206 0.527 . . . . 0.0 109.673 178.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 80' ' ' HIS . 78.1 m-85 -73.53 153.94 40.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.952 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.98 -28.07 7.96 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.274 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 m -129.29 165.19 21.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 0.0 110.808 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.85 -28.52 66.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.064 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -71.57 -49.31 41.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -49.99 -58.71 4.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.992 0.425 . . . . 0.0 110.738 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -51.39 -41.65 60.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.686 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.54 -34.97 65.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.501 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.667 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 6.4 tp60 -73.99 -45.23 51.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.001 0.429 . . . . 0.0 111.24 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.498 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 2.7 t80 -52.62 -53.87 41.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.97 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.944 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -60.65 -31.71 70.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.423 . . . . 0.0 110.596 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.28 -66.33 0.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.197 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.57 -43.58 76.1 Favored Glycine 0 CA--C 1.507 -0.426 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.931 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.901 ' CE ' HD21 ' A' ' 110' ' ' LEU . 13.8 tpt -47.58 -59.55 3.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.908 0.385 . . . . 0.0 110.36 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 111' ' ' GLU . . . -47.5 -41.34 20.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.741 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -34.41 72.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.358 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . . . -70.95 -44.69 65.56 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 121.035 0.445 . . . . 0.0 110.725 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.901 HD21 ' CE ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -72.71 -34.04 66.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.486 -179.346 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 1.9 tt0 -75.1 -22.63 58.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.964 0.411 . . . . 0.0 111.45 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.39 -3.52 28.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.675 0.75 . . . . 0.0 109.088 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.712 HD13 ' C ' ' A' ' 67' ' ' VAL . 5.4 mt -92.21 -41.64 10.32 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.6 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -99.66 -31.23 11.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.852 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.506 179.937 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.797 0.332 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 p -140.5 140.27 35.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -143.82 -170.53 3.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.107 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.0 m -121.87 123.78 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.637 HG11 ' NE2' ' A' ' 37' ' ' GLN . 34.9 t -73.85 153.81 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.638 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.44 HG13 ' C ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -103.53 -69.48 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 -176.73 3.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.029 0.443 . . . . 0.0 111.935 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.535 ' CB ' ' HG2' ' A' ' 37' ' ' GLN . 6.2 p -155.89 121.91 5.05 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.065 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 38.7 t -134.23 155.77 49.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.971 0.415 . . . . 0.0 111.71 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.6 ttp85 -97.85 128.79 44.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.454 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.642 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -170.92 -175.89 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.217 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 m -119.53 96.85 5.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.415 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.711 HG21 HG23 ' A' ' 61' ' ' VAL . 41.1 t -48.88 151.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.116 0.484 . . . . 0.0 111.153 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 89' ' ' TRP . 0.6 OUTLIER -151.64 144.9 24.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.578 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.486 ' HG ' ' HB2' ' A' ' 26' ' ' ALA . 3.6 mt -121.8 116.22 24.06 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 13.7 t80 -81.19 141.35 34.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.145 0.497 . . . . 0.0 112.017 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.538 ' OD1' HD12 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -117.1 84.95 2.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.577 178.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.77 -23.55 4.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.609 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.17 -27.96 7.83 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.263 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -142.73 16.78 1.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.721 0.296 . . . . 0.0 110.947 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER 48.19 87.1 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.93 0.395 . . . . 0.0 111.291 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.47 142.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.747 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 35.2 m95 -61.39 -178.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.538 HD12 ' OD1' ' A' ' 17' ' ' ASP . 3.0 mt -177.01 114.11 0.25 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.218 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -40.92 99.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.816 2.344 . . . . 0.0 112.917 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -44.03 -40.33 4.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.68 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.92 -102.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.476 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.684 HG23 ' HD2' ' A' ' 30' ' ' PRO . 2.1 t -133.42 -46.23 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.379 . . . . 0.0 110.886 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.75 -66.32 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.062 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HD2' HG23 ' A' ' 28' ' ' THR . 9.5 Cg_endo -53.62 163.16 2.92 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.723 2.282 . . . . 0.0 112.099 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -142.07 139.79 32.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.077 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -170.99 45.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 55.31 173.51 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.784 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' ALA . 24.4 m -167.14 151.35 6.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.645 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.75 98.62 11.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.72 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.833 HG22 ' HA3' ' A' ' 51' ' ' GLY . 23.7 t -97.34 119.92 46.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.259 0.552 . . . . 0.0 111.949 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.637 ' NE2' HG11 ' A' ' 5' ' ' VAL . 47.8 mt-30 -109.76 166.54 10.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.543 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.509 HD13 ' HA ' ' A' ' 106' ' ' MET . 55.1 mt -109.9 151.59 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.52 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.448 ' CE1' HG21 ' A' ' 50' ' ' VAL . 5.5 m-85 -112.65 117.13 31.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.991 0.424 . . . . 0.0 111.349 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.498 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 5.0 t-160 -93.88 90.97 6.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.634 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -103.14 86.85 1.13 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 83.1 Cg_endo -76.35 -19.7 14.91 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.339 2.026 . . . . 0.0 112.536 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -50.26 -32.1 15.91 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.991 0.424 . . . . 0.0 110.551 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.29 6.11 6.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.219 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.45 49.16 5.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.248 0.547 . . . . 0.0 110.039 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.5 m -136.64 150.44 48.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.207 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.833 ' CE2' HD23 ' A' ' 113' ' ' LEU . 59.2 m-85 -120.62 174.01 6.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.563 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 9.8 ttp180 -164.34 149.34 10.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.093 0.473 . . . . 0.0 111.592 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.498 HG23 HG12 ' A' ' 62' ' ' ILE . 5.3 m -109.42 126.31 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.798 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.8 t -129.69 121.09 51.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.802 0.334 . . . . 0.0 111.429 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.833 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -137.43 148.87 20.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.866 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.29 146.62 52.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 110.972 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm -54.08 157.4 2.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.159 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 5.8 mtt -103.52 46.4 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -129.0 163.31 46.56 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -51.04 -24.89 15.18 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.605 2.203 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.99 -44.45 69.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.932 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 60.37 99.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -142.05 138.2 31.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.72 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 60' ' ' VAL . 13.4 m -70.77 122.22 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.189 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.711 HG23 HG21 ' A' ' 13' ' ' VAL . 3.8 m -93.84 -29.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.493 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.755 HD12 ' CE3' ' A' ' 89' ' ' TRP . 17.2 tt -138.55 138.15 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.874 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -165.89 63.18 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 110.539 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.3 t -126.99 135.28 50.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.911 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . . . -75.36 136.48 40.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.678 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -111.62 168.28 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.592 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 66' ' ' ILE . 19.0 m -157.06 -173.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.628 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.726 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -57.69 87.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.208 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.37 -30.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.686 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.88 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.6 t -83.14 133.42 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 117.38 0.59 . . . . 0.0 111.093 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.67 115.61 23.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.845 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.57 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 0.9 OUTLIER -64.56 106.05 1.08 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -99.77 96.98 7.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 91.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -58.52 -37.79 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.2 p -151.49 176.35 2.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.405 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 74.3 Cg_exo -49.89 -25.71 12.6 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.289 1.993 . . . . 0.0 112.107 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -138.18 65.89 1.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.649 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 2.0 t80 -165.9 112.25 0.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.356 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.94 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 2.0 m80 -110.62 101.33 10.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.061 0.458 . . . . 0.0 110.555 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.757 ' HG3' HG12 ' A' ' 88' ' ' VAL . 6.1 tt0 -107.68 150.28 27.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.057 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.88 ' HB2' HG13 ' A' ' 70' ' ' VAL . 46.0 p90 -151.31 148.57 28.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.965 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -112.29 112.54 24.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.223 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -93.45 -92.07 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.453 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.82 -69.38 0.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.988 0.423 . . . . 0.0 110.979 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 22.7 ttp180 -144.49 11.02 1.46 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.055 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.57 159.69 28.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.108 0.48 . . . . 0.0 110.571 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.757 HG12 ' HG3' ' A' ' 81' ' ' GLN . 1.5 t -120.3 114.35 43.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.471 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.755 ' CE3' HD12 ' A' ' 62' ' ' ILE . 66.4 m95 -93.51 94.63 8.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.116 0.484 . . . . 0.0 111.301 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.501 ' HA3' ' CH2' ' A' ' 23' ' ' TRP . . . -86.13 118.48 4.87 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.664 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.68 HD23 ' CH2' ' A' ' 82' ' ' TRP . 2.7 mm? -104.39 110.59 22.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.599 0.238 . . . . 0.0 111.377 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.411 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -92.49 106.3 18.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.219 0.533 . . . . 0.0 109.936 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 80.1 m-85 -73.81 159.27 33.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.135 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.83 -27.71 15.99 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.312 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.98 161.62 38.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 110.729 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.4 -28.82 67.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.078 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.9 -55.4 14.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.0 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -48.63 -59.15 3.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.977 0.418 . . . . 0.0 110.42 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.573 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -47.45 -35.72 8.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.685 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.98 -30.02 62.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.366 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.601 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 7.1 tp60 -76.79 -49.75 15.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.285 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.502 ' CE2' ' HG ' ' A' ' 91' ' ' LEU . 4.1 t80 -51.3 -53.31 36.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.94 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -62.28 -33.17 74.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.832 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -45.62 -67.64 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.208 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.1 -40.85 98.49 Favored Glycine 0 CA--C 1.506 -0.524 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.54 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.911 ' CE ' HD21 ' A' ' 110' ' ' LEU . 16.5 tpt -50.94 -58.57 5.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.93 0.395 . . . . 0.0 110.43 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.83 -37.63 6.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.777 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 t -64.37 -37.96 89.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.045 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.582 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.69 -53.05 46.31 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.684 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 106' ' ' MET . 10.0 mt -66.43 -15.22 63.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.054 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -98.79 -23.14 15.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.678 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . . . -97.35 -1.1 45.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.144 0.497 . . . . 0.0 109.91 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.833 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -115.93 -33.36 5.12 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.286 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 37.6 mt-10 -93.07 -28.7 16.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.708 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.362 -1.243 . . . . 0.0 112.536 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttp . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.844 0.354 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.18 117.35 7.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 61.45 -172.19 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.7 m -135.56 146.57 48.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.091 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.647 HG11 ' NE2' ' A' ' 37' ' ' GLN . 32.9 t -83.18 151.89 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.524 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.476 HD11 ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -108.34 -66.86 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.506 ' SG ' HD12 ' A' ' 38' ' ' ILE . 29.3 p -118.61 178.46 4.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.716 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -157.76 106.63 2.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.453 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.498 ' CB ' ' HB2' ' A' ' 102' ' ' PHE . 28.2 t -126.21 151.55 47.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.022 0.439 . . . . 0.0 111.766 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -93.97 132.46 38.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.289 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.77 ' HB3' HD12 ' A' ' 91' ' ' LEU . . . -174.59 -179.82 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.89 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.585 HG21 ' CD ' ' A' ' 31' ' ' GLN . 1.3 m -116.89 89.98 3.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.35 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.719 HG12 ' CB ' ' A' ' 26' ' ' ALA . 93.7 t -46.07 139.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.213 0.53 . . . . 0.0 110.725 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.51 ' HG2' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -137.25 155.33 49.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.383 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD21 ' CE2' ' A' ' 89' ' ' TRP . 10.0 mt -128.01 112.42 14.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.352 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 15.9 t80 -76.13 147.5 38.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 111.633 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.14 86.03 2.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.106 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.33 -25.11 5.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.39 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.09 -27.87 23.97 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.407 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -138.33 12.15 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.559 0.219 . . . . 0.0 111.362 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 tttt 51.94 83.71 0.05 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.7 0.286 . . . . 0.0 111.197 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 178.24 168.79 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.981 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.547 ' CZ3' ' HB2' ' A' ' 16' ' ' TYR . 25.7 m95 -88.15 172.6 9.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.698 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.765 HD23 ' HD2' ' A' ' 25' ' ' PRO . 1.8 mt -163.21 126.23 1.73 Allowed Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.765 ' HD2' HD23 ' A' ' 24' ' ' LEU . 91.8 Cg_exo -41.95 101.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.784 2.323 . . . . 0.0 112.962 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.719 ' CB ' HG12 ' A' ' 13' ' ' VAL . . . -47.03 -48.77 21.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.534 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.12 -118.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.754 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.0 p -118.68 -81.41 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 0.0 111.147 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.51 -83.92 0.5 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.665 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.12 156.39 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.605 2.203 . . . . 0.0 112.396 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.585 ' CD ' HG21 ' A' ' 12' ' ' THR . 4.6 tt0 -143.26 142.47 31.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.189 0.518 . . . . 0.0 111.228 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' A' ' 31' ' ' GLN . . . -169.67 44.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.897 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 64.79 -175.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.201 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -173.45 159.33 3.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.036 0.446 . . . . 0.0 111.147 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HB2' ' HE2' ' A' ' 54' ' ' MET . 0.7 OUTLIER -98.86 95.35 7.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.417 178.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.824 HG22 ' HA3' ' A' ' 51' ' ' GLY . 21.9 t -94.22 122.4 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.45 0.643 . . . . 0.0 112.163 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.647 ' NE2' HG11 ' A' ' 5' ' ' VAL . 19.4 mt-30 -113.73 171.79 7.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.43 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.563 HD11 ' HB2' ' A' ' 106' ' ' MET . 88.9 mt -117.01 154.22 18.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.417 ' CE1' HG21 ' A' ' 50' ' ' VAL . 7.5 m-85 -112.86 119.55 38.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.025 0.44 . . . . 0.0 111.804 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.551 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 3.7 t-160 -93.82 89.56 6.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.825 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -99.95 93.74 2.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 40' ' ' HIS . 98.6 Cg_endo -81.54 -23.25 5.06 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.35 2.033 . . . . 0.0 112.45 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -47.75 -30.26 3.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -130.98 6.53 4.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.296 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.439 ' ND2' HD22 ' A' ' 113' ' ' LEU . 8.4 t-20 61.03 49.46 5.69 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.22 0.533 . . . . 0.0 109.916 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.567 ' HA ' HG12 ' A' ' 67' ' ' VAL . 57.9 m -133.53 154.43 50.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.432 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.789 ' CE2' HD23 ' A' ' 113' ' ' LEU . 59.6 m-85 -124.54 172.12 9.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.561 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.579 ' HD2' ' HB2' ' A' ' 65' ' ' ALA . 9.4 ttt-85 -162.97 150.97 13.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 0.0 111.584 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.588 HG13 HG12 ' A' ' 62' ' ' ILE . 4.9 p -108.75 131.09 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.242 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG21 ' CE1' ' A' ' 39' ' ' TYR . 1.5 t -139.03 121.86 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.033 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.824 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . -142.82 142.14 11.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.83 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.1 158.84 35.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.743 0.306 . . . . 0.0 110.86 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -58.34 168.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.55 ' HE2' ' HB2' ' A' ' 35' ' ' ARG . 1.6 mtt -107.05 42.88 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.135 0.493 . . . . 0.0 110.79 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -128.27 162.29 51.38 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.802 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.2 -31.24 11.93 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.604 2.202 . . . . 0.0 112.773 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.06 -50.51 61.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.797 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.04 94.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -125.39 125.21 43.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 60' ' ' VAL . 9.5 m -62.79 119.09 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 111.272 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.48 HG23 HG21 ' A' ' 13' ' ' VAL . 3.2 m -93.85 -20.4 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.109 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.588 HG12 HG13 ' A' ' 49' ' ' VAL . 10.8 tt -138.81 136.5 43.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.388 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -161.79 68.57 0.29 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.977 0.418 . . . . 0.0 110.819 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.437 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -131.31 134.7 46.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.915 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.579 ' HB2' ' HD2' ' A' ' 48' ' ' ARG . . . -77.47 142.08 39.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.692 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.4 125.63 74.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.851 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 46' ' ' SER . 17.8 m -140.14 111.06 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.65 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.699 ' N ' HD12 ' A' ' 113' ' ' LEU . 12.2 ttt-85 27.88 74.31 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.871 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.47 -34.82 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.683 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 82' ' ' TRP . 2.5 t -92.46 140.68 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 111.331 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.84 108.68 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.468 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.557 ' CE1' ' CE3' ' A' ' 82' ' ' TRP . 1.5 m-30 -52.48 124.62 13.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.25 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.26 110.36 16.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.758 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.64 92.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.936 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.24 90.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.03 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 77' ' ' PRO . 1.7 p -146.64 173.62 4.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.471 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 76' ' ' THR . 78.2 Cg_exo -50.8 -25.26 15.06 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.349 2.033 . . . . 0.0 112.292 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -142.43 61.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.731 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 4.5 t80 -163.39 105.72 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.186 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.923 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 1.1 m80 -97.73 115.93 28.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 110.459 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.682 ' HG3' HG12 ' A' ' 88' ' ' VAL . 27.7 tt0 -121.9 144.69 48.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.922 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.796 ' HB2' HG13 ' A' ' 70' ' ' VAL . 43.7 p90 -143.23 150.08 38.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.29 0.567 . . . . 0.0 112.098 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -112.86 117.59 32.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.229 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.61 -81.03 0.38 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.248 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.71 -66.39 0.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.966 0.413 . . . . 0.0 111.09 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 -139.67 -5.56 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.48 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.416 ' HG2' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -108.24 179.58 4.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.985 0.422 . . . . 0.0 110.761 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.682 HG12 ' HG3' ' A' ' 81' ' ' GLN . 2.1 t -139.03 116.1 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.378 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.539 ' CE2' HD21 ' A' ' 15' ' ' LEU . 72.9 m95 -93.67 83.86 4.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.289 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.798 ' O ' HD22 ' A' ' 91' ' ' LEU . . . -70.41 159.28 53.6 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.228 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.798 HD22 ' O ' ' A' ' 90' ' ' GLY . 1.1 mm? -144.24 108.09 4.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.532 0.206 . . . . 0.0 110.984 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.31 102.43 14.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.28 0.562 . . . . 0.0 109.925 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.612 ' CD2' ' HB2' ' A' ' 99' ' ' ALA . 76.7 m-85 -69.17 159.99 31.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.864 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.55 18.84 19.87 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.341 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.43 163.23 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.74 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -69.57 -30.37 68.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.68 -49.28 48.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.966 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -49.97 -62.76 1.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.994 0.426 . . . . 0.0 110.582 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.612 ' HB2' ' CD2' ' A' ' 93' ' ' PHE . . . -49.43 -36.66 22.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.693 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.85 -33.96 64.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.243 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.479 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 55.3 tp60 -77.32 -42.68 35.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.388 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.498 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 6.3 t80 -54.88 -50.74 67.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.298 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.923 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -68.11 -30.06 69.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.965 0.412 . . . . 0.0 110.969 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 101' ' ' GLN . . . -47.79 -64.95 0.65 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.268 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.3 -50.34 56.72 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.985 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.975 ' HE3' HD21 ' A' ' 110' ' ' LEU . 12.2 tpt -48.94 -60.82 2.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.9 0.381 . . . . 0.0 110.476 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -43.72 -36.24 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.08 -39.78 82.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.046 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -61.79 -57.04 13.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.618 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.975 HD21 ' HE3' ' A' ' 106' ' ' MET . 8.0 mt -58.54 -20.55 47.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -92.72 -23.41 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.611 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.16 1.21 44.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.216 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.789 HD23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -113.71 -29.67 7.03 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.344 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' HA ' ' HG3' ' A' ' 68' ' ' ARG . 3.7 mt-10 -99.05 -30.34 12.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.335 -1.259 . . . . 0.0 112.499 179.97 . . . . . . . . 0 0 . 1 stop_ save_